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Mitral valve disease is widely prevalent among pediatric and adult population 
across the world, and it encompasses a spectrum of lesions which include congenital 
valve defects, degenerative valve lesions, and valve dysfunction due to secondary 
pathologies. Though replacement of the diseased mitral valves with artificial heart valves 
has been the standard of care until early 1990’s, current trends have veered towards 
complete surgical repair. These trends are encouraging, but current repair techniques are 
plagued with lack of durability and high rates of failure within 10 years after repair. With 
increasing number of patients receiving mitral valve repair, there is now an immediate 
need to understand the mechanisms of repair failure, and assess the role of several 
clinical risk factors on valve repair. In this thesis, an in vitro pulsatile left heart simulator 
was developed to mimic the congenital and adult mitral valve pathological morphologies 
in normal porcine valves, and simulate the pathological valve hemodynamics and 
mechanics. Different surgical repair techniques were used to correct the valve lesions, 
and the post repair valve hemodynamics, mechanics and geometry were assessed using 
quantitative measurement techniques. The extent to which each repair restores 
physiological valve function and mechanics was assessed, and the impact of different 
pathological risk factors on repair failure mechanisms was investigated. It is expected 
that the knowledge from this thesis would play an important role in the evolution of 
mitral valve surgical repair, and guide the development of more effective and long-lasting 










1.1 THE MITRAL VALVE  
The Mitral Valve [MV], which is the left atrioventricular valve in the human 
heart, maintains unidirectional blood flow from the left atrium [LA] into the left ventricle 
[LV]. The valve has a complex structure with multiple components, which work 
synchronously and maintain a delicate force balance to ensure proper valve function. 
During diastole, the valve opens to allow blood from the left atrium to fill the left 
ventricle; and during systole the valve closes to restrict back flow or regurgitation 
through the valve into the left atrium. 
1.2 DISEASES OF THE MITRAL VALVE 
Mitral valve disease is widely prevalent among pediatric and adult population 
across the world. The disease encompasses a spectrum of lesions which include 
congenital, degenerative, and functional pathologies. In the congenital population ( ≤ 15 
years of age), common pathologies include mitral annular stenosis [MS], common 
atrioventricular valve in complete atrioventricular canal defects [AVCD],  mitral valve 




in rheumatic heart disease. Among adults (≥ 15 years of age), mitral valve lesions can be 
primarily classified into degenerative and functional etiologies. The first kind, 
degenerative mitral valve disease is most prevalent in the western world, manifesting as 
Barlow's syndrome [BS] involving leaflet and chordal thickening, or Fibroelastic 
Deficiency [FED] involving leaflet and chordal thinning. The second type, functional 
mitral deficiencies are caused due to geometric distortion of the mitral valve structure due 
to underlying ventricular disease, either ischemic or idiopathic dilated cardiomyopathy. 
1.3 MITRAL VALVE REPLACEMENT 
Whether a diseased mitral valve should be replaced with a mechanical heart valve 
[MHV] or bio-prosthetic heart valve [BHV] has been a topic of controversy since early 
1980's. Historically, surgical repair of mitral stenosis was attempted as early as 1942 but 
was associated with high rates of mortality due to the crude surgical techniques used, and 
dearth in techniques to arrest the heart during surgery[2]. With the advent of the heart-
lung machine in early 1950's and the use of hypothermic cross clamping to completely 
arrest the heart [3], focus has shifted from improving the crude surgical techniques 
towards development of mechanical heart valves [4]. Several mechanical and 
bioprosthetic valves were used to replace the diseased mitral valves, with decent success 
[4-6]. However, the results from aortic valve replacement [AVR] could not be replicated 
on the mitral position due to complex valve hemodynamics, loss of annular-ventricular 




1.4 BEGINNINGS OF MITRAL VALVE REPAIR 
In an honorary lecture at the 63rd annual meeting of the American Association of 
Thoracic Surgeons in 1983, a French surgeon Dr. Alain Carpentier presented a landmark 
paper titled "The French Correction", on mitral valve repair [7]. In his talk and 
subsequent paper, he presented an armamentarium of surgical techniques to repair 
degenerative mitral valve pathologies that laid the cornerstone for the shift towards mitral 
valve repair [MVRe]. Though Dr. Carpentier was not the first one to propose the use of 
prosthetic rings for mitral valve repair[8], his talk encouraged the use of “remodeling 
annuloplasty rings” to “support the mitral valve repair”. From a low repair rate of 5% in 
1980's, the number of mitral valve repairs has consistently risen to 40.53% in 2000, and 
59.78% in 2008 in patients with degenerative valve disease in the United States alone. 
Today, mitral valve repair is the standard of care over mitral valve replacement [MVR], 
with 99% of the patients offered valve repair at surgical centers experienced in valve 
repair and about 40% receiving valve repair at less experienced centers [9]. 
1.5 CURRENT TRENDS IN MITRAL VALVE THERAPY 
In the current era of cardiac surgery, the benefits of mitral valve repair are well 
established, with increasing number of surgeons shifting towards complete repair over 
replacement. However, clinical data from retrospective trials indicates suboptimal 
outcomes with valve repair, with 15% to 80% of the patients presenting with recurrent 
mitral regurgitation [MR] due to repair failure within 10 years after the primary surgery 




with higher repair success in degenerative lesions and lower repair success in congenital 
and functional lesions. 
1.6 RISK FACTORS FOR REPAIR FAILURE 
Mechanistic insights into the failure mechanisms for mitral valve repair are 
currently lacking. Though substantial clinical literature on outcomes of valve repair 
exists, the risk factors or a detailed knowledge of the mechanisms leading to repair failure 
are currently unknown. Results from most clinical studies are inconclusive, as the 
patients included in such studies have variable severities of the disease, different medical 
histories, and the institutional policies for repair techniques may vary. To overcome these 
shortcomings, animal models of mitral valve disease have been developed, but are limited 
to functional mitral regurgitation [FMR] [13-19]. Genetics behind congenital and 
degenerative mitral valve lesions are vague, thus impeding the development of animal 
models for these lesions. 
1.7 OBJECTIVE OF THIS THESIS WORK 
In this thesis, an in vitro pulsatile mitral valve model that can simulate congenital, 
degenerative and functional mitral valve lesions is developed. Echocardiographic and 
cadaveric data from human subjects is used to carefully mimic different mitral valve 
pathologies in this in vitro model, and different surgical techniques to correct these 
lesions are compared from hemodynamics and mechanics perspectives. The mechanisms 
of repair failure are understood by replicating different clinically identified risk factors on 
these surgically repaired valves, and their impact on valve function and mechanics is 




the basis for improved repair techniques that have better acute and chronic outcomes, and 
also guide the development of optimal next generation mitral valve repair technologies. 
1.8 EXPERIMENTAL DESIGN 
This thesis is primarily classified into three specific aims focused on – [Aim 1] 
congenital mitral valve repair, [Aim 2] degenerative mitral valve repair, and [Aim 3] 
repair for functional mitral regurgitation. In the first aim, the hemodynamics of cleft 
mitral valve repair in atrioventricular canal defects was investigated. In the second aim, 
various studies focused on assessing the hemodynamics of current degenerative mitral 
valve repair techniques and engineering methods to improve the durability of repair were 
investigated. In the third aim, studies focused on understanding the role of pre operative 
mitral valve geometry in mitral valve repair for functional defects of the mitral valve as 
seen in ischemic and idiopathic dilated cardiomyopathy. 
1.9 SUMMARY OF RESULTS 
The results from this thesis provide mechanistic insights into the failure 
mechanisms of various surgical techniques practiced in current clinical setting. Impact of 
hemodynamic, structural and mechanical risks factors on the acute and extrapolated 
chronic outcomes of valve repair are reported. The data thus emphasizes on the need to 
shift focus from intra operative relief of mitral regurgitation, towards a structure-to-
function approach to understand mitral valve pathologies and tailor repair techniques to 








CHAPTER 2  
 
LITERATURE REVIEW 
2.1 THE HUMAN CARDIOVASCULAR SYSTEM 
The human body is a collection of organ systems, which have specific functions 
and work in tandem with one another. The cardiovascular (Greek Etymology, Kardia = 
Heart; Vasculum = Small Vessel) system is one such organ system that delivers nutrients, 
gases, hormones and cells to all the organ systems in the body, while maintaining their 
homeostasis. Every organ in the human body is perfused by the cardiovascular system 
through a complex vascular network that is designed to provide sufficient nutrients to 
every single cell in the human body, independent of its location in the human body. 
 The earliest known reference to the cardiovascular system is in the Ebers Papyrus 
in 16th Century BCE, where the connection between the heart and the arteries is 
acknowledged. By 6th century BCE, the knowledge of life sustaining fluids flowing 
through the body was known to Sushruta, an ayurvedic physician in ancient India [20]. In 
a recent review of his works, Dwivedi et al. reported reference to arteries as the channels 
carrying these vital fluids to distal organs[21]. Around 4th century BCE, valves in the 




function was unknown. The Greek physician, Herophilus (335-280BC) distinguished 
arteries from veins but attributed the vascular pulse as an inherent property of the vessels. 
In 2nd century AD, the Greek physician Galen identified the dark red fluid flowing 
through the veins and the bright red fluid flowing through the arterial system, and 
proposed that the venous blood is created in the liver while the arterial blood was 
generated in the heart, with no blood coming back to either the liver or the heart. Later he 
corrected his findings, and proposed that blood is sucked into the heart from the venous 
system into the left ventricle, which ultimately passes through pores in the intra 
ventricular septum into the right ventricle. The pulsation of the arteries was thought to 
move the blood from the heart to the distal organs, but not the beating of the cardiac 
muscle. In 1025, Avicenna a Persian physician accepted Galen’s view but developed 
accurate theories on cardiac cycles, contraction and relaxation of the myocardium, and 
valvular function. By 1242, Ibn al-Nafis an Arabic physician discovered the pulmonic 
circulation, and stated that the blood has to pass from the right ventricle into the lungs 
through the vena arteriosa, mingle with air in the lungs, and pass through the ateria 
venosa into the left ventricle. He also discovered that small communications or pores 
between the pulmonary artery and vein are necessary for transfer of blood and thus laid 
the foundation for the discovery of the capillary system. Few centuries later, William 
Harvey an English physician conducted a series of experiments and in 1628 reported that 
the beats produced by the heart provide continuous circulation of blood through minute 
connections between the arteries and veins, developing the closed system theory [22]. 
Though his ideas were a leap ahead of his predecessors, he did not discover the capillary 




physicians and keen scientific thinkers established the fundamental structure of the 
cardiovascular system shown in Figure 2-1, one organ at a time, and in this section a brief 














 Figure 2-1 The Human Cardiovascular System 




The complex cardiovascular system primarily consists of three main components[23]: 
•  Heart  
• Blood Vessels, and 
• The Blood 
2.1.1 THE HUMAN HEART 
 The human heart is an electro-mechanical pump with remarkable properties, but 
one whose failure is the leading non-accidental cause of death in developed countries. 
The primary function of the heart is to pump blood through the network of blood vessels 
to deliver nutrients and remove metabolic wastes from different organs. The heart has 
four chambers: two atria that are the low pressure reservoirs and two ventricles which are 
the high pressure pumping chambers as shown in Figure 2-2 [24]. The atrial walls are 
separated from the ventricular walls by a basal skeleton, which is a fibrous framework 
formed by the rings of the four heart valves and surrounding connective tissue. The two 
atrioventricular valves connect the atria to the ventricles and the two semilunar valves 
join the ventricles to the outflow tracts. These valves maintain unidirectional blood flow 





















2.1.2 MYOCARDIAL ARCHITECTURE 
2.1.2.1 Tissue Level Architecture 
The mechanical function of the heart depends to a large extent on its material 
properties. The atria are thin walled compliant chambers that act as reservoirs for the 
blood flow to and from the lungs. The ventricular chambers, which are the pumps, are 
thick-walled muscular chambers. The right ventricle (max pressure: 2.5 kPa) which 
pumps blood to the lungs is much compliant and thinner than the left ventricle (max 
pressure: 15 kPa) that pumps blood to the distal organs of the body. The cardiac muscle is 
a composite of discrete layers of myocardial muscle fibers tightly bound by collagen, a 
protein that forms the connective network. The heart wall can be classified into three 
layers as shown in Figure 2-3 [25]: (a) Epicardium – the outermost layer of the heart that 
is reinforced with fibers that provide structural integrity, (b) Myocardium – the middle 
layers which is a synctium of contractile cardiac myocytes- the force generating 
Figure 2-2 Illustration of the human heart 




components, and (c) Endocardium – the innermost layer of endothelial cells that is in 
constant contact with blood. These layers have several lamineae that are loosely coupled 
and can slide relative to each other. The lamineae are four to six cells thick and branch in 











2.1.2.2 Cellular Micro Architecture 
Cardiac myocytes or muscle cells generate the active force in the myocardium, 
resulting in ejection of blood or the heart beat. Typically, myocytes are cylindrical with 
lengths ranging from 80 to 100µm and widths ranging from 10 to 20µm as shown in 
Figure 2-4 [26]. These myocytes are arranged in 3D patterns throughout the myocardium 
and are connected to one another through intercalated disks at their ends. These 
intercalated disks allow conduction of the voltage from one cell to another during 
electrical depolarization. Electrical impulses are generated by the pacemaker cells in the 
sino-atrial node, and these impulses propagate through the ventricular wall through a 
Figure 2-3 Layers of the Heart Wall  




specialized conduction system of Purkinje fibers. As the electrical impulses pass through 
the heart wall, the membrane potential of the Myocyte is altered. Multiple voltage gated 
ion channels are present in the cellular membrane that open due to the change in the 
voltage in the cell membrane. This result in influx and efflux of Ca2+, K+ and Na+ ions 










2.1.2.3  Sub-Cellular Contractive Biophysics 
The rate of ionic flux across the cell membrane determines the magnitude of 
contractile force generated by the Myocytes. As the voltage gated channels on the cell 
membrane of the Myocyte open, the Ca2+ entering the cell combine with the contractile 
proteins in the cell and initiate contraction. The fundamental contractile or force 
generators of the Myocytes are the Sarcomeres, which are a network of the proteins Actin 
and Myosin. The Sarcomeres are typically 2µm in length and a chain of these Sarcomeres 
span between the two ends of the cardiac cell. Each cardiac Myocyte typically consists of 
Figure 2-4  Sub-cellular structure of the cardiac myocyte depicting the myofibrils each of 
which contain myofilaments 




40-50 Sarcomeres in series and interconnected end-to-end through intercalated disks with 
an intricate network of a variety of proteins as shown in Figure 2-5. Myosin is the protein 
that makes up the thick filaments of the myofibril, and is related to the muscle’s speed of 
contraction. Each Myosin molecule is composed of two heavy protein chains that 
intertwine to form a long coiled tail and a pair of tadpole like heads. Actin is the protein 
that makes up the thin filaments of the muscle fiber. One Actin molecule is a globular 
protein (G-Actin), represented by a round ball. Multiple globular proteins polymerize to 
form long chains or filaments (F-Actin). In three-dimensional array, the Actin and 
myosin molecules form a lattice of parallel, overlapping thin and thick filaments as 
shown in Figure 2-5[26]. As the muscle contracts, the thick and thin filaments slide past 
each other, moving the Z-disks of the sarcomere closer together. The force that pushes 
the Actin filament is the movement of the Myosin crossbridges that link Actin and 
Myosin. During muscular contraction, movement of the flexible Myosin crossbridges 
pushes Actin filaments towards the center of the sarcomere. At the end of the power 
stroke or contraction, the Myosin head releases its bound Actin, then swings back and 




2.1.2.4  Electro Mechanical Coupling 
 A key property of cardiac muscle is the ability of a single muscle fiber to execute 
graded contractions, in which the fiber varies the amount of force it generates. The force 
generated depends upon the number of active cross bridges in the Actin-Myosin system, 
which depends upon the cytosolic Ca2+ concentration. The flow of Ca2+ ions to the 
myocytes is determined by voltage gated Ca2+ channels on the membrane of the Myocyte. 
These voltage gated channels open when they receive an action potential generated by the 
auto rhythmic pacemaker cells via the electrical conduction system that spreads through 
the entire atrial and ventricular muscle. Electrical potential is generated by the pacemaker 
cells in the sinoatrial node (SA node), which spreads through adjacent myocytes via the 
gap junctions. As shown in Figure 2-6 [27], the depolarization wave starts in the SA 
Figure 2-5 Schematic of the Actin-Myosin System 




node, passes rapidly through the atrial muscle to the atrioventricular node (AV node). 
Ventricular depolarization subsequently starts when the depolarization wave spread 
towards the apex through the Purkinje fibers and then upwards from the apex along the 






















Figure 2-6 (A) The depolarization wave generated by the pacemaker cells spreading
through adjacent myocytes via the gap junctions. (B) Path of the depolarization wave
in a normal heart that induces sequential mechanical events in a cardiac cycle.  





2.1.3 THE CARDIAC CYCLE 
 A cardiac cycle is defined as the duration from the beginning of one heart beat to 
the beginning of the next one. It is primarily divided into two phases: systole, the time 
when the muscle is contracted; and diastole, the time when the muscle is relaxed. In 
normal humans with an average heart rate of 70 beats per minute, the systolic duration is 
between 290-350 msec and diastole around 550-600msec, with the rest associated with 
isovolumic contraction and relaxation. Figure 2-7[27] schematically illustrates the events 
in one complete cardiac cycle, with the associated pressure and flow waveforms 














Figure 2-7 Wiggers diagram showing the relationship between the electrocardiogram,





2.1.4 BLOOD VESSELS  
 Blood vessels are the channels through which oxygenated blood is transported to 
the distal organs, allows exchange of nutrients in the organs, and then carries waste away 
from the organs. Based on their function, blood vessels can be classified into arteries, 
which carry blood away from the heart; capillaries, which allow exchange of nutrients 
from the blood to the organs; and veins, which carry blood from the capillaries back to 
the heart. Both arteries and veins have a three layered structure – [Innermost] called the 
Tunica Intima, consists of endothelial cells that are form a synctium through the 
Glycocalyx, a polysaccharide intracellular network; [Middle] called the Tunica Media, 
consists of smooth muscle cells, circularly arranged elastic fibers, connective tissue and 
other polysaccharide substances; and [Outermost] called the Tunica Adventitia, entirely 
made of connective tissue and is vascularized. A schematic of the gross laminar cross 
section of the blood vessels is shown in Figure 2-8[27], though the thickness and 










Figure 2-8 Cross sectional schematic of a blood vessel depicting the laminar structure and





 Blood is a life sustaining bodily fluid that delivers necessary nutrients, gases and 
hormones to cells and transports away their waste. It is a multi phase emulsion that 
consists of: (A) Red Blood Cells, (B) White Blood Cells, and (C) Platelets. Plasma is the 
fluid portion of the blood, within which cellular elements are suspended. Waster is the 
main component of plasma, accounting for about 92% of its weight. Proteins account for 
another 7%, with the remaining 1% consisting of dissolved organic molecules, ions,  
Figure 2-9 Plasma and cellular elements of human blood. [Figure reproduced from





vitamins, and dissolved oxygen and carbon dioxide. The liver makes most plasma 
proteins, Albumins, and releases them into the blood stream. The presence of proteins in 
blood increases its osmotic pressure compared to the interstitial fluid, and thus creates a 
gradient to pull water from the interstitial fluid into the capillaries. The plasma proteins 
serve several purposes including blood clotting, immune response, and carriers for steroid 
hormones, cholesterol, ions, and drugs. Figure 2-9 summarizes the composition of blood, 
separating the plasma and the cellular elements[27].  
2.1.6 THE HEART VALVES 
 Valves in the heart ensure unidirectional blood flow through the heart, with one 
set of valves between the atria and the ventricles, and another between the ventricles and 
the great arteries as shown in Figure 2-10 [27]. Though both sets of valves serve the same 
purpose of preventing backward flow of blood, they are structurally distinct. The valves 
between the atria and the ventricles are called the atrioventricular valves, which includes 
the mitral valve between the left atrium and the left ventricle, and the tricuspid valve 
[TV] between the right atrium [RA] and the right ventricle [RV]. These valves are thin 
flaps of tissue that are attached at their base to the atrioventricular ring, and on the 
ventricular side the collagenous chordae tendineae [CT] attach the flaps to the papillary 
muscles [PM] in the myocardium. The second set of valves between the ventricles and 
the outflow tracts are called the semi lunar valves, which includes the aortic valve [AV] 
between the left ventricle and the aorta, and the pulmonary valve [PV] between the right 




blood and close under reverse pressure gradient. Because of their shape, these valves do 


























Figure 2-10(A) Schematic of the human heart depicting the four heart valves, (B) The
mitral valve with the two leaflets, chordae and the two papillary muscles; (C) The
tricuspid valve with the three leaflets and three papillary muscles; (D) The pulmonary
valve with its three semi lunar leaflets; (E) The aortic valve with its two coronary and




2.1.7 THE MITRAL VALVE 
 The focus of the current study, the Mitral Valve or the left atrio-ventricular valve, 
is located between the left atrium and the left ventricle. The function of the mitral valve is 
to control the flow of oxygenated blood from the pulmonary veins to the left ventricle. 
The normal mitral valve opens during diastole, when the left atrium is filled and at a 
higher pressure than the left ventricle, which is relaxed in this cardiac phase. During 
systole the left ventricle contracts, and the increase in the pressure in the ventricle causes 
the MV to close, preventing blood from leaking into the left atrium and ensuring all the 
blood in the ventricle flows through the aortic valve to the distal organs. 
2.1.7.1 Mitral Valve Anatomy 
 Physiological function of the MV requires interplay between the valve’s four 
main components: the mitral annulus, valve leaflets, chordae tendineae and papillary 
muscles, shown in Figure 2-11 [28, 29]. A fibro muscular atrioventricular ring forms the 
base of the mitral valve at the junction of the left atrium and the left ventricle, with a veil 
of tissue attached to it all along its circumference, which form the mitral leaflets. Fibrous 
chordae tendineae extend from the ventricular surface of the two leaflets, and extent 
apically towards the papillary muscles in the left ventricle. These chordae follow a 
pattern of insertion, such that the leaflets assume an optimal systolic configuration that 
ensures complete valve competence. The two papillary muscles, antero-lateral and 
postero-medial, are myocardial structures that extend into the left ventricular cavity. 
Vasculature from the ventricular muscle richly perfuses the papillary muscles, and 
















2.1.7.1.1  The Mitral Annulus 
The mitral annulus is the anatomical junction between the left atrium and the left 
ventricle, and serves as the basal insertion site for the mitral valve leaflets. The anterior 
portion of the annulus is continuous with the base of the aortic non coronary and right 
coronary leaflets. The extremities of this anterior annular section are clearly demarcated 
by two fibrous trigones, which are dense fibrous protrusions. However, histological 
studies demonstrate a lack of fibrous ring in the anterior section but demonstrate tendon 
like structures that extend dorsally from the trigones along one-half of the mitral ring. In 
this region, the region where the mitral tissue inserts is attached directly to the left atrial 
and left ventricular endocardium. The posterior part of the annulus is a nebulous fibrous 
ring that is not visually distinct as the anterior annulus, but can be felt upon touch. 
(A) (B) 
Figure 2-11 (A) Schematic of the mitral valve depicting its individual components;
[Figure adapted from www.mitralvalverepair.org] (B) Actual human mitral valve from
a cadaver heart [Figure adapted from Anderson R.H, Becker A.E. Thieme; Stuttgart,




Though the entire mitral annulus has historically been defined as an incomplete and 
diaphanous structure, several studies have established the importance of the mitral 
annulus in the hemodynamic function of the mitral valve.  Figure 2-12A shows the mitral 
annulus in an explanted heart, and Figure 2-12B[29] shows a histological cross section of 













The mitral annulus is a dynamic structure, which changes in its shape and size 
during the cardiac cycle, as demonstrated in animal and human studies. Tsakiris et al. in 
1971 demonstrated the dynamic contraction of the mitral annulus in anesthetized dogs 
using biplane roentgenograms, and deduced that the annulus is not a rigid structure as 
previously assumed[30]. The size of the annulus increased in late diastole until it reached 
its maximum area, which was coincident with the P wave of the electrocardiogram. Then 
(A) (B) 
Figure 2-12 (A) An atrial view of a porcine mitral valve depicting the D-shaped mitral
annulus, where the distinction of the annulus is easier along the anterior than the
posterior segment; (B) A histological cross section of the region where the posterior
mitral leaflet inserts into the mitral annulus. Figure adapted from Anderson R.H, Becker




a rapid narrowing of the ring was observed during the atrial and ventricular contractions, 
followed by a rapid increase in size during ventricular iso-volumetric relaxation. Under 
control conditions in these dogs, a decrease of 19% to 34% was observed from the 
diastolic ring size. The most striking observation was that nearly two thirds of the annular 
size reduction occurred during atrial contraction, and the valve annulus was significantly 
reduced before the onset of ventricular systole as shown in Figure 2-13[30]. Mitral 
annular narrowing is also eccentric, with the largest shortening occurring due to the 
posterior segments extending from the commissures. This reduction in size is 











































Figure 2-13(A) Roentgenograms of beads implanted around the mitral annulus in
anesthetized dogs; (B) Changes in mitral annular area (bold solid line) under different





The mitral annulus in addition to change in its planar area also undergoes an 
apical-basal flexing, imparting it a saddle shape during systole from its flat diastolic 
configuration.  Levine et al. were the first to discover this three dimensional shape of the 
mitral annulus when defining an optimal echocardiographic assessment technique for 





















Figure 2-14 (A) Echocardiographic planes used in this study; (B) Manual tracings of
the plane of leaflet coaptation in the 4 and 2 chamber views; (C) Tracings of the
vertical distance from the least square fit of the annulus; (D) The reconstructed 3D
shape of the mitral annulus demonstrating the saddle shape.[Figure reproduced from




2.1.7.1.2    Valve Leaflets 
 The mitral valve consists of a continuous veil of tissue inserted around the entire 
circumference of the mitral orifice, which is distinguished into [i] the anterior leaflet, and 
[ii] the posterior leaflet. The anterior leaflet that has a triangular structure and attaches to 
the mitral annulus between the trigones, with the greatest leaflet height at the free edge as 
shown in Figure 2-15. The basal portion of the leaflet is continuous with the aorto mitral 
curtain along the non coronary and left coronary aortic leaflets, while the apical portion 
of leaflet forms the free edge of the leaflet that aids coaptation. The posterior leaflet on 
the other hands covers the entire circumference from one commissure to another 
commissure, covering three fifths of the entire mitral annulus. The leaflet is divided into 
three individual scallops identified as the P1 (anterior or medial scallop), P2 (the middle 
scallop), and P3 (posterior or lateral scallop). The height of the posterior leaflet varies 
from the P1 cusp to the P3 cusp, with P2 cusp having the greatest height from the base to 










Figure 2-15 (A) Illustration of the systolic closed configuration of the mitral valve leaflets;
(B) An excised spread out view of a porcine mitral valve depicting the smooth and rough
















 Fenoglio and colleagues, in 1972 reported the laminar structure of the mitral valve 
leaflets with zonal distinction of the leaflet cross section into fibrosa and spongiosa as 
shown in Figure 2-16A [32]. Using histological examination they observed that the 
Fibrosa had dense collagen fibrils, while the Spongiosa had loose collagen with 
interstitial cells sparsely distributed in this zone. The atrial and ventricular surfaces of the 
leaflets are lined with endothelial cells, though of a different morphology on both sides. 
These authors also hypothesized a fan like distribution of the collagen fibrils in the 
leaflets  that emerge from the region of chordal insertion and fan out to the base of the 
mitral valve leaflet as shown in Figure 2-16B [32].  
Figure 2-16 (A) Histological cross section of the anterior leaflet of the mitral valve
composed of two distinct zones, the fibrosa(Fb) and the spongiosa(Sp) with loose
collagen and scattered interstitial cells. The atrial endocardial surface (AE) has plump
endothelial cells, while the cells on the ventricular surface are more flattened. (B) A
depiction of the collagen orientation in the anterior leaflet of the mitral valve depicting
the fan like structures emanating from the chordae tendineae and fanning to the mitral





2.1.7.1.3  Chordae Tendineae 
The mitral chordae are tendinous structure that arise from the papillary muscle 
tips and insert into the ventricular surface of the anterior and posterior leaflets. They 
differ in number between each valve, but can be broadly classified into three classes 
based on the region of their insertion into the leaflet shown in Figure 2-17: 
[1] Primary chordae tendineae (also called Marginal) 
[2] Secondary chordae tendineae (also called Secondary/Strut) 











The mitral valve typically consists of 8-12 chordae tendineae, 15-20mm long, and 
approximately 0.45mm in diameter before branching, either at the tip of the papillary 
muscle or their insertion into the leaflet. The chordae inserting into the anterior leaflet are 
Figure 2-17 The anterior leaflet of the mitral valve divided into regions based on the site of
chordal insertions. (Green Region) Free edge of leaflet with marginal chordal insertion,
(Red Region) Belly of the leaflet with strut chordal insertion, (Blue Region) Basal region
of the leaflet with basal chordae insertion, (Brown Region) Commissures with chordal




obliquely aligned along their longitudinal axis, while the ones on the posterior leaflet 
insert parallel to each other. Table 2-1 summarizes the chordal types, their average 






The anterior leaflet has three types of chordae, the marginal chordae that insert 
into the free edge, the secondary that insert into the belly of the leaflet, and the basal that 
insert closer to the mitral annulus. The marginal chordae soon after their origin from the 
papillary muscle split into three branches, one inserting into the free margin of the leaflet, 
one into the intermediate area in the rough zone, and one slightly beyond the line of 
coaptation. The secondary chordae which are the thickest chordae originate from the tips 
of the anterior lateral and posterior medial papillary muscles and insert at the transition 
from the rough to the smooth zones. They are the thickest and carry the most load during 
systolic loading on the valve, and are also speculate to maintain annular-ventricular 
continuity. The third chordal type, the basal chordae, insert into the anterior leaflet close 
to the annulus and towards the commissural sections. Their exact function in the global 
mitral valve hemodynamic or mechanical function is currently unknown.  
 
Table 2-1 Classification of length and thickness of chordae tendineae based on their site
















On the posterior leaflet, the chordal distribution is similar to the anterior but with 
a few exceptions. Posterior basal chordae, that are unique to this leaflet, are a set of 
chordae that extend directly from the papillary muscle to the insertion of the leaflet and 
do not divide along their entire stem. Additionally, cleft chordae are also seen at the 
regions dividing the posterior cusp into P1-P2 and P2-P3, where then fan out at the cleft 
to restrict it from prolapsing into the atrium during systole. Two sets of cleft chordae are 
(A) (B) 
(C) 
Figure 2-18 (A) The cleft chordae on the posterior commissures that show the fan like
structures; (B) The marginal chordae emerging from the papillary muscle and splitting
into three web of chordae; (C) Chordal distribution on the anterior leaflet of a human




observed in humans, which divide the entire posterior leaflet into three scallops as shown 
in Figure 2-18[34]. 
Mechanical properties of chordae tendineae vary with their type and size. Liao 
and colleagues reported in 2003 that chordal grouping based on cross sectional area, there 
is a stark correlation between the chordal size, type and mechanical properties [35-38].  
In this study, they reported that the thicker strut chordae are more extensible and less stiff 
than the thinner marginal chordae as shown by the data in Table 2-2 and Table 2-3. With 
increase in chordal diameter, the average crimp period of the collagen core that forms the 
chordae decreased. The marginal chordae that are the thinnest had smaller fibril 
diameters and a greater average fibril density than the other chordae. On the other hand 
the extensibility of the chordae seems to increase with increasing chordal diameter, but 
with a reduction in the tensile modulus. In the thicker chordae, the collagen fibrils are 
extensively crimped and thus allow better elongation than their thinner counterparts. 
These finds by Liao et al. [35-38] corroborate with other data reported in literature by 






Table 2-2 Comparison of mechanical properties of chordae according to their cross








Lim et al. reported a non-linear quasi static elastic response of the mitral valve 
chordae using uni-axial testing [40-44]. Once the outer elastic sheath of the chordae was 
removed, there was no change in the non linearity indicating that the mechanical 
properties of the chordae are determined primarily by the inner collagen core. In their 
study they also reported that with increased stretch, a greater force was required to strain 
the tissue indicating the non linearity. When the collagen fibrils are completely un-
crimped, the bonds between each fibril start to stretch and this stretching requires a much 
higher force. Sedransk et al in 2002 investigated the failure mechanics of the chordae 
tendineae, and reported that the marginal chordae and the posterior leaflet chordae are 
thinner and failed at lower loads that the anterior chordae[45]. These findings are in 
agreement with the data from Lim et al., which reports that the marginal chordae have 
decreased extensibility in comparison to thicker strut and basal chordae. It was also 
concluded that the failure strength of the chordae was dependent primarily on the 
insertion position and not on the leaflet of insertion[44]. 
Ritchie et al. compared the mechanical properties of the chordae to their structural 
constituents using histological methods and confirmed that chordal loading correlated 
well with the variations in collagen and elastic content [46, 47]. Subsequently in 2006, 
Table 2-3 Comparison of mechanical properties of chordae according to chordal type [ Data




Jimenez et al. reported dynamic measurements of the chordal forces in an in vitro left 
heart simulator. In this study, the authors reported that under dynamic conditions the strut 
chordae bore the maximum load when compared to the marginal or basal chordae [48-






2.1.7.1.4   Papillary Muscles 
The mitral valve function is integrally related to the ventricle, with the annulus 
residing in the left atrio-ventricular groove and the chordae tendineae connecting the 
ventricle via the papillary muscles. There are two papillary muscles arising from the left 
ventricular myocardium: the antero-lateral papillary muscle and the postero-medial 
papillary muscle. The antero-lateral papillary muscle often consists of one body or tip and 
obtains its blood supply from the left anterior descending and the diagonal or a marginal 
branch of the circumflex artery. Whereas, the postero-medial papillary muscle consists of 
two tips and gets its blood supply from the left circumflex or right coronary artery. 
Because of its single system of blood supply it is prone to injury from myocardial 
infarction. The attachment of the papillary muscles to the lateral wall of the left ventricle 
makes the ventricular wall an integral part of the mitral valve complex. Chronic or acute 





left ventricular dilatation can lead to papillary muscle displacement with increased leaflet 
tethering due to tension on the chordae tendineae. The papillary muscles are active 
components that contract during systole and maintain a constant distance between the 
annulus and the papillary muscle tip, restricting the prolapse of the mitral leaflets into the 
atria during systolic closure. Their contraction is possible through the extensive vascular 














(A) (B) (C) 
Figure 2-19 Arterial vasculature of the human left ventricular papillary muscles (A)
finger like papillary muscle with a central artery distributing blood, (B) mixed type of
papillary muscle with segmental distribution of vasculature, and (C) tethered type of
papillary muscle with long penetrating intra myocardial vessels [Figure reproduced




2.1.8 PHYSIOLOGICAL MITRAL VALVE FUNCTION 
 The primary function of the mitral valve is to allow blood flow from the left 
atrium to the left ventricle during diastole, and prevent the backflow of blood from the 
left ventricle to the atrium during systole. To perform this physiological function 
synchronously with the cardiac phase, the mitral valve components works in tandem with 
one another to ensure proper closure of the leaflets. At the beginning of systole, higher 
pressure in the left ventricle and lower pressure in the left atrium accelerates the valve 
leaflets basally towards the mitral annulus. As the leaflets move closer to the mitral 
annulus, the limited extensibility of the chordae tendineae restricts the leaflets from 
prolapsing into the atrium. The chordae tendineae are inserted along the leaflet surface 
such that, they not only restrict leaflet prolapse but also impart a curvature to the leaflets 
that results in good anterior and posterior leaflet overlap and good coaptation. Typically, 
in humans the coaptation height measured along the A2-P2 ranges between 5mm to 8mm 
and varies with the valve size and body surface area of the subject [51, 52]. At peak 
systole, the papillary muscles also contract and transfer a force on the annulus that is 
apically directed. This force can be speculated to change the shape of the mitral annulus 
for a flat diastolic configuration to a three dimensional systolic saddle shape. Though the 
exact dynamics and interaction between each mitral valve component is currently 
unknown, it is demonstrated to some extent in this thesis that the transfer of forces from 
the sub annular to the annular planes plays a critical role in optimizing leaflet coaptation. 
As the ventricular pressure is rapidly falling during late systole, rapid left atrial filling 
increases the chamber pressure until an inflection point is reached when the mitral valve 




the mitral leaflets apically to their complete open position. The strut chordae on the 
anterior leaflet ensure that the open mitral leaflets do not obstruct the left ventricular 
outflow tract, and unobstructed left ventricular filling occurs. Figure 2-20 depicts the 
different forces acting on the mitral valve during the systolic and diastolic phase of the 
cardiac cycle, and illustrate the structure to function relationship between the chamber 




















Figure 2-20 (A) Forces acting on the mitral valve structure during systolic closure. Fp
is the pressure force acting on the leaflets due to elevated left ventricular pressure, Fc
is the papillary muscle contraction force during systole, Fac is the annular contraction 
force, and Fab is the annular bending component. (B) Fsf is the tension in the anterior
strut chordae during diastole when the chord prevents systolic anterior motion of the




2.1.8.1 Valve Hemodynamics 
 Figure 2-21 presents the synchronous recording of the mitral valve flow, and 
ventricular and atrial chamber pressures in a calf [53, 54]. The duration of the total 
cardiac cycle is divided into six cardiac phases, and the events in each cardiac phase are 
discussed. Phase I is the time period of low flow rate and volume at pre diastole, when 
the mitral valve is just about to open. Phase II begins at the time point when the 
atrioventricular pressure gradient is positive and during this period the flow from the left 
atrium rapidly accelerates into the left ventricle and slowly declines. Phase III 
commences at atrial systole, when the left atrium contracts and pushes the fluid volume 
left in the chamber into the left ventricle, which is synchronous with the second bump on 
the flow. Though reversal of pressure gradient occurs at this stage, the flow decelerated 
yet persisted to fill the ventricle for an additional 15 msec. Phase IV is the only period of 
flow reversal, occurring during the isovolumic contraction. This volume could either be 
slight regurgitation or can be the volume of the fluid displaced by the valve leaflets into 
the left atrium, termed as the closing volume. Phase V varied between 15-40 msec and 
consisted of a small volume and low rate of flow following the atrial “c” wave. Phase VI 


























 Tsakiris et al. also studied the motion of the mitral valve leaflets during the 
cardiac cycle, by placing beads on the free edges of the anterior and posterior mitral 
cusps in anesthetized dogs [55]. The time series in Figure 2-22 shows the motion of the 
bead from systole to diastole, wherein the systolic closed position is considered the 
baseline. At the onset of diastole, both the mitral leaflets rapidly opened to their fully 
open position, surprisingly started to reclose immediately, and had a short period of rapid 
Figure 2-21 Mitral valve flow recorded during different phases on the cardiac cycle in





reopening and then systolic closure. The initial diastolic closing following the full open 
position coincided with the formation of a left ventricular vortex behind the valve leaflet 
when the ventricle still has a smaller volume. As the flow through the mitral valve 
continued and was directed towards the apex and gained volume, leaflet closure was 
decelerated. Finally as the flow diverged and ran parallel to the ventricular walls, leaflet 


















Figure 2-22 Motion of the free edges of the anterior and posterior leaflet in an





2.1.8.2 Valve Mechanics 
2.1.8.3  In Vivo Annular Strain Measurements 
In 2009, Eckert et al. reported mitral annular kinematics in normal sheep using 
sonomicrometry crystals placed around the annular circumference [56]. From the 
measured displacement of the sonomicrometry crystals, they reported the annular axial 
strain, strain rate, bending and twist around the annulus. Axial strain showed spatial and 
temporal heterogeneity, the peaks ranging from -10% to 4%. Largest strain was measured 
around the commissures and along the posterior annular segment, but neither bending nor 
twist was observed in this study. Figure 2-23 summarizes the time series of the axial 










Figure 2-23 Axial strain at individual crystals placed along the circumference of the
mitral annulus in a sheep. Data depicts the heterogeneity in the spatial strain pattern




2.1.8.3.1  In Vivo Leaflet Strain Measurements  
In 2006, Sacks et al measured the dynamic deformation of the anterior leaflet of 
the mitral valve in sheep using sonomicrometry [57]. The anterior leaflet of nine Dorsett 
sheep was instrumented with nine 1-mm crystals, and the regional deformation was 
assessed. Data from their study, shown in Figure 2-24, demonstrated large anisotropic 
strains and peak strain rates of 400%/second, with a deformation plateau during systole. 
They also reported that with increased left ventricular pressure or annular geometry, the 
leaflet stiffness significantly increased and proposed this as a mechanism for leaflet 












Figure 2-24 Time series of anterior leaflet deformation. (A) Depicts the temporal changes
in the major principal strain that coincides with the circumferential axis of the leaflet; (B)
Temporal changes in the minor principal strain along the radial axis of the leaflet; (C)
Changes in the areal strain throughout the cardiac cycle; (D) Temporal changes in strain





2.1.8.3.2  In Vitro Leaflet Strain Measurements 
He and colleagues in 2002 and 2005 reported dynamic leaflet deformation of the 
anterior and posterior leaflets in an in vitro pulsatile left heart simulator[58, 59]. Results 
on the anterior leaflet shown in Figure 2-25 demonstrated that during valve closure the 
leaflet experienced large, anisotropic strains with peak stretch rates of 500%-1,000%/s. 
This rapid stretching was followed by a plateau phase characterized by relatively constant 
strain state. On the posterior leaflet, their findings shown in Figure 2-25 indicated a rapid 
rise in leaflet strain during valve closure followed by a plateau where no additional strain 
(i.e., no creep) occurred.  The strain field was highly anisotropic with larger stretches and 
stretch rates in the radial direction. There were negligible stretches, or even compression 












Figure 2-25 (Top Row) Dynamic areal stretch and areal stretch rate on the anterior





2.1.8.3.3  In Vivo Chordal Force Measurements 
Salisbury and colleagues in 1962 measured the forces on the strut chord of the 
anterior leaflet of the mitral valve under different hemodynamic and pathological 
conditions, and reported a dynamic change in the chordal force with changes in the 
hemodynamics and left ventricular shape and health [60]. Figure 2-26 shows the 
transducer that was used to measure these forces and the force measurements under 














 Jimenez et al, in 2006 reported measurements on six chordae tendineae on a 
porcine mitral valve conducted in an in vitro heart simulator, under normal and 
Figure 2-26 (A) The force transducer used to measure the chordal force in the mongrel
dogs; (B) The graphs depict the measured forces on the chord at physiological left





pathological conditions where the papillary muscles were displaced in different spatial 
directions [48-50]. 
2.1.8.3.4  Computational Mechanics of the Mitral Valve 
Kunzelman and colleagues in 2007 summarized their computational model of a 
mitral valve in which they sought to study the contribution of individual components of 
the valve to its observed mechanics [61-64]. A 3D model of the mitral valve, with fluid 
structure interaction was developed that includes the mitral leaflets and the chordae 
tendineae. Figure 2-27 shows their model with results obtained under different loading 
conditions on the valve. Peak strain was measured at the central A2 and P2 cusps, along 














Figure 2-27 (A) The computer generated 3D model of the mitral valve; (B) The stress
strain characteristics that were used in the computational model to calculate the leaflet
stress; (C) Circumferential Almansi strain in the leaflet under normal geometry and





2.2 MITRAL VALVE PATHOLOGIES 
 Mitral valve pathologies encompass a spectrum of lesions which include 
congenital defects, degeneration of valve tissue, and geometric distortions to the valve 
due to secondary reasons. Congenital lesions of the mitral valve include annular 
calcification leading to mitral stenosis, leaflet prolapse due to Marfan’s syndrome, 
isolated cleft valve, undivided atrioventricular valve in ostium primum or septum 
secondum defects, and mitral regurgitation due to congestive heart failure caused by 
severe stenosis of the left main coronary artery. Though the underlying etiology of each 
congenital lesion is different, the common manifestations between all the lesions are 
leaflet and sub annular malformations that reduce valve competence. Degenerative mitral 
valve lesions occur in both children and adults, due to either genetic mutations such as 
Marfan’s syndrome (lack of Fibrillin-1 gene), or acquired secondary diseases such as 
Rheumatic heart disease in developing countries, Fibroelastic deficiency in adult life due 
to collagen deficiencies, and Barlow’s syndrome speculated to be caused due to genetic 
and mechanical factors. The last classification of mitral valve lesions, termed as the 
functional mitral valve defects, are caused due to perturbations to the mitral valve 
geometry secondary to other lesions such as ischemic dilated cardiomyopathy or 
hypertrophic dilated cardiomyopathy.  
 Irrespective of the lesion, surgical repair is currently the accepted standard of care 
over valve replacement, due to risks associated with anti coagulation therapy, growth of 
cardiac structure in pediatric patients, and lack of durability of the artificial valves. 




decades. In the current era of cardiothoracic surgery, valve surgery to repair a diseased 
mitral valve has become a routine procedure that is associated with low mortality rates 
and excellent acute outcomes. With better understanding of pathological anatomy of 
mitral valve lesions and increasing surgical experience, several innovative methods for 
mitral valve repair are now established. However, long term durability and chronic 
outcomes using these techniques are concerning, with failure rates ranging from 5% to 
40% for different mitral valve lesions. These disconcerting statistics indicate that, mitral 
valve repair for acute correction of regurgitation or stenosis are achieved, but chronic 
failure of these repair is inevitable and poorly understood. In the subsequent sections, a 
historical perspective of each mitral valve lesion studied in this thesis is presented, 
current patient outcomes are discussed, and a case for carefully investigating the 
hemodynamics and function of each surgical procedure is presented.  
2.2.1 PEDIATRIC MITRAL PATHOLOGIES 
 In infants and children with complex congenital heart defects involving the left 
atrioventricular valve, surgical repair is the standard of care over valve replacement. Lack 
of an ideal mechanical or bio-prosthetic substitute for the mitral position is the primary 
reason. Secondly, valve replacement is not a definitive procedure for the underlying 
congenital lesion as the patient will inevitably outgrow the valve while being exposed to 
the risk of anti coagulation therapy. Repair of the mitral valve is thus attempted in all 
pediatric patients, by adopting a creative and carefully thought out approach to repair in 




2.2.1.1 Atrio Ventricular Valve Repair in Canal Defects 
Atrioventricular canal defects encompass a spectrum of lesions that are caused 
due to regressed growth of endocardial cushions, resulting in abnormalities of the 
atrioventricular valve form and function, and also presenting with atrial and ventricular 
communication [65]. In these patients, proliferative deficiencies in the endocardial 
cushions restrict the development of the canal septum posteriorly towards the actual atrial 
septum, and anteriorly towards the actual ventricular septum, thus resulting in a common 
atrioventricular valve without distinction between the mitral and tricuspid valves shown 
in Figure 2-28. Each morphological abnormality can occur to different degrees of 










Figure 2-28 Surgical perspective of  the common atrioventricular valve as seen through
the right atrial access and through the atrial septal defect (Inset) Schematic of a heart
with an ostium primum and septal secundum defects resulting in a common
atrionventricular valve without separation of the annuli of the mitral and tricuspid





Indications for surgery depend upon the form of the atrioventricular defect, and 
symptoms of congestive heart failure, at which point surgical correction is attempted. For 
the most severe of the cases, surgery may be in the first few weeks of life and in the 
asymptomatic patients within 6 months of birth as it is associated with lower mortality. 
Lillehi and associates were the first to attempt surgical correction of such defects in 1954 
using cross circulation, but subsequent surgical management of this lesion carried a high 
mortality rate due to insufficient understanding of the anatomy of the atrioventricular 
canal [3]. In 1958, Lev described the conduction system in canal defect patients thereby 
allowing avoidance of complete heart block induced by surgery and thus reducing 
mortality rates [66]. Bharati et al. [67-69] and Rastelli et al. [70-77] contributed 
significantly towards understanding the anatomy of this lesion, leading to the 
development of various surgical techniques for reconstruction.  
The natural focus of surgical repair in the initial years emphasized the 
management of atrioventricular valve tissue, and several surgical centers attempted these 
repairs. Rastelli and associates reported their experience with complete repair of the atrial 
ostium primum defect, the ventricular foramen closure and atrioventricular valve 
construction in infants in 1968 [74, 76], while Barratt-Boyes reported surgical repair 
under deep hypothermic circulatory arrest in 1973 [78]. At best, a 10% morality rate was 
reported in all these studies. This practice is now standardized, and in patients with inter-
atrial or inter-ventricular communication, patch closure of the ventricular defect is 
performed first, followed by atrioventricular valve reconstruction and finally patch 




septal closure procedures and excellent acute and chronic outcomes are reported in these 
patients.  
Historically, atrioventricular valve reconstruction is performed in a staged 
approach with continuous saline testing for valve competence as shown in Figure 2-29. A 
pledgeted polypropylene suture is placed at the base of the cleft near the annulus, and the 
apposition of the cleft edges is tested by filling the ventricle with saline. Regurgitation is 
often observed through the cleft, and further closure of the cleft is attempted with 
repeated saline testing until complete valve competence is achieved. Commissurotomy is 
then performed to reduce the annular size and increase the length of central coaptation of 
the two apposing leaflets. In 1978, Carpentier proposed that the left atrioventricular valve 
can be constructed as a trifoliate valve without closing the anterior leaflet cleft[79]. He 
proposed that the open cleft may act as a commissure and enable apposition of the edges 
of the cleft, which was later proven to be inefficient due to the development of severe 
valvular regurgitation in the post operative period. Though this concept is still in practice 
at few centers, partial or complete closure of the cleft is prevalent as open clefts have 
been shown to be unpredictable and regurgitation is shown to cause thickening of the 
edges. Disagreement prevails in this aspect, as both success and failure have been 
reported using both approaches.   
In the current era of surgical repair for congenital atrioventricular canal defects, 
the measure of operative success has shifted from early mortality to freedom from 
reoperation for residual valve lesions. In these patients, repair of the septal defects has 




atrioventricular valve still remains a challenging problem. More than 15% of the patients 
surviving repair have hemodynamically significant regurgitation, the causes of which 







2.2.1.2 Risk Factors for Recurrent Regurgitation in Canal Defects 
2.2.1.2.1  Procedural Risk Factors 
Murashita and associates in 2004 reported their experience with left 
atrioventricular valve regurgitation after repair of ostium primum defect in a 61 patient 
series [12]. In their series ranging in age from 1 month to 62 years old patients (median 
age of 5.3 years old), 7 patients had a completely open cleft, 41 patients had partial cleft 
closure and 9 patients had complete cleft closure. Preoperative and postoperative 
regurgitation at hospital discharge, and late follow up was performed to assess the 
severity of regurgitation. In their series, left atrioventricular valve regurgitation was 
diagnosed pre operatively in all the patients; 25 patients with NYHA grade I 




Figure 2-29 (A) The common atrioventricular valve with the bridging leaflets; (B) Cleft
mitral valve formed after surgical separation of the annuli and septal defect closure; (C) 
Completely closed cleft with commissurometry to reduce annular size. Figures




regurgitation. After surgical correction and at hospital discharge, 18 patients had grade II 
regurgitation and 2 had grade III regurgitation. At long term follow up, nearly 20% of the 
patients had regurgitation of severity grade III or more, and they report that age at time of 
surgery, pre operative severity of regurgitation, and acute post operative severity of 
regurgitation, seemed to have dominant risk factors for late occurrence of regurgitation 
after surgical repair. Patients who are less than 2 years of age at surgery seemed to have 
poor outcomes over their older counterparts, as the recurrence of late regurgitation was 
higher in the younger population. This can be attributed to the early growth in the cardiac 
structures, which happens during the first year of life. Patients that presented with higher 
severity of regurgitation before surgery seemed to be more prone to recurrence of post 
operative regurgitation. Though the underlying reasons are not discussed in this 
publication, it can be speculated that the patients who present with severe grades of pre 
operative regurgitation may have abnormal annular or sub annular geometries, smaller 
leaflets and abnormal chordal insertions from the ventricular trough.  Additionally, this 
report also indicates that even after rigorous surgical correction, acute remnant 
regurgitation is seen in some patients that worsen with time. However, the authors 
reported that the length of cleft closure did not seem to have any correlation with the late 
outcomes based on their statistical analysis, but the graphs clearly demonstrated that with 
a complete cleft closure at 15 years follow up nearly 80% of the patients had 
regurgitation. Figure 2-30 depicts the actuarial freedom from late regurgitation at acute 








Figure 2-30 (A) Actuarial freedom from late atrioventricular valve regurgitation (LAVR) of Grade III or more after repair of cleft
mitral valve with ostium primum defect; (B) Actuarial freedom from LAVR grade III or more in patients aged less than 2 years old
(   ) and equal to or greater than 2 years old (  ) depicting poor outcomes in infants; (C) Actuarial freedom from LAVR grade III or
more in patients with post operative LAVR grade II or more (  ) and with LAVR less than grade II     (  ); (D) Actuarial freedom
from LAVR grade III or more in patients with preoperative LAVR more than grade III or more (   ) and with LAVR less than grade
II (  ); (E) Actuarial freedom from LAVR grade III or more in patients without cleft repair (  ), partial cleft closure (  ), and with
complete cleft closure  (   ).  





2.2.1.2.2  Morphological Risk Factors 
In a more recent report by Kanani and colleagues in 2006, the authors report a 
morphological perspective on late incompetence of the left atrioventricular valve after 
repair of atrioventricular septal defects [1]. The authors compared the mitral valves from 
92 normal hearts to those with atrioventricular septal defect with common 
atrioventricular junction, determining the shape of the leaflets and the arrangement of the 
sub annular apparatus in these hearts. The anterior leaflet of the mitral valve constructed 
after closure of the ostium primum defect and the ventricular foramen, was rectangular in 
shape with a triangular cleft at its center, compared to a triangular anterior leaflet in 
normal hearts as shown in Figure 2-31. In normal hearts the anterior leaflet is continuous 
with the left and non coronary aortic leaflets through the anterior annulus and the fibrous 
trigones, and in spite of its broad base covers only a third of the valve perimeter. On the 
Figure 2-31 (A) Photograph of the anterior leaflet of the mitral valve from cadaver’s
depicting the triangular shape of the leaflet with an orderly radial arrangement of the
chordae tendineae; (B) Photograph of the surgically constructed anterior leaflet of the
cleft mitral valve shaped as a rectangle with a triangular cleft in the middle. In this case
the cleft is closed partially using unpledgeted sutures. Figures reproduced from Kanani




other hand, the surgically constructed rectangular cleft anterior leaflet covers less than 
one third of the total circumference of the annulus. 
The papillary muscles in the normal heart are located beneath the two 
commissures of the mitral valve leaflets, with chordae tendineae emerging from the tip of 
each papillary muscle and inserting into the ventricular surface of the anterior and 
posterior leaflets. As the chordae emerge from the papillary muscle, the stem of the chord 
splits into multiple branched webs, one of which inserts into the free edge of the leaflets, 
second into the base of the ventricle forming the strut chordae, and the third inserting 
near the base of the leaflet close to the mitral annulus. This type of chordal arrangement 
ensures a consistent and optimized configuration of the leaflet at peak systole for 
increased leaflet coaptation. Compared with such a physiological chordal distribution, in 
surgically created anterior leaflet in atrioventricular canal defects the chordae run along 
the longitudinal axis of the leaflet, reduced in number than the normal valve and 











Figure 2-32 (A) Fused chordae running along the longitudinal axis of the leaflet in a
surgically created anterior leaflet in canal defects; (B) Chordal distribution in a normal
mitral valve leaflet depicting the distinction between the primary, secondary and




Kohl and Silverman, using echocardiography techniques compared the position of 
the anterior leaflet cleft with papillary muscle position to differentiate between isolated 
cleft mitral valve and atrioventricular canal defect patients [80]. The authors report that in 
patients with canal defects, both papillary muscles originated closer to each other and 













2.2.1.2.3  Cardiac Structural Growth with Ageing 
 The congenital nature of canal defects requires surgical correction in the early 
weeks of life and current surgical techniques to not take into consideration the growth of 
cardiac structure with age. Figure 2-34 show nomograms that illustrate the changes in 
body surface area, and mitral valve structures with age in congenital heart defect patients.  
(A) (B) 
Figure 2-33 (A) Schematic depicting the papillary muscle positions in subjects with
normal mitral valves (N), with isolated cleft mitral valve(CI-MV), and with complete
atrioventricular canal defect (AVSD). In AVSD hearts, the papillary muscles are
posteriorly and laterally displaced towards each other potentially due to the scooped
ventricular geometry; (B) An atrial view of the common atrioventricular leaflet with the
relative position of the papillary muscle with respect to the anterior leaflet cleft before




From birth to 15 years of age body surface area increases from 0.2 m2 to 1.4m2, a 700% 
increase. With increasing body surface area, the mitral annular width along anterior and 
posterior axis also increased from 12mm to 30mm. Annular growth following surgical 
repair in conjunction with the smaller mural leaflet and rectangular anterior leaflet may 




















Retrospective clinical studies identified several risk factors in these patients that 
induce regurgitation, and ultimately require reoperation or valve replacement. However, 
the biggest drawback of these clinical studies is that they are confined to speculation or 
statistical inference, but cannot provide a structure-to-function relationship between the 
risk factors and the outcomes. Controlled experimental models are thus required to 
simulate different levels of the pathological lesion, and investigate the independent and 
combined impact of each of the risk factors on valve competence. Large animal models 
would provide an ideal setting to conduct such experiments, but creating congenital 
lesions in large animal models is challenging and is associated with very limited success. 
These limitations call for the development of ex vivo or in vitro systems wherein the 
pathological valve geometry can be simulated and different risk factors and surgical 
techniques can be assessed for their hemodynamic efficacy and long term function. 
(C) 
Figure 2-34 (A) Predicted growth in body surface area from birth to 15 years of age in
patients with congenital heart defects; (B) Measured increase in mitral annular antero
lateral dimension with increasing body surface area; (C) Numerical values for changes in




2.2.2 DEGENERATIVE MITRAL PATHOLOGIES 
 Degenerative mitral valve disease is the most prevalent pathology among all 
mitral valve lesions, and afflicts 2.4% to 5% of men and women in most industrialized 
nations [81]. Even though the exact pathogenesis of the disease is currently unknown, 
degenerative mitral valve lesions can be primarily classified based on their etiology into – 
[a] Rheumatic valve degeneration, [b] Myxomatous valve degeneration, and [c] Fibro 
elastic deficient valve degeneration.  
2.2.2.1 Rheumatic Valve Disease 
 Rheumatic fever is widely prevalent in the developing countries, and is the 
leading contributor to the increasing burden of heart valve disease in these nations. World 
Health Organization (WHO) estimated that 5-to-20 million children and young adults 
across the world suffer from chronic rheumatic heart fever, with a projected mortality rate 
of 90,000 per year [82]. Caused due to group A-beta hemolytic Streptococcus bacteria 
that infiltrate the epithelial cells of the upper respiratory tract, release of enzymes into the 
connective tissue results in a sequel of events such as endocarditis and pericarditis that 
ultimately lead to complete heart failure[83]. The bacteria also infiltrate the mitral valve 
leaflet tissue, increasing the leaflet thickness and stiffness, and resulting in fusion of the 
commissures and chordae tendineae as shown in Figure 2-35. These manifestations result 
in mitral stenosis and mitral regurgitation, and depending on the severity of degeneration 
the lesions are corrected either by surgical valve reconstruction/repair or by complete 




unsatisfactory, due to problems associated with anti coagulation therapy and durability of 









2.2.2.2 Barlow’s Disease 
 Barlow’s disease is the most prevalent degenerative mitral valve lesion in the 
Western world. Though the syndrome of mid-systolic click with a late systolic murmur 
was described in late 1800s, it was only in early 1960’s was it associated with mitral 
regurgitation due to leaflet billowing as demonstrated by Barlow and colleagues using 
cine ventriculography[84-87]. Criley et al. identified the mechanism of regurgitation as 
posterior leaflet prolapse and coined the term mitral valve prolapse to explain this 
pathology[88]. Carpentier and colleagues later characterized the surgical lesions resulting 
from the myxoid changes in this pathology, reporting extensive leaflet thickening, leaflet 
distention and redundancy, chordal elongation and rupture, and annular dilatation[89]. 
Researchers have attributed both genetic mutations, and mechno-biological factors to 
play a role in the onset of tissue degeneration. Grau JB and colleagues in a recent review 
(A) (B) 
Figure 2-35 (A) Endocardial vegetations on the mitral valve leaflets in a patient with
rheumatic heart disease;(B) Leaflet thickening and chordal fusion caused due to




point to three different loci on chromosomes 16,11 and 13, but no specific gene has been 
described yet[90]. They also reported that mitral valve prolapse due to degeneration is 
typically found in patients with connective tissue disorders such as Marfan’s syndrome, 
Ehlers-Danlos, and Osteogenesis Imperfecta. Pedersen et al stretched explanted porcine 
tissue to different levels of strain and demonstrated the over expression of endothelin-1 
receptors, which is typically seen in prolapsing valves[91, 92].  Irrespective of the disease 
mechanisms, myxoid degeneration process affects the entire valve and patients with this 
disease generally have complex valve pathology and dysfunction, which is often multi 










Patients presenting with Barlow’s disease are generally old and aged 50 years or 
higher, who were aware for decades that they had a heart murmur. These patients are 
referred to the cardiologist only upon manifestation of symptoms such as atrial 
fibrillation, shortness of breath and fatigue, or ventricular or atrial enlargement as 
(A) (B) 
Figure 2-36 (A) Echocardiographic image of the mitral valve billowing into the left
atrium; (B) Surgical view of a Barlow’s mitral valve showing the multi segmental





observed on echo, and in some cases pulmonary hypertension. Based on the severity of 
regurgitation, the patients are subsequently referred to a cardiac surgeon for valve repair 
or replacement. With increased surgical expertise and robotic surgery, mitral valve repair 
has become the standard of care in these patients.  
 The most common surgical techniques to repair degenerative valves include 
resection of redundant leaflet tissue, with concomitant annuloplasty to stabilize the repair, 
though the scientific evidence behind the need for annuloplasty is not clearly understood. 
The choice of leaflet resection techniques is typically based upon the cardiac surgeon, the 
leaflet requiring repair, and the extent of leaflet billowing. Quadrangular resection is the 
most commonly used procedure on the posterior leaflet[7], which involves resecting a 
quadrilateral shape of the P2 cusp, followed by leaflet reconstruction and plication of the 
(A) (B) 
(C) (D) 
Figure 2-37 (A) Dotted line depicting the quadrangular section of the P2 that is
resected; (B) Valve after complete leaflet reconstruction; (C) Dotted line depicting the




annulus as shown in Figure 2-37. This procedure not only reduces the leaflet area but also 
the height of the leaflet at the P2 cusp. However, the procedure is technically challenging 
and requires modification on an individual patient basis. Limited triangular resection is 
another procedure that is increasingly used [93], which involves resection of a smaller 
triangular segment at the free edge of the posterior leaflet as shown in Figure 2-37, but 
does not require annular plication.  A folding plasty procedure was also recently 
proposed, but its clinical efficacy or technical feasibility is yet to be published [94, 95].  
In the last decade, few non resective surgical techniques have also been developed 
shown in Figure 2-38, such as Neochordoplasty which involves replacement of the 
elongated or ruptured chordae with ePTFE chordae[96, 97], Edge-to-Edge repair which 
involves placement of a stitch between the edges of the anterior and posterior leaflets thus 
forming a double orifice mitral valve[98], and chordal translocation which involves 
translocation of the secondary chordae to the ruptured marginal positions[99-101]. Data 
on the efficacy of Neochordoplasty is abundant in recent literature, and Falk et al recently 
demonstrated the improved valve function and outcomes with this procedure over other 





























Figure 2-38 (A1) ePTFE suture with pledgeted ends placed on the tips of the papillary
muscles; (A2) The ePTFE sutures passed through the free edges of the prolapsing
posterior leaflet and knotted on the atrial surface after adjusting the chordal length; (B1)
An “8” shaped stitch placed between the anterior and posterior free edges to provide
structural support to the prolapsing segment; (B2) The double orifice valve formed after
the edge to edge repair; (C1) Translocation of the secondary chordae on the prolapsing
leaflet to the marginal position to restrict the free edge prolapse; (C2) Schematic




2.2.2.3 Fibro Elastic Deficiency 
 Fibroelastic deficiency is a common degenerative lesion of the mitral valve, 
specifically in younger patients [102]. In contrast to Barlow’s disease, fibroelastic 
deficiency manifests with reduced leaflet tissue resulting from deficiencies in the 
production of collagen, elastin and proteoglycans [102]. Regressed ability of the cells to 
produce connective tissue, results in leaflet and chordal thinning and leaflet prolapse 
under chronic conditions. Histological analysis of these valves demonstrates alterations in 
the elastic fibers, even though the tri layered structure of the valve is completely 
preserved. Myxoid changes or thickening of the prolapsing segment is commonly seen in 
these patients, but are isolated to this segment. Figure 2-39 shows a fibroelastic deficient 
mitral valve with no visible distension of the mitral leaflets, isolated prolapse of the P2 
segment with some myxoid changes.  
 
















Figure 2-39 (A) Echocardiograph of the prolapsing mitral valve in a patient with
fibroelastic deficiency. Unlike Barlow’s disease that presents with significant leaflet
billowing, chordal rupture in this case results in complete movement of the prolapsing
leaflet into the left atrium, developing a large regurgitant orifice; (B) Myxoid changes
to the prolapsing posterior mitral leaflet after chronic regurgitation, though the myxoid
changes and leaflet thickening were isolated to the prolapsing segment; (C) Surgical
view of the ruptured marginal chordae that caused the prolapse [ Images courtesy of Dr.




 Even though the etiology of Barlow’s disease and Fibroelastic deficiency are 
quite different, most surgeons typically use the same resective techniques as used for the 
distended leaflets. Neochordoplasty is increasingly gaining popularity to repair valves 
with this lesion, and a very recent study by Falk V et al. demonstrated the improved 
outcomes with this procedure [96]. Edge to edge repair and chordal translocation are also 
used at times, but there is no published data reporting the clinical outcomes of these 
procedures in this particular disease setting.  
2.2.2.4  Clinical Outcomes of Degenerative Mitral Repair 
 Patients with degenerative mitral valve disease are the most suitable for 
reconstructive surgery. Filsoufi F et al. reported in their clinical series that the operative 
mortality in these patients is as low as 0.5% at experienced centers with good ventricular 
function[103]. Long term survival in these patients is comparable to age-matched, gender 
adjusted series that did not undergo cardiac surgery. Carpentier in a recent report 
followed 162 patients for >20 years, who received reconstructive surgery for 
degenerative mitral valve lesions [104]. Mitral annuloplasty was performed in all the 
patients, with 126 patients receiving leaflet resection, and the rest receiving shortening or 
transposition of the chordae tendineae. The linearized rate of reoperation in these patients 
was 0.4% per year, and the freedom from reoperation was 97% for posterior leaflet 
repair, 86% for anterior leaflet repair and 83% for bi-leaflet repair. Figure 2-40 shows an 
estimate of reoperation rate based on the data reported by Carpentier, demonstrating the 





Flameng and coworkers in 2008 compared the durability of mitral valve repair in 
Barlow’s patients with those with fibroelastic deficiency [10]. In 348 patients, survival 
was at 80.1% at 10 years after surgery and reoperation rates were at an acceptable 94.4%. 
However, the rate of recurrence of mitral regurgitation (>2/3 grade) was significantly 
higher at 98.7% at 1 month, 82.2% at 5 years and 64.9% at 10 years. The linearized 
recurrence rate was 3.2% per year in all the patients, but was higher at 6% in the 
Barlow’s repairs than the 2.6% observed in fibroelastic deficiency. This data clearly 
indicates that reoperation rates are poor indicators of the actual outcomes of surgery, and 
since significant experience with degenerative mitral valve repair is now available the 
focus should veer towards optimizing repair techniques that restrict recurrence of mitral 
regurgitation after surgery. Figure 2-41shows the calculated reoperation and recurrence 
of mitral regurgitation rates as presented in this study. 
Figure 2-40 Reoperation rates at 20 years after mitral valve reconstruction using
Carpentier techniques. Figure reproduced from Filsoufi F et al. Seminars in Thoracic and





























Figure 2-41(A) Reoperation rates after degenerative mitral valve surgery with a
distinction between the Barlow’s and Fibroelastic deficient valves; (B) Recurrence of
mitral regurgitation within 10 years of the primary surgery between Barlow’s and
Fibroelastic Deficient Valves. Figures reproduced from Flameng et al. JTCVS 2008,




 Falk et al. in 2008 presented an excellent study comparing the use of neochordae 
loops to resection techniques to correct posterior leaflet prolapse due to fibroelastic 
deficiency [96]. Mitral valve repair was accomplished in 129 patients by randomizing 
them either to neochordoplasty group or to the resection group. Echocardiographic 
comparison of leaflet parameters was done in both the groups, and Figure 2-42 
summarizes the results in these groups. Significant reduction in leaflet coaptation length 
in the resective group was observed in comparison to those who received neochordae. 
Restricted mobility of the leaflet after resection was also reported, but no quantitative 


















Figure 2-42 Echocardiographic indices measured at baseline conditions and after surgery
with either neochordoplasty or leaflet resection. Data reproduced from Falk et al. JTCVS




 Though mitral valve repair for degenerative valve disease is considered a routine 
procedure with excellent outcomes, data fails to support the long term durability of the 
repairs. The risk factors leading to repair failure seem to be multi factorial, including 
timing of surgery, surgeon experience with valve repair, etiology of the valve, extent of 
degeneration, type of surgical procedure, technical details of the surgical procedure, 
presence of annular dilatation, and progression of disease after the repair. It is impossible 
to design clinical studies that can isolate the impact of each of these factors, and thus 
emphasizing the need for either ex vivo or in vitro hemodynamic and mechanics studies. 
While an optimal mitral valve repair technique may not exist, correlating the type of 
surgical repair to the etiology may provide the right direction towards improving surgical 
outcomes not only acutely after surgery but also at chronic follow up. 
2.2.3 FUNCTIONAL MITRAL REGURGITATION 
 Regurgitation due to pure geometric perturbations to the mitral valve is the least 
understood and the most challenging pathology to manage clinically. Often diagnosed in 
patients with ischemic or hypertrophic cardiomyopathy, this mitral valve pathology is 
associated with changes in the annular and ventricular geometry due to other events. In 
cardiomyopathic patients, ventricular remodeling following a myocardial infarction or 
myocardial hypertrophy results in global dilatation of the left ventricle with outward 
displacement of the ventricular free wall. These changes to the ventricular geometry 
induce dilatation and flattening of the mitral annulus, and displacement of the papillary 






























 Hueb and colleagues, and Ahmed et al had reported detailed studies on the 
dimensional changes in the mitral annulus in cardiomyopathic patients and animal 
models[105]. Hueb et al separated the annulus into fibrous portion (the anterior segment) 
and muscular portion (the posterior segment) and quantified the changes in their 
dimensions in ischemic and idiopathic cardiomyopathy patients and compared them to 
normal’s. As shown in Figure 2-44A, significant changes in annular dimensions was 
observed on both segments, though changes were higher in the muscular section than the 
Figure 2-43 Summary of the geometric distortions to the mitral valve induced by
ischemic or non ischemic dilated cardiomyopathy. The distinct changes to annular
geometry include dilatation and flattening of the mitral annulus. Sub annular distortions
to the valve were caused due to displacement of the papillary muscles apically, laterally
or posteriorly from the mitral annular plane resulting in leaflet tenting as shown in the
right most schematic. Figures adapted from Hueb et al. JTCVS 2002, 124:1216; Kaji S et





fibrous section of the annulus [106, 107]. Ahmed et al additionally measured other 
relevant geometric parameters of the annulus, and reported the asymmetry in mitral 























Figure 2-44 (A) Changes in the mitral annular dimension as reported by Hueb et al,
distinguishing between the anterior fibrous section and the posterior muscular
section. (B) Changes in the annular perimeter, area and intertrigonal distance
measured by Ahmed et al depicting the significant increases in annular perimeter and
annular area between normal and ischemic heart disease patients, but showing no
significant changes in the inter trigonal distances. Data adapted from Hueb et al.




 In 2005, Watanabe et al. also described the differences in annular geometry with 
the extent and location of the myocardial infarction [109-111]. As shown in Figure 2-45, 
three dimensional images of the mitral annulus were obtained using 3D echocardiography 
and the annulus was reconstructed. Normal subjects had an elliptical D-shaped annulus 
with the saddle configuration during systole, but in patients with inferior myocardial 
infarction dilatation of the posterior annulus was observed, localized predominantly to the 
free wall region with significant flattening of the saddle shape. Similarly, in patients with 
anterior myocardial infarction, the increase in annular area was the highest, with 















Figure 2-45 Three dimensional changes in the mitral annular size and shape with
different infarct locations as measured from echocardiography. The saddle shaped D 
configuration of the normal annulus is clearly evident, that is lost with both anterior and
inferior myocardial infarction. Maximum dilatation was observed in the anterior





 Using 3D echocardiography, Kaji S et al. quantified the changes in the three 
dimensional saddle shape of the mitral annulus in normal subjects and patients with 
chronic ischemic mitral regurgitation [106]. In patients with chronic ischemic mitral 
regurgitation, clear loss of the saddle shape was evident with associated annular 
dilatation. Whether the loss of saddle occurred due to changes in the left ventricular 
geometry, or if the changes occurred to altered force balance in the valve is unknown and 
needs further investigation. Figure 2-46 shows the points along the mitral annulus where 
the annular perimeter was traced and the three dimensional changes in the annular 

















Figure 2-46 Mitral annular non planarity in normal and chronic ischemic mitral
regurgitation patients was assessed using multi plane echocardiography at different points
on the mitral annulus shown in (A). (B) Normal subjects without ischemic mitral
regurgitation had a significant saddle shape of the mitral annulus; (C) Chronic ischemic
mitral regurgitation subjects had a flattened annulus. Figure reproduced from Kaji, S. et




 Tibayan and colleagues [17-19], and the Gorman laboratory [13-16] were the first 
to quantify the changes at the sub annular level in animal models of ventricular ischemia. 
Tibayan et al using a chronic ischemic mitral regurgitation model in sheep reported the 
changes in the papillary muscle tip positions in 3-dimensional space. Figure 2-47 
summarizes the changes observed in the dimensions measured between the papillary 













 Several animal and human studies quantified these changes in the valve geometry, 
their relevance to pathological valve function or mechanics are poorly understood. He et 
al. in 1997 demonstrated using an in vitro left ventricular simulator that the mitral valve 
leaflets have an area that is large enough to compensate for annular dilatation upto 80% 
of the normal size [112, 113].  However, as the papillary muscles were displaced 
Figure 2-47 Changes in the papillary muscle tip positions in animals without chronic
ischemic mitral regurgitation and with chronic ischemic mitral regurgitation. A significant
increase in the distance of the trigones to the tips of the posterior papillary muscle were
observed with outward movement of the posterior free wall. Figure reproduced from




outwardly from the mitral annulus, the compensatory mechanism was lost and significant 














 Mitral annuloplasty is the current standard of care for surgical repair of functional 
mitral regurgitation, which involves undersizing the dilated mitral annulus to improve 
leaflet coaptation and reduce regurgitation. Several commercial annuloplasty rings that 
are either rigid, semi rigid or completely flexible are in use today in clinical practice, but 
Figure 2-48 Schematic summarizing the in vitro experimental data from He et al.
Isolated annular dilatation did not induce significant regurgitation until it was 80% of
the normal annular size. Symmetric papillary muscle displacement along with a dilated
annulus offset the regurgitation to higher magnitudes, but asymmetric papillary muscle
displacement resulted in significant increases in the regurgitation volume even at 40%




the improvements of using one type of ring over another still remains vague. Some of the 
annuloplasty ring types are shown in Figure 2-49, with their different shapes, sizes and 















Figure 2-49 (A) Schematic depicting the annular undersizing concept used to
reduce regurgitation and improve coaptation in the tethered mitral valve; (B) The
three most common annuloplasty ring types used clinically with different material 
properties, sizes and shapes. Figure’s courtesy - Dr. David H. Adams MD, Mt Sinai 




2.2.3.1 Clinical Outcomes and Repair Durability 
 Overall clinical outcomes with annuloplasty for functional mitral regurgitation 
have been suboptimal, with high rates of persistent or recurrent mitral regurgitation even 
after rigorous surgical repair. Tahta et al used echocardiography to follow patients who 
have received mitral annuloplasty and measured the acute changes in mitral regurgitation 
immediately after mitral annuloplasty, and at 3 years after surgical repair[114]. Figure 
2-50 summarizes the results from this study based on the grades of regurgitation acutely 
and at 3 years after mitral annuloplasty. Though clinically the poor outcomes of mitral 
annuloplasty are attributed to the annuloplasty ring type, but most recent data from 
Magne et al. clearly demonstrated that recurrence of regurgitation is seen irrespective of 











Figure 2-50 Percentage of patients in different regurgitation grades immediately after
mitral annuloplasty and at 3 year follow up after mitral annuloplasty for functional
mitral regurgitation. Acutely after surgery, a significant number of patients were either
with absolutely no or trace regurgitation. However at a chronic 3 year follow up, 
significant number of patients developed upto 2-3+ regurgitation. Data reproduced 















Figure 2-51 Data reproduced from Magne et al. on the efficacy of complete and semi complete annuloplasty rings that
demonstrated the same outcomes with nearly 80% of the patients showing recurrent regurgitation within 5 years after




2.2.3.2  Risk Factors of Failure of Mitral Annuloplasty in Functional Mitral 
Regurgitation 
 Failure of mitral annuloplasty for ischemic mitral regurgitation is a multi factorial 
problem. One of the primary causes of repair failure is that the ventricular aspect of the 
disease is rarely addressed and thus progressive left ventricular remodeling after 
annuloplasty, impedes leaflet coaptation and results in regurgitation. An important aspect 
of this problem that is clinically ignored is the variability in the ventricular and valve 
geometry between individual patients. Agricola et al. reported in 2004 the differences in 
the leaflet tethering patterns between anterior and inferior myocardial infarction and 
demonstrated that the geometry of the valve is significantly different between the two 
groups as shown in Figure 2-52 [115]. Srichai et al. also reported that the extent of 
scarring of the infarcted myocardium had a significant impact on the grade of 
regurgitation, in addition to the changes observed between the infarct locations. Figure 
2-53summarizes these findings, and shows the clear differences in regurgitation between 
individual patients [116]. They also reported that even though in both the cases, there is 
statistically no difference in the mitral annular diameter, the extent of leaflet tethering 
measured as leaflet tenting area was significantly different. On these lines, Watanabe et al 
reported in 2006 that the pattern of leaflet tethering is significantly different between the 
two groups, with localized central tethering for an anterior infarct location and a diffused 
pattern of leaflet tethering for a posterior infarct location as shown in Figure 2-54[110]. 
Though this data exists, there is a absolute need for controlled experimental studies to 




























Figure 2-53 (A) Relationship between anterior myocardial scarring grade and the
severity of mitral regurgitation, with higher levels of regurgitation with increased
scarring; (B) Similar trends in severity of regurgitation were seen with posterior
myocardial scarring. Figure reproduced from Srichai et al. Annals of Thorac Surg,
2005, 80(1): 170-8.[116] 
Figure 2-52 Differences in the tethering patterns between an anterior and posterior
myocardial infarction, demonstrating the differences in the regurgitation grade between





























Figure 2-54  (A) 3D reconstruction of the leaflet tenting geometry with inferior and 
anterior myocardial infarction, showing the differences in tethering between the
two geometries. In the inferior infarction case, the tethering was more localized
than the diffused pattern observed with anterior myocardial infarction; (B) 
Projection of the tenting pattern onto the plane of the mitral annulus, where the
differences in tenting are clearly evident. Figures reproduced from Watanabe et al.




2.2.4 ENGINEERING STUDY OF MITRAL VALVE REPAIR 
2.2.4.1 Computational Study on the Impact of Mitral Annular Saddle on Leaflet 
Stress 
Salgo et al. in 2002 demonstrated using a simplified model of the mitral valve that 
a 3-dimensional mitral annular saddle shape significantly improves systolic leaflet 
curvature and reduces stress in the leaflets[117]. Two types of fundamental shapes were 
first generated, an elliptic paraboloid to mimic leaflet billowing with a flat annulus and a 
hyperbolic paraboloid to model annular non-planarity without leaflet billowing. A linear, 
static, orthotropic material model was selected to mimic the collagen orientation in the 
leaflets, a constant thickness was maintained across the entire leaflet, and a 16kPa load 
was uniformly applied over the entire geometry. Their results shown in Figure 2-55 
demonstrated a significant reduction in the peak leaflet stress between flat and curved 
leaflets, and with a flat versus saddle shaped annulus. A significant reduction in leaflet 
stress was observed at 15% saddle (defined as the ratio of the annular height to 
commissural width), which conformed well to the degree of saddle measured in healthy 
humans and animals. Additionally, lower leaflet stress was computed in curved leaflets 
over flat leaflets indicating that the mitral annular saddle may optimize the curvature of 
the leaflets, which in turn reduces the systolic stress acting on them. Based on this data, 
they conclude that nature conserves the saddle shape of the mitral annulus to provide a 
mechanical benefit to the valve. Though a very insightful study, the computational 
geometry used by these authors was simplified and lacked the sub-annular apparatus 

























Figure 2-55 (A) A paraboloid shape used to mimic leaflet billowing, (B) A hyperboloid
shape used to mimic annular saddle shape. (C) Significant reduction in peak leaflet stress
with increasing height of the major commissural diameter, (D) Reductioin in leaflet stress
with increasing degree of saddle, (E) Higher stress with flat leaflets and (F) Lower stress







2.2.4.2 Finite Element Analysis of the Geoform Mitral Annuloplasty Ring 
Votta et al. in 2007 reported a computational study on the impact of ring shape on 
the mitral valve function and mechanics [118]. In this finite element study, the authors 
compared the leaflet stresses between a simulated pathological functional mitral 
regurgitation case, a flat Physio® annuloplasty ring and a hump shaped Geoform® 
annuloplasty ring (Edwards Lifesciences, Irvine, CA). From their finite element study, 
they report that a Geoform ring has enhanced performance in the correction of 
regurgitation over a flat shaped ring. Leaflet coaptation length was significantly higher 
with a Geoform ring over a Physio ring, without the need for excessive annular 
undersizing as shown in Figure 2-56. . They also report that both the rings significantly 
altered the leaflet stress from the pathological state, even though there was minimal 
difference between the two ring types as shown in Figure 2-57.  
 
 
Figure 2-56 Cross sections of the mitral valve along the septal lateral plane at three






2.2.4.3 Role of Annular Tension on Dilatation of the Mitral Annulus in Leaflet 
Prolapse 
He et al. recently reported a unique study on the role of mitral annular tension in 
dilatation of the annular size[119].  The authors hypothesize that during systolic valve 
closure, the radially outward forces imposed by the mitral leaflets resize the mitral 
annulus and increase the overall dimension. To test this hypothesis, the authors explanted 
porcine mitral valves and instrumented the annular circumference with multiple load 
cells, and pressurized the valve to systolic closure as shown in Figure 2-58. Under static 
loading conditions, they measured the forces along the annular circumference and report 
lower forces at the commissural sections and higher at the septal lateral sections.  
Figure 2-57 The maximum principal stress on the mitral valve under pathological
conditions, after flat ring annuloplasty and Geoform annuloplasty. Three different
positions of the papillary muscle were studied, by simulating apical displacements of































Figure 2-58 (A) Experimental setup used in this study depicting the 16 load cells that
were mounted along the circumference of the mitral annulus, (B) Schematic of the
hypothesized force distribution on the mitral annulus during systolic closure of the
valve, (C) Force distribution along the different annular points at static pressure of 16
kPa, and (D) Schematic demonstrating higher forces at the septal-and-lateral sections




2.2.4.4 Hemodynamics of the Mitral Valve after Edge-to-Edge Repair 
Li S et al. reported the impact of edge-to-edge repair on blood flow through the 
mitral valve under steady flow conditions using digital particle image velocimetry. They 
investigated the impact of length of the suture loop and position of the suture on valve 
fluid dynamics. Figure 2-59 depicts the Reynolds shear stress measured using particle 
image velocimetry at the three stitch locations. With a central stitch, diastolic flow was 
split into two symmetric jets on either sides of the suture. With lateral displacement of the 
stitch towards the commissure, the jets became asymmetric and when the stitch was 














Figure 2-59 (Top) Three different locations of the edge-to-edge stitch that were
investigated in this study; (Bottom) Reynolds shear stress calculated from particle image




2.2.4.5 Single vs. Double Balloon Valvuloplasty to Relieve Mitral Stenosis 
Schievano et al. in 2009 reported a finite element study comparing single to 
double balloon catheter systems to relieve mitral stenosis in patients with rheumatic heart 
disease[120]. The authors reported a finite element analysis in which they compared the 
impact of using one single large balloon, over two smaller balloons to relieve stenosis 
and improve valve hemodynamics. A fluid structure interaction model of the mitral valve 
was developed as shown in Figure 2-60, and the single and double balloon designs were 
incorporated into the computational model. Principal stress in the balloon and the mitral 
valve leaflets was calculated, and the authors reported that a double balloon was more 













Figure 2-60 (A) Geometric models of the single and double balloons, (B) The
virtual mitral valve model used in this study, (C) Strain calculated in the single and
double balloons during valvuloplasty, (D) Stresses in the mitral valve with the two 






CHAPTER 3  
 
HYPOTHESIS AND SPECIFIC AIMS 
3.1 HYPOTHESIS AND OBJECTIVES 
Clinical data on mitral valve repair indicates that irrespective of the pathology, 
whether congenital, degenerative or functional, recurrence of mitral regurgitation is seen 
in 10% - 80% of the patients. At 10 years after primary surgery, recurrence of mitral 
regurgitation remains at ~15% in congenital mitral valve repairs [12], ~40% in 
degenerative mitral valve repairs [10], and ~80% in repairs for functional mitral 
regurgitation [11]. This data reveals a disheartening fact that even though experience with 
mitral valve repairs has increased significantly in the last two decades and excellent acute 
patient outcomes are reported, the long term durability and chronic outcomes remains 
very poor. In the current era of cardiac surgery, where the focus has shifted from valve 
replacement towards valve repair, such a scenario is unacceptable.  
The reasons for failure of mitral valve repairs are multifactorial, and are poorly 
understood due to several reasons. Firstly, abundant clinical literature on mitral valve 
repair outcomes is available today, but the data are muddied by the usage of confusing 
nomenclature by different institutions, variability in the surgeon’s expertise and the finer 




institutions, and to a large extent an increased focus on the annuloplasty ring type than 
the valve pathology. Secondly, industry impetus is focused towards establishing 
annuloplasty as the standard of care for all mitral valve lesions and further introducing 
percutaneous repair procedures, even though clinical outcomes and basic science studies 
clearly do not support these opinions and emphasize the need to better understand the 
valve pathological function, hemodynamics and mechanics.  
 The objective of this doctoral thesis was thus to develop an experimental 
framework that allows controlled investigation of the mechanisms leading to failure of 
mitral valve repair techniques. To achieve this goal, the thesis is structured into three 
focus areas: [a] design in vitro models of mitral valve pathologies that mimic the human 
pathology; [b] design techniques to measure and quantify the function, kinematics and 
mechanics of the valve; and [c] provide mechanistic insights into failure of mitral valve 
repairs using the hemodynamic and mechanics measurements.  
 Thus the central hypothesis of this thesis is that, an ideal mitral valve repair 
should aim to restore physiological function and mechanics of the valve, from its 
pathological state. Controlled experimental studies to understand the hemodynamics 
and mechanics of various mitral valve repairs will aid in identifying the efficacy of 
current repair techniques, understand their drawbacks, and open avenues for future 
improvements.  
 To test this central hypothesis, an in-vitro experimental methodology was 
developed wherein congenital, degenerative and structural abnormalities of the mitral 




annular geometries is literally impossible and is not practical in the scope of this thesis. 
Thus native porcine mitral valves of different sizes were used in this thesis, which were 
structurally altered to mimic different valve pathologies. Precise control over the three 
dimensional mitral valve geometry, and the sub annular function in this in vitro system 
allowed mimicking different mitral lesions; which is challenging to create in animal 
models. A unique advantage of this system is that the efficacy of various surgical 
techniques can be simultaneously assessed on the same valve specimen, which is 
impossible to perform in an animal model. Additionally, the in-vitro system provides 
visual access and real-time measurement of valve regurgitation volume, leaflet and 
chordal kinematics and mechanics, which provides a complete understanding of valve 
function.  
 With this overall goal, in this thesis three specific mitral valve lesions were 
studied and the efficacy of surgical repair techniques applicable to each lesion was 
assessed. The three mitral valve lesions studied are: 
 [Specific Aim 1]: Congenital Cleft Mitral Valve in Atrioventricular Canal Defects 
 [Specific Aim 2]: Degenerative Mitral Prolapse due to Acute Chordal Rupture 
• Isolated Posterior Leaflet Prolapse 
• Isolated Anterior Leaflet Prolapse 
 [Specific Aim 3]: Functional Mitral Regurgitation in Cardiomyopathies 
The specific aims represent the spectrum of mitral valve lesions for which 
surgical repair is the recommended option, and in which post-surgical repair failure is 




3.2 SPECIFIC AIMS 
3.2.1 SPECIFIC AIM 1 – PEDIATRIC MITRAL VALVE REPAIR 
 Atrioventricular canal defects encompass a spectrum of lesions of which the cleft 
mitral valve is very common. Correcting the ostium primum and septum secondum 
defects with separation of the common atrioventricular valve annuli into mitral and 
tricuspid valves, resulting in a mitral valve anatomy with a cleft in the anterior leaflet. 
Surgical closure of the cleft is currently recommended, but as the patient grows the repair 
fails resulting in recurrent regurgitation. Based on these clinical observations, it is 
hypothesized that dilatation of the mitral annulus due to increase in overall cardiac 
chamber size induces regurgitation at chronic follow up after primary surgery. 
Balanced use of annuloplasty with partial cleft closure may be a beneficial strategy to 
avoid late recurrence of regurgitation in these patients. 
To test this hypothesis, the following objectives are proposed-  
 (A) Develop an in vitro model of cleft mitral valve in canal defects 
 (B) Understand the hemodynamic function of the cleft mitral valve 
(C) Delineate the impact of length of cleft closure, post-procedural changes in  
annular size on valve hemodynamics, and 
(D) Investigate the role of undersizing annuloplasty as an adjunct procedure to   
improve long term post-operative hemodynamic outcomes 
 To develop an in vitro cleft mitral valve model, echocardiographs of patients with 
cleft mitral valves are analyzed and specific anatomical characteristics of the valve will 
be identified. Normal porcine mitral valves are anatomically altered to mimic the 




hemodynamic function of the valve. Firstly, the impact of the length of cleft closure on 
the regurgitant volume will be assessed, as it still remains controversial in the surgical 
community. Though complete closure of the cleft is the most intuitive option to restrict 
regurgitation, it restricts mobility of the anterior leaflet and induces mitral stenosis in the 
long term. Thus, the first objective of this aim is to investigate an optimal cleft closure 
length at which mitral regurgitation can be eliminated without inducing stenosis in the 
valve. Secondly, the impact of growth in cardiac structure on the impact of the repaired 
cleft mitral valve will be assessed to understand if increase in mitral annular size in the 
post-operative period induces recurrent regurgitation. Thus, a mitral annular model whose 
annular area can be changed to desired dimensions will be built and the cleft mitral valve 
will be studied in this setup. Thirdly, the significance of mitral annuloplasty in restricting 
annular growth and avoiding recurrence of regurgitation in the long term will be studied. 
Mitral annuloplasty is rarely performed in pediatric patients currently because of the 
rigidity of the rings and the potential to induce stenosis. Thus, in this study not only will 
the impact of annuloplasty on reducing regurgitation will be assessed, but also the 
potential to induce mitral stenosis will be quantified. It is expected that an optimal level 
of combining annular undersizing with incomplete cleft closure may have the best 
hemodynamic outcomes compared to the current procedures. 
3.2.2 SPECIFIC AIM 2 – DEGENERATIVE MITRAL VALVE REPAIR 
 Myxomatous degeneration or fibro-elastic deficiency of the mitral valve is the 
most common mitral valve lesion and accounts for the largest proportion of mitral valve 




types of degeneration, the etiology underlying the disease varies and calls for different 
surgical procedures for optimal outcomes. Today, Myxomatous mitral valve repair 
procedures have become the “standard of care” and used indiscriminately for fibroelastic 
deficient valves as well, without diligent examination of the underlying etiology, 
resulting in higher rates of late recurrence of regurgitation. The hypothesis of this aim is 
that etiologic classification of degenerative mitral valve repairs is important to tailor 
surgical techniques to the lesion. In fibroelastic deficient valves, the use of routine 
leaflet resection techniques should be opposed and leaflet preservation should be 
practiced.  
To test this hypothesis, the following objectives are proposed. 
(A) Develop an in vitro model of posterior and anterior prolapse due to acute 
chordal rupture. 
(B) Compare resective vs. non- resective techniques for posterior leaflet prolapse 
(C) Compare neochordoplasty to chordal translocation for posterior prolapse 
(D) Compare resective vs. non-resective techniques for anterior leaflet prolapse 
(E) Understand the efficacy of percutaneous edge-to-edge repair in correcting 
posterior and anterior prolapse 
(F) Investigate the role of saddle annuloplasty compared to flat annuloplasty in 
improving mechanics of the mitral valve leaflets 
In this thesis, the studies will be confined to fibro-elastic degeneration of the 
mitral valve due to lack of information on myxomatous degeneration and the complexity 
in simulating the biological changes in normal mitral valves. Fibro-elastic degeneration 




leaflet, or anterior leaflet, with minimal leaflet distension or myxoid changes. In vitro 
models of uni-leaflet prolapse will be developed using normal porcine valves in which 
chordal rupture is mimicked. Hemodynamic valve function, and leaflet kinematics can be 
measured in this in vitro system using various measurement techniques. The in vitro 
pathological valve will then be repaired using standard surgical techniques, and the 
efficacy of the repairs in restoring physiological valve function and mechanics is 
quantified.  Specifically for posterior leaflet prolapse, five surgical techniques will be 
studied – quadrangular resection of prolapsing cusp with plication of the mitral annulus, 
limited triangular resection of the prolapsing cusp, replacement of the ruptured marginal 
chordae with poly-tetrafluoro ethylene (ePTFE) suture loops, translocation of posterior 
strut chordae to the marginal positions and percutaneous edge-to-edge repair procedure. 
On the anterior leaflet, triangular resection of the prolapsing segment, replacement of the 
ruptured marginal chordae with neochordae and edge-to-edge repair will be assessed. 
Quadrangular resection with annular plication and chordal translocation will not be 
performed on the anterior leaflet due to limited tissue on the anterior leaflet and the 
importance of strut chordae in governing leaflet mobility and ventricular function 
respectively. In the final sub-aim, the impact of flat vs. saddle annuloplasty on the 
mechanics of the posterior leaflet will be studied, to investigate if the use of 3D 
commercial annuloplasty rings may reduce the suture line stresses in degenerative valve 





3.2.3 SPECIFIC AIM 3 – SURGICAL REPAIR FOR FUNCTIONAL MITRAL 
REGURGITATION 
 Functional mitral regurgitation, either due to ischemic or non-ischemic dilated 
cardiomyopathy remains a surgical challenge. Persistent or recurrent mitral regurgitation 
is diagnosed in most patients after mitral annuloplasty, and is attributed to progressive 
ventricular disease, and variability in valve geometry between individual patients. 
Though widely accepted as a risk factor for repair failure, the impact of mitral valve 
geometry on annuloplasty and sub annular repair techniques is currently unknown and 
may be a significant risk factor to consider. The hypothesis of this aim is that the three 
dimensional geometry of the mitral valve impacts the hemodynamic outcomes of 
annular and sub annular repairs for functional mitral regurgitation. A patient specific 
approach to quantify valve geometry is required to tailor surgical techniques to 
individual subjects.  
To test this hypothesis, the following objectives are proposed. 
[A] To develop an in-vitro model of functional mitral regurgitation in which the 
3D mitral valve can be precisely altered 
[B] Investigate the failure mechanisms of annuloplasty under different mitral 
valve geometric configurations 
[C] Investigate the role of 3D mitral valve geometry on the efficacy of secondary 
chordal cutting procedure, and 
[D] Quantify the impact of chordal cutting on the chordal force redistribution  
An in-vitro simulator that allows precise control over the 3D annular and sub-




setting of functional mitral regurgitation. Two mitral valve geometries will be studied, 
annular dilatation + 10mm apical displacement of the papillary muscles, and secondly 
annular dilatation + 10mm apical-posterior-lateral papillary muscle displacement. 
Hemodynamic function of the valve will be assessed under physiological and 
pathological settings, and parameters that describe systolic coaptation geometry and 
leaflet mobility will be quantified. Upon establishing the disease models, mitral 
annuloplasty will be performed using an adjustable annulus model in which the septal 
lateral dimension of the mitral valve can be changed to desired levels in the range of 24-
40 mm. The hemodynamic function and mechanics of the mitral valve will be carefully 
assessed after mitral annuloplasty and compared to those obtained under physiological 
and pathological conditions, to assess the degree to which annuloplasty improved valve 
function and the underlying reasons for failure to restore complete valve competence. 
Secondary chordal cutting is the sub-valvular technique that will be studied 
concomitantly with annuloplasty, wherein the secondary “strut” chordae on the anterior 
leaflet are transected to improve anterior leaflet mobility and leaflet coaptation. The 
impact of secondary chordal cutting in restoring physiological valve function and 
mechanics will be studied, and the potential redistribution of chordal forces due to 







3.3 EXPECTED OUTCOMES AND CLINICAL RELEVANCE 
 
The overall impact of these studies is expected to be two-fold: 
3.3.1 SCIENTIFIC APPROACH TO MITRAL VALVE REPAIR 
 Data from this thesis will provide mechanistic insights into the failure 
mechanisms of surgical techniques that are currently in clinical practice. Etiologic 
classification of the pathology, and the impact of relevant risk factors on chronic 
outcomes would guide the surgeon towards a scientific decision making approach rather 
than an experience/intuition based approach to valve repair. Cultivating such an approach 
may be useful in improving the long term outcomes of mitral valve repair, and also pave 
the path towards an “individualized, patient specific” approach compared to a “one for 
all” approach to mitral valve repair.  
3.3.2 GUIDE THE DEVELOPMENT OF VALVE REPAIR TECHNOLOGIES 
 The data from this thesis may also provide impetus to develop valve repair 
technologies that not just focused on the mitral annulus. Several sub annular and 
percutaneous techniques are currently in development, with the primary focus to translate 
sub optimal surgical techniques to percutaneous delivery approaches. However, this 
thesis would provide the data and literature required to push device development in the 










CHAPTER 4  
 
MATERIALS 
In this chapter the design and operating principles of the major equipment used in 
this thesis are described. Specifically, the hardware and functional capabilities of the in 
vitro pulsatile left heart simulator, C-ring force transducers, high speed image acquisition 
system and 2D/3D ultrasound system are described in detail.  
4.1 PULSATILE LEFT HEART SIMULATOR 
 
All the experiments were conducted in the in vitro left heart simulator developed 
in the Cardiovascular Fluid Mechanics Laboratory at Georgia Institute of Technology. 
The simulator is a pulsatile, pump-driven system, in which physiological and 
pathological hemodynamic function of mitral valves can be studied. As shown in Figure 
4-1, the simulator consists of nine main components: (a) Reservoir; (b) Left Atrial 
Chamber; (c) Mitral Annular Plate; (d) Left Ventricular Chamber; (e) Papillary Muscle 
Positioning System; (f) Pulsatile Prime Mover; (g) Programmable Solenoid System; (h) 






4.1.1 DESCRIPTION OF THE LEFT HEART SIMULATOR 
4.1.1.1 Lung Reservoir 
A reservoir of saline maintained at a static pressure of 12mm Hg is connected to 
the left atrial chamber using polyvinyl chloride pipes of 1” Ø ID, to simulate the atrial 
pressure head. An in-line electromagnetic flow probe (6-Series - 28mm, Carolina 
Medical Instruments, NC) is placed between the reservoir and the atrium to measure the 
mitral inflow and regurgitant volume. 
4.1.1.2 Left Atrial Chamber 
The left atrium is a cuboid shaped chamber with a length of 89 mm, width of 
70.17 mm and a height of 45.31mm as shown in Figure 4-2. The total cavity volume of 
the atrial chamber is 283 cm3, which is equivalent to the largest physiological volume of 





the left atrium in normal adults. The chamber has an inlet on its anterior face that is 
connected to the lung reservoir and allows fluid flow from the reservoir into the atrial 
chamber. The chamber’s posterior face chamber consists of an open flange that attaches 
to the mitral annular plate. The superior and the medial faces of the left atrium have two 
ports with leur lock valves that allow air bleeding from the simulator and a connection 










4.1.1.3 Mitral Annular Plate Model 
The mitral annular plate is a metal frame that houses the silicone mitral annulus 
onto which the porcine mitral valve is sutured. The silicone annulus consists of a tension 
spring embedded in silicone and enclosed by a water proof cloth forming a D-shaped 
annulus depicted in Figure 4-3. The annulus is then sutured onto a thicker membrane 





(Darlexx, Shawnut Mills, MA), which is then fastened onto the aluminum frame of the 
annular plate. In this thesis, two types of silicone annulus models were designed and 













4.1.1.3.1  Variable Annular Size Model 
This model was designed to allow precisely controlled adjustment of the mitral 
annular area, either to simulate pathological mitral annular dilatation or a reduction in 
annular size consistent with an annuloplasty procedure. A spring-rope mechanism was 
used to adjust the annular area to several levels ranging between 6 cm2 to 14 cm2. A 
stainless steel wire rope was passed through the spring core of the silicone annulus, and 
the two ends of the wire were pulled from the open ends of the annulus. The ends of the 
Figure 4-3 Photograph of the adjustable size mitral annular plate with a spring loaded




wire were then crossed and the two ends passed through the aluminum frame and 
connected to an aluminum shaft as shown in Figure 4-4. By rotating the shaft, the septal-
lateral dimension of the mitral annulus was adjusted to the desired lengths, ranging from 










4.1.1.3.2  Variable Annular Shape Model 
This model was used to alter the 3-dimensional shape of the mitral annulus; from 
a flat shape to different degrees of saddle. The internal core of this annulus consists of a 
flexible linked chain that can flex in the out-of-plane direction as shown in Figure 4-5A. 
The chain is then embedded in silicone and formed into a D-shape such that the curved 
part of the D represents the posterior annulus and the straight part represents the anterior 
annulus. A sliding element that can move along its axis was connected at the posterior 
end of the annulus, such that the septal-lateral dimension of the annulus is self-adjusted 
when the degree of non-planarity of the annulus increases. Two push-rods are connected 
Figure 4-4 (A) En face view of the adjustable mitral annulus model; (B) Side view of the 





at the two commissures of the mitral annulus so as to impose an apical force on the 
















4.1.1.4  Left Ventricular Chamber 
The left ventricular chamber is a rigid acrylic chamber with a flow inlet, a flow 
outlet, and a connection to a bladder pump that generates the physiological pressure and 
flow conditions. Inside, the mitral valve sutured onto the annular plate is positioned at the 
flow inlet using papillary muscle positioners as shown in Figure 4-6A, such that the valve 
(A) (B) (C) 
(D) (E) 
Figure 4-5 (A) Flexible link chain used in the saddle annulus model; (B) The link
chain mounted onto the atrial chamber and sutured to a sliding element at the bottom;
(C) Push rods built into the atrial chamber at the two commissural points to deform
the annulus in the out-of-plane direction; (D) Side view of the annulus in the flat




controls the flow of saline from the atrium into the ventricle. A mechanical tilting disc 
aortic valve (Medtronic Hall Valve, MN) shown in Figure 4-6B was used in the flow 
outlet position to maintain uni-directional flow from the ventricle into the outflow tract. 
The medial face of the chamber has a pressure port located at the same height as the atrial 
pressure port as shown in Figure 4-7 , and the top face of the chamber has two ports to 
which plastic syringes are connected. These syringes are used to inject air into the 


















Figure 4-6 (A) Porcine mitral valve sutured onto the silicone annulus and the two papillary
muscle positioners in the left heart simulator; (B) The tilting disc artificial heart valve used

















4.1.1.5 Papillary Muscle Positioning System 
Two geared fixtures were designed to hold the mitral valve papillary muscles in 
the left ventricular chamber, pictured in Figure 4-8A. They consist of five components: 
(a) stainless steel frame, (b) Teflon connectors, (c) linear adjustment screw with bevel 
gears, (d) external positioning system, and (e) water-proof flanges. The stainless steel 
frames are inserted into the left ventricular chamber through water proof flanges on the 
apical plate of the ventricle, and the linear adjustment screw with the bevel gears (Part 
#A1X4MY06020, SDP-SI Inc, NY) are mounted onto this frame as shown in Figure 
Figure 4-7 The acrylic left ventricular chamber used in the study with the bladder 
pump on the left (not shown), the left ventricular outflow(black tape) at the right top




4-8B . The long stainless steel shaft connected to the driving bevel gear allows rotation of 
the linear screw and thus anterior-posterior motion of the papillary muscles. The stainless  
steel frame can also be slid and rotated to simulate apical-basal and lateral displacement 
of the papillary muscles respectively. The Teflon connectors are sutured onto the base of 
the papillary muscles and mounted onto the linear adjustment screw using a male 
threaded stud. This setup allows for precise displacement of the papillary muscles in the 











A simple calculation system based on trigonometric ratios was developed that 
enables conversion of angle rotations into linear projections, as shown in Figure 4-9  to 





Figure 4-8 (A) Close up view of the bevel gears that drive the linear motion of the
threaded stud and thus the shaft on which the papillary muscles are sutured onto;



































l = (10mm)/(cos θ) 
θ : measured angle  
# of rotations = l / 0.91  
where 0.91 is the pitch of the screw 
stud of the papillary muscle system 
Figure 4-9 Schematic depicting the trigonometric ratio’s used to calculate the angles




4.1.1.6 Pulsatile Bladder Pump 
The prime mover to generate the pulsatile pressure and flow conditions was a 
compressible bladder pump that was built in the laboratory. It consists of a silicone 
bladder (Clear Silicone Shore 30- Cured at 400 F for 2 hours, Hi-Tech Elastomers Co 
Ltd, CA) that is enclosed in an air-tight cylindrical acrylic chamber (Part # 8486K593, 
McMaster-Carr, GA) and metallic plates (Part # 9057K13, McMaster-Carr, GA) as 
shown in Figure 4-10. The chamber is provided with one inlet and two outlet ports that 
allow filling and draining of the chamber with compressed air. The ports are connected 
using clear silicone tubing to a series of solenoid valves and an air compressor. When 
compressed air is let into the chamber, the positive pressure gradient between the 
chamber and the silicone bladder make the bladder collapse. Since the bladder is directly 
connected to the ventricle through polyvinyl pipes, the collapsing action increases the left 
ventricular pressure and thus simulating systolic ventricular contraction. When the 
compressed air is rapidly drained from the chamber, the bladder expands back to its 










4.1.1.7  Programmable Solenoid Valve System 
The contraction and relaxation of the bladder pump is controlled via a series of 
programmable solenoid valves (Model 6213, Burkert Fluid Control Systems, Irvine, CA) 
which govern the flow of compressed air into the compressible bulb pump chamber. 
These valves are controlled via a DC signal such that a positive voltage opens the valves 
while a zero voltage would close them. Three solenoid valves were used in the pulsatile 
left heart simulator. Two valves were dedicated to rapidly drain the compressed air from 
the pump chamber and one valve to fill the chamber. The valves were connected in a 
parallel fashion as shown in Figure 4-11 using copper tubing (Part # 8967K893, 
McMaster Carr, GA ) and end-connectors (Part # 5520K815, McMaster Carr, GA), and 
the entire system was then connected to a air compressor (Part # T-35HD-1 HP Ultra Oil-
Less Air Compressor, Thomas Air-Pac, WI) that maintained a constant air flow at a 
pressure of 20 psi. Each valve was controlled using a timed relay circuit that could be 
interfaced via a DOS program (Trigger.exe) with an internal clock. The relay circuit 
consists of several analog switches that can be independently timed, so as to allow 
current to the solenoid valves in a controlled fashion. Using this program desired heart 
rates, systolic and diastolic duration and any time delays can be programmed into the 






















4.1.1.8  Flow Loop Plumbing 
A combination of polyvinyl pipes and rubber tubing were used to complete the 
flow loop plumbing. The same silicone bladder used to make the pump was used 
downstream of the aortic valve to simulate compliance of the aorta, and adjustable hose 
clamps (Part # 05-846Q, Castaloy Jumbo Hosecock Clamp,Fisher Scientific, Pittsburgh,  




Figure 4-11 The bladder pump system connected to a parallel series of solenoid
valves. The valve # 1 is the systolic valve connected to an air compressor providing





4.1.2 DATA ACQUISITION HARDWARE AND SOFTWARE 
 
To continuously monitor the hemodynamic conditions in the left heart simulator, 
a data acquisition system was built using components from different vendors that suit the 
specifications of the system. The main hardware components used in the data monitoring 
and recording system are: (a) differential pressure transducer with signal conditioner; (b) 
electromagnetic flow probe with signal conditioner; (c) portable data acquisition card 
with signal connector; and (d) custom data acquisition software.  
4.1.2.1 Differential Pressure Transducer 
A variable reluctance differential pressure transducer (DP-09, Northridge, CA, 
USA) was used to measure the pressures in the left heart simulator. The DP-09 model is a 
low cavity volume stainless steel pressure transducer that can measure differential 
pressures ranging from ±0.5 psi to ±500 psi, while maintaining ± 0.5% linearity at high 
natural frequencies. This model was best suited to measure transvalvular pressure 
gradients up to 200 mm Hg at a highest heart rate of 2.6 Hz, without any drift or non-
linearity in the measured signal. The transducer as shown below in Figure 4-12 consists 
of a magnetic permeable stainless steel diaphragm clamped between two blocks of 
























 In the un-deflected state, the diaphragm is centered between the two blocks 
maintaining an equal distance of 0.005” between the diaphragm and the legs of the E-
shaped core. As a differential pressure is applied on the two sides of the diaphragm, it 
deflects into the lower pressure cavity thus reducing the cavity volume on the deflected 
side. Thus the reluctance of the cavity into which the diaphragm has deflected into, is 
reduced and that on the higher pressure side is increased. The transducer is connected 
into an AC bridge circuit forming one half of a four arm bridge, and the center tapped 
secondary of the carrier transformer in the signal demodulator forming the other half. The 
(A) (B) 
(C) 
Figure 4-12 (A) Validyne differential pressure transducer; (B) Cross sectional view of
the transducer depicting the inductance coils and the pressure cavities;   (C) Circuitry




output of the transducer is thus an AC signal whose peak-to-peak amplitude is dependent 
upon the deflection of the diaphragm and whose phase is determined by the direction of 
deflection. A CD23 digital signal conditioner (Validyne Engineering, Northridge, CA) 
was used with the differential pressure transducer. The CD23 provides a 5-Vrms, 5 KHz 
carrier excitation voltage to the transducer and has the solid state circuitry to amplify, 
demodulate and filter the transducer signals and also to output a ± 10 VDC signal. Before 
using the DP-09 transducer with the CD23 conditioner in the left heart simulator, it was 
calibrated against ten different barometric differential pressures using a protocol 
described in section 5.3.1. 
4.1.2.2  Electro Magnetic Flow Meter 
An in-line electromagnetic flow meter (EFP) (26mm, 600 Series, Carolina 
Medical Electronics, East Bend, NC) was used to measure the diastolic flow and systolic 
regurgitant flow in the left heart simulator. The 600 series EFP works on the principle of 
Hall effect, wherein charge carries of a current carrying conductor when placed in a 
transverse magnetic field experience a sideways Lorentz force resulting in a charge 
separation in the direction perpendicular to the magnetic and the current. The resultant 
voltage difference obtained due to charge separation is proportional to the applied 
magnetic field, and is famously known as the Hall Effect. The flow measurement system 
consists of three main components: (a) Flow Probe, (b) Ground and (c) Signal 
Conditioner. The flow probe as shown in Figure 4-13 is a donut shaped device consisting 
of a copper coil that generates a magnetic field when current is passed through it. This 




Wave Digital Flow Conditioner, Carolina Medical Electronics, East Bend, NC) that can 
measure low noise, high resolution pulsatile data with a frequency response selectable up 
to 100 Hz. The signal conditioner sends a 500 Hz square wave, 0.5 A, up to ± 15 V signal 
to the flow probe, and measures the voltage difference due to charge separation using two 
polarizer’s on the flow probe. The voltage difference measured from the flow probe is 
amplified using a solid state circuitry in the signal conditioner, and flow rates in the range 
of 5 ml/min to 19.99 L/min can be measured. The flow probe and the signal conditioner 











4.1.2.3 Portable Data Acquisition Card and Signal Conditioning System 
Pressure and flow data were synchronously monitored and recorded using a data 
acquisition system (DAQ) that was custom built in the laboratory. The DAQ system 
consists of three components: (a) BNC-2110 Isolated Signal Connector, (b) PCMCIA 
(A) (B) 
(C) 
Figure 4-13 (A) Carolina medical electromagnetic flow probe; (B) The transmitted and
flow probe configuration that generates the charge separation proportional to the flow




1200 Signal Acquisition Card, and (c) a PCMCIA port accessible laptop with the 
hardware to run LABVIEW software. All the above components including the software 
were obtained from National Instruments, Austin, Texas, USA. The BNC 2110 series 
signal connector blocks with signal-labeled BNC connectors as shown in Figure 4-14  are 
used for easy connectivity of analog I/O, digital I/O and counter/trigger signals to the 
multifunction PCMCIA card. The NI-DAQ 1200 is a legacy, low cost, multifunction I/O 
card for PCMCIA that provides eight single ended or four differential analog inputs at 
100kS per second, 12-bit performance. It also allows digital triggering from an external 
source, and has three built in 16-bit, 8 MHz counters; two 12-bit analog outputs; and 24 
digital I/O lines. The DAQ card is inserted into the PCMCIA slot in the laptop (F-Series 
VAIO, Sony Corporation, USA) and the data was monitored and recorded using custom 
software (DAQANAL) built in LABVIEW 5.1. The software was designed such that the 
sampling frequency, trigger timing and delay, and signal filters can be prescribed as 
desired by the user. Graphical interfaces to monitor the measured data were provided, 
and the flow and pressure data over multiple cardiac cycles can be synchronously 







Figure 4-14 (A) BNC-2110 Connector Block; (B) DAQCARD 6024-E portable data




4.1.3 C-RING FORCE TRANSDUCERS 
To measure the forces on individual mitral valve chordae tendineae, force 
transducers were designed and manufactured in the laboratory. The design specifications 
of the force transducers are: 
• Small size such that physiological function of the chordae tendineae or the       
valve is not disturbed 
• Deformation that matches the elongation of the chordae tendineae 
• Measure high frequency forces in saline without baseline drift while 
maintaining linearity 
• Ability to sustain function for atleast 48 hours when submerged in saline 
Based on these design specifications, a C-ring force transducer with a maximum 
dimension of 4mm, and a thickness of 1mm was developed using 2 strain gauges as 
shown in Figure 4-15. Also, the total mass of the C-ring transducers is low which allows 
multiple transducers to be instrumented on the same valve. The operating principles and 








Figure 4-15 (A) Isometric view of the brass C-ring design used in the force transducer; 




The C-ring transducer is based on strain gauge (SG) technology that detects the 
slightest deformation of the chordae tendineae to measure the corresponding force 
governing the deformation. The miniature size allowed easy implantation of the 
transducers onto the chordae without intervening with the physiological function of the 
valve.  
4.1.3.1 Operating Principles 
The C-ring force transducer is based on the simple principle that the linear 
deformation of a material can be detected using precision strain gauges that can be 
translated into a force with prior calibration. Strain gauges measure deformation through 
a proportional change in their resistance, resulting in a change in voltage difference in a 
constant current circuit. However, the change in resistance is very small and thus a 
Wheatstone bridge configuration is typically used to detect the relative changes in 
resistance. In this study, a half bridge Wheatstone circuit was used as shown in Figure 
4-16, where one gauge is mounted along the longitudinal centerline of the convex surface 
of the C-ring, with a mating gauge on the corresponding concave surface. These two 
gauges form the adjacent arms in the bridge circuit, and assuming uniform temperature 
throughout the thickness of the C-ring, the bridge output is doubled. 
By providing an excitation voltage VEX to the bridge, it is possible to generate a 
voltage drop across the bridge and thus determine the resistance of the strain gauge. The 
generated voltage differences are normally very small, and thus the signal is amplified 
with dedicated instrumentation. Elaborating on the operating principles from a 










The resistance R0 of a metal, i.e. a SG, is given by Equation 4-1: 




    R0: resistance [Ω] 
    ρ: resistivity [Ωm] 
    l0: length [m] 
    A0: area [m2] 
 
 When a force F stresses the brass ring, it is elongated by some amount ∂l so 
that the new length is l + ∂l. It is also true that in such a stress-strain- condition, 
although the C-ring lengthens, its volume will remain nearly constant. Because the 










the length increases, then the area must decrease by some amount ∂A defined by 
Equation 4-2: 




Combining Equation 4-1 and Equation 4-3, the new resistance can be calculated as 




Therefore the change in resistance can be defined by Equation 4-5 as: 
 
 
Equation 4-5 clearly shows that the strain ∂l/l converts directly into a resistance change. 
Thus, the gauge factor G, describes the relationship between the change in resistance and 







































4.1.3.2 Signal Amplification 
To amplify the small voltage differences generated by the half bridge circuit, a 
signal amplifier was built using OEM components. Figure 4-17 outlines the flow of data 
through the various components of the signal conditioning system which amplifies, filters 
and smoothens the signal for recording using the data acquisition system.  
 
The design specifications for the signal amplifier are: 
• 6 channel input/output 
• 350 Ω bridge resistors for the Wheatstone half bridge that act as passive resistors 
to complete the half-bridge circuit 
• Potentiometers of the required ratings for offset adjustment to balance the 
Wheatstone bridge 
• 120V power supply with galvanic separation from the Wheatstone bridge circuit 
• Signal filtering that decreases aliasing and improves signal to noise ratio for 
optimal force measurements 





4.1.3.3 Manufacturing Methods 
 The detailed protocol for manufacturing the C-ring force transducers and the 
signal amplifier are now presented. The C-ring made of Brass is 6mm in Ø and has a 
thickness of 0.8mm, with a notch and two holes at either ends that allow suturing the ring 
onto the mitral valve chordae tendineae. The C-rings are designed and custom 
manufactured at a local machine shop (J. M. Machining, Lawrenceville) and the strain 
gauges were purchased from a strain gage vendor (Part # 031-DE Vishay Micro 
measurements, NC).After acquiring these materials, the C-ring force transducers were 
then manufactured using 15 sequential steps as described below: 
Step 1 – Positioning the C-ring: The manufactured brass C-rings were clamped in a 
miniature vice to position the C-ring for ease of handling, optimal visual access and to 
avoid contamination due to contact with other objects.  
Step 2: Degreasing the C-ring: To remove the surface contamination and particulate 
matter on the C-rings a degreaser (CSM-1A, Measurement Group, Raleigh, NC) was 
applied on the surface using a sterilized cotton swab. An even coat of the degreaser was 
first applied on the ring and another sterilized swab was used to remove the degreaser 
from the surface. Evaporation of the degreaser to dry the C-ring surface is not an optimal 
choice as it does not remove the particular matter present on the C-ring as physical 
scraping using a cotton swab. To avoid recontamination of the surface, the cotton swabs 
should scrape the surface in one direction and in only one pass. During this process, 
surface contamination due to contact with human fingers must be avoided by wearing 




Step 3: Surface Conditioning: The surface conditioner is a water based solution that 
allows better adhesion of chemical bonding agents to the metal surface of the C-ring. 
Using a new cotton swab, step 2 was repeated with a surface conditioner (M-Prep 
Conditioner, Measurement Group, Raleigh, NC, USA).  
Step 4: Surface Neutralization: The surface neutralizer reduces any residual charge on 
the brass surface, and Step 2 was repeated with a surface neutralizing solution (M-Prep 
Neutralizer 5A, Measurement Group, Raleigh, NC, USA). 
Step 5: Surface Bonding: After applying the surface conditioner and neutralizer, the C-
ring surface is chemically clean and pH neutral. To manufacture the C-rings, a bonding 
material with optimal viscosity was selected (M-Bond 43B, Measurement Group, 
Raleigh, NC, USA) and stored at room temperature. At its optimal state, the bonding 
material was applied to the surface of the C-rings with due care to avoid covering the 
holes and notches in the C-ring to allow suturing the rings onto the chordae tendineae. 
After covering the C-rings in an even coat of bonding solution, the rings are baked in an 
oven for 1 hour at 257°F (125 °C). This step is repeated twice after which the C-ring is 
ready for mounting the strain gages.  
Step 6: Preparing the Strain Gages: Two strain gauges (EA-06-031DE-350. 
Measurement Group, Raleigh, NC, USA) are selected and carefully removed from their 
package and stored in a sterile and dry container. The membrane onto which the strain 
gages are printed onto is typically larger than the width of the C-ring and thus using a 
fine scissors, the membrane is carefully trimmed as shown in Figure 4-18, to match the 




from human contact by using forceps. The membrane can be trimmed very close to the 
circuit, but care should be taken to avoid any scratches or cuts into the actual circuitry. 
The terminals at the top and bottom of the C-rings can be trimmed to a desired length but 




Step 7: Mounting the Strain Gages: Commercially available super glue was used to 
mount the strain gages onto the C-ring surface as shown in Figure 4-19. In this case, 
super glue instant bond adhesive (Cortec Spray Technologies Division, Spooner, WI, 
USA) was used to fix the inner and outer strain gages to the brass surface.  
Inner Strain Gauge Mounting: The C-ring is positioned in the vice such that the two ends 
are facing upwards with direct visual access to the concave section of the ring. 
Appropriate quantity of super glue was applied onto the inner surface of the ring and 
evenly spread over the surface using a piece of paper. Using two forceps the trimmed 
strain gauge is positioned onto the glued surface (approximately at the middle of the C-
ring) and carefully placed on the C-ring while applying minimal pressure. A thin thread 
(134-AWP Single Conductor, Measurement Group, Raleigh, NC, USA) is tightly held in 
the two hands of another person, and carefully the tightened string is rolled over the strain 
= cutting line 




gage to attach it to the underlying bonding surface. This procedure ensures that the entire 
strain gauge is firmly attached to the brass surface and any excessive glue is squeezed out 
from below the strain gage.  
Outer Strain Gauge Mounting: The C-ring is now flipped around in the vice with the two 
ends of the C-ring facing downwards. The procedure explained above is repeated again 
with another strain gauge and extensive care is taken to avoid disturbing the position of 
the already glued inner strain gage. After both the stain gauges are mounted, three fine 
strings are used to firmly hold the gages to the surface until the glue cures and perfect 







Step 8: Protecting the C-ring: To avoid damage to the strain gages in the next steps of 
manufacturing, they were covered in drafting tape (PDT-1, Measurement Group, Raleigh, 
NC, USA).  
Step 9: Pre-soldering the Terminals: To interconnect the strain gages and attach the wire 
conductors to the strain gages, the terminals are pre-soldered by placing a minute quantity 
(a) (b) 
Figure 4-19 Schematic depicting the strain gage mounting method – (a) Outer gage




of tin solder on the strain gage terminal. The soldering should be done carefully and 
swiftly as the strain gages can be damaged by exposure to excessive heat from the solder 
for prolonged periods.  
Step 10: Interconnecting Strain Gages: To put the two resistors in a Wheatstone circuit, 
the strain gages need to be interconnected to each other as described previously.  Using a 
thin metal conductor with enamel coating (134-AWP Single Conductor, Measurement 
Group, Raleigh, NC, USA) one end of the inner strain gage is connected to another end 
on the outer strain gage. The C-ring is first braced in the vice and with the conductor in 
one hand and the soldering iron in another; the conductor is soldered into the pre-solder 
on the inner strain gage. The conductor is then bent around the ring and adjusted for 
appropriate length to avoid residual stress or bending, and the other end of the conductor 
is soldered to the outer strain gage terminal. The connection is then tested using an 
ohmmeter, ensuring that the resistance measured across each strain gage is 350±5Ω. If 
the resistance is less, probably the strain gage was damaged due to the solder connecting 
to the circuitry and if this happens, the strain gages should be removed and all the steps 
starting from Step 4 should be repeated. If the resistance is higher than desired, the strain 
gage may be under constant strain either due to poor bonding or shrinking of the plastic 
membrane of the strain gage under prolonged exposure to soldering iron.  
Step 11: Soldering Conductors to Terminals:  3.3 feet of a 3-conductor cable (336-FTE, 
Measurement Group, Raleigh, NC, USA) was used to connect the strain gage terminals to 
the signal conditioner. The conductors were first tinned appropriately to ensure active 




positions of the strain gage terminals without bending. The ends of the conductor cable 
are stripped to approximately 1.5mm using a flame lighter. The exposed ends of the 
connectors are then soldered onto the terminals longitudinally while holding the soldering 
iron in one hand and the conductor in the other. The conductor cable has three 
conductors, each with a different color (white, black and red). The black conductor 
connects to the outer gage, at the end where the inter-connect from the inner gage 
connects to the outer as shown in Figure 4-20. The red conductor attaches to the other 
end of the outer gage, and the white conductor to the non-interconnect end of the inner 
gage. The connections are then tested using an ohmmeter to ensure a resistance of 350Ω 
is measured across the circuit.  
 
Step 12: Fixing the Wire:  The solder terminals on the strain gages are fragile, and may 
easily break due to bending of tethering of the wire. To avoid such damage, the wires are 
clamped onto the C-ring frame using a thin string as shown in Figure 4-21 
 










Step 13: Second Bond to Cover Solder Terminals: Step 5 is repeated thrice on the C-ring 
to cover the solder terminals and the ends of the conductor with the adhesive bond.  
Step 14: Rubber Coating for Use in Water:  To use the force transducers in saline 
solution, the entire C-ring force transducer is covered in a Nitrile rubber coating (M-Coat 
B, Measurements Group, Raleigh, NC, USA). The M-Coat B should be applied when it is 
cold (atleast 1 hr in the fridge) as at lower temperatures it has lower viscosity and is 
therefore easier to apply on the C-ring. 3 hours after applying the first coat, a second coat 
should be applied and the C-rings must be allowed to cure for 24 hours at room 
temperature and to increase their chemical resistance, baked for 1 hour at +200°F 
(+95°C).  
Step 15: Solder to connector: 3.3 feet of the 3 conductor cable (300-FTE, Measurement 
Group, Raleigh, NC, USA) is used to connect the C-ring to the signal amplifier. The end 
of the conductor cable is connected to a HR10A-7P-4S plug with four connectors (Hirose 




Electric Inc, Simi Valley, CA, USA) with only three active terminals being used. When 
the plug is positioned into the female end in the amplifier, the red cable is connected to 
terminal 1, white to terminal 2 and black to terminal 4 on the plug.  
4.1.3.4 Signal Amplifier Manufacturing Methods 
The signal amplifier used in this work was developed in the laboratory using 
OEM parts and allows simultaneous measurement of signals from six C-rings. Since the 
six channels have identical circuits and are replicated using the same components, the 
manufacturing methods for a single channel are described here. 
4.1.3.4.1 Wheatstone Bridge Specifications 
The passive strain gages used in the amplifier complete the Wheatstone half-
bridge and 350Ω resistors were chosen based on previous studies. To ensure stability of 
the strain gages, the power dissipation of the gages should be within limits that allow 
good dynamic range in measurements with good signal to noise ratio. Large dynamic 
ranges can be obtained using higher excitation voltages but that quadruples the power 
dissipation expressed mathematically by Equation 4-7: 
 
. 
 The manufacturer of the strain gages (Vishay Measurement Group, Raleigh, NC, 
USA) recommends a power dissipation of approximately 5mW, in the half-bridge 
configuration. To ensure stability and safety of the strain gages an additional resistor RS 

















The maximum current allowed through each bridge is given by Equation 4-8: 
 
 
Since the current flows through both the bridge branches, the maximal excitation current 
required is calculated by Equation 4-9: 
 
 
The strain gage input modules used in the signal amplifier (Dataforth, Dallas, TX) 
provide a stable 3.333V supply voltage and thus the total resistance in the circuit should 






























Knowing this, RS can easily be found from Equation 4-11: 
 
 
4.1.3.4.2   Completing the Wheatstone Bridge 
 The miniature size of the C-ring transducers does not allow completion of the 
Wheatstone bridge on the ring, thus passive resistors were used in the signal conditioner 
to complete the bridge circuit.  
4.1.3.4.3   Offset Balancing 
 Due to leakage currents from saline solution and other reasons, the strain gages can 
drift substantially from their zero ground. Therefore a provision to adjust the base zero of 
the circuit is required in the amplifier. This was achieved by balancing the Wheatstone 
bridge on the input size of the amplifier by shunting the strain gage.  A potentiometer was 
connected in parallel to the strain gage allowing shunt calibration. The larger the 
potentiometer range, the better is the outcome as smaller resistances allow finer 
adjustments. The strain gage manufacturer specifications indicated that the resistance of 
the gage changes by ± 10 Ω, and thus if one strain gage is 340Ω the other would be 
















































When the two shunts are in their extreme positions with least resistances, the total 
resistance of the circuit will be RS + 2⋅Rpot,min = 235 Ω + 2⋅2 Ω = 239Ω. The maximum 




Thus the power dissipation in the potentiometers at least resistance is thus given 
by Equation 4-14: 
 
 
The power dissipation in RS will thus be 45.4 mW which is within the specified 
range by the manufacturer. Thus all components were within the allowable power 
dissipation limits even in the worst case scenario. The diagram of the entire circuit on the 
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Equation 4-14
Figure 4-23 Input circuit of the entire strain gage – amplifier with shunt potentiometers
and safety resistances. The four terminals to the right in the diagram are attached to the
SCM5B board. The terminals –P,-S, S and P go directly to the Strain Gauge Input





The potentiometers were connected in parallel to the lead wire in series with the 
active strain gages. A TFE-336 low resistance wire was used as the lead (Measurements 
Group, Raleigh, NC, USA) as it has a thin diameter (0.127mm) resulting in a resistance 
of 1.414Ω/m @+24°C. The potentiometers are calibrated such that there is zero bridge 
output when no force is acting on the force transducer.  
4.1.3.4.4  Strain Gauge Input Module Specifications 
            Special strain gage input modules (SCM5B38-03, Dataforth Inc, Dallas) were 
used that can acquire data from strain gages in a Wheatstone half bridge circuit as shown 
in Figure 4-24, and provide an output voltage of ±5V. This voltage output range is 
compatible with the data acquisition system and the input modules offer a 100dB CMRR 
at the critical mains frequency around 60Hz. A wide signal bandwidth of 10kHz is 
available and above 10 KHz they filter signals using a low pass filter with 120dB/decade. 
Good accuracy, linearity with minimal drift, and a stable excitation voltage of 3.333V 













4.1.3.4.5  Galvanic Separation from Power Supply 
 The strain gage input modules provide galvanic separation of the C-rings from the 
power supply. Galvanic separation removes any disadvantages due to voltage differences 
between the input and output circuits. As mentioned previously, the fully isolated 
excitation voltage from the input modules is used in the Wheatstone half bridge. The 
power supply for the amplifier was chosen such that it had short circuit protection, over 
voltage protection, a stable 5V output and is of reasonable physical size. A power supply 
rated at 5V at 3 Amps (Condor D.C Power Supplies Inc) was used as it fit the 
requirements well.  
4.1.3.4.6  Signal Amplifier 
 The amplifier box was made of metal with small holes drilled into the sides to 
minimize the interference originating from electromagnetic radiation. BNC connectors 
were used to connect the C-rings to the strain gage input modules and all the wires were 
insulated enough to avoid inference due to electromagnetic radiation. A small fan was fit 








































Figure 4-25 Outline of the amplifier box. The four inputs per channel seen on the left
in the diagram are the same four as seen in the figure 17with the shunt calibrators.





4.1.3.5 High Speed Imaging System 
To compute the leaflet strains at high temporal and spatial resolution, a high speed 
camera system was used as described below.  
4.1.3.5.1  Layout of the High Speed Imaging System 
The instrument layout for the high speed imaging system used in this thesis is 
shown in Figure 4-26. It consists of a two high speed monochromatic frame grabbers 
equipped with a progressive scan CMOS sensor and macro lens with 105mm focal length 
which are connected to a camera link PCI bus interface with 4 GB buffer memory. The 
PCI bus provides an interface between the dual channel data acquisition system and the 
software drives on the computer hard drive. Detailed specifications and operating 














4.1.3.5.2  Frame Grabbers 
High performance digital cameras from Basler Corp, Germany (504 Series) 
shown in Figure 4-27, were used to image the valve leaflets in this study. The camera 
consists of a 1.3 megapixel (1280 X 1024 pixels) monochromatic progressive scan 
CMOS sensor, resulting in a pixel size of 12µ X 12µ. The progressive scanning 
capability of the imaging sensor enabled continuous image scanning, thus allowing 
acquisition of high resolution images of the mitral valve at 500 frames per second. The 
cameras were powered through a single source 12-VDC power supply. They 
communicated with the control unit through a Camera Link frame grabber system that 
allowed a maximum data transfer rate of 680 megabytes per second. The cameras have an 














4.1.3.5.3  Optical Lens 
Two macro lenses from Nikon Corporation (Micro Nikkor 105mm f: 1-2.8) were 
used as they optimally fit the required focal length for imaging the valve leaflets. The 
optical components of the lens were made of glass and the design of the lens keeps the 
bore length constant at various magnifications. The aperture size could be manually 
adjusted to the desired size using an aperture ring on the lens, with the ability to adjust 
between f-stop values of 1 and 2.8. Due to the fixed focal length of the lenses, the 
cameras were mounted on two tripods whose location could be adjusted to obtain the 
desirable image clarity.  
4.1.3.5.4 Data Acquisition System 
A commercial package software (EPIX, EPIX imaging, Buffalo Grove, IL) was 
used to control the frame grabbers and to acquire and save the images to the computer. 
The software has the provision to adjust the exposure time, number of frames to acquire 
and the resolution at which to acquire them. To synchronize the image acquisition to the 
hemodynamics of the flow loop, an RS-232 cable was connected to the PCI bus port and  
a square wave corresponding to the beginning of systole was used as a trigger to acquire 
the high speed images. As the images are acquired they were stored in the temporary 
memory on the PCI card, and were later transferred as a series of TIFF files to the hard 





4.1.3.6 Ultrasound Imaging System 
A real-time 3D ultrasound imaging system (Philips iE33 system, Philips 
Healthcare, Andover, MA) was used to acquire 3D and 2D tissue Doppler and color 
Doppler images of the valves in the left heart simulator. Two matrix array probes (X7-1 
Pediatric Probe; X3-2 Adult Probe) were used that enable acquisition of 2D planes and of 
3D volumes. The probes have a matrix of piezoelectric crystals that are sequentially 
timed to acquire multiple slices along the sagittal and longitudinal planes to reconstruct a 
3D volume. The acquisition was timed with the hemodynamics of the left ventricular 
flow loop. A photograph of the imaging system with the two ultrasound probes is show in 










Figure 4-28 (A) The Philips iE33 Ultrasound System; (B) The X7-2 and X3-1 probes




4.1.3.6.1  Ultrasound Probes 
The ultrasound probes contain a 2D matrix of piezoelectric crystals that can be 
electrically excited to produce sound waves, which can be focused into the region of 
interest in the human body. In response to an applied excitation voltage, the piezoelectric 
crystals expand and generate sound waves of finite frequencies as shown in Figure 4-29A 
that are directed into the body. When the sound waves approach a tissue, they are 
reflected back and the pressure of the sound wave in turn makes the piezoelectric crystals 











Figure 4-29 (A) The piezoelectric crystals in the ultrasound transducer generate sound
waves upon expansion due to a finite electrical voltage applied to them; (B) The
pressure wave generated due to reflection of sound waves from the human body 






In this thesis, the X7-2 and X3-1 probes were used which could generate 
frequencies in the range of 7 to 2 MHz and 3 to 1 MHz respectively. Both probes have an 
array of 2400 crystals that can be sequentially excited to generate a live 3D rendering of 
the mitral valve, but at the same time generate 2D slices and color Doppler images as 
well. The X 3-1 probe was used mainly because the frequencies of the transducer 
matched the depth of imaging very well. 
4.1.3.6.2  QLAB Software 
 The ultrasound images acquired using the matrix probes were transferred to a 
server, and analyzed using QLAB, licensed software from Philips Medical Systems 
(Andover, MA). The software allowed 3D viewing of the valve image, custom cropping 
along multiple planes, distance and angle measurement between structures, and also 
calculation of regurgitant volume by direct integration of flow through the traced 
regurgitant orifice. For all the experiments conducted in this thesis, both 2D and 3D 
echocardiographic images were recorded and images that are optimal for the required 











CHAPTER 5  
 
METHODS AND PROTOCOLS 
In this chapter, the methods and protocols used to conduct the experiments in each 
of the specific aim are presented. Firstly, general protocols pertinent to valve selection, 
development of in vitro pathological valve models, and operation of the left heart 
simulator are presented. Secondly, technical details and protocols for surgical repair of 
each of the mitral valve lesions are discussed. Finally, the methods to acquire 
hemodynamic, echocardiographic and mechanics data are presented.  
5.1 INTRODUCTION 
  The common objective of the experiments presented in this thesis is to understand 
the hemodynamics and mechanics of the mitral valve under pathological and post-
procedural conditions. Firstly, models of different mitral valve lesions were mimicked by 
altering the anatomy of normal porcine mitral valves and thoroughly validated against 
clinical data. After rigorous validation of the disease model, various clinically relevant 
surgical techniques were used to repair the valves and post-repair valve hemodynamics 
and function were assessed and compared to the control conditions. On these lines, this 




5.2 VALVE SELECTION AND PREPARATION 
5.2.1 PORCINE MITRAL VALVE MODEL 
In this thesis, mitral valves from fresh porcine hearts of varying sizes were used. 
The porcine heart is structurally and functionally very similar to the human heart, and 
with the limited availability of normal human hearts for research studies, we chose to use 
porcine hearts for these studies. The morphology of the porcine and human mitral valves 






   
 
Figure 5-1A shows the anterior leaflet of the mitral valve with the primary/ 
marginal chordae inserting into the free edge of the anterior leaflet and a set of 
secondary/basal/strut chordae originating from the same stem as the marginal chordae, 
but inserting into the base of the anterior leaflet. Another web of chordae insert into the 
commissural region of the anterior leaflet and directly into the mitral annulus closer to the 
commissures, called the tertiary/commissural chordae. In the human mitral valve shown 
(A) (B) 
Figure 5-1 (A) Photograph of a porcine mitral valve demonstrating the anterior leaflet
structure with the primary, secondary and tertiary chordae tendineae; (B) Photograph
of a human mitral valve with similar leaflet structure and distribution of the chordae




in Figure 5-1B, the overall distribution of chordae tendineae and the region of insertion 
into the anterior leaflet are identical. Previously, He et al. also compared the 
hemodynamic function of porcine and human mitral valves in a similar in vitro left heart 
simulator and obtained comparable leaflet kinematics, regurgitant volumes and leaflet 
coaptation lengths between the two species [112, 113]. Published data comparing the 
mechanical properties of human and porcine mitral valve chordae tendineae from 
Kunzelman et al. [39, 63] and Veseley et al. [35-38] also showed similarity between the 
valve material properties, further strengthening the choice of porcine mitral valves for 
this study. 
5.2.2 VALVE SELECTION 
Fresh porcine hearts were obtained from the local abattoir (Holifield Farms, 
Covington, GA) and transported to the laboratory within 2 hours of slaughter. In the 
laboratory, the hearts were cleaned under warm water to remove blood clots within the 
ventricular cavity and preserved in 0.9% vol/vol saline solution. The membranous 
pericardial sac surrounding the heart muscle was removed and the left atrium was 
carefully excised at its base, exposing the mitral valve as shown in Figure 5-2A. To 
maintain consistency between the size of the valves used and the gross anatomy of the 
valve, an annuloplasty ring sizer (Physio® Annuloplasty Ring, Edwards Lifesciences®, 
Irvine, CA) was used to measure the size of the anterior leaflet of the mitral valve as 
shown in Figure 5-2B. Upon identifying valves of similar sizes, a longitudinal incision 
was made through the aortic valve along the left anterior descending artery until the apex 




exposing the entire mitral valve structure. The valve is carefully inspected so that there 
are no anatomical malformations, ruptured chordae tendineae or multiple diffused 

















Figure 5-2 (A) Atrial face of the mitral valve exposed after excising the left atrium;
(B) Sizing the mitral valve using the annuloplasty ring sizer; (C) Incision made along
the left anterior descending artery of the heart until the apex to expose the mitral
valve subvalvular apparatus; (D) Entire mitral valve structure exposed for






5.2.3 VALVE EXTRACTION 
After choosing the hearts with mitral valves of required sizes, they were carefully 
extracted from the heart while preserving the annular and sub-annular geometry intact. 
Using a scissors, the mitral valve was separated from the left atrium at the level of the 
annulus and using a scalpel the two papillary muscles were carefully separated from the 
left ventricular myocardium. After extracting the valve, the remaining myocardium 
surrounding the mitral annulus was trimmed to a thin layer with utmost care to avoid 
cutting through the mitral leaflets. 5mm of the left atrial tissue surrounding the mitral 
annulus was left behind, to enable suturing the mitral valve onto the silicone annulus 
shown in Figure 4-3. The anterior leaflet surface was also carefully cleaned by removing 
the non-coronary aortic leaflet and trimming the fibrous trigones until flush with the non-
fibrous anterior annulus. The mitral valve at different stages of the extraction process is 












Figure 5-3 (A) Mitral valve exposed but before explantation from the heart; (B)




5.2.4 VALVE PREPARATION 
Upon extraction, the mitral valve annulus loses its native D-shape and to ensure 
that the valve is appropriately sutured onto the silicone annulus, five positioning knots 
were placed at the two trigones, the two commissures and at the annulus along the central 
posterior cusp as shown in Figure 5-4A. Once the valve is positioned, a preliminary test 
for valve closure was conducted by pressing the anterior and posterior leaflets to coapt. If 
the valve was either too undersized or the leaflets were abnormal, they were excluded 
from the study. After selecting an appropriately sized valve, it was sutured onto the 
silicone annulus in a continuous loop fashion to ensure firm attachment of the mitral 
annulus to the silicone ring without kings or openings in the annular suture line as shown 
in Figure 5-4B. The papillary muscles are then enclosed in Dacron®, and two small 
Teflon® rings are sutured onto the base of the muscles to mount the valve onto the 









Figure 5-4 (A) Extracted mitral valve positioned onto the D-shaped silicone
annulus using positioning sutures; (B) The mitral valve after suturing onto the




5.3 IN VITRO LEFT HEART SIMULATION – OPERATION AND 
CALIBRATION 
The left heart simulator was maintained regularly, with routine maintenance 
procedures involving replacement of the rubber gaskets between the walls of the 
ventricular and atrial chamber to reduce fluid leaks and pressure loss, replacing the screw 
studs and wing nuts as they tend to rust from contact with saline, and routinely clean the 
bevel gears in the papillary muscle system for smooth rotation. Specific protocols for 
calibrating the pressure transducer, flow transducer and the C-ring force transducer are 
presented in the following sections. 
5.3.1 PRESSURE TRANSDUCER CALIBRATION 
The Validyne® differential pressure transducer was calibrated at monthly 
intervals and tested for stability as well. Figure 5-5A shows a schematic of the pressure 
transducer, with the two inlet valves (yellow) and the two bleed valves (blue). The inlet 
valves are three-way leur lock valves, one end of which are connected to the inlet of the 
transducer, one end is connected to a manometer and one end to a syringe filled with 
saline. The bleed valves are three-way leur lock valves that remove air bubbles caught in 
the transducer and ensure that the inner chambers of the transducer are completely filled 
with saline. Electrical output from the transducer was connected to the signal conditioner 
and the value on the digital display was zeroed and the span was set at 50%. A voltmeter 
was then connected to the output of the signal conditioner, to measure the actual voltage 




The input valves were then connected to the two arms of a U-tube manometer 
(‘positive’ arm and ‘negative’ arm) shown in Figure 5-5B and the two tubes were filled 
with saline upto 185mm of the column. Both the columns were equally filled with saline 
upto 190mm first, and to remove any air trapped in the chambers both the columns were 
bled to 185mm mark. After removing the air and ensuring both the columns of the 
manometer were stable at 185mm mark on the scale, the transducer was zeroed again.  
While keeping the positive arm at 185mm, the level of saline in the negative arm was 
adjusted to 163.1mm, 136.1mm, 108.8mm, 81.6mm, 54.4mm, 27.2mm and 0mm 
respectively. At each saline level, the voltage output from the signal conditioner was 
recorded. After reaching 0mm, the negative arm is filled back to 185mm Hg and the 
procedure was repeated with the positive column at 163.1mm and 136.1mm and the 
voltage output was recorded. The calibration was performed thrice, and the average 
voltage output for each pressure reading was plotted against each other. A linear 
regression fit was performed through the data and the slope of the line was used as the 
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Figure 5-5 (A) Schematic of the pressure transducer depicting the inlet and bleed
valves on both the chambers; (B) Setup for the pressure transducer calibration where




Figure 5-6 shows an example calibration curve performed on the Validyne® 
pressure transducer. The data presented are the average of 3 trials at each pressure. Since 
the transducer is zeroed when the pressure is zero, the linear regression fit is forced to 
pass through the origin thus making the intercept zero.  
5.3.2 FLOW TRANSDUCER CALIBRATION 
 The flow probe and amplifier were calibrated at regular intervals to ensure 
accuracy and stability of the measurements.  The square wave electromagnetic flow has 
high sensitivity and adequate frequency response, with a selectable frequency response 
upto 100Hz. The amplifier has separate recorder output that can provide mean and 
pulsatile data simultaneously, with protective circuits to detect large deviations from 
Figure 5-6 A representative calibration curve depicting the relationship between the




normal operating parameters. The range of accuracy for the flow measurements is 
between ± 5% after a 30-minute warm up period.  
 The voltage output of the flow probe was calibrated against measured flow rates 
in a closed loop system, in which a calibrated rotameter was used. A schematic of the 
flow loop is shown in Figure 5-7, where the electromagnetic flow probe is connected in 
series with a centrifugal pump and a rotameter. Firstly, the rotameter was calibrated by 
pumping saline through it for 60 seconds and collecting the saline draining from the 
rotameter into a graduated flask, while recording the position of the rotameter float on the 
vertical scale. This bucket-and-stop watch method helped in validating the accuracy of 
the rotameter for the given fluid media. The rotameter calibration was performed at 
different flow rates, and a linear regression was performed between the “calculated” flow 
rates from the bucket-and-stop watch method, and the “measured” flow rates from the 
rotameter as shown in Table 5-1 and Figure 5-8. In the second step, the electromagnetic 
flow probe was connected to the square wave electromagnetic amplifier, and the power 
knob on the amplifier was positioned at null. Using the “null” knob, the digital readout on 
the amplifier was adjusted to “zero”. The power knob is then positioned on “balance” and 
the digital readout is adjusted to “zero” again, as it typically shifts a little in this position. 
In the final step, the power knob on the amplifier is positioned to “+”, and the frequency 
response to 10Hz and the digital readout is tuned to “zero” again. While performing the 
initial “zeroing”, care is taken to ensure that the centrifugal pump is switched off, air 
bubbles are removed and there is no flow through the closed loop. A voltmeter was then 
connected to the “PULSE” channel on the back of the amplifier to record the exact 




pump was then powered through a 120V wall power supply, and connected to a rheostat 
that allowed precise control over the rotational speeds of the pump impeller and thus 
control the flow rates in the loop. The voltage output of the flow probe was calibrated 
against 5 flow rates in the forward flow direction, and 5 flow rates in the backward flow 
direction as shown in Figure 5-10 . Each calibration was repeated twice and the measured 
voltage was averaged. After completing the calibration, the mean voltage measurements 
were plotted against the rotameter measurements and a linear regression analysis was 
performed, with the gradient of the linear regression fit considered as the “calibration” 
value.  
Figure 5-7 Schematic of the flow loop setup to calibrate the square wave




























Table 5-1 A illustrative example of the flow rate measurements from the
bucket and stopwatch method and the rotameter 
Figure 5-8 A typical rotameter calibration curve showing the correlation





























Figure 5-10 (A) Representative calibration plot for forward flow in the
electromagnetic flow probe; (B) Representative calibration plot for backward






5.3.3 C-RING FORCE TRANSDUCER CALIBRATION 
Due to the miniature size and fragility of the strain gauges used to construct the 
C-ring force transducer, they are regularly calibrated for stability and sensitivity. The C-
ring transducer is part of a Wheatstone half bridge, thus if the strain gauge resistances are 
not within the prescribed range of 350 ± 10Ω, the bridge circuit becomes unstable. The 
deviation in the resistance should then be eliminated using a shunt potentiometer 
provided on each channel. After “zeroing” each transducer and the corresponding 
channel, the voltage output of the transducer is calibrated against standard weights. The 
C-ring transducer is suspended from a steady frame as shown in Figure 5-11, using thin 
134 AWP wire (Measurements Group, NC). The thin 134 AWP wire is passed through 
the top hole of the C-ring and tied into a loop to suspend the ring from the frame. A 
second wire is similarly passed through the bottom hole of the C-ring and tied into a loop 
to suspend weights. Pre-measured weights were suspended in the lower loop using 
shortened polyester 2-0 suture (E-sutures, NY), with the tapered needle of the suture bent 
into a hook.  
 The sensitivity of the C-ring transducer is measured at various static weights, with 
the applied force on the transducer defined by Equation 5-1: 
 
where   F = force acting on the C-ring transducer 
  m = mass  
  a = acceleration due to gravity (9.8 m2/sec) 





The transducer is connected to one of the 6 channels on the amplifier, and a 
voltmeter (Fluke, 27) is connected to the corresponding output channel. The C-ring is 
then positioned on the steady frame, and without suspending any loads the output voltage 
on those channels is slowly adjusted to zero by turning the potentiometer using a flat 
head screwdriver. After “zeroing” the transducers, four different weights are suspended 
from the transducer and the corresponding voltage output from the transducer for each 
weight is recorded. The measurements are conducted thrice for every weight and the 
voltage output measured for the three trials is averaged, and a calibration plot with the 
suspended weights on the abscissa and the voltage output on the ordinate was plotted. A 
linear regression fit was performed through the plotted data, and the slope of the line was 
considered as the “calibration” coefficient for that C-ring transducer for that particular 




channel. Each transducer was thus calibrated for a corresponding channel, and was used 
for that channel alone as the sensitivity and stability of the potentiometers on each 
channel varied slightly. A representative chart of a C-ring calibration is shown in Table 















Table 5-2 A representative tabulation of the weights used and the corresponding average
voltage output measured from the C-ring transducer 
Figure 5-12 A representative calibration plot for the force transducer showing




 Though the strain gauges were sealed in a multi layer polymer coating and 
isolated from moisture, when completely immersed in saline they tend to drift due to 
leakage currents. The leakage currents offset the Wheatstone bridge, resulting in drifting 
of the C-ring from its baseline zero point. Thus, after suturing the C-rings onto the mitral 
valve chordae tendineae and mounting the valve into the left heart simulator, the 
transducers were “zeroed” again after complete immersion in the saline solution. Thus, 
the baseline for all the force measurements using C-ring transducers was with the mitral 
valve in the diastolic open position in the left heart simulator, with minimal to no forces 
acting on the chordae tendineae. Typically, the voltage output of the transducer was 
within a range of ± 200 mV, which falls sufficiently within the ± 5V range of the data 
acquisition system.  
5.3.4 HEMODYNAMIC DATA ACQUISITION AND ANALYSIS 
 All the data acquisition was performed using the hardware described in Chapter 4. 
Custom software developed in the laboratory, DAQANAL (Labview 5.1, National 
Instruments, Austin, TX) was used as an interface between the data acquisition hardware 
and computer. DAQANAL is a multi-channel acquisition system in which data can be 
simultaneously recorded from 8 analog channels, either continuously or synchronized 
through a digital trigger. The software was equipped with frequency filters, signal 
smoothening modules and bandwidth adjustment to record the data appropriately. The 
data are stored in a temporary buffer by the software, which sequentially writes the data 
to the desired directory on the computer. Few screenshots of the software are shown in 





















 In this program, a maximum of 2 channels can be simultaneously monitored in 
real time in a quantitative fashion, even though qualitatively all 8 channels can be 
visualized on the same window shown in Figure 5-14 .  
Figure 5-13 Screenshot of a window in DAQANAL software used to input signal
conditioning parameters, calibration coefficients for each channel based on the hardware





 Upon acquiring and storing the data to the hard drive, the analysis module of 
DAQANAL is used to average the data over multiple cardiac cycles, and perform 
numerical integration of the data to calculate the regurgitation volume, net stroke volume, 
gross stroke volume, regurgitation fraction and other derived parameters from the 
recorded data. Fourier analysis of the data can also be performed, and probability 
distributions plots for the data can be plotted as required. Figure 5-15 shows screen shots 
of the program to calculate the regurgitation volume and stroke volume using numerical 
integrating of the flow curve. The red and the green sliders allow traversing the curve and 
defining the bounds of the curve that need to be integrated.  




5.3.5 ECHOCARDIOGRAPHIC DATA ANALYSIS 
 Echocardiographic data analysis was performed using QLAB 5.1 (Philips Medical 
Systems, Andover, MA) under a licensed agreement, or using PMDSVIEW 2.1 (Philips 
Medical Systems, Andover, MA). For all echocardiographic analysis, a double-blinded 
multi user analysis was performed to consider the inter-user variability and avoid any 
bias in the data analysis. All the echocardiographic acquisitions were performed at the 
same depth and along identical planes, so that comparison of the data between different 
experimental conditions was possible.  
 
Figure 5-15 Screenshot of the analysis module to calculate the regurgitation volume and




5.4 PATHOLOGICAL MODELS OF MITRAL VALVE LESIONS 
 The crux of this thesis work weighted significantly on the development of bench 
top models of mitral valve defects/pathologies in congenital, degeneration and ischemic 
mitral valve lesions. As previously mentioned, porcine mitral valves with normal 
anatomy and material properties were selectively altered to mimic each pathological 
lesion. Upon altering the valve components or anatomy, it was mounted in the in-vitro 
left heart simulator and tested under pulsatile hemodynamic conditions so that videos and 
echocardiographic images of the valve could be obtained and compared to human data, to 
validate the accuracy of the model to clinical scenario. Each of the lesions developed in 
this study are explained in detail in the following sections.  
5.4.1 CLEFT MITRAL VALVE IN CONGENITAL ATRIOVENTRICULAR 
CANAL DEFECT 
The main anatomical features of a cleft mitral valve in humans with complete 
atrioventricular canal defects are: 
[a] Leaflet Defects: 
• wedge shaped cleft in the central part of the anterior leaflet 
• smaller posterior leaflet with the commissures moved posteriorly  
[b] Annular Defects: 
• Oval shaped annulus, with a flat anterior and ovoid posterior annulus 
[c] Sub-annular Defects: 
• Scooped ventricular geometry with posterior and lateral displacement of 




• Both papillary muscle heads are closer to one another than in normals 
To mimic these anatomical deficiencies, the native porcine mitral valve anatomy was 
altered in sequential steps:  
Step 1 Reduction in Posterior Leaflet Size 
To reduce the posterior leaflet area and create a triangular shaped leaflet, a 
quadrangular section of the leaflet was resected from the P2 cusp of the posterior leaflet 
as shown in Figure 5-16. Following resection, the annulus at this region was plicated 
outwards and sutured together using a compression stitch with 3-0 silk sutures. Once the 
opposite edges of the resected region moved closer after annular plication, a 4-0 prolene 
suture was used to carefully approximate the edges in an interrupted fashion. Several 
interrupted knots were used to approximate the edges, such that there were no crevices or 
openings between the knots that may lead to regurgitation.   
 
Figure 5-16 (A) Quadrangular resection of the posterior leaflet of the porcine mitral
valve, with the dotted circles depicting the position of the papillary muscles; (B) Plication
of the annulus at the region of resection and suturing, which brings the free edges closer;
(C) Final leaflet shape after closing the free edges in an interrupted fashion 




Step 2 Creating Wedge Shaped Anterior Leaflet Cleft 
After reducing the size of the posterior leaflet and reconstructing it, a wedge 
shaped cleft was made in the anterior leaflet as shown in Figure 5-17. The cleft was made 
by first section the anterior leaflet along a straight line dividing the A2 cusp, and the A2 
was divided into two leaflets. Then, two cuts were made by trimming the free edges 
starting from the annulus to the free edge, such that the base of the cleft at the free edge 
was 1/6th the total height of the anterior leaflet. After creating the cleft, the papillary 





Figure 5-17 (A) A straight incision was first made along the dotted line at the center of
the anterior leaflet from the free edge to the annulus; (B) Two more incisions were made
along the free edges such that the base of the cleft is a sixth of the height of the cleft,
which is equivalent to the height of the anterior leaflet; (C) Anterior cleft after trimming,
with the papillary muscle positions moved towards the posterior leaflet from the
commissures and laterally towards each other to depict the scooped geometry of the
ventricle 




Step 3 Simulating the Scooped Geometry of the Ventricle 
 To simulate the scooped geometry of the ventricle and pathological position of the 
papillary muscles, both the muscles were displaced posteriorly and laterally towards each 
other. From a short axis perspective of the left ventricle, Figure 5-18 shows the 
displacement of the papillary muscles in the ventricle to simulate the smaller and severely 







5.4.2 POSTERIOR LEAFLET PROLAPSE IN FIBROELASTIC DEFICIENCY 
 Posterior leaflet prolapse in fibroelastic deficient mitral valves typically occurs 
due to rupture of the marginal chordae tendineae inserting into the free edge of the P2 
cusp. These chordae being the thinnest and most stretched due to motion of the free edge, 
are prone to rupture in this disease wherein absence of fibrillin-1 gene results in 
degeneration of the mechanical properties of the native mitral valve leaflet. Rupture of 
these chordae results in isolated prolapse of the P2 free edge into the left atrium, though 
the leaflet structure typically remains unchanged and comparable to normal subjects. In 
Figure 5-18 (a) Papillary muscles depicted as  in their normal positions with the red
arrows showing the direction of their displacement to mimic the canal defect conditions;





this study, acute posterior leaflet was created by selectively transecting the marginal 
chordal web inserting into the free edge of the posterior leaflet from both the papillary 
muscle heads as shown in Figure 5-19A. This chordal transection resulted in prolapse of 




Figure 5-19 (A) The red lines depict the transection of the marginal chordal web
inserting into the free edge of the posterior mitral leaflet; (B) Isolated P2 prolapse
resulting from marginal chordal transection; (C) A side sectioned view of the valve
leaflets showing prolapse of the posterior leaflet and its movement above the anterior






5.4.3 ACUTE ANTERIOR LEAFLET PROLAPSE MODEL 
 Similar to posterior leaflet prolapse, rupture of the anterior marginal chordae 
tendineae is seen in patients with fibroelastic deficiency. Identical in mechanisms, rupture 
of the marginal chordae that insert into the A2 cusp of the anterior mitral leaflet result in 
isolated prolapse of the A2 segment. In this study, anterior marginal chordal rupture was 
induced by transecting those chordae, which in turn resulted in prolapsing of the A2 cusp 
into the left atrium as shown in Figure 5-20, and an oblique posteriorly directed 
regurgitation jet.  
5.4.4 ANNULAR SHAPE CHANGES IN FUNCTIONAL MITRAL 
REGURGITATION 
 The mitral annulus assumes a physiological saddle shape in normal subjects, 
however flattening of the mitral annulus is commonly seen in pathologies such as 
ischemic and non-ischemic dilated cardiomyopathy or artificial flattening of the mitral 
(A) (B) 
Figure 5-20 (a) Anterior leaflet prolapse resulting from transecting the marginal chordae
tendineae inserting into the free edge of the A2 cusp; (b) An isometric view of the
prolapsing anterior leaflet showing the movement of the A2 free edge into the atrium thus




annulus in degenerative valve disease by surgically implanting a flat annuloplasty ring 
onto a native saddled annulus.  To study the impact of mitral annular flattening on mitral 
valve mechanics, an adjustable shaped mitral annulus was developed as shown in Figure 
4-5. The degree of the non-planarity of the mitral annulus was defined by Equation 5-2. 
 
5.4.5 3D GEOMETRIC PERTURBATIONS OF THE MITRAL VALVE TO 
MIMIC FUNCTIONAL MITRAL REGURGITATION 
 Functional mitral regurgitation, either due to ischemic or non-ischemic dilated 
cardiomyopathy occurs mainly due to geometric changes of the mitral valve at the 
annular and sub-annular levels. Typically, the three predominant geometric changes that 
are reported in this lesion are - (a) annular dilatation; (b) annular flattening; and (c) 
papillary muscle displacement. The three changes typically occur together in patients 
with this pathology, but the extent to which the annulus dilated, flattens or the papillary 
muscles are displaced varies largely between the patients. In this study, only few 
geometric variations that are significantly different between the patients were simulated, 
and typically the maximum extent to which they occur in patients was studied. The mitral 
annulus was dilated from a native 28mm to 36mm, the annulus was flattened completely 
and two settings of papillary muscle displacements were studied: 
• 10mm apical displacement only 
• 10mm apical + 10mm lateral + 10mm posterior displacement 




In all the cases only symmetric displacement of both the papillary muscles was 
studied, though in practice both symmetric and asymmetric papillary muscle 
displacement may occur depending on the region and extent of infarction on the left 
ventricular wall. Figure 5-21 illustrates the geometric alterations imposed on the porcine 














(C) (D) (E) 
Figure 5-21 (A) Left ventricular shape depicted by the dotted line in a normal volunteer;
(B) A dilated left ventricle in a patients with chronic ischemic cardiomyopathy; (C)
Dilatation of the mitral annulus simulated by increasing the septal lateral dimension of the
silicone annulus; (D) Annular flattening simulated by imposing a 0% saddle on the
annulus; (E) Sub-annular papillary muscle displacement simulated by displacing the




5.5 PROTOCOLS TO PERFORM SURGICAL TECHNIQUES 
5.5.1 SPECIFIC AIM 1 - CLEFT MITRAL VALVE REPAIR  
 The open cleft on the anterior mitral leaflet was closed using 4-0 Prolene sutures 
in an interrupted fashion as shown in Figure 5-22. Interrupted knots were used as they are 
most optimal in bringing the free edges of the leaflet together, without overlapping the 
edges and tethering the leaflet. The cleft was closed to three different levels starting from 
the mitral annulus – 1/3rd of the cleft length, 2/3rd of the cleft length and complete cleft 
length closed. At each level of cleft closure, five annular configurations were studied – 
Normal, Dilated – 20% and 40%, and Undersized – 20% and 40% respectively.  













Figure 5-22  (Top) Different levels of cleft closure in the pathological model of the cleft




5.5.1.1 Experimental Protocol 
Eight (N=8) porcine mitral valves will be used for this study and each valve was 
studied under the following experimental conditions. 
Baseline/Control Conditions 
 The freshly extracted porcine mitral valve (before altering the geometry) is 
mounted into the experimental setup and tested under pediatric hemodynamic conditions 
of: 120beats/min heart rate, 85mm Hg peak left ventricular pressure and an average 
cardiac output of 2.5L/min. For this test, the annular size is maintained at the normal size 
of the valve while in the intact heart, and the papillary muscles in their physiological 
positions. The normal position of the papillary muscles is determined such that the 
commissural chordae are in a single plane and the tips of the papillary muscles are in the 
plane passing through the leaflet coaptation. The flow rate and transmitral pressure 
gradient are measured and the regurgitation volume is calculated. 
Disease Conditions 
 The geometry of the valve is then altered as described in the preceding sections 
and the experiments are repeated under the same pediatric hemodynamic conditions. This 
valve shall mimic the anatomy of the LAV valve in AVC defects, and is tested under two 
papillary muscle positions: (a) Normal position as the baseline condition and (b) 
Obliquely displaced position with 10 mm displacements in the posterior and lateral 
directions. The oblique position of the papillary muscles is typically found in patients 




measurements are then obtained. After this step, an anterior leaflet cleft is created by 
sectioning the skirt of the anterior leaflet from the free edge to the mitral annulus. 
Repair/Risk Factor Conditions 
Cleft Closure  
 To investigate the impact of cleft closure, the cleft is closed to four levels which 
are: (a) Fully open cleft (b) One-third cleft closed (c) Two-third cleft closed and (d) Cleft 
completely closed. The extent of cleft closure for individual valves is determined by 
measuring the total length of the cleft and dividing into three equal lengths. For each 
level of cleft closure, the cleft is closed using evenly spaced interrupted knots of 4-0 
Prolene sutures (Ethicon Inc, Somerville, NJ, USA). The valves are studied under 
identical pediatric hemodynamic conditions used previously and relevant hemodynamic 
parameters are obtained. 
Annular Dilatation 
 Annular dilatation is simulated on each of the four cleft closure conditions, by 
increasing the mitral annular area by 20% and 40% of its normal size. The annular area is 
calculated by measuring the septal-lateral and commissure-to-commissure dimensions of 
the mitral annulus and approximating the shape to an ellipse. The annulus is made to an 
area of 4.0 cm2 initially, and then increased to 4.8 cm2 for the 20% dilated size and to 5.6 
cm2 for the 40% dilated size. These two levels of dilatation are selected as they represent 
the mitral annular growth rate from infancy to 5 years after birth, assuming the repair is 
conducted during infancy. Dilatation of the annulus is simulated on the four cleft closure 






 To investigate if reducing the annular size during primary repair could be of any 
benefit, the annulus is undersized from its normal size of 4.0 cm2 to 3.2cm2 simulating 
20% undersizing and 2.4cm2 simulating 40% undersizing. The effect of undersizing is 
studied on the open cleft, one-third closed cleft, two-third closed cleft and the fully closed 
cleft conditions.  
5.5.1.2 Measured Endpoints 
Regurgitation Volume 
 Regurgitant volume through the valve is calculated from the recorded transmitral 
flow curve. The flow curve is averaged over 15 cardiac cycles and the area under the 
negative part of the flow curve is integrated to obtain the regurgitation volume.  
Effective Orifice Area 
 To measure the degree of stenosis after undersizing the annulus, the diastolic 
effective orifice area (EOAs) for each valve under all test conditions is calculated using 
the modified Bernoulli equation. The mean diastolic flow rate (Qrms) and the root mean 
squared diastolic transmitral pressure gradient (∆Pmean) are obtained from the recorded 











2D echocardiographic measurements were obtained at frequencies between 38-60 
Hz, at an imaging depth of 12 cm and a transducer frequency of 3.7 MHz.  Apical long-
axis views cutting the leaflets across the anterior and posterior leaflets are acquired at 
different points on the mitral annulus. Three-dimensional (3D) echocardiographic 
measurements are obtained with a 3D matrix-array ultrasound sector transducer (X7-2 
Matrix Probe, iE33 System, Philips Medical Systems, Andover, MA) at 3.75 MHz, 
adjusted to provide optimal imaging with the highest possible frame rate at a sampling 
depth of 12 cm. Color Doppler images were obtained at the same depth, at a baseline 
velocity of 61.7 mm/sec and a color gain of 25-35%, which is optimized to individual 
acquisitions. Echocardiographic and color Doppler images are obtained to assess the 
forward and the leakage flow through the cleft and the coaptation regions. The images are 
imported into QLAB software for quantification of various Doppler parameters, and into 
PMDSVIEW for length measurements. 
5.5.1.3 Statistical Analysis 
 All the data are reported as mean ± 1 standard deviation. The data are tested for 
normality using an Anderson-Darling test (MINITAB 15). Different experimental groups 
are compared using paired t-tests considering statistical significance at a p value of < 0.05 




5.5.2 SPECIFIC AIM 2 – SURGICAL REPAIR FOR POSTERIOR LEAFLET 
PROLAPSE 
 In this thesis, three commonly used surgical techniques were used to repair 
isolated posterior leaflet prolapse due to chordal rupture – (a) Quadrangular resection 
with annular plication; (b) Limited triangular resection; and (c) Artificial 
neochordoplasty. The protocols adopted to perform each of the surgical techniques are 
presented here. 
5.5.2.1 Part A – Resective vs. Non-Resective Techniques for Repair of Posterior 
Leaflet Prolapse 
 Quadrangular Resection with Annular Plication 
Quadrangular resection was performed on each valve by resecting a rectangular 
section of the P2 segment and compressing the annulus at this region as shown in Figure 
5-23. The dimensions of the resected segment were chosen such that the breadth of the 
rectangle equaled the distance between the two ruptured marginal chordae, and the length 
extended from the free edge to the mitral annulus. The section of the annulus in the 
resected region was then plicated and approximated using 3-4 compression sutures. The 
free edges after resection were carefully approximated using interrupted knots with 3-0 























Triangular resection was performed on the free edge of the P2 scallop as shown in 
Figure 5-25. The total height of the posterior leaflet from the free edge to the annulus was 
measured and a triangular segment that has a height of 1/3(total leaflet height) and a base 
width equal to the length between the two ruptured marginal chordae was resected as 
Figure 5-23 (A) Dotted line depicts the quadrangular section of the prolapsing leaflet 
that will be resected; (B) Quadrangular section resected from the leaflet 
 
(B) (A) 
Figure 5-24 (A) Annular compression at the resected region; (B) The reconstructed 





reported in an earlier study by Gazoni et al. [93]. The posterior leaflet was reconstructed 
by carefully approximating the free edges of the triangular resection using interrupted 3-0 
silk sutures (Ethicon Inc, NJ), such that minimal tension was induced on the residual 
leaflet segments. Upon reconstructing the leaflet the valve was again tested under 











 In this procedure, the transected marginal chordae tendineae were replaced with 
loops of 5-0 ePTFE sutures as shown in Figure 5-26 . The ventricular chamber was filled 
with saline to close the mitral valve, and length of the neochordae was adjusted and tied 
onto a Teflon® pledget on the tip of the papillary muscle. The valve was then tested 
under pulsatile hemodynamic flow conditions as listed in the previous sections and 
relevant hemodynamic and echocardiographic endpoints were measured. 
 
 
Figure 5-25 (A) Dotted line showing the section of the posterior leaflet that will be












5.5.2.1.1 Experimental Protocol 
Each mitral valve is studied under the experimental conditions in the order listed 
below: 
Baseline/Control Conditions 
The annulus is maintained at its normal size, and the papillary muscles are fixed 
in their normal positions, i.e., with the papillary muscle tips perpendicular to the mitral 
annular plane and in the plane passing through leaflet coaptation, such that the 
commissural chordae from the same papillary muscle are parallel to each other. The valve 
is studied under adult hemodynamic conditions of 120 mm Hg peak transmitral pressure, 
5L/min cardiac output at 70bpm. The regurgitant volume and stroke volume are 
volumetrically measured, and leaflet coaptation length, and indices that elucidate leaflet 
mobility are recorded using 3d echocardiography. 
 
 
Figure 5-26 (Left) Inserting the neochordae into the tips of the papillary muscles; (Right)






After acquiring the baseline data, the two marginal chordae on the free edge of the 
posterior leaflet are transected resulting in severe segmental prolapse of the P2 cusp. The 
simulator is again run under identical hemodynamic conditions, and the hemodynamic 
and echocardiographic measurements are obtained. P2 prolapse is validated by 
reconstructing the 3D geometry of the mitral valve from the echocardiographic images 
and superimposed with only the reverse color Doppler data, showing the regurgitation jet. 
The regurgitation and stroke volumes are also quantified using the flow probe.  
Repair Conditions 
Neochordoplasty 
 In this procedure, the transected marginal chordae tendineae are replaced with 
loops of 5-0 ePTFE sutures. The ventricular chamber is filled with saline to close the 
mitral valve, and length of the neochordae are adjusted and tied onto a Teflon® pledget 
on the tip of the papillary muscle. The valve is then tested under pulsatile hemodynamic 
flow conditions as listed in the previous sections and relevant hemodynamic and 
echocardiographic endpoints are measured. 
Limited Triangular Resection 
Upon acquiring data in step (c), the neochordae are removed and a triangular 
resection is performed on the free edge of the P2 scallop. The total height of the posterior 
leaflet from the free edge to the annulus is measured and a triangular segment that has a 
height of 1/3(total leaflet height) and a base width equal to the length between the two 




The posterior leaflet is reconstructed by carefully approximating the free edges of the 
triangular resection using interrupted 3-0 silk sutures (Ethicon Inc, NJ), such that minimal 
tension is induced on the residual leaflet segments. Upon reconstructing the leaflet the 
valve is again tested under pulsatile hemodynamics conditions. 
Quadrangular Resection with Annular Compression 
Quadrangular resection is performed on the same valve by resecting a rectangular 
section of the P2 segment and compressing the annulus at this region. The dimensions of 
the resected segment are chosen such that the breadth of the rectangle equaled the 
distance between the two ruptured marginal chordae, and the length extended from the 
free edge to the mitral annulus.  The section of the annulus in the resected region is then 
plicated and approximated using three of four compression sutures. The free edges after 
resection are carefully approximated using interrupted knots with 3-0 silk sutures, in a 
similar fashion to the triangular resection group. The valve is then tested under pulsatile 
hemodynamic conditions.  
5.5.2.1.2 Measured Endpoints 
Regurgitation Volume 
Regurgitant volume through the valve is calculated from the recorded transmitral 
flow curve. The flow curve is averaged over 15 cardiac cycles and the area under the 








2D echocardiographic measurements were obtained at frequencies between 38-60 
Hz, at an imaging depth of 12 cm and a transducer frequency of 3.7 MHz.  Apical long-
axis views cutting the leaflets across the anterior and posterior leaflets are acquired at 
different points on the mitral annulus. Three-dimensional (3D) echocardiographic 
measurements are obtained with a 3D matrix-array ultrasound sector transducer (X7-2 
Matrix Probe, iE33 System, Philips Medical Systems, Andover, MA) at 3.75 MHz, 
adjusted to provide optimal imaging with the highest possible frame rate at a sampling 
depth of 12 cm. Color Doppler images were obtained at the same depth, at a baseline 
velocity of 61.7 mm/sec and a color gain of 25-35%, which is optimized to individual 
acquisitions. Echocardiographic and color Doppler images are obtained to assess the 
forward and the leakage flow through the cleft and the coaptation regions. The images are 
imported into QLAB software for quantification of various Doppler parameters, and into 
PMDSVIEW for length measurements. Peak systolic leaflet coaptation length, posterior 
leaflet angle and distance of the coaptation plane from the posterior annulus are 
measured.  
5.5.2.1.3 Statistical Analysis 
All the data are reported as mean ± 1 standard deviation. The data are tested for 
normality using an Anderson-Darling test (MINITAB 15). Different experimental 
condition groups are compared using paired t-tests considering statistical significance at a 




5.5.2.2 Part B – Neochordoplasty versus Chordal Translocation for Repair of 
Posterior Leaflet Prolapse 
 A novel surgical technique studied in this thesis to correct posterior leaflet 
prolapse is translocation of the posterior strut chordae to the marginal position. The 
underlying hypothesis of this procedure is that on the posterior leaflet, the marginal 
chordae control the motion of the free edge and the strut chordae even though important 
in determining the curvature of the leaflet, may not play a detrimental role. As shown in 
figure xx, the strut chordae were transected at their insertion points on the base of the 
posterior leaflet, and using 4-0 prolene sutures were relocated to the free edge of the 
leaflet. These translocated strut chordae now restrict prolapse of the free edge into the left 










Figure 5-27 (A) Transection of the strut chordae tendineae; (B) Translocation fo the







5.5.2.2.1  Experimental Protocol 
Each mitral valve is studied under the experimental conditions in the order listed below: 
Control/Baseline Conditions 
 The annulus is maintained at its normal size, and the papillary muscles are fixed 
in their normal positions, i.e., with the papillary muscle tips perpendicular to the mitral 
annular plane and in the plane passing through leaflet coaptation, such that the 
commissural chordae from the same papillary muscle are parallel to each other. The valve 
is studied under adult hemodynamic conditions of 120 mm Hg peak transmitral pressure, 
5L/min cardiac output at 70bpm. The regurgitant volume and stroke volume are 
volumetrically measured, and leaflet coaptation length, and indices that elucidate leaflet 
mobility are recorded using 3d echocardiography. 
Posterior Leaflet Prolapse 
After acquiring the baseline data, the two marginal chordae on the free edge of the 
posterior leaflet are transected resulting in severe segmental prolapse of the P2 cusp. The 
simulator is again run under identical hemodynamic conditions, and the hemodynamic 
and echocardiographic measurements are obtained. P2 prolapse is validated by 
reconstructing the 3D geometry of the mitral valve from the echocardiographic images 
and superimposed with only the reverse color Doppler data, showing the regurgitation jet. 








In this procedure, the transected marginal chordae tendineae are replaced with 
loops of 5-0 ePTFE sutures. The ventricular chamber is filled with saline to close the 
mitral valve, and length of the neochordae are adjusted and tied onto a Teflon® pledget 
on the tip of the papillary muscle. The valve is then tested under pulsatile hemodynamic 
flow conditions as listed in the previous sections and relevant hemodynamic and 
echocardiographic endpoints are measured. 
Chordal Translocation 
The secondary chordae on the posterior leaflet were transected atleast 2mm from 
their insertion into the leaflet, and transferred to the marginal chordal position using 
Prolene sutures. The sutures are passed through the chord and then the leaflet, and are 
knotted on the atrial surface. After the procedure, the left ventricular chamber is filled 
with saline and the valve is tested for its static competence before studying it under 
pulsatile hemodynamic conditions.  
5.5.2.2.2  Data Acquisition 
Regurgitation Volume 
Regurgitant volume through the valve is calculated from the recorded transmitral 
flow curve. The flow curve is averaged over 15 cardiac cycles and the area under the 







2D echocardiographic measurements were obtained at frequencies between 38-60 
Hz, at an imaging depth of 12 cm and a transducer frequency of 3.7 MHz.  Apical long-
axis views cutting the leaflets across the anterior and posterior leaflets are acquired at 
different points on the mitral annulus. Three-dimensional (3D) echocardiographic 
measurements are obtained with a 3D matrix-array ultrasound sector transducer (X7-2 
Matrix Probe, iE33 System, Philips Medical Systems, Andover, MA) at 3.75 MHz, 
adjusted to provide optimal imaging with the highest possible frame rate at a sampling 
depth of 12 cm. Color Doppler images were obtained at the same depth, at a baseline 
velocity of 61.7 mm/sec and a color gain of 25-35%, which is optimized to individual 
acquisitions. Echocardiographic and color Doppler images are obtained to assess the 
forward and the leakage flow through the cleft and the coaptation regions. The images are 
imported into QLAB software for quantification of various Doppler parameters, and into 
PMDSVIEW for length measurements. Peak systolic leaflet coaptation length, posterior 
leaflet angle and distance of the coaptation plane from the posterior annulus are 
measured.  
5.5.2.2.3 Statistical Analysis 
 All the data are reported as mean ± 1 standard deviation. The data are tested for 
normality using an Anderson-Darling test (MINITAB 15). Different experimental 
condition groups are compared using paired t-tests considering statistical significance at a 




5.5.2.3 Part C – Mechanics of Strut Chordae Insertion Region 
 In this section the techniques to measure surface strains on the transitional zone 
where the anterior strut chordae insert into the leaflet are described.  
5.5.2.3.1 Experimental Setup 
The region of interest on the ventricular surface of the anterior leaflet was marked 
with a uniform grid of tissue dye markers, and the motion of the markers throughout the 
cardiac cycle was imaged using a high frame rate imaging system described in 4.1.3.5. 
The two cameras were positioned on the ventricular chamber such that the insertion 
region can be imaged throughout the cardiac cycle. A frame rate of 250 frames/second 
was used with optimal aperture size to ensure adequate temporal resolution within the 
cardiac cycle. The acquired images were saved as a series of TIFF (Tagged Image File 
Format) images, and the coordinates of each marker were obtained using custom codes 
written in MATLAB provided in Appendix B. 
5.5.2.3.2  Marker Tracking 
The markers on the each image frame from camera A were first digitized using a 
custom MATLAB code, and the [x, y] coordinates of each marker for each frame were 
saved to a tab delimited text file. Since the images were acquired at a high frame rate of 
250 frames/ sec, each cardiac cycle had approximately 200 images of the valve opening 
and closure. Manual digitization of each marker in every image would be extremely time 
consuming, thus an adaptive grid interpolation scheme (ACGI) previously developed in 
our laboratory was used to interpolate the marker positions between every 10 images 




compared to the manual method. Using the ACGI technique, the markers in all the frames 
for both the cameras was performed as representatively shown in Figure 5-28. The [x, y] 
coordinates from camera 1 were saved to a text file titled ‘acoord.txt’ and the coordinates 










5.5.2.3.3 Calibration for Direct Linear Transformation 
To define a reference coordinate frame between the two cameras, a calibration 
cube of known dimensions is used. An aluminum cube of 10.6mm edge dimension was 
designed, and machined with a long end connector that allows insertion of the cube into 
the left heart simulator. After setting up the cameras in their required positions, the 
calibration cube is inserted into the left ventricle through the open top part of the 
Figure 5-28 A representative image pair of the calibration cube and of the chordal




chamber, and positioned exactly in the mitral annular plane. The cube is inclined such 
that 6 common cube vertices are clearly visible in both the cameras. Once the cube 
positioned is finalized, still images of the two cubes are captured in both the cameras and 
saved to the hard drive in TIFF format.  
The saved images are then exported into Sigma Scan Pro (Systat Software Inc, 
San Jose, CA) and a common coordinate system is defined that is consistent between the 
two cameras. The vertices are numbered in a clockwise direction, starting with the face 
closest to the camera lens, and by carrying the numbering to the face farthest from the 
camera lens. Once the vertices were digitized, the vertex coordinates from both cameras 
were saved to two separate tab delimited text files. Since the length of each edge of the 
cube is known as 10.6mm, a text file that defines the coordinate system starting with 
vertex # 1 as the origin [0,0,0], vertex # 2 as [10.6,0,0], vertex # 3 as [10.6,10.6,0], vertex 
# 4 as [0,10.6,0], vertex # 5 as [0,0,10.6], and vertex # 6 as [10.6,0,10.6].  
5.5.2.3.4 Direct Linear Transformation 
The individual 2D marker coordinates of image pairs are converted into a 3D 
coordinate system using a Direct Linear Transformation (DLT). This method is based on 
the simple fact that recording images using a camera, is a simple mapping of object O in 
the object space to image I’ in the film plane. For digitizing this recorded image it is 













 For simplicity, the projected image and the object can be directly related as shown 
in Figure 5-30, and a new point N which is the new node point or the projection center. 
Two reference frames are now defined, object-space reference frame (the XYZ system) 
and image-plane reference frame (the UV system). Points I, N & O thus form a straight 
line and this is the so-called collinearity condition. To make the image-plane reference 
frame 3-dimensional, an axis W from the nodal point N to the image plane reference 






Figure 5-29 (A) Projection of an object O from object space to the film space I`;
(B) Projection of the object from film space I’ to projection space I to enable 












5.5.2.3.5  Surface Fitting and Strain Computation 
To compute the strain field, a custom MATHCAD program was used (PTC, 
Needham, MA) to transform the 3D coordinates into an in-plane coordinate system (u-v-
n) based on a tangent plane. The u-v coordinates were then projected onto the deformed 
surface and thus formed a convective coordinate system that deforms with the surface. 
The origin of the u-v-n system was located at the center of the marker array, with 
corresponding unit vectors, eu, ev, and en. In this thesis, eu was defined parallel to the 
markers 1 and 7, en the surface normal was computed using en = eu X em4-m31, where em4-
m31 is the unit vector parallel to markers 4 and 31 and ev = en X eu. Each marker x-y-z 
coordinate triplet for each frame was subsequently translated and rotated into the 
reference frame u-v-n coordinate system.  
Figure 5-30 Direct projection of the object from object space into projection/image




 To compute the strain field within the insertion region delimited by the markers, a 
finite element-based C2 surface interpolation is used. The position of any marker in the 
reference state is given by R0(u,v) = ueu + vev+ nen , where n represents the normal 
component. To fit the marker array, a C2 cubic hermite shape element was used for each 
displacement component. The reference surface fit yields the initial shape of the chordal 
insertion region defined by the 31 marker array. The metric tensor in the reference 
configuration, g0 was computed from R0 using formulae reported in literature [122]. To 
determine the strains for each frame f and component i = (1, 3) the displacements for 
each marker dif were first computed as the difference between the reference and deformed 
spatial marker positions. Thus the position vector for frame f of any point on the 
deformed surface is given by Rf(u, v) = d1f eu+ d2f ev+ d3f en + R0(u,v), where dif (u, v) is 
the fitted displacement field for the axial component i for the current frame f.  From Rf , 
the components of the metric tensor gf  in the deformed configuration are computed and 
the resulting Almansi (i.e., Eulerian) finite strain tensor for each frame was determined 
using e = 0.5(gf – g0).  The principal values of e were expressed as principal stretches λ1 
and λ2, with corresponding principal angle θp referred to the u-axis of the reference state. 
The areal stretch, representing the total change in the leaflet area, was computed using Δ 
= λ1* λ2. The corresponding stretch rates for each frame were computed using a three-







5.5.2.3.6 Data Analysis and Statistical Methods 
All the parameters computed at each marker position and averaged over the eight 
valves. The temporal and peak magnitudes of each parameter are reported, and compared 
using a paired t-test for statistical significance at 95% confidence interval.  
5.5.2.4 Part D – Efficacy of Edge-to-Edge Repair for Posterior Leaflet Prolapse 
Minimally invasive edge-to-edge repair is a technique gaining popularity to 
correct posterior leaflet prolapse due to its procedural ease and ability to perform the 
procedure through percutaneous technologies. In this study, a surgical version of edge-to-
edge repair was studied wherein the prolapsing posterior leaflet was anchored onto the 
structurally stable anterior leaflet. An “8” shaped stitch was used to perform the edge-to-
edge procedure as shown in Figure 5-31 , so that the overlap region between the leaflets 
was maximized and higher stability was ensured. After performing the edge-to-edge 
repair, the valve was tested at three annular configurations: normal, 15% dilatation and 







Figure 5-31 (A) Isolated posterior leaflet prolapse due to acute chordal rupture; (B) The”8”
shaped stitch showing the suture passing through the posterior leaflet, followed by the
anterior leaflet and then sutured onto the posterior leaflet so that atleast 5mm of contact is
established between the anterior and posterior leaflet; (C) The mitral valve after edge to
edge repair 




5.5.2.4.1 Experimental Protocol 
Each mitral valve is studied under the experimental conditions in the order listed 
below: 
Control/Baseline Conditions 
The annulus is maintained at its normal size, and the papillary muscles are fixed 
in their normal positions, i.e., with the papillary muscle tips perpendicular to the mitral 
annular plane and in the plane passing through leaflet coaptation, such that the 
commissural chordae from the same papillary muscle are parallel to each other. The valve 
is studied under adult hemodynamic conditions of 120 mm Hg peak transmitral pressure, 
5L/min cardiac output at 70bpm. The regurgitant volume and stroke volume are 
volumetrically measured, and leaflet coaptation length, and indices that elucidate leaflet 
mobility are recorded using 3D echocardiography. 
 
Posterior Leaflet Prolapse 
 After acquiring the baseline data, the two marginal chordae on the free edge of 
the posterior leaflet are transected resulting in severe segmental prolapse of the P2 cusp. 
The simulator is again run under identical hemodynamic conditions, and the 
hemodynamic and echocardiographic measurements are obtained. P2 prolapse is 
validated by reconstructing the 3D geometry of the mitral valve from the 
echocardiographic images and superimposed with only the reverse color Doppler data, 
showing the regurgitation jet. The regurgitation and stroke volumes are also quantified 





Edge to edge repair was performed by placing an “8” shaped stitch between the 
prolapsing free edge of the P2 cusp, and the structurally stable A2 cusp. The stitch is 
placed atleast 4mm above the leaflet margin, and a laterally overlap of ~1cm is ensure 
between the two leaflets at the location of the stitch. The repair is first tested with a 
normal annular size (32mm), and then dilated by 15% to 34mm and by 30% to 36mm 
respectively. At each level of annular dilatation, hemodynamic and echocardiographic 
data are acquired and quantified. 
5.5.2.4.2 Measurement Techniques 
Regurgitation Volume 
Regurgitant volume through the valve is calculated from the recorded transmitral 
flow curve. The flow curve is averaged over 15 cardiac cycles and the area under the 
negative part of the flow curve is integrated to obtain the net regurgitation volume.  
Echocardiographic Measurements 
2D echocardiographic measurements were obtained at frequencies between 38-60 
Hz, at an imaging depth of 12 cm and a transducer frequency of 3.7 MHz.  Apical long-
axis views cutting the leaflets across the anterior and posterior leaflets are acquired at 
different points on the mitral annulus. Three-dimensional (3D) echocardiographic 
measurements are obtained with a 3D matrix-array ultrasound sector transducer (X7-2 
Matrix Probe, iE33 System, Philips Medical Systems, Andover, MA) at 3.75 MHz, 
adjusted to provide optimal imaging with the highest possible frame rate at a sampling 




velocity of 61.7 mm/sec and a color gain of 25-35%, which is optimized to individual 
acquisitions. Echocardiographic and color Doppler images are obtained to assess the 
forward and the leakage flow through the cleft and the coaptation regions. The images are 
imported into QLAB software for quantification of various Doppler parameters, and into 
PMDSVIEW for length measurements. Peak systolic leaflet coaptation length, posterior 
leaflet angle and distance of the coaptation plane from the posterior annulus are 
measured.  
5.5.2.4.3 Statistical Analysis 
All the data are reported as mean ± 1 standard deviation. The data are tested for 
normality using an Anderson-Darling test (MINITAB 15). Different experimental 
condition groups are compared using paired t-tests considering statistical significance at a 
p value of < 0.05 with a 95% confidence interval. 
 
5.5.2.5 Part F – Impact of Mitral Annular Saddle Shape on the Deformation of the 
P2 Segment of the Posterior Mitral Leaflet 
To understand the impact of annuloplasty ring shape on the mechanics of the 
posterior leaflet of the mitral valve, strain was measured on the central P2 cusp at 0%, 
10% and 20% static annular saddle. The experimental setup, and methods used to 






5.5.2.5.1 Experimental Setup 
A 4x4 array of markers (~200µ) are placed on the atrial surface of the P2 cusp and 
the valve is mounted into the left heart simulator and studied under pulsatile 
hemodynamic conditions. Two high speed cameras are placed facing the left atrial 
surface and separated by ~ 30o, and the marker array is imaged throughout the cardiac 
cycle. Image acquisition through both cameras is triggered synchronously with the 
cardiac timing of the left heart simulator and the hemodynamic acquisition and the 
acquired images shown in Figure 5-32 from each camera are stored as a series of TIFF 
files onto the hard drive. A calibration cube of edge size 10.6mm is then inserted into the 
left heart simulator through the top face of the ventricle, and placed in the plane of the 
mitral annulus. The calibration cube is then imaged using both cameras and the static 





Figure 5-32 A representative image pair of leaflet markers obtained from the two high





5.5.2.5.2 Marker Digitization and Direct Linear Transformation 
Detailed techniques to digitize the 2D marker coordinates from the sequence of 
images from each camera are explained in previous sections. Identical MATLAB codes 
reported in these sections are used to reconstruct the 2D marker coordinates from the 
camera images, and direct linear transformation is used to calculate the 3D marker 
coordinates. Once the 3D cloud of markers for each temporal point is obtained, a 
previously developed algorithm is used to compute the leaflet strains.  
5.5.2.5.3 Surface Fitting and Strain Computations 
A C0 surface fitting algorithm was used to reconstruct the reference and deformed 
surfaces. The position of any marker in the reference state is given by R0(u,v) = ueu + 
vev+ nen , where n represents the normal component. The reference surface fit yields the 
initial shape of the leaflet region defined by the 16 marker array. The metric tensor in the 
reference configuration, g0 was computed from R0 using formulae reported in literature 
[122]. To determine the strains for each frame f and component i = (1, 3) the 
displacements for each marker dif were first computed as the difference between the 
reference and deformed spatial marker positions. Thus the position vector for frame f of 
any point on the deformed surface is given by Rf(u, v) = d1f eu+ d2f ev+ d3f en + R0(u,v), 
where dif (u, v) is the fitted displacement field for the axial component i for the current 
frame f.  From Rf , the components of the metric tensor gf  in the deformed configuration 
are computed and the resulting Almansi (i.e., Eulerian) finite strain tensor for each frame 
was determined using e = 0.5(gf – g0).  The principal values of e were expressed as 




of the reference state. The areal stretch, representing the total change in the leaflet area, 
was computed using Δ = λ1* λ2. The corresponding stretch rates for each frame were 
computed using a three-point numerical derivate algorithm and expressed as percent per 
second.  
5.5.2.5.4 Data Analysis and Statistical Methods 
All the parameters computed at each marker position and averaged over the eight 
valves. The temporal and peak magnitudes of each parameter are reported, and compared 
using a paired t-test for statistical significance at 95% confidence interval.  
5.5.3 SPECIFIC AIM 3 - SURGICAL REPAIR FOR FUNCTIONAL MITRAL 
REGURGITATION 
5.5.3.1 Impact of Pre-Operative Valve Geometry on the Outcomes of Annular and 
Sub-annular Repair for Functional Mitral Regurgitation 
 3D geometry of the mitral valve plays a key role in determining the efficacy and 
long term durability of repair for functional mitral regurgitation. In this aim, the impact of 
valve geometry on undersizing annuloplasty and anterior strut chordal cutting was 
investigated. Annuloplasty is the current standard of care in clinical practice, and was 
performed in this study by reducing the size of the mitral annulus to 28mm from its 
dilated size. Sub-annular repair was performed by resecting the two strut chordae 














5.5.3.1.1  Experimental Protocol 
Each mitral valve was studied under the following conditions: 
Control/Baseline Conditions 
 The annulus is maintained at its normal size, and the papillary muscles are fixed 
in their normal positions, i.e., with the muscle tips perpendicular to the mitral annular 
plane and in the plane passing through leaflet coaptation, such that the commissural 
chordae from a papillary muscle are parallel to each other. The valve is studied under 
physiological hemodynamic conditions of 120 mmHg peak transmitral pressure, 5L/min 
cardiac output at 70 beats per minute (bpm). Mitral valve hemodynamics, regurgitation 




Figure 5-33 (Left) Tethering of the anterior leaflet after annuloplasty but no
secondary chordal cutting; (B) Strut chordal transection performed on the anterior






 Mitral regurgitation is induced in the normal valve by simulating two different 
pathological conditions: (a) annular dilatation (36mm) + 10mm apical papillary muscle 
displacement; and (b) annular dilatation (36mm) + 10mm apical, 10mm lateral, 10mm 
posterior papillary muscle displacement. Resulting mitral valve geometry due to the 
imposed geometric changes is measured using 3D echocardiography and the 
hemodynamic endpoints are quantified.  
Repair Conditions 
Annular Repair Technique - True Sizing Annuloplasty 
 The first objective is to assess if ring annuloplasty would suffice in reducing 
mitral regurgitation in both pathological geometries. Ring annuloplasty procedure is 
simulated on the regurgitant valves by reducing the septal lateral dimension to 28mm, 
restoring it to its physiological levels. Commercial annuloplasty rings were not used to 
avoid any pre conceived bias. After true-sizing of the annulus, reduction in regurgitation 
volume is measured and the mitral valve geometry is carefully quantified from the 
echocardiographic images.  
Sub-annular Repair Technique - Secondary Chordal Cutting 
 In this study, only anterior strut chordal cutting is performed and its benefits in 
increasing anterior leaflet mobility and improving valve competence are studied. 
Maintaining the annulus at the true dimension of 28mm, the two basal strut chordae 




into the leaflet using a scalpel, without disturbing the annular dimensions or papillary 
muscle positions. The valves are again tested under identical hemodynamic conditions, 
and all the hemodynamic and geometric parameters are quantified.  
5.5.3.1.2 Measurement Techniques 
Regurgitation Fraction 
 The transmitral flow curve is averaged over 15 cardiac cycles and the negative 
part of the flow curve is integrated to obtain the regurgitation volume per beat, and 
normalized with the stroke volume to obtain the regurgitant fraction. 
Echocardiographic Study 
 3D echo and color Doppler measurements were obtained with a X7-2 pediatric 3D 
matrix array probe (iE33 System, Phillips Medical Systems, Andover, MA) at 3.75 MHz, 
at the highest possible frame rate at the sampling depth of 12 cm. Echocardiographic 
images were acquired (1) along the apical long-axis view cutting across both the leaflets 
antero-posteriorly at the midpoint of the major axis of the annulus, (2) apical long-axis 
view to the left of center, capturing the P1- A1 coaptation and (3) to the right of center 
capturing P3-A3 coaptation.  From views (1), (2), (3) the systolic leaflet coaptation 
length, and tenting height/area were quantified in a double blinded fashion using QLAB 






5.5.3.1.3  Statistical Analysis 
 All the measured endpoints are reported as mean ± standard deviation. The data 
are tested for normality using the Anderson-Darling Test in MINITAB 15. The 
experimental groups were compared using a paired t-test considering statistically 
significant difference at a p < 0.05 with a 95% confidence interval. A non-parametric 
Wilcoxon signed-rank test was conducted on the echo data, as some experimental 
conditions were not normally distributed. The same P value and confidence interval 



















CHAPTER 6  
 
RESULTS 
The results are organized into three primary sections based on the specific aims: 
[1] Congenital Mitral Valve Repair; [2] Degenerative Mitral Valve Repair; and [3] 
Surgical Repair for Functional Mitral Regurgitation. In each section, the results are 
organized in the following order: 
 [A] Validation of the in-vitro pathological valve model 
 [B] Pre-Surgical Hemodynamics, Kinematics and Function 
 [C] Post-Surgical Hemodynamics, Kinematics and Function 
 To validate the in-vitro pathological valve models, 3D echocardiographic images 
of the porcine valves were obtained in the pulsatile left heart simulator and compared to 
echocardiographic images from human subjects with that specific valve pathology. 
Relevant indices such as morphological features, hemodynamic outcomes and leaflet 
kinematics were quantified and compared to the data available in the literature. However 




the literature and thus validation of the model was limited to comparison of geometric 
features.  
 The surgical repairs used in this thesis were performed according to clinical 
guidelines and standards. If a surgical repair is currently practiced clinically, it was 
replicated as it is performed on human subjects to avoid deviation in results due to 
procedural differences between the laboratory setting and actual clinical practice. All the 
repairs were first practiced on porcine hearts under the guidance of an experienced 
cardiac surgeon, after which they were replicated on the valves in the pulsatile left heart 
simulator.  
 To study the impact of geometric factors on the valve function and mechanics 
after surgery, changes in annular or sub-annular features were simulated based on a 
thorough literature review. Though changes in cardiac geometries in human subjects 
depends largely on their individual physiology, valve geometry or the timing of their 
surgery, a general trend in annular dimensions or ventricular geometry could be outlined 
from literature. The studies were thus limited to these features, as simulating every 
geometric variation would be impractical within the scope of this thesis.  
 The end points measured in each specific aim are either currently used in clinical 
practice to diagnose mitral valve pathologies and quantify surgical repair outcomes, or 
are new with high potential for translation. In the latter case, realistic endpoints were 
developed using measurement techniques that are practical in the clinical setting and thus 




visualization method was used which cannot be implemented in-vivo, but can be used as 
a “truth method” to validate 3D echocardiography for mechanics measurements.  
 
6.1 CONGENITAL MITRAL VALVE REPAIR 
6.1.1 VALIDATION OF CLEFT MITRAL VALVE MODEL 
 To validate the isolated anterior leaflet cleft valve model used in this study, we 
acquired 3D echocardiographic images (Philips iE33 Echocardiography System, 
Andover, MA) of the porcine valve in the pulsatile left heart simulator. Figure 6-1A-F 
show the sequential alterations to the valve geometry to simulate the cleft mitral valve 
pathology, and Figure 6-1G-H show the systolic reconstructions from a human subject 
with a cleft mitral valve [1] and the in-vitro heart model, respectively. In Figure 6-1G, the 
dotted black line represents the mitral annular shape with a straight anterior portion and a 
curved posterior portion. The anterior leaflet is clearly divided into two bridging leaflets 
(Superior Bridging Leaflet (SBL) and Inferior Bridging Leaflet (IBL)) by the central 
cleft, while the posterior/mural leaflet is significantly smaller compared to a normal 
valve. The commissures are displaced posteriorly and thus tether on the anterior leaflet 
edges, potentially restricting the motion of the free edges of the anterior leaflet. During 
systole, a combination of restricted anterior leaflet and smaller posterior leaflet results in 
opening of the anterior cleft and loss of leaflet coaptation as seen in Figure 6-1G. Similar 
geometric characteristics were seen in the systolic echocardiographs obtained on the in-




hemodynamics was not compared, as the pressure and flow recordings in pediatric 




















Figure 6-1 (A-F) Sequential steps to alter the native mitral valve geometry to mimic the left atrioventricular valve in the
canal defects. The dotted circles indicate the position of the papillary muscles. The images on the right (G,H) compare the
valve structure with cleft (arrow) obtained from our in-vitro setup under pulsatile hemodynamic  conditions with one





6.1.2 IMPACT OF SMALLER MURAL LEAFLET AND OBLIQUE 
PAPILLARY MUSCLE POSITION ON VALVE HEMODYNAMICS 
 To understand the impact of smaller posterior leaflet area, and the scooped 
ventricular geometry on the hemodynamic function of the cleft mitral valve, the 
regurgitation volumes of the normal mitral valve before creating the cleft defects and the 
valve after creating the pathological geometric features (still without the cleft) were 
measured. With the physiological valve geometry i.e., normal annular size and 
physiological papillary muscle positions, there was no regurgitation recorded across the 
valve. Reducing the area of the mural leaflet with posterior annular plication, (but with 
normal annular size and papillary muscle positions) induced 0.7±0.3 ml/beat of 
regurgitation that was statistically insignificant (p=0.12). Oblique displacement of the 
papillary muscles with posterior and lateral displacement of the muscles increased the 
regurgitation volume to 0.7±0.3 ml/beat with a normal annular size (p=0.07), though no 
statistical difference between the groups could be established. These results indicate that 
the smaller posterior leaflet or the pathological papillary muscle positions by themselves 
do not directly impact the hemodynamic function of the valve. However, when the mitral 
annulus was dilated by 20% and 40% respectively, a significant increase in the 
regurgitation volumes was measured as tabulated in Table 6-1. With the oblique papillary 
muscle position, the regurgitation volume increased to 4.2±1.1 ml/beat (p< 0.0001) at 
20% annular dilatation and 9.3±2.4 ml/beat at 40% annular dilatation (p < 0.0001 ), in 





Table 6-1 Comparison of the regurgitation volumes between the normal papillary muscle 
position and the obliquely positioned pathological papillary muscle position at different 
annular sizes 
 
6.1.3 IMPACT OF LENGTH OF CLEFT CLOSURE 
Four levels of cleft closure were evaluated in this study with a normal size 
annulus: unclosed cleft, 1/3rd cleft closed, 2/3rd cleft closed and full cleft closure, as 
shown in Figure 6-2. For each length of cleft closure, the regurgitation volumes were 
measured by direct flow measurement. Figure 6-3 illustrates the comparison between 
regurgitation volumes for the four levels of cleft closure at a normal annular size. With 
the cleft fully open a regurgitant volume of 12.56±2.4 ml/beat was recorded, which is can 
be considered a moderate amount of regurgitation under pediatric hemodynamic 
conditions. Closure of the cleft to one-third of its total length reduced the regurgitant 
volume to 9.96±2.1 ml/beat and with statistically significant reduction from the fully 
open cleft case (p = 0.001). Two-thirds cleft closure further reduced the regurgitation to 
4.9±1.9 ml/beat, which was significantly smaller than the fully open cleft (p<0.001) and 
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one-third cleft closure (p=0.001) respectively. With complete closure of the cleft, most of 
the regurgitation was reduced to mild levels of 1.4 ± 1.6 ml/beat, which was a significant 








To clearly illustrate the role of the length of cleft closure, the regurgitation 
volumes with different cleft lengths were normalized by the volume with the fully open 
cleft. A strong inverse correlation was observed between the length of cleft closure and 





Normalized Regurgitant Volume = -0.956(Cleft Closure Length) + 1.012 
Figure 6-2  Schematic showing the three levels of cleft closure used in this study. (A)
1/3rd cleft closure wherein only the region closest to the annulus was closed, (B) 2/3rd
cleft closure with most of the cleft closed except for the region near the free edge, (C)
Cleft completely closed 
1/3rd Cleft Closed 2/3rd Cleft Closed Full Cleft Closed 





























Figure 6-3 Regurgitation volumes obtained for an open, one-third closed, two-
third closed and completely closed cleft lengths 
Figure 6-4 Normalized regurgitation volume plotted against the cleft closure 
length for each valve. Normalized regurgitation volume was obtained by
dividing the regurgitation volume for the one-third, two-third and fully-closed 
conditions with the corresponding open cleft regurgitation volume. The equation
clearly shows a negative correlation between the regurgitation volume and the




6.1.4 IMPACT OF POST SURGICAL ANNULAR DILATATION 
One of the challenges with pediatric mitral valve repair is the growth of cardiac 
structures in the post-operative period. As the body surface area of the patient increases 
with age, a 20-40% increase in mitral annular area has been reported in normograms from 
these patients. To understand the impact of such increase in annular size on the 
competence of the repaired cleft valve, for each level of cleft closure 20% and 40% 
annular dilatation was simulated and its impact on regurgitation volume was quantified. 
Results from these experiments demonstrated that annular dilatation induced significant 
increase in regurgitant volume irrespective of the length of cleft closure. For a fully open 
cleft the regurgitant volume increased from 12.2 ± 2.1 ml/beat at normal annulus size to 
13.7 ± 1.1 ml/beat (p = 0.001 ) for 20% dilatation and 14.7 ± 0.8 ml/beat  (p=0.027) for 
40% dilatation respectively. When a third of the cleft was closed, a 20% increase in the 
annular size resulted in a significant change in the regurgitant volume from 9.9 ± 2.8 
ml/beat at normal size to 12.1 ± 2.4 ml/beat ( p = 0.001). With further dilatation of the 
annulus to 40%, the regurgitant volume increased to 14.0 ± 1.7 ml/beat, which was 
significantly different from both the normal annulus (p =0.002) and the 20% dilated 
annulus (p =0.007). For the two-third cleft closure, the regurgitant volume changed from 
4.7 ± 3.3 ml/beat at normal annulus size to 8.5 ± 2.5 ml/beat ( p = 0.002) and 11.4 ± 1.8 
ml/beat (p=0.0001), for 20% and 40% increase in annular size respectively.  
When the cleft was completely closed these levels of annular dilatation resulted in a 
significant increase in the regurgitant volumes from 1.4 ± 2.8 ml/beat for normal annular 
size to 4.5 ± 2.3 ml/beat ( p = 0.0001 ) for 20% increase in annular size and 8.7 + 1.5 





















Figure 6-5 Increase in the systolic regurgitation volume due to annular dilatation for the
three levels of cleft closure. (Left) At 1/3rd cleft closure, a 50% increase in regurgitation is
visible from the normal to the most dilated state. (Center) With 2/3rd cleft closure a 60%
increase in regurgitation was measured at the most dilated state, (Right) At complete cleft




6.1.5 IMPACT OF ANNULAR UNDERSIZING ON REGURGITATION 
 The results from the previous section clearly demonstrate that with increase in 
annular area, regurgitation significantly increases. Thus to test if mitral annular 
undersizing has an impact in reducing regurgitation volume and if it renders the valve 
stenotic, valve competence with 20% and 40% annular undersizing were also studied. 
Figure 6-6 illustrates the effect of undersizing the annulus on the regurgitant volume for 
the four cleft closure lengths. For the fully open cleft, a 20% reduction in the annular area 
from the normal decreased the regurgitant volume from 12.56 ± 2.4 ml/beat to 10.83 ± 
1.8 ml/beat and to 9.8 ± 1.9 ml/beat for 40% annular undersizing. Similarly, for the one-
third cleft closure length, a 20% reduction in annular area decreased the regurgitant 
volume from 9.95 + 3 ml/beat to 7.78 + 2 ml/beat (p = 0.007). An additional 20% 
reduction in annular area (40% cumulative reduction in the annulus size), decreased the 
regurgitation volume significantly to 4.44 + 1.9 ml/beat (p = 0.001). Similarly, for the 
two-third cleft closure length the regurgitation volume decreased from 4.73 + 2.8 ml/beat 
at the normal annular size to 2.05 + 2.1 ml/beat ( p = 0.518 )for 20% reduction in the 
annulus size and further undersizing by an additional 20% decreased the MR to 0.7 + 1.2 
ml/beat (p = 0.533). The p-values are in comparison to the regurgitation volume of the 
valve with a smaller posterior leaflet and obliquely placed papillary muscles, and without 









Figure 6-6 Decrease in the systolic regurgitation volume with 20% and 40% annular




6.1.6 DIASTOLIC EFFECTIVE ORIFICE AREA: PRE AND POST SURGERY 
Mitral annular undersizing though beneficial in reducing regurgitation in the cleft 
mitral valve, it could potentially induce mitral stenosis due to restricted growth of the 
mitral annulus. Such mitral stenosis may potentially impede diastolic ventricular filling, 
which could have several deleterious effects on the ventricular function and also may 
lead to chronic pulmonary hypertension. For the eight valves studied, diastolic effective 
orifice area was calculated from the transvalvular flow and pressure gradient, both pre 
and post surgery. Figure 6-7 demonstrates the average effective orifice area for each 
experimental condition in comparison to the baseline (fully open cleft and normal annular 
size). At baseline conditions, the calculated effective orifice area was 3.23±0.49 cm2. 
When 1/3rd of the cleft was closed and the annular size was at its normal levels, the 
orifice area changed to 4.32±1.95 cm2 and with 40% undersizing of the annulus reduced 
to 3.46±1.81cm2. However the differences between these groups were not statistically 
significant (p =0.734). When the cleft was further closed to 2/3rd of its total length and the 
annular size was normal, the calculated effective orifice area was 3.94±1.76 cm2 and with 
20% undersizing was 3.37±1.09, with no statistical difference between the groups. 
Complete cleft closure with normal sized annulus had an effective orifice area of 
3.5±1.5cm2. It should be noted that the effective orifice area was calculated for the 
groups that demonstrated reduction in regurgitation and thus have the potential for 
restoring valve competence, thus the 1/3rd cleft closure with 20% undersizing and 2/3rd 






6.1.7 ECHOCARDIOGRAPHIC IMAGING OF REGURGITANT JETS 
To validate the quantitative hemodynamic results, 3D echocardiographic images 
were obtained using an adult matrix probe array (X7-2, Philips Medical Systems, 
Andover, MA) for each experimental condition. Figure 6-8 shows the 3D color Doppler 
images showing the regurgitant jet and the valve leaflets during peak systole. The results 
demonstrate that when the anterior cleft is completely open, irrespective of manipulating 
the annular size, and significant regurgitation persisted. These findings corroborate with 
the quantitative hemodynamic results reported earlier in sections 6.1.3, 6.1.4, and 6.1.5. 
Figure 6-7 Pre and post surgical effective orifice areas measured from the




Similar results were observed with 1/3rd cleft closure, however with a slightly reduced 
severity of regurgitation. The 3D color Doppler images show the overall regurgitation 
through the valve, but were not used to quantify the direction of the jet or the region of 
regurgitation specifically. With 2/3rd of the cleft closed, regurgitation was observed with 
the normal or dilated annulus configuration, but not when the annulus was undersized. 
With reduction in the septal-lateral dimension of the annulus, the open part of the cleft 
may be included into the coaptation and thus provide the required seal to stop 
regurgitation during systole. Full cleft closure eliminated regurgitation completely as 
expected, as during systole there would be no regurgitant orifice through which blood can 
flow back into the left atrium. However when the annulus was dilated, mild regurgitation 






        
Figure 6-8 Color Doppler images of the cleft mitral valve at different cleft closure lengths and annular sizes, depicting the




6.2 DEGENERATIVE MITRAL VALVE REPAIR 
 Degenerative mitral valve disease encompasses a spectrum of lesions, with 
different etiologic basis and pathologic manifestations. In the western world the two most 
common adult degenerative mitral valve lesions are Barlow’s disease and Fibroelastic 
deficiency. There is a large volume of work on surgical strategies for Barlow’s disease, 
but knowledge of optimal techniques to repair fibroelastic deficient mitral valves has 
been minimal. In this study, an in vitro model of mitral valve prolapse due to acute 
chordal rupture was developed to simulate the clinical case of fibroelastic deficiency.  
6.2.1 VALIDATION OF IN VITRO MODEL FOR ACUTE POSTERIOR 
LEAFLET PROLAPSE 
 Leaflet prolapse was simulated in normal porcine mitral valves by transecting the 
marginal chordae inserting into the free edge of the leaflet, either posterior or anterior 
based on the experiment. Typically, valves with fibroelastic deficiency are structurally 
normal without any distension or billowing which justifies the use of normal valves for 
this study. The prolapsing valves were studied in the pulsatile left heart simulator, and 
echocardiographic images were obtained to record the leaflet motion and regurgitation 
jets. The acquired data was then compared to intra-operative videos and 
echocardiographs provided by Dr. David H. Adams from the Mt. Sinai School of 
Medicine. Accuracy of the valve model was ensured with a qualitative comparison of the 

























Figure 6-9 (A) 2D echo of a normal mitral valve with excellent coaptation, (B)
Posterior leaflet prolapse after marginal chordal rupture, (c) 3D echocardiographic
image of the normal valve with good coaptation, (d) An eccentric anteriorly directed
regurgitation jet due to posterior leaflet prolapse, (e) An intra-operative image with an




Figure 6-9A shows the 2D-echocardiographic image along the septal lateral plane 
of the mitral valve, at the A2 and P2 valve cusps. Excellent leaflet coaptation is evident 
from the images, without any regurgitation evident on the valve. After marginal chordal 
transection, isolated prolapse of the P2 cusp is observed as shown in Figure 6-9B with the 
posterior leaflet overriding the anterior leaflet and resulting in a regurgitation orifice. En-
face 3D echocardiographic image of the normal valve as shown in Figure 6-9C depicts 
good coaptation from the commissure-to-commissure of the valve. Figure 6-9D shows an 
eccentric regurgitant jet in a posterior leaflet prolapse valve, flowing along the anterior 
leaflet surface into the left atrium which is equivalent to the clinical setting. Figure 6-9E 
shows an intra operative image of the valve with the isolated posterior chordal rupture, 
which was the scenario simulated in the in vitro model.  
6.2.1.1 Part A – Hemodynamic Comparison of Resective and Non- Resective 
Techniques to Correct Acute Posterior Leaflet Prolapse 
 Three types of surgical repair techniques were compared in this study to correct 
posterior leaflet prolapse in a fibro-elastic deficient valve, and the post-repair 
hemodynamics and valve kinematics are reported. The efficacy of each technique in 
restoring physiological valve function and mechanics is reported and discussed. 
6.2.1.1.1 Impact of Leaflet Resection on Post-Repair Regurgitation 
Mitral regurgitation volumes were measured pre and post surgery in the in-vitro 
acute posterior leaflet prolapse model. Under control/baseline conditions with normal 
porcine mitral valves, no regurgitation was recorded as shown in Figure 6-10. 




isolated P2 prolapse with severe regurgitation of 19.31±4.3ml/beat. Surgical correction of 
the valves was performed in three sequential steps, with neochordoplasty being 
performed first, followed by triangular resection and finally quadrangular resection with 
annular plication. Neochordoplasty significantly reduced mitral regurgitation compared 
to the prolapse group, with an average remnant regurgitation of 2.8±1.2ml/beat (p=0.007, 
compared to prolapse). Limited triangular resection also reduced regurgitation 
significantly to 2.5±1.0ml/beat (p=0.008), and was comparable to the neochordoplasty 
group. Remnant regurgitation after quadrangular resection was slightly higher than the 
other two repair groups at 4.3±1.5ml/beat, but the reduction was significant compared to 










Figure 6-10 Pre and post repair regurgitation volumes for the three procedures





6.2.1.1.2 Impact of Leaflet Resection on Leaflet Coaptation Length 
During systolic valve closure, the length or area of coaptation of the anterior and 
posterior leaflets plays a key role in determining the severity or lack of regurgitation. In 
this study, 2D leaflet coaptation length was measured along the septal-lateral plane of the 
mitral annulus under control and post-repair conditions. At baseline with native porcine 
mitral valves, an average coaptation length of 11.4±1.4mm was measured, which 
corroborates with previously published data on porcine mitral valves. With marginal 
chordal transection and isolated P2 prolapse, coaptation along the A2-P2 cusps was 
completely lost as shown in Figure 6-11. Neochordoplasty restored coaptation to 
physiological levels of 11.8±1.7mm, and was statistically comparable to the control 
group (p=0.2). Limited triangular resection at the P2 free edge restored coaptation length 
to 9.4±1.4mm, which was significantly smaller than the control group (p=0.01) and also 
compared to neochordoplasty group (p= 0.05). Quadrangular resection with annular 
plication was the last procedure, and the coaptation length with this surgical procedure 
was reduced to 7.2±0.8mm, which was significantly smaller than the control (p=0.0001), 



















6.2.1.1.3 Leaflet Mobility as an Index to Assess Repair Durability 
Posterior leaflet mobility after each surgical repair was assessed using simple 
echocardiographic measurements:(a) Perpendicular distances from the leaflet coaptation 
zone to the posterior (∆p) and anterior (∆a) annulus in the septal-lateral plane; (b) Peak 
systolic excursion angles of the posterior (α) and anterior (β) leaflets; and (c) Depth of 
leaflet coaptation from the mitral annular plane as shown in Table 6-2. The distance of 
the coaptation zone from the anterior and posterior annulus were nearly equal in the 
control case (∆p=14.2±1.9mm, ∆a=20.8±1.9mm), showing that the leaflet coaptation was 
centrally positioned from the anterior and posterior annulus in normal valves. A similar 
Figure 6-11 Pre and post operative leaflet coaptation lengths for the three procedures
demonstrating higher coaptation lengths for non-resective neochordoplasty in 




coaptation geometry was observed after Neochordoplasty (∆p=15.4±1.2mm, p=0.09; 
∆a=20±2.1mm, p=0.35) as the control group. However, both limited triangular resection 
(∆p=13.1±1.4mm, p=0.03; ∆a=22.2±2.6mm, p=0.04) and quadrangular resection 
(∆p=10.2±2.0mm, p=0.006; ∆a=23.9±2.5mm, p=0.01) restricted posterior leaflet 
mobility, resulting in displacement of the coaptation zone posteriorly. Additionally, we 
quantified the peak systolic leaflet angles made by the posterior and anterior leaflets with 
the mitral annulus as a measure of systolic leaflet mobility. The posterior leaflet angles in 
the neochordoplasty group (α=34.2±3.6o, p=0.77), and limited triangular resection 
(α=37.4±3.3o,p=0.25) were comparable to the control (α=33.5±6.6o), but were 
significantly higher in the quadrangular resection group (α=51.2±10.8o, p=0.01), as 
shown in Table 6-2. The anterior leaflet angles were consistent between the four 
conditions, indicating that the anterior leaflet has a threshold beyond which it cannot 














# and * represents statistical difference compared to neochordoplasty (p<0.05) and control (p<0.05) respectively. 
 
 




6.2.1.1.4  Analysis of Opening and Closing Leaflet Kinematics 
 2D echocardiographic images of the mitral valve leaflets along the septal-lateral 
plane were obtained to assess leaflet mobility and systolic coaptation geometry. As 
shown in Figure 6-12A-2, under physiological geometry the mitral valve had good 
coaptation with the line of coaptation nearly midway from the anterior and posterior 
mitral annulus. Transecting the marginal chordae induced isolated P2 prolapse as shown 
in Figure 6-12B-2 inducing an anteriorly directed regurgitation jet (not shown in the 
figure). Figure 6-13 shows the diastolic and systolic leaflet positions after the three 
surgical repair techniques. The most significant finding from these echocardiographic 
images was that with increased leaflet resection or plication of the annulus, the mobility 
of the posterior leaflet was significantly reduced. As seen with quadrangular resection 
with annular plication case in Figure 6-13 C-1 & C-2, the coaptation plane is moved 
posteriorly from the anterior annulus due to the restricted leaflet mobility.  
 Systolic coaptation geometry is significantly different between the three repair 
groups, with quadrangular resection and annular plication case significantly worse 
compared to the control case. Comparing the diastolic and systolic positions of the 
posterior leaflet after quadrangular resection indicates minimal leaflet movement even 
with raising transvalvular pressure gradient, implying that the leaflet is experiencing an 
opposing force that contributed to the leaflet immobility against the ventricular driving 
force. On the other hand, limited triangular resection of the prolapsing free edge did not 
seem to impact leaflet mobility and was comparable to neochordoplasty and the 











Figure 6-12 (A-1) Diastolic open position of the mitral valve leaflets under control
conditions; (A-2) Systolic closed position of the valve leaflets under control conditions;
(B-1) Diastolic open position after posterior marginal chordal transection; (B-2) Isolated






















Figure 6-13 Diastolic fully open and peak systolic closed positions of the mitral valve after the resective and non-resective
procedures. (A-1) Diastolic fully open position after chordal reconstruction using ePTFE neochordae; (A-2) Peak systolic
coaptation after neochordoplasty demonstrating the excellent overlap between the anterior and posterior leaflets, midway from
the anterior and posterior annuli; (B-1) Diastolic open position after triangular resection; (B-2) Systolic closed position after
triangular resection; (C-1) Diastolic open position after quadrangular resection; (C-2) Systolic closed position after




6.2.1.2 Part B – Efficacy of Neochordoplasty and Chordal Translocation to Correct 
Acute Posterior Leaflet Prolapse 
6.2.1.2.1 Comparison of Hemodynamic Efficacy 
Under control/baseline conditions with normal porcine mitral valves, no 
regurgitation was recorded as shown in Figure 6-14. Transecting the marginal chordae 
inserting into the free edge of the P2 cusp induced isolated P2 prolapse and a 
regurgitation of 13.7 ± 12.7 ml/beat. Surgical correction of the valves was performed in 
two steps, with neochordoplasty being performed first, followed by translocation of the 
secondary chordae on the posterior leaflet to the ruptured marginal chordal position on 
the prolapsing posterior cusp. Neochordoplasty significantly reduced mitral regurgitation 
compared to the prolapse group, with an average remnant regurgitation of 3.2 ± 2.9 
ml/beat (p=0.007 – compared to prolapse). Chordal translocation also reduced 
regurgitation to 2.3±2.6ml/beat (p=0.008), and was comparable to the neochordoplasty 
group. The results clearly indicate that from a hemodynamic perspective, both 


















6.2.1.2.2 Comparing Leaflet Coaptation Length 
2D leaflet coaptation length was measured along the septal-lateral plane of the 
mitral annulus under control and post-repair conditions. At baseline with native porcine 
mitral valves, an average coaptation length of 11.0±4.0 mm was measured, which is in 
the range of previously published data on porcine mitral valves. With marginal chordal 
transection and isolated P2 prolapse, coaptation along the A2-P2 cusps was completely 
lost as shown in Figure 6-15. Neochordoplasty restored coaptation to physiological levels 
of 14.0 ± 4.0 mm, and was statistically comparable to the control group (p=0.2). An 




















Figure 6-14 Comparison of pre-repair and post-repair regurgitation volumes with
neochordoplasty and chordal translocation for acute posterior leaflet prolapse,














6.2.1.2.3 Comparing Posterior Leaflet Mobility after Surgical Repair 
Posterior leaflet mobility after each surgical repair was assessed using simple 
echocardiographic measurements: (a) Perpendicular distances from the leaflet coaptation 
zone to the posterior annulus in the septal-lateral plane, (b) Peak systolic posterior angle. 
The distance of the coaptation zone from posterior annulus were statistically equal in the 
control (19.8 ± 2.2mm), Neochordoplasty (19.8 ± 0.5 mm) and chordal translocation 
(20.5 ± 1.0 mm) cases. The results shown in Figure 6-16 demonstrate that the systolic 
posterior angle was comparable between neochordoplasty and chordal translocation, 
Figure 6-15  Leaflet coaptation length after neochordoplasty and chordal translocation




which is an indicator that both repairs effectively restore posterior leaflet mobility to the 
















Figure 6-16 Comparison of pre-repair and post-repair posterior leaflet angle with 




6.2.1.3 Part C – Mechanics of the Strut Chordae Insertion Region 
6.2.1.3.1 Reference Surface Fitting and Marker Array Placement 
 The finite element surface fitting technique fit the spatial positions of the 31 
marker array very well, with R2 ≥ 0.98 and a mean error of ±0.07 mm as shown in Figure 
6-17. Figure 6-18 illustrates the deformation of the finite element mesh from late diastole, 
through systole, till early diastole, depicting the regions where the largest out of plane 










Figure 6-17 Averaged goodness of fit between the marker coordinates and the finite
element surface at different time points in the cardiac cycle. Excellent fit was
obtained throughout the cardiac cycle validating the use of appropriate shape





Figure 6-18 Deformation of the chordal insertion zone represented as a finite element mesh, with the red dots depicting the 31
markers used to reconstruct the zone and the while lines representing the elements that form the mesh. It can be clearly seen that
during diastole when the valve is completely open, the finite element mesh is flat. But with increasing transmitral pressure,




6.2.1.3.2 Areal Stretch Distribution 
 The strain field over the chordal insertion region is heterogeneous with higher 
stretch magnitudes concentrated at the edges of the insertion region than the central 
region. Figure 6-19A shows the chordal insertion region on the anterior leaflet marked 
with tissue dye, and Figure 6-19B depicts the sub-division of the chordal insertion zone 
into sub-divisions for data analysis. Figure 6-19C depicts the areal stretch magnitude 
mapped over the region delimited by the markers, and the heterogeneity in the stretch 
magnitude is clearly evident. A banded stretch pattern was observed with the focal point 
at the region of bifurcation of the cylindrical collagen core of the chord into a planar 
collagen structure of the leaflet. Bands of lower stretch magnitude were observed near the 
center, while those with significantly higher stretch magnitude were concentrated towards 
the edges of the insertion zone during systole. At diastolic loading, a homogenous 
distribution of stretch was recorded.  
 Figure 6-20 shows the temporal changes in areal stretch averaged over the eight 
valves at multiple markers. Highest stretch magnitudes were observed at markers 1 and 7 
that are closer to the regions where the strut chordae has mostly fanned out into a planar 
leaflet structure. These markers are proximal to the leaflet regions that move basally 
towards the mitral annulus during systolic loading, thus higher stretches are expected at 
these markers. However, stretch at the central marker 4, which is along the same latitude 
as markers 1 and 7, was significantly smaller in magnitude. The peak areal stretch 
magnitude was different at each of these markers, 1.89±0.73 at marker 1, 1.22±0.33 at 




compared to marker # 4). However there was no significant difference between the 
measured stretch at markers 1 and 7 (p=0.354). Overall, the temporal changes in the areal 
stretch pattern are different between the three regions – the left edge (markers 1, 15, 25) 
has a gradual increase in stretch until it reaches a peak after which it gradually restores 
back to the reference state, the central region (markers 4,17,26,31) has minimal stretch 
throughout the cardiac cycle, whereas the right edge (markers 7,19,27) has a rapid 



















Figure 6-19 (A) Tissue marker array on one of the anterior strut chordae insertion zone; (B) The insertion zone sub divided
into local regions for data analysis, considering the heterogeneity in the stretch distribution; (C) Temporal changes in the
areal stretch over the entire chordal insertion zone from end diastole, through systole till end systole demonstrating the














Figure 6-20 Temporal changes in the averaged areal stretch magnitude at selected markers in the chordal insertion 




6.2.1.3.3 Major and Minor Principal Stretches  
  Figure 6-21(Top)  shows a typical mapping of the major principal stretch 
magnitudes and vectors and Figure 6-21 (Bottom) shows the minor principal stretch on 
the entire region of the strut chordae insertion during systolic valve closure. Similar to 
trends in areal stretch, major principal stretch magnitude is significantly higher along the 
edges of the insertion region than the center. Regional stretch in the radial direction is 
significantly higher in the sub-regions along the left chordal edge and the right basal edge 
compared to rest of the insertion region.  Direction of the major principal stretch is 
predominantly in the radial direction throughout systole, with the vectors pointing 
towards the annulus. Small changes in the principal vector direction were recorded 
indicating that cross-fiber shear stress is quite small. Minor principal stretch magnitude is 
significantly higher on the basal edges of the insertion zone than the center or towards the 
chord, with the minor principal stretch vector predominantly in the circumferential 
direction. Figure 6-22 shows the temporal changes in the major principal stretch at 
selected markers on different sub regions of the chordal insertion region, and Figure 
6-23shows the changes in the minor principal stretch at the same locations. In the major 
principal direction, the maximum stretch was at marker 31 on the strut chord, followed by 
the right edge and the smallest being along the left edge of the chordal insertion zone. In 
the minor principal direction, the maximum stretch was at the left edge of the chordal 





Figure 6-21(Top Gallery) The series of images demonstrate the change in major principal stretch magnitude and direction during





Figure 6-22 Temporal changes in the major principal stretch at different points in the chordal insertion zone demonstrating the





Figure 6-23 Temporal changes in the minor principal stretch at different points in the chordal insertion zone demonstrating the




6.2.1.3.4 Regional Stretch Rate 
Stretch rates in the two principal directions are used to assess the regional variations 
in strains. In Table 6-3 report the stretch rate at 3 markers on the left edge, 3 on the 
central axis, 3 on the right edge of the insertion zone, and finally 1 marker on the strut 
chord. In the major principal direction, the stretch rates on the left edge were significantly 
higher than the right edge and the central axis where the stretch rate is smallest. 
Maximum stretch rates are recorded on the strut chordae (marker 31) that corroborated 
with previous findings from our laboratory[46]. In the minor principal direction, there are 
few localized regions of high stretch rate compared to the rest of the region of interest. 
These hot spots were mainly at the regions that are close to the A2 cusp that has the 
largest basal motion during systolic coaptation (markers 1, 15); and in the region close to 
the leaflet commissure, (markers 7 and 19).  
6.2.1.3.5 Ultrastructural Examination 
 Small angle light scattering and histological data demonstrated a complex 
transition from the highly aligned chordae to the leaflet main body as shown in Figure 
6-24.  In particular, a drop in alignment (OI values changed from 25° to 45° within a few 
mm as observed on the collagen fibril distribution mapping, with substantial arching in 


















Table 6-3 Peak major and minor principal stretch and stretch rate at different markers on the left and right edges

















Figure 6-24 (A) Image of an ovine MVAL fixed at 5 mmHg showing the chordae, (B) corresponding SALS data showing




6.2.1.4 Part D – Hemodynamic and Kinematic Insights into the Efficacy of Edge-to-
Edge Repair to Correct Posterior Leaflet Prolapse in a Normal and Dilated Annulus 
6.2.1.4.1 Hemodynamic Efficacy of Edge-to-Edge Repair 
 Mitral regurgitation fraction (MRF = (MR/SV)*100) was calculated for the eight 
valves, and the averaged data are reported in Figure 6-25. Under control conditions, all 
valves had excellent competence without any regurgitation observed on the color Doppler 
images. Marginal chordal transection induced isolated P2 prolapse and an average 
regurgitant fraction of 10.2±5.0. Edge-to-edge stitch between the prolapsing P2 cusp and 
the A2 cusp significantly reduced regurgitation to 2.0±1.1 at normal annular size of 
28mm. However, with annular dilatation recurrent regurgitation of 4.2±1.4 at 15% 









Figure 6-25 Mitral regurgitation volumes after Edge to Edge repair with a physiologic 




6.2.1.4.2 Impact of Annular Dilatation on Leaflet Coaptation Length Following Edge-
to-Edge Repair 
The leaflet coaptation length was measured across A1-P1, A2-P2 and A3-P3 
planes and the measurements were averaged over the eight valves. Figure 6-26 shows the 
averaged coaptation length data measured under control conditions at 8.22±0.6mm at A1-
P1 plane, 9.47±1.5mm at A2-P2 plane, and 8.37±0.7mm at A3-P3. The prolapse group 
did not have leaflet coaptation due to the prolapse induced by marginal chordal rupture. 
Edge-to-edge repair with a normal annulus corrected P2 prolapse, and restored coaptation 
length to 7.70±0.8mm at A1-P1, 8.83±0.9mm at A2-P2 and 7.70±1.14mm at A3-P3 
planes. With 15% dilatation, the coaptation length along each of the planes reduced to 
6.70±1.0mm at A1-P1, 7.86±0.6mm at A2-P2 and 6.88±1.35mm at A3-P3. With 30% 
dilatation, a further reduction in coaptation length to 5.90±0.8mm at A1-P1, 7.18±0.7mm 









Figure 6-26 Changes in leaflet coaptation length with increase in annular size from a




6.2.1.5 Part E – Impact of Mitral Annular Non-planarity on Mechanics of the 
Posterior Mitral Leaflet 
6.2.1.5.1 Temporal Changes in Areal Strain with Different Degrees of Annular Saddle 
Figure 6-27 illustrates the temporal changes in areal                        
strain with a flat, 10% and 20% saddled annulus, during systole.  All valves experienced 
rapid stretch rate during early systole with subsequent peaking of the stretch due to 
collagen locking at peak systole, and finally rapid unloading from late systole to early 
diastole. A similar trend was seen in both the major and minor principal strains 
respectively for all the valves as shown in Figure 6-28 and Figure 6-29. The total time of 
leaflet deformation, i.e. the duration during which the leaflet deformed from the reference 
state to a peak and then returned to the reference state, was significantly different 
between the three annular shapes. With a flat annulus (0% AHCWR), the total 
deformation time was significantly larger at 389±10ms compared to 360±9ms for 10% 

















Figure 6-27 Temporal changes in the areal strain magnitude between the three degrees of annular saddle. Maximum areal















Figure 6-28 Temporal changes in the circumferential strain magnitude between the three degrees of annular saddle. 














Figure 6-29 Temporal changes in the radial strain magnitude between the three degrees of annular saddle. Maximum radial




6.2.1.5.2 Peak Areal Strain Magnitudes 
 The peak areal strain magnitude was computed for the eight valves tested in this 
study and the average magnitudes are reported in Figure 6-30. Areal strain magnitudes 
significantly decreased from 0.68±0.1 for a flat annulus, to 0.57±0.1 for a 10% AHCWR 














Figure 6-30 Average peak systolic areal strain magnitudes at different degrees of
mitral annular saddle measured from the in vitro experimental setup. Significant





6.2.1.5.3 Peak Radial and Circumferential Strain Magnitudes 
Similar reductions were observed in peak strains both in the circumferential 
(commissure-commissure direction) and radial (free edge to annulus) directions. In the 
circumferential direction, the peak systolic strain did not change from 0.18±0.07 at 0% 
AHCWR to 0.17±0.08 at 10%AHCWR (p=0.816), but significantly reduced to 0.1±0.08 
at 20% AHCWR (p=0.01) as shown in Figure 6-31. Similarly, in the radial direction there 
was no significant change in the peak strain magnitude from 0.44±0.13 at 0% AHCWR to 
0.35±0.12 for 10% saddle (p=0.196), but reduced significantly to 0.29±0.08 at 20% 


























6.2.1.5.4 Principal Angle 
 Principal angle measured as the angle between the geometric axis of the leaflet 
and the principal strain vectors, at each time point in the cardiac cycle. This parameter is 
a measure of the shear strain in the leaflets, because if the shear strain in leaflets is 
minimal the principle angle is low and vice versa.  In this study, the peak principal angles 
over the entire cardiac cycle were nearly equal for the flat (0.91±0.60), 10% saddle (-
0.38±0.56) and 20% saddle (0.02±1.11), indicating minimal shear strain in the leaflets 
during systolic valve closure.  




6.3 REPAIR FOR FUNCTIONAL MITRAL REGURGITATION IN DILATED 
CARDIOMYOPATHY 
 Variability in the valve geometry between individual patients is hypothesized to 
impact the outcomes of mitral valve repair in treating functional mitral regurgitation. To 
test this hypothesis, in this thesis an in vitro model of functional mitral regurgitation was 
developed. The model was designed such that precise control over the annular size, 
annular shape and spatial position of the papillary muscles was possible, which allowed 
simulating different pathological valve geometries. Mitral annuloplasty was performed on 
each valve, followed by a sub-annular secondary chordal cutting procedure. In this 
section, detailed results on the impact of 3-dimensional valve geometry on the post-repair 
valve hemodynamics and mechanics are presented.  
6.3.1 VALIDATION OF IN VITRO REGURGITATION MODEL  
 In this thesis, two mitral valve geometries were studied – [a] annular dilatation 
with 10mm isolated apical papillary muscle displacement; and [b] annular dilatation with 
10mm apical+ 10mm posterior+ 10mm lateral displacements. Previous studies from our 
lab demonstrated that a significant change in valve function was seen when the papillary 
muscles were displaced only in one spatial direction versus in all the three directions. 
Thus we expect that the outcomes of the valve repair may also be significantly different 
between the two geometries, and thus may provide mechanistic insights into clinical 
annuloplasty failure.  
 2D echocardiographic images obtained along the septal lateral plane of the mitral 




resulting in restricted leaflet mobility. When the papillary muscles are displaced from 
their normal positions, the anterior leaflet assumes a sea-gull shape due to localized 
tethering at the strut chordal insertion regions. Figure 6-33A shows a normal mitral valve 
coaptation, Figure 6-33B shows a mitral valve with dilated annulus and apical papillary 
muscle displacement, and Figure 6-33C shows a mitral valve with a dilated annulus and 
apical, posterior and lateral papillary muscle displacement. With apical papillary muscle 
displacement, there was increase in tenting area as measured from echocardiographs and 
significant loss of coaptation. The leaflet curvature at peak systolic coaptation also 
changed significantly. With apical, posterior and lateral displacement, the changes in 
systolic coaptation geometry were more pronounced with significant tethering and 
bending of the anterior leaflet at the site of the strut chordae insertion. These observations 
corroborate with the clinical findings reported from patients with dilated cardiomyopathy, 






























Figure 6-33 (A) Systolic coaptation of a normal mitral valve with excellent
coaptation and minimal tenting area between the leaflets and the mitral annular
plane, (B) Systolic coaptation geometry after annular dilatation and apical
displacement of the papillary muscles, depicting increased tenting area and
reduced leaflet coaptation, (C) Coaptation geometry after apical, posterior and
lateral papillary muscle displacement with significantly high tenting area and slight





6.3.2 ROLE OF 3D MITRAL VALVE GEOMETRY ON THE OUTCOMES OF 
MITRAL ANNULOPLASTY 
6.3.2.1 Impact of 3D Valve Geometry on the Hemodynamic and Kinematic 
Outcomes of True Sizing Mitral Annuloplasty for Functional Mitral Regurgitation 
 True-sized mitral annuloplasty to restore physiological septal-lateral dimension 
and reduce/eliminate functional mitral regurgitation is the current clinical standard of 
care. However, regurgitation persists or recurs within 5 years after mitral annuloplasty 
and in this study the mechanisms leading to persistence/recurrence of mitral regurgitation 
in this disease etiology are studied. To simulate the variability in mitral valve geometry 
between patients, two types of pathologic valve geometric scenarios were simulated: [a] 
annular dilatation with apical papillary muscle displacement; and [b] annular dilatation 
with apical-posterior-lateral papillary muscle displacement.  
 With physiological valve geometry (Control/Baseline), all the eight valves were 
competent with no mitral regurgitation. Annular dilatation with displacement of the 
papillary muscles by 10mm in the apical direction induced an average regurgitation 
fraction of 10.54±5.5, which is significantly higher compared to the baseline conditions 
(p=0.001). True-sizing the mitral annulus from its dilated size to its physiological size of 
28mm reduced MRF to 4.78 ± 5.27, which was significantly smaller than the disease 
state (p=0.032) and was comparable to the regurgitation volume in the control group 




The experiment was repeated with the second pathological valve geometry, i.e. 
annular dilatation with apical-posterior-lateral papillary muscle displacement. With 
physiological valve geometry (Control/Baseline), all the eight valves were competent 
with no mitral regurgitation. Annular dilatation with displacement of the papillary 
muscles by 10mm in the apical direction, 10mm in the posterior direction and 10mm in 
the lateral direction induced an average regurgitation of 23.02±5.7, which is significantly 
higher compared to the baseline conditions (p=0.001). True-sizing the mitral annulus 
from its dilated size to its physiological size of 28mm reduced mitral regurgitation to 
16.70 ± 7.8, which was reduced compared to the disease state (p=0.01) , but by clinical 
standards still considered to be moderate to severe. Remnant regurgitation was 
significantly higher than the control group or the post-annuloplasty group in the latter 























6.3.3 IMPACT OF ANNULOPLASTY ON REDUCTION IN TENTING HEIGHT  
 Mitral annuloplasty reduces the septal-lateral dimension of the mitral valve, but 
does not address the sub-valvular tethering induced by papillary muscle displacement. 
However the hemodynamic results demonstrated that isolated mitral annuloplasty could 
have a beneficial effect with apical papillary muscle displacement, but not when the 
muscles are displaced apically, posteriorly and laterally. To explain these results, the 
impact of mitral annuloplasty on the sub-valvular mechanics of the mitral valve was 
investigated on the two simulated pathological valve geometries. Both tenting height and 
tenting area were measured along A1-P1, A2-P2 and A3-P3 cusps on all the valves as 
Figure 6-34 Mitral regurgitation volumes after true-sizing annuloplasty for functional




they are used as representative indices to assess sub-valvular tethering in the clinical 
setting.  
Along the central A2-P2 cusps, the measured systolic tenting height was 7.3±1.7 
mm under control/baseline conditions. Annular dilatation and 10mm apical displacement 
of both the papillary muscles tethered the mitral leaflets and increased the tenting height 
during systolic closure to 9.86± 2.0 mm, which was significantly higher than the baseline 
group (p=0.036). Annuloplasty reduced tenting height to 8.7±1.8 mm, which was not 
significantly different from the disease group (p=1.00). Along the left commissural cusps 
(A1-P1), a tenting height of 5.4 ± 1.8 mm was measured under control/baseline 
conditions. With annular dilatation and papillary muscle tethering, the tenting height 
increased to 7.68±1.95 mm (p=0.05) indicating leaflet tethering even at the commissural 
cusps. After annuloplasty, commissural tenting increased slightly to 8.14 ± 1.9 mm 
(p=0.312 ) compared to the diseased group. Similarly along the right commissural cusps 
(A3-P3) , annular dilatation and papillary muscle displacement increased tenting height to 
8.11 ± 2.0mm from a baseline value of 5.02 ± 1.3mm (p = 0.018 ). Annuloplasty did not 
seem to have an impact on tenting height as a distance of 7.84 ± 2.0 mm (p=0.72) was 
measured even after the repair along the A3-P3 commissural cusps as shown in Figure 
6-35, Figure 6-36 and Figure 6-37. 
In the second pathological case with annular dilatation and 10mm apical-10mm 
lateral-10mm posterior displacement of the papillary muscles, a tenting height of 12.7 ± 
1.7 mm was measured along the A2-P2 central cusps, which was significantly higher 




tenting height to 10.5 ± 3.0 mm (p=0.04). Along the left commissural cusps (A1-P1), a 
tenting height of 5.4 ± 1.8 mm was measured under control/baseline conditions. With 
annular dilatation and papillary muscle tethering, the tenting height increased to 11.45 ± 
2.06 mm (p=0.001) indicating significant leaflet tethering even at the commissural 
cusps. After annuloplasty, commissural tenting reduced slightly to 9.68 ± 3.0 mm 
(p=0.038) compared to the diseased group. Similarly along the right commissural cusps 
(A3-P3) , annular dilatation and papillary muscle displacement increased tenting height 
to 11.94 ± 3.2 mm from a baseline value of 5.02 ± 1.3mm (p=0.002). Annuloplasty did 
not seem to have an impact on tenting height as a distance of 9.54 ± 4.0 mm (p=0.02) 
was measured even after the repair along the A3-P3 commissural cusps as shown in 








 Figure 6-35 Tenting height measured at the commissural A1-P1 commissural section



















Figure 6-36 Tenting height measured at the central A2-P2 section under different
experimental conditions 
Figure 6-37 Tenting height measured at the commissural A3-P3 section under




6.3.4 EFFICACY OF ANNULOPLASTY IN REDUCING TENTING AREA 
 Tenting height as measured in the previous section describes the perpendicular 
distance of the point of leaflet coaptation to the mitral annular plane. Obviously, as sub-
valvular tethering increases the point of leaflet coaptation moves apically towards the 
ventricular apex and can thus be used as a measure of ventricular tethering. However, 
tenting height does not provide any information regarding the leaflet systolic geometry, 
because for the same tenting height different leaflet configurations can exist. To 
overcome this limitation, tenting area enclosed between the two mitral leaflets and the 
mitral annulus during peak systole was measured.  
 Along the central A2-P2 cusps, the measured systolic tenting area was 60.9 ± 31 
mm2 under control/baseline conditions. Annular dilatation and 10mm apical 
displacement of both the papillary muscles tethered the mitral leaflets and increased the 
tenting area at peak systolic closure to 129.7 ± 28.4 mm2, which was significantly higher 
than the baseline group (p=0.01). Annuloplasty reduced tenting area to 87 ± 17.1 mm2, 
which was significantly reduced from the disease group (p=0.021) but not comparable to 
the control (p= 0.021). Along the left commissural cusps (A1-P1), a tenting area of 58.7 
± 23.1 mm2 was measured under control/baseline conditions. With annular dilatation and 
papillary muscle tethering, the tenting height increased to 100.5 ± 28 mm2 (p=0.004) 
indicating leaflet tethering even at the commissural cusps. After annuloplasty, 
commissural tenting decreased slightly to 91.5 ± 26 mm2 (p=0.47) compared to the 
diseased group. Similarly along the right commissural cusps (A3-P3) , annular dilatation 




baseline value of 64.33 ± 27.74 mm2 (p=0.049 ). Annuloplasty seemed to have some 
impact on tenting area as 66.07 ± 17.0 mm2 (p=0.052) was measured even after the 
repair along the A3-P3 commissural cusps as shown in Figure 6-38, Figure 6-39, and 
Figure 6-40.  
In the second pathological case with annular dilatation and 10mm apical-10mm lateral-
10mm posterior displacement of the papillary muscles, a tenting area of 186.43 ± 36.4 
mm2 was measured along the A2-P2 central cusps, which was significantly higher than 
the baseline value of 60.89 ± 31 mm2 (p<0.001 ). Annuloplasty slightly reduced tenting 
area to 128.66 ± 44 mm2 (p=0.006). Along the left commissural cusps (A1-P1), a tenting 
area of 58.74 ± 23.17 mm2 was measured under control/baseline conditions. With 
annular dilatation and papillary muscle tethering, the tenting area increased to 170.73 ± 
40 mm2 (p=0.001) indicating significant leaflet tethering even at the commissural cusps. 
After annuloplasty, commissural tenting reduced slightly to 116.09 ± 23.4 mm2 
(p=0.007) compared to the diseased group. Similarly along the right commissural cusps 
(A3-P3) , annular dilatation and papillary muscle displacement increased tenting area to 
160.3 ± 52.7 mm2 from a baseline value of 64.3 ± 27.7 mm2 (p=0.003). Annuloplasty 
did not seem to have an impact on tenting area as an area of 106.61 ± 39.19 mm2 
(p=0.003) was measured even after the repair along the A3-P3 commissural cusps as 

























Tenting Area along A2-P2 cusps 
Tenting Area along A1-P1 cusps 
Figure 6-38 Changes in systolic tenting area under different experimental conditions,
both before and after annuloplasty along the A1-P1 commissural cusps 
Figure 6-39 Changes in systolic tenting area before and after annuloplasty along the













6.3.5 IMPACT OF ANNULOPLASTY ON SYSTOLIC LEAFLET 
COAPTATION LENGTH 
 Septal-lateral reduction of the mitral annulus is assumed to restore better leaflet 
coaptation compared to the pre-annuloplasty disease case. However, annuloplasty alone 
as shown by results in the earlier sections does not reduce sub-valvular tethering and thus 
may restrict leaflet mobility and may not improve leaflet coaptation as desired. To test 
this hypothesis, the leaflet coaptation length along A1-P1, A2-P2 and A3-P3 cusps of the 
mitral valve was measured using 2D echocardiography.   
Along the central A2-P2 cusps, the measured leaflet coaptation length was 
9.7±1.0 mm under control/baseline conditions. Annular dilatation and 10mm apical 
displacement of both the papillary muscles tethered the mitral leaflets and decreased the 
Tenting Area along A3-P3 cusps 
Figure 6-40 Changes in systolic tenting area before and after annuloplasty along the




leaflet coaptation length during systolic closure to 7.49± 0.9 mm, which was significantly 
lower than the baseline group (p=0.001). Annuloplasty increased leaflet coaptation length 
to 9.03 ± 0.7 mm, which was significantly higher than the disease group (p=0.002) and 
close to the baseline measurements (p=0.013). Along the left commissural cusps (A1-P1), 
a leaflet coaptation length of 7.47 ± 1.0 mm was measured under control/baseline 
conditions. With annular dilatation and papillary muscle tethering, the leaflet coaptation 
length decreased to 6.68 ± 0.85 mm (p=0.06). After annuloplasty, commissural leaflet 
coaptation length increased to 7.47 ± 0.93 mm (p=0.246) compared to the diseased group, 
but the change was insignificant. Similarly along the right commissural cusps (A3-P3) , 
annular dilatation and papillary muscle displacement changed leaflet coaptation length to 
7.18 ± 0.6 mm from a baseline value of 8.09 ± 0.8 mm (p=0.01). Annuloplasty did not 
seem to have an impact on coaptation length, as a distance of 7.47 ± 0.9 mm (p=0.379) 
was measured even after the repair along the A3-P3 commissural cusps.  
In the second pathological case with annular dilatation and 10mm apical-10mm 
lateral-10mm posterior displacement of the papillary muscles, a leaflet coaptation length 
of 6.97 ± 0.8 mm was measured along the A2-P2 central cusps, which was significantly 
lower than the baseline value of 9.77 ± 1.0 mm (p<0.001). Annuloplasty slightly 
increased leaflet coaptation length to 7.27 ± 1.5 mm, but the increase was not statistically 
significant (p=0.434). Along the left commissural cusps (A1-P1), a leaflet coaptation 
length of 7.47 ± 1.0 mm was measured under control/baseline conditions. With annular 
dilatation and papillary muscle tethering, the leaflet coaptation length decreased to 5.98 ± 




the commissural cusps. After annuloplasty, commissural tenting coaptation length 
slightly increased to 6.75 ± 0.75 mm (p=0.014) compared to the diseased group. 
Similarly along the right commissural cusps (A3-P3) , annular dilatation and papillary 
muscle displacement decreased coaptation length to 6.17 ± 0.6 mm from a baseline value 
of 8.09 ± 0.8 mm (p=0.003). Annuloplasty did not seem to have an impact on coaptation 
length as a distance of 6.66 ± 0.5 mm (p=0.122) was measured even after the repair along 
the A3-P3 commissural cusps. 
6.3.6 IMPACT OF 3D MITRAL VALVE GEOMETRY ON THE EFFICACY OF 
SUB-ANNULAR SECONDARY CHORDAL CUTTING TECHNIQUE 
6.3.6.1 Impact of Mitral Valve Geometry on the Hemodynamic Efficacy of 
Secondary Chordal Cutting Procedure 
 2D echocardiographs of mitral valves in patients with ischemic mitral 
regurgitation due to dilated ventricles often demonstrate tethering of the anterior leaflet at 
the basal region and subsequent reduced mobility. Based on this observation transection 
of the two second order chordae that insert into the base of the anterior leaflet was 
proposed as a procedure to eliminate regurgitation in these valves. In this section, the 
results from investigating the efficacy of secondary chordal cutting in reducing mitral 
regurgitation in two pathologic valve geometries are presented.  The two types of 
pathologic valve geometric scenarios are: [a] annular dilatation with apical papillary 
muscle displacement; and [b] annular dilatation with apical-posterior-lateral papillary 




 With physiological valve geometry (Control/Baseline), all the eight valves were 
competent with no mitral regurgitation. Annular dilatation with displacement of the 
papillary muscles by 10mm in the apical direction induced an average regurgitation 
fraction of 10.54 ± 5.5, which is significantly higher compared to the baseline conditions 
(p=0.001). True-sizing the mitral annulus from its dilated size to its physiological size of 
28mm reduced mitral regurgitation to 4.78 ± 5.27, which was significantly smaller than 
the disease state (p=0.032) and was comparable to the regurgitation volume in the control 
group (p=0.07). After secondary chordal cutting, regurgitation was reduced to trace levels 
of 3.61 ± 2.87, which was closer to the baseline conditions though statistically different 
(p=0.01). 
 The experiment was repeated with the second pathological valve geometry, i.e. 
annular dilatation with apical-posterior-lateral papillary muscle displacement. With 
physiological valve geometry (Control/Baseline), all the eight valves were competent 
with no mitral regurgitation. Annular dilatation with displacement of the papillary 
muscles by 10mm in the apical direction, 10mm in the posterior direction and 10mm in 
the lateral direction induced an average regurgitation fraction of 23.02±5.7, which is 
significantly higher compared to the baseline conditions (p=0.001). True-sizing the mitral 
annulus from its dilated size to its physiological size of 28mm reduced mitral 
regurgitation to 16.70 ± 7.8, which was smaller compared to the disease state (p=0.003) , 
but by clinical standards still high. These results summarized in Figure 6-41, clearly 
demonstrate that in the efficacy of annuloplasty and secondary chordal cutting depends to 




significant remnant mitral regurgitation of 18.56 ± 4.19, which was not significantly 
different from the annuloplasty group (p=0.176) and significantly higher than the baseline 
conditions (p<0.0001). These results clearly indicate that in this pathological geometric 
setting of the mitral valve, cutting the secondary chordae on the anterior leaflet did not 

















Figure 6-41 Changes in mitral regurgitation fraction under different experimental
conditions. As expected under disease states, there was moderate to severe regurgitation
that was dependent on the pathological geometry of the valve. Annuloplasty reduced 
regurgitation in both cases, but regurgitation was persistent in both cases. Chordal
cutting reduced regurgitation only in the apical displacement case but not in the apical-




6.3.6.2  Impact of Secondary Chordal Cutting on Systolic Tenting Height  
 Results from previous sections clearly illustrate that isolated mitral annuloplasty 
may reduce mitral regurgitation, but does not eliminate the sub-valvular tethering caused 
due to papillary muscle displacement. Hypothetically, transecting the secondary chordae 
should relieve sub-annular tethering to some extent and aid movement of the systolic 
coaptation length towards the mitral annulus and reduce regurgitation. However, 
hemodynamic results from the previous section clearly indicate that secondary chordal 
cutting restored valve competence only when the papillary muscles were displaced 
apically but not when they were displaced apically, posteriorly and laterally. To 
understand the mechanisms underlying the difference in results, the tenting height after 
secondary chordal cutting at the A1-P1, A2-P2 and A3-P3 cusps was measured.   
Along the central A2-P2 cusps, the measured systolic tenting height was 7.3±1.7 
mm under control/baseline conditions. Annular dilatation and 10mm apical displacement 
of both the papillary muscles tethered the mitral leaflets and increased the tenting height 
during systolic closure to 9.86± 2.0 mm, which was significantly higher than the baseline 
group (p=0.036). Annuloplasty reduced tenting height to 8.7±1.8 mm, which was not 
significantly different from the disease group (p=1.00). Secondary chordal cutting 
reduced tenting height to 6.46 ± 1.26 mm, which was significantly smaller than the 
disease state (p=0.006) and also the annuloplasty group (p=0.008). Along the left 
commissural cusps (A1-P1), a tenting height of 5.4 ± 1.8 mm was measured under 
control/baseline conditions. With annular dilatation and papillary muscle tethering, the 




commissural cusps. After annuloplasty, commissural tenting increased slightly to 8.14 ± 
1.9 mm (p=0.312) compared to the diseased group. Secondary chordal cutting reduced 
tenting height to 6.32 ± 0.75 mm, which was smaller than the annuloplasty  group 
(p=0.07) and approaching statistical significance.  Similarly along the right commissural 
cusps (A3-P3) , annular dilatation and papillary muscle displacement increased tenting 
height to 8.11 ± 2.0mm from a baseline value of 5.02 ± 1.3mm (p=0.018). Annuloplasty 
did not seem to have an impact on tenting height as a distance of 7.84 ± 2.0 mm was 
measured (p=0.720 compared to disease) even after the repair along the A3-P3 
commissural cusps. Secondary chordal cutting reduced tenting height to 6.49 ± 0.91mm, 
which was significantly smaller than the disease (p=0.219) but the change was 
statistically insignificant. 
 In the second pathological case with annular dilatation and 10mm apical-10mm 
lateral-10mm posterior displacement of the papillary muscles, a tenting height of 12.7 ± 
1.7 mm was measured along the A2-P2 central cusps, which was significantly higher than 
the baseline value of 7.26 ± 1.7 mm (p<0.001). Annuloplasty slightly reduced tenting 
height to 10.5 ± 3.0 mm, but the reduction was not statistically significant (p=0.1). 
Secondary chordal cutting did not seem to have an impact on tenting height as a distance 
of 10.0 ± 3.32 mm was measured, which was not significantly different from the 
annuloplasty group (p=0.761). Along the left commissural cusps (A1-P1), a tenting 
height of 5.4 ± 1.8 mm was measured under control/baseline conditions. With annular 
dilatation and papillary muscle tethering, the tenting height increased to 11.45 ± 2.06 mm 




annuloplasty, commissural tenting reduced slightly to 9.68 ± 3.0 mm (p=0.04 ) compared 
to the diseased group. Secondary chordal cutting did not change tenting height as a 
distance of 9.45 ± 2.96 mm  persisted even after the procedure, which was not different 
from the annuloplasty (p=0.895 ) group. Similarly along the right commissural cusps 
(A3-P3) , annular dilatation and papillary muscle displacement increased tenting height to 
11.94 ± 3.2 mm from a baseline value of 5.02 ± 1.3mm (p=0.002 ). Annuloplasty reduced 
tenting height to a distance of 9.54 ± 4.0 mm along the A3-P3 commissural cusps 
(p=0.02). After secondary chordal cutting a tenting height of 9.78 ± 2.79 mm was 
measured, which was statistically equivalent to the tenting height measured after 











Figure 6-42 Changes in tenting height along the commissural A1-P1 cusps before






















Figure 6-43 Changes in tenting height along the central A2-P2 cusps before
surgical repair, after annuloplasty and after sub-annular chordal cutting 
Figure 6-44 Changes in the tenting height along the commissural A3-P3 cusps




6.3.6.3 Impact of Secondary Chordal Cutting on Systolic Tenting Area 
 Tenting area, defined as the area enclosed by the two mitral leaflets and the mitral 
annulus is reported here as a quantifiable measure of sub-valvular tethering, pre and post 
surgical repair. Secondary chordal cutting should relieve local leaflet tethering of the 
anterior leaflet base, if not the entire leaflet and thus may restore the normal anterior 
leaflet curvature from the tethered sea-gull shaped leaflets.   
Along the central A2-P2 cusps, the measured systolic tenting area was 60.9 ± 31 
mm2 under control/baseline conditions. Annular dilatation and 10mm apical displacement 
of both the papillary muscles tethered the mitral leaflets and increased the tenting area at 
peak systolic closure to 129.7 ± 28.4 mm2, which was significantly higher than the 
baseline group (p<0.001) Annuloplasty reduced tenting area to 87 ± 17.1 mm2, which 
was significantly reduced from the disease group (p=0.02) but was not completely 
relieved . Cutting the secondary chordae on the anterior leaflet reduced tenting area to 
65.9 ± 8.5 mm2 which is comparable to the baseline conditions (p=0.68).  At the left 
commissural cusps (A1-P1), a tenting area of 58.7 ± 23.1 mm2 was measured under 
control/baseline conditions. With annular dilatation and papillary muscle tethering, the 
tenting height increased to 100.5 ± 28 mm2 (p<0.001) indicating leaflet tethering even at 
the commissural cusps. After annuloplasty, commissural tenting decreased slightly to 
91.5 ± 26 mm2 (p=0.47) compared to the diseased group. Additionally secondary chordal 
cutting further reduced tenting area to 57.07 ± 19.3 mm2, which was comparable to the 
baseline (p=0.007). Similarly along the right commissural cusps (A3-P3) , annular 




from a baseline value of 64.33 ± 27.74 mm2 (p<0.001). Annuloplasty reduced tenting 
area to 66.07 ± 17.0 mm2 after the repair along the A3-P3 commissural cusps as shown in 
Figure 6-45. Chordal cutting further reduced tenting area to 56.06 ± 12.26 mm2 , which 
was comparable to the baseline (p=0.04).  
In the second pathological case with annular dilatation and 10mm apical-10mm 
lateral-10mm posterior displacement of the papillary muscles, a tenting area of 186.43 ± 
36.4 mm2 was measured along the A2-P2 central cusps, which was significantly higher 
than the baseline value of 60.89 ± 31 mm2 (p=0.001). Annuloplasty slightly reduced 
tenting area to 128.66 ± 44 mm2 (p=0.006), and secondary chordal cutting though 
reduced tenting area to 105.83 ± 35.75 mm2 it was not comparable to the baseline 
(p=0.07) . Along the left commissural cusps (A1-P1), a tenting area of 58.74 ± 23.17 
mm2 was measured under control/baseline conditions. With annular dilatation and 
papillary muscle tethering, the tenting area increased to 170.73 ± 40 mm2 (p=0.001) 
indicating significant leaflet tethering even at the commissural cusps. After annuloplasty, 
commissural tenting reduced slightly to 116.09 ± 23.4 mm2 (p=0.006 ) compared to the 
diseased group, and secondary chordal cutting further reduced tenting area to 96.03 ± 
35.24 mm2 which was significantly higher than the baseline (p=0.07). Similarly along the 
right commissural cusps (A3-P3) , annular dilatation and papillary muscle displacement 
increased tenting area to 160.3 ± 52.7 mm2 from a baseline value of 64.3 ± 27.7 mm2 
(p<0.001 ). Annuloplasty did not seem to have an impact on tenting area as an area of 




cusps as shown in Figure 6-45. Chordal cutting failed to impact tenting area, which was 
















Figure 6-45 Tenting area measured along the central and commissural cusps of the mitral valve pre and post chordal cutting.
Measurements along both the central and commissural cusps indicate a decrease in tenting area with ring and chordal cutting, but a




6.3.6.4 Impact of Secondary Chordal Cutting on Systolic Leaflet Coaptation Length 
 Relieving sub-valvular tethering to some extent using secondary chordal cutting 
may allow better leaflet mobility and thus may aid in increasing systolic leaflet 
coaptation length. To investigate this hypothesis, the leaflet coaptation length along A1-
P1, A2-P2 and A3-P3 cusps of the mitral valve was measured using 2D echocardiography 
before and after chordal cutting procedure.  
 Along the central A2-P2 cusps, the measured leaflet coaptation length was 
9.7±1.0 mm under control/baseline conditions. Annular dilatation and 10mm apical 
displacement of both the papillary muscles tethered the mitral leaflets and decreased the 
leaflet coaptation length during systolic closure to 7.49± 0.9 mm, which was significantly 
lower than the baseline group (p=0.001). Annuloplasty increased leaflet coaptation length 
to 9.03 ± 0.7 mm, which was significantly higher than the disease group (p=0.002) and 
comparable to the baseline measurement.. Secondary chordal cutting further enhanced 
leaflet coaptation length to 10.36 ± 1.74 mm.  Along the left commissural cusps (A1-P1), 
a leaflet coaptation length of 7.47 ± 1.0 mm was measured under control/baseline 
conditions. With annular dilatation and papillary muscle tethering, the leaflet coaptation 
length decreased to 6.68 ± 0.85 mm (p=0.002). After annuloplasty, commissural leaflet 
coaptation length increased to 7.47 ± 0.93 mm (p=0.013) compared to the diseased group 
and secondary chordal cutting further increased coaptation length to 8.97 ± 1.55 mm.  
Similarly along the right commissural cusps (A3-P3) , annular dilatation and papillary 
muscle displacement decreased leaflet coaptation length to 7.18 ± 0.6 mm from a 




on coaptation length as a distance of 7.47 ± 0.9 mm was measured even after the repair 
along the A3-P3 commissural cusps as shown in Figure 6-46. However secondary 
chordal cutting increase coaptation length to 10.38 ± 0.67 mm, which was comparable to 
the baseline.  
In the second pathological case with annular dilatation and 10mm apical-10mm 
lateral-10mm posterior displacement of the papillary muscles, a leaflet coaptation length 
of 6.97 ± 0.8 mm was measured along the A2-P2 central cusps, which was significantly 
lower than the baseline value of 9.77 ± 1.0 mm (p<0.001). Annuloplasty slightly 
increased leaflet coaptation length to 7.27 ± 1.5 mm, but the increase was not statistically 
significant (p=0.4). Chordal cutting increased the coaptation length to 8.77 ± 0.53 mm, 
which was comparable to the baseline. Along the left commissural cusps (A1-P1), a 
leaflet coaptation length of 7.47 ± 1.0 mm was measured under control/baseline 
conditions. With annular dilatation and papillary muscle tethering, the leaflet coaptation 
length decreased to 5.98 ± 0.63 mm (p<0.001) indicating significant leaflet tethering and 
loss of coaptation even at the commissural cusps. After annuloplasty, commissural 
tenting coaptation length slightly increased to 6.75 ± 0.75 mm compared to the diseased 
group. Chordal cutting did not impact leaflet coaptation at this commissural section, as a 
length of 6.89 ± 0.44 mm was measured.  Similarly along the right commissural cusps 
(A3-P3) , annular dilatation and papillary muscle displacement decreased coaptation 
length to 6.17 ± 0.6 mm from a baseline value of 8.09 ± 0.8 mm . Annuloplasty did not 
seem to have an impact on coaptation length as a distance of 6.66 ± 0.5 mm  was 




6-46.  Chordal cutting did not aid restoration of leaflet coaptation, evident from the 










Figure 6-46 Variations in leaflet coaptation length with annular and sub-annular repair techniques at the central and
commissural cusps. In the apical displacement case, secondary chordal cutting restored coaptation to physiological levels,




6.3.6.5 Impact of Secondary Chordal Cutting on Anterior Marginal Chordal 
Tension 
 Secondary chordae on the anterior leaflet are the main load bearing elements in 
the mitral valve structure, and play a key role in determining leaflet kinematics during 
systole and diastole. Anatomically, the secondary chordae and the marginal chordae in 
the porcine hearts emerge from the same chordal stem, but at different locations on the 
stem. Thus, secondary chordal cutting may significantly redistribute the forces on the 
marginal chordae emerging from the same chordal stem and may be detrimental to their 
performance and failure. In this section, the forces on the marginal chordae before and 
after secondary chordal cutting with three papillary muscle positions – 10mm apical, 
10mm apical+10mm lateral, 10mm apical+10mm posterior +10mm lateral are reported. 
In Figure 6-47, the changes in left and right anterior marginal chordal forces with normal 
valve geometry, with papillary muscle displacement and after secondary chordal cutting 
are presented. On the left anterior marginal chord, a peak force of 0.0302N at control, 
0.045N with apical papillary muscle displacement, and a force of 0.060N after secondary 
chordal cutting. With apical and lateral displacement of the papillary muscles, the peak 
force increased to 0.084 N, and with subsequent chordal cutting increased to 0.180 N. 
With apical, lateral and posterior displacement, the force increased to 0.122 N and after 
chordal cutting increased to 0.230 N. Similarly, on the right anterior marginal chord, a 
peak force of 0.065N was measured at control, 0.072 N with apical papillary muscle 
displacement, and 0.079 N after chordal cutting in this case. With apical-lateral papillary 
muscle displacement a peak force of 0.102 N was measured, with a corresponding 




displacement, a peak force of 0.173N was measured, which increased to 0.3222N after 
chordal cutting.  
 Figure 6-48 depicts the temporal changes in the marginal chordal forces under 
different experimental conditions.  In the top row, the temporal changes in the left 
marginal chordal force are shown wherein the force pattern changed with the 
experimental condition. Under control conditions, the peak marginal chordal force was 
measured immediately after the rapid rise in the systolic pressure, following which a flat 
plateau was observed until end-systole. A similar trend was observed with apical 
papillary muscle displacement as well, with a rapid rise in force followed by a plateau 
and gradual fall in the measured force. However, after chordal cutting, the maximum 
force on the marginal chordae seems to be slightly offset towards mid systole and a 
plateau in the forces was not observed. A similar trend was observed with apical and 
lateral displacement of the papillary muscles, but the magnitude of forces was 
significantly higher in this group compared to the apical papillary muscle displacement. 
However, with apical-posterior-lateral displacement, under disease condition itself the 
systolic plateau in forces was not observed, with a rapid rise and subsequent rapid fall in 
the force before and after secondary chordal cutting. A similar trend in forces was 




















Figure 6-47 Changes in the marginal chordal force with different papillary muscle positions, before and after chordal cutting









Figure 6-48 (Top Row) Temporal force measurements on marginal chordae tendineae under physiological, three different pathological
mitral valve geometries, and after secondary chordal cutting in the three different conditions. The figures demonstrate a significant








CHAPTER 7  
 
DISCUSSION 
In this chapter, the results for each specific aim are presented from an analyzed 
and a morphological or hemodynamic basis to the results is presented. An engineering 
perspective on the acute outcomes observed in this thesis is presented, and a discussion 
on the relevance of these findings to clinical practice and outcomes are delineated. 
Finally, the limitations of the studies in each aim are outlined and improvements to 
current studies are recommended.  
7.1 CONGENITAL CLEFT MITRAL VALVE REPAIR 
Congenital heart defects are complex anatomical defects, which are surgically 
challenging to repair. Surgical procedures performed in the pre-natal stages or at early 
age lack long term durability due to several reasons. With increased surgical experience 
focus has veered from mortality as an index of operative success towards the long term 
quality of life subsequent to surgical repair[1]. Often the long term outcomes are sub 
optimal due to partial or complete failure of the repair, due to growth of the cardiac and 
valvular structures after surgery, changes in cardiac hemodynamics and to some extent 




Atrio-Ventricular Canal (AVC) defect is one such congenital cardiac lesion for 
which surgical repair is challenging and is typically associated with poor long term 
durability. Surgical correction of this lesion involves a sequence of procedures that 
encompass separation of the atrioventricular valve from the muscular septum, closure of 
the atrial and ventricular septal defects, and reconstruction of the mitral and tricuspid 
valves. Though success with repair of septal defects has been excellent, late 
incompetence of the left atrioventricular valve remains a challenge and reoperation rates 
remain disconcertingly high. Pathological morphology of the valve, structural 
deficiencies at the annular and sub annular levels and disarray in the chordal structures 
are some of the risk factors, though the contribution of each is currently unclear.  
7.1.1 IMPACT OF CLEFT VALVE MORPHOLOGY ON VALVE FUNCTION 
Understanding the morphological deficiencies of the valve is the first step towards 
identifying risk factors for repair failure, or to develop new techniques for valve 
reconstruction. Kanani et al. reported an excellent study on the morphology of the left 
atrioventricular valve in these patients, clearly delineating the leaflet and chordal 
geometries[1]. They compared the mitral valve structures between normal hearts (N=92, 
Cardiac Registry, Children’s Hospital, Boston, MA) and hearts with atrioventricular 
septal defect with a common atrioventricular junction (N=72; Cardiac Archive, Great 
Ormond Street Hospital, London (28), Children’s Hospital of Pittsburgh, PA (30), 
Children’s Hospital, Boston, MA (14)). They observed that the anterior leaflet of the 
mitral valve was uniformly triangular in normal mitral valves with the base of the leaflet 




aortic valve as shown in Figure 7-1A. The chordal structures were distributed across the 
entire leaflet, classified based on their insertion regions into primary chordae (free edge), 
secondary chordae (middle of leaflet), and tertiary chordae (at commissures or directly 
into the annulus). In comparison, the newly created neo-anterior leaflet in the repaired 
left atrioventricular valve was more rectangular, with a triangular recess at the distal end 
of the surgically closed cleft as shown in Figure 7-1B. The chordae inserted 
longitudinally into the leaflet, and were separate from each other than splitting from one 
chordal stem as seen in the normal mitral valve. In the in-vitro cleft valve model, the 
leaflet was forced to be rectangular by moving the commissures laterally, and a wedge 
shaped cleft was created to mimic the triangular recess at the distal end after cleft closure. 
However, deficiencies in the chordal insertion were simulated only to the extent to which 
the altered leaflet change forces change in their orientation, but no morphological 




























Additionally fusion of the chordae tendineae with chordal tags are reported in 
these pathological valves, with absence of the central chordae tendineae in the vicinity of 
the cleft as shown in Figure 7-2. By creating a wedge shaped cleft, all of the primary and 
some of the secondary chordae were removed in the in vitro model, and thus the strut 
chordae inserting longitudinally near the annulus and the tertiary chordae were the 
primary load bearing elements. Chordal fusion was not simulated in this model, as there 
are no data available on the structure, function or mechanics of these fused chordae in 
comparison to the normal chordae tendineae.  
 
Figure 7-1 Schematic representation of the anterior leaflet of a normal mitral valve and
the neo-anterior leaflet of the reconstructed mitral valve in an atrioventricular canal
defect. (A) The triangular anterior leaflet with the base continuous with the aortic valve
leaflets through the fibrous trigones. The chordae tendineae are systematically arranged
into primary, secondary and tertiary chordae that insert from the free edge to the base of
the leaflet. (B) The neoanterior leaflet on the other hand is more rectangular with a
triangular recess in the center where the cleft was closed. The chordal structure is
malformed as well with the chordae running into the longitudinal axis of the leaflets.















Kohl et al. using echocardiographic analysis analyzed the video recordings of 11 
children to study the nature of the cleft position, chordal attachments and associated 
pathology of both entities[80]. They found that in patients with atrioventricular canal 
defects, the cleft position was positioned centrally on the anterior leaflet, and was 
consistent between patients. However, the papillary muscles in these patients were 
posteriorly displaced towards one another, with reduced included angle between the two 
papillary muscles as shown in Figure 7-3A. In the in vitro simulator, this morphological 
feature was simulated by displacing the papillary muscles in the heart simulator laterally 
by 10mm and posteriorly by 10mm towards each other until the positions reported in 
Kohl et al. were achieved. Often this sub annular geometry is not corrected surgically, 
and thus assessing the impact of the scooped geometry of the ventricle on the valve 
function is important and was studied in this model.  The posterior leaflet was also 
Figure 7-2 Sub annular apparatus from heart specimens with atrioventricular canal
defects. (A) chordal fusion and leaflet straddling due to proximity of the papillary muscle
head to the leaflet edge; (B) Abnormal chordal forms and tags inserting into the leaflet
from the papillary muscles and the ventricular wall, but with absence of central chordae.





reduced in size to mimic the triangular shape of the mural leaflet in these defects as 






















Figure 7-4 (A) Construction of the left and right atrioventricular valves from the
common atrioventricular valve orifice using a suture knot at the annular-anterior leaflet
junction; (B) The oval shaped annulus formed after patching the septal defects using
pericardial patches at the base of the valve. Figure reproduced from Castaneda et al.
Chapter 10, Atrioventricular Canal Defects, Congenital Heart Defects and Procedures. 
(A) (B) 
Figure 7-3 (A)Mean position of the papillary muscles in the atrioventricular cleft mitral
valves in comparison to an isolated cleft mitral valve, demonstrating the posterior and
lateral displacement of the two papillary muscle heads in the former case; (B)
Schematic representation of the common atrioventricular orifice, with respect to the





Finally, the mitral annular shape in the in vitro model was shaped to mimic the 
pathological annular shape resulting from the pericardial patching of the septal defects at 
the atrial and ventricular levels. As shown in Figure 7-4 , a suture knot at the cleft-
annulus junction and pericardial patching of the septum resulted in a “semi-oval” shaped 
annulus that was used in this study.  
3D echocardiographic images from the in vitro cleft valve model and in vivo 
echocardiographs clearly demonstrated the similarity between the two models. Figure 7-5 
depicts the in vitro vs. in vivo [123] comparison at systolic ejection, where the open cleft 















Figure 7-5 (A) In-vivo 3D echocardiograph of the mitral valve depicting the cleft in the
anterior segment with the two bridging leaflets and a smaller posterior leaflet, (B)
Shows an in vitro echocardiograph demonstrating the similarities between the two
valves at systolic ejection with loss of coaptation between the opposing bridging leaflets






7.1.2 IMPACT OF CLEFT CLOSURE AND ANNULAR DILATATION ON 
VALVE HEMODYNAMICS 
The in vitro methodology adopted in this study is thus functionally equivalent to 
the atrioventricular valve defect-like anatomy. This model overcomes the unavailability 
of large animal models, which are challenging to develop for congenital defects such as 
these, as the exact genetic exclusions or biological mechanisms underlying the defect are 
unknown. Though in-vitro methodology is limited by its rigid ventricular chamber, non-
physiological ventricular shape and lack of annular dynamics, these limitations do not 
affect the variables that are investigated in this study. Additionally, the in-vitro approach 
provides precise control over the valve geometry, hemodynamic conditions and also 
provides the ability to study different repair procedures on the same valve. 
Using this in vitro model, the risk factors for left atrioventricular valve 
regurgitation after complete cleft closure were investigated and some surgical measures 
to address this challenge are suggested. The first important conclusion of this study is that 
complete cleft closure reduces regurgitation completely in comparison to partial cleft 
closure, with a normal annulus. This result is intuitive, because closing the cleft 
completely will eliminate any crevices or holes in the anterior leaflet and thus avoid 
regurgitation. The regurgitation volume decreased from the open cleft case by 18% for 
one-third cleft closure, by 61% for  two-third cleft closure, and by 90% when the cleft 
was completely closed. These data clearly demonstrate that the best hemodynamic 
outcomes are possible, only when the cleft is completely closed from the mitral annulus 
to the leaflet free edge. However, clinically it is thought that complete cleft closure may 




not measure any statistically significant increase in the stenosis, and mobility of the 
anterior leaflet was not compromised. However, if partial cleft closure is intended, at 
least two thirds of the cleft should be closed to achieve hemodynamic benefit.  Closing 
the cleft only proximal to the mitral annulus leaves a majority of the cleft open, allowing 
regurgitation, and thus should be avoided.  When more than two-thirds of the cleft is 
closed, regurgitation is reduced as the posterior leaflet may blanket the open part of the 
cleft at systolic coaptation. Often, mild regurgitation persists through this region as the 
edges of the cleft are thin and unstable at high systolic pressures. These results agree with 
the clinical findings of Wetter et al. who confirmed in 96 patients that larger the extent of 
cleft closure better are the hemodynamics [124].  
Notwithstanding complete cleft closure, significant regurgitation can still occur in 
these valves. Acar et al. reported a nice echocardiographic analysis of valve anatomy 
after surgery for septal defects in the atrioventricular canal defect patients [125]. They 
observed that post operative regurgitation was typically observed at two locations 
Figure 7-6 (A) A 3D echocardiograph of the surgically reconstructed mitral valve after
cleft closure and septal defect patching; (B) A four chamber view depicting the
regurgitation jet through the residual cleft that is medial to the annulus, (C) Another four
chamber view depicting a regurgitation jet at the coaptation zone between the bridging
leaflets and mural leaflets. Figures reproduced from Acar, P et al. Am J Cardiol, 1999;
83. 




medially from the region of the coaptation of the superior and inferior components of the 
anterior leaflets (the residual cleft); and from the region of coaptation with the mural 
leaflet as shown in Figure 7-6. This study led to the hypothesis that even after complete 
cleft closure, loss of coaptation between the bridging and mural leaflets is possible which 
is typically not addressed surgically.  
As the in vitro model already accounts for the reduced leaflet size, the impact of 
post surgical annular dilatation on the valve hemodynamics was studied. The nomograms 
in Figure 7-7 depict the expected changes in the mitral annular anterior-posterior 
diameter with increase in body surface area of the patient, and these projected annular 
dimensions were simulated in the in vitro model.  Results from this study demonstrate 
that increase in the septal lateral dimension of the mitral annulus, induces clinically 
significant regurgitation, even if the cleft is completely closed. Figure 7-8 depicts the 
regurgitation through the valve with a dilated annulus at different cleft closure lengths. It 
is clearly evident from these echocardiograms that when the cleft is completely or 
partially open, regurgitation occurs through the residual opening. Figure 7-8 provides a 
key insight that even after complete cleft closure it is still possible to have central 
regurgitation due to loss of coaptation between the anterior and the posterior leaflets. 
With a 20% increase in annular size, regurgitation volumes increased up to 45% for a 
two-third cleft closure and by 69% for complete cleft closure. At 40% annular dilatation, 
regurgitation increased by 59% for the two-third cleft closure and by 84% for the 
complete cleft closure. An interesting inference from these results is the higher rate of 
increase in regurgitation due to annular dilatation, for a fully closed cleft compared to a 















Figure 7-7 (A) Nomogram of the relationship between age or patients with congenital heart defects and the predicted body surface
area; (B) Nomogram depicting the expected mitral annular anterior-posterior dimension of the mitral valve with increase in body
surface area; (C) A table depicting the change in the major and minor axis of the mitral valve dimensions with body surface area. Data 






Annular dilatation, simulated as an increase in the septal lateral dimension of the 
annulus, may induce regurgitation via two mechanisms. He et al. in an in vitro study 
demonstrated that normal mitral valve leaflets can compensate up to 60% increase in 
annular size, with trivial regurgitation through the valve [113]. In these congenitally 
malformed valves, the leaflets are smaller in size and lose their ability to compensate for 
higher levels of annular dilatation. Thus even at low levels of annular dilatation, loss of 
central coaptation and ensuing regurgitation is possible. Secondly, interaction between 
the two malformed mitral leaflets and the annulus may restrict adequate leaflet motion for 
Figure 7-8 (A) Severe regurgitation through the valve with annular dilatation and a
completely open cleft, (B) Moderate regurgitation with one third cleft closed, (C)
Moderate regurgitation at the residual cleft after 2/3rd cleft closure but with annular
dilatation, and (D) Regurgitation through the valve due to annular dilatation but with a
completely closed cleft. [Obtained at Georgia Institute of Technology using Philips




proper systolic valve closure. Posterior displacement of the annulus moves the chordal 
insertion points on the posterior leaflet away from the tips of the papillary muscles. 
Tethering of the posterior leaflet is possible due to this chordal misalignment, and may 
restrict proper systolic valve closure as shown in Figure 7-9. Additionally, chordae 
inserting into the anterior leaflet edges tether on the leaflets which could be confounded 
















Figure 7-9 Schematic depicting the impact of annular dilatation on the leaflet-
papillary muscle   interaction.  The yellow circle on each picture represents the tip of
the papillary muscle, and the angle depicts the included angle between the leaflet
tangent and a normal from the papillary muscle tip to the mitral annular plane.  (A)
Dilated annulus with a larger included angle than the normal annulus shown in (B).
Similarly, (C) and (D) depict the leaflet position with respect to the vertical axis,
where in the dilated state tethering of the leaflet is evident from the slight bend in the
leaflet, which is absent in the normal state. [Obtained at Georgia Institute of





These important valve features have to be acknowledged when surgically 
repairing the valve in these defects. Often posterior leaflet augmentation techniques are 
adopted to extend the leaflets to compensate for annular dilatation, but such procedures 
are challenging to perform due to fragility of the leaflet tissue and the risk of severing the 
chordae inserting into the ventricular surface of the leaflets.  
7.1.3 ANNULAR UNDERSIZING AND ITS ROLE IN IMPROVING POST 
REPAIR HEMODYNAMICS 
Annular undersizing may be a promising alternative to patch augmentation in 
repairing these valve defects. In this study annular undersizing was simulated as 
reduction in the septal-lateral dimension, and its impact on different levels of cleft closure 
was assessed. With a completely open cleft, as expected regurgitation persisted through 
the cleft even after 40% annular undersizing and thus was considered a failed repair. At 
one-third cleft closure, significant reduction in regurgitation was measured at 40% 
annular undersizing. However, it may be risky to severely undersize the annulus in these 
young patients as in the long term they may develop mitral stenosis, which can have 
detrimental impact on left ventricular diastolic function. With two third cleft closure and 
20% annular undersizing, regurgitation was reduced by 58% from the normal annular 
size at the same cleft length. This study supports the hypothesis that a partial cleft closure 
is sufficient when undersizing the annulus. Acknowledging this fact is useful when 
confronting difficult anatomies such as in valves with a single papillary muscle. 
Additionally, the open part of the cleft could provide better leaflet mobility benefitting 




7.1.4 CLINICAL IMPLICATIONS 
Undersizing in these patients could serve three purposes: restrict annular 
dilatation, enhance leaflet coaptation and restore complete valve competence with only a 
partial cleft closure. Since canal defects are corrected at infancy, restricting annular 
dilatation during initial years after the repair could prevent late regurgitation. However, 
this procedure has to be considered cautiously, and adult mitral annuloplasty rings should 
not be used due to their rigidity and lack of growth potential in the long term. Using 
Polydioxanone or absorbable annuloplasty rings is recommended since they allow 
somatic growth of the annulus by gradual degradation with time. This strategy may 
attenuate early morbidity, and also allow for better long term valve growth and 
performance. Honjo et al. [126] in their retrospective report on infants who underwent 
mitral valve repair for congenital mitral regurgitation, reported a desirable growth of the 
mitral annulus following a mitral annular repair without artificial material, shown in 
Figure 7-10. Biodegradable rings may provide similar outcomes, and thus should be 
increasingly used in pediatric mitral valve repair. One such ring that is commercially 
available in Europe today is the BioRing® (Bioring SA, Lonay, Switzerland) and is being 



















7.1.5 LIMITATIONS OF THE IN VITRO STUDY 
 Although the in vitro model adopted in this study simulates human AVC-like 
valve anatomy and function to a good extent, it has some inherent limitations. In this 
model, chordal attachments in the cleft vicinity inserting from the ventricular septum 
(Rastelli type A) were not simulated. These chordal attachments could contribute to some 
extent to the postoperative regurgitation. The rigid ventricular chamber used in this study 
does not mimic the ventricular motion, whose effects on the valve function were not 
studied.  
Figure 7-10 Annular growth curve reported by Honjo et al after mitral
annular techniques that do not use artificial materials and thus allow growth
of the annulus. Though initially the mitral annular diameter is reduced due to
undersizing or commissurotomy, the annulus grows and tends to catch up
with a physiological growth rate [Figure reproduced from Honjo et al,





In summary, this study provides novel mechanistic insights into a complex problem of 
LAV repair in AVC defects. Cleft closure and post-operative annular dilatation have a 
significant impact on repair outcome. To reduce reoperation rates and to maintain long-
term valve competence, it is demonstrated that cleft closure with annular undersizing is 
proven to be beneficial.  
7.2 DEGENERATIVE MITRAL VALVE REPAIR 
7.2.1 SURGICAL REPAIR FOR FIBROELASTIC DEFICIENCY 
Mitral valve prolapse is a common manifestation of a spectrum of degenerative 
lesions, which encompass chordal elongation, chordal rupture, leaflet distension and 
annular dilatation. Cuffer and Barbillon, first reported the midsystolic click and systolic 
murmur syndrome in 1887, but early studies attributed it to extracardiac disease until 
1966, when Barlow et al using ventricular imaging demonstrated the aneurysmal 
protrusion of the valve leaflet into the left atrium. Since Criley first proposed the term 
“mitral valve prolapse”; focus has been on echocardiographic diagnosis of mitral valve 
prolapse and indicators for surgical referral [88, 127]. Carpentier in his seminal paper 
titled the “French Correction”, reported the first series of patients in whom repair of 
anterior and posterior leaflet prolapse was performed [7]. In the subsequent decades, the 
Carpentier procedures became standardized techniques for mitral valve repair for 
degenerative lesions. Though prolapsing mitral valves are routinely corrected today using 
the ‘standardized procedures’, differentiation of the degenerative lesion and optimizing 




clinical study compared the use of PTFE suture loops to leaflet resection for posterior 
leaflet prolapse in fibroelastic deficient lesion, and reported better outcomes with 
neochordoplasty than resection due to the absence of leaflet distension in these valves 
[96]. Data from this study clearly illustrates that even though leaflet resection may be the 
“standard” technique to correct leaflet prolapse, it should not be the procedure adopted in 
all patients with leaflet prolapse. Flameng et al. also reported a retrospective study on the 
durability of mitral valve repair for Barlow’s disease and fibroelastic deficiency, and 
observed that 33.1% of the patients had recurrent mitral regurgitation at 10 years after 
surgery [10]. These studies strengthen the hypothesis that choice of surgical repair should 
be governed by the lesion, and thus emphasizing on the need for controlled experimental 
data comparing different surgical techniques for a given lesion. 
7.2.2 VALIDATION OF THE IN VITRO POSTERIOR LEAFLET PROLAPSE 
MODEL 
In this study, posterior leaflet prolapse due to acute rupture of the marginal 
chordae tendineae, as frequently reported in fibroelastic deficient mitral valves, was 
simulated. Transecting two pairs of posterior marginal chordae resulted in prolapse of the 
free edge of the P2 cusp, which is identical to the type of leaflet prolapse observed in 
fibroelastic deficient mitral valve patients. 3D echocardiographic images obtained from 
the in vitro simulator clearly demonstrate the prolapse, and the direct comparison to 

























Figure 7-11 (A) A 2D long axis view of the prolapsing posterior leaflet
from the in vitro left heart simulator; (B) An intra operative photograph of
the mitral valve with the ruptured posterior leaflet chord (Courtesy –
David H. Adams, MD, Mt Sinai School of Medicine); (C) An
echocardiograph obtained from a patient with fibroelastic deficiency
depicting prolapse of the P2 cusp (white arrow), with no billowing of the
anterior leaflet of the valve (Courtesy - David H. Adams, MD, Mt Sinai




An eccentric regurgitation jet going along the anterior leaflet into the left atrium, 
was recorded on the color Doppler as shown in Figure 7-12, which is identical to the 
regurgitation jets that are seen clinically in patients with isolated posterior leaflet 









The three surgical procedures to repair the prolapsing leaflet: neochordoplasty 
with PTFE sutures; limited triangular resection; and quadrangular resection with annular 
compression at the P2 cusp were chosen, as they are the most common procedures used 
in humans. Quadrangular resection with annular plication or compression  was proposed 
by Carpentier for repair of distended valves in Barlow’s syndrome[7], triangular resection 
by Kron for a spectrum of degenerative valve lesions[93] and neochordoplasty by Mohr 
for isolated chordal rupture[96]. Results from this study demonstrated that for fibroelastic 
deficient valves, with acute chordal rupture but no leaflet distension, both resective and 
Figure 7-12 (A) 3D color Doppler acquisition of the in vitro valve model depicting the
eccentric regurgitation jet riding along the anterior leaflet of the valve; (B) A color
Doppler acquisition from a patient with isolated posterior leaflet prolapse, depicting the




non-resective techniques had identical hemodynamic outcomes. However, significant 
differences in the leaflet motion and kinematics were recorded which may have a 
detrimental role to play in the durability of the repair.  
7.2.3 IMPACT OF SURGICAL REPAIR TYPE ON POST REPAIR VALVE 
MORPHOLOGY AND FUNCTION 
To understand the relevance of each surgical repair to acutely prolapsing valves, it 
is important to understand the changes that each surgical technique induces on the valve 
structure. Quadrangular resection with annular plication, is widely used for correction of 
posterior leaflet prolapse, but was initially proposed by Carpentier [7] for use on severely 
distended leaflets in which excess tissue needs to be resected to reconstruct a normal 
valve. Typically applicable for Barlow’s valves, this procedure involves removal of the 
entire P2 cusp and plication of the annulus at this region as shown in Figure 7-13, thus 
removing the prolapsing segment and also preventing leaflet billowing. However, in 
fibroelastic deficient valves that do not have any leaflet tension, resecting the P2 cusp 
using quadrangular resection restricts the mobility of the reconstructed leaflet. This loss 
in mobility is supported by the data from this study, which can be explained using two 
mechanisms as depicted in Figure 7-13A-D. Firstly, lack of extra tissue requires forceful 
closure of the cleft resulting from the P2 resection and induces significant tethering on 
the suture line. During systolic valve closure, the suture line may tether the commissural 
cusps inwards towards the P2 cusp and this complex loading may restrict proper leaflet 
motion. Secondly, with removal of the P2 cusp the secondary chordae on the P2 cusp are 




superior strut chordae may restrict leaflet motion, and thus induce abnormal tethering on 
the center of the leaflet. Therefore, this study puts emphasis on the importance of 
selecting the appropriate subset of patients with prolapse and distended tissue to adopt 


















Figure 7-13 (A) Dotted line depicting the region resected from the posterior leaflet
using the quadrangular resection procedure; (B) Red arrows depict the forces imposed
on the suture line after leaflet reconstruction using sutures; (C) Ventricular view of the
valve after removal of the quadrangular section of the leaflet from the P2 cusp, and (D)
Relocation of the secondary chordal insertion points after posterior leaflet




 Additionally, the P2 segment has the largest area and leaflet height and thus 
contributes significantly towards achieving a good leaflet coaptation length. Removal of 
the P2 cusp thus reduces the leaflet area/height available for restoring physiological 
coaptation length in the fibroelastic deficient valves. In Barlow’s syndrome valves, both 
the leaflet area and leaflet height are significantly increased and quadrangular resection is 
aimed at reducing redundant leaflet area and also reducing leaflet height to restrict 
systolic anterior motion of the valve. This aspect of the surgery is often ignored by 
surgeons, and thus adopted as a “generic prolapse repair” resulting in poor outcomes for 
the fibroelastic deficient valve lesions [10]. Often, quadrangular resection in non 
distended leaflets results in a mono-cusp valve with completely restricted posterior leaflet 
motion and abnormal valve closure.  
Limited triangular resection is a conservative tissue resection approach, which 
may be a good alternative option that significantly reduces the size of resection and 
eliminates the need for annular plication. Findings from this study indicate that in non-
distended leaflets, triangular resection restricts leaflet prolapse and preserves good leaflet 
coaptation and posterior leaflet mobility. While the outcomes of triangular resection were 
better than quadrangular, a 2.0 mm reduction in coaptation length and a 2.3mm posterior 
displacement of the leaflet coaptation were measured in comparison to the control group. 
Even though mobility in this case is better than that with the quadrangular resection case, 
this type of resection may induce tension in the free edge of the leaflet as depicted in 
Figure 7-14.  Whether these minor differences between triangular resection and controls 




clinical trial. However, this procedure overcomes the two major drawbacks of 
quadrangular resection and maybe a procedure that should be used more extensively. 
In recent years, several surgical centers have reported the use of neochordoplasty 
for correction of prolapse, and emphasize on the importance of leaflet preservation for 
better hemodynamics and long term durability [96]. This study confirms that hypothesis, 
and demonstrates that posterior leaflet mobility and leaflet coaptation length can be 
restored to physiological levels using this procedure. By replacing the ruptured marginal 
chordae with PTFE chordae, the native leaflet structure of the chordal insertion regions 
are not disturbed and thus theoretically the valve function may be restored completely.  
Figure 7-14 Schematic depicting the concept of free edge tethering after triangular
resection that may restrict the motion of the posterior leaflet to some extent. The close




Neochordoplasty, as performed in this study seemed to have a benefit over leaflet 
resection in acute leaflet prolapse without leaflet distension. Replacing the ruptured 
chordae with a single ePTFE loop not only eliminated regurgitation as efficiently as the 
standard resection procedures but also restored leaflet coaptation length to physiological 
levels, with excellent mobility of the posterior leaflet.  In this study, each papillary 
muscle head had two pairs of neochordae; one pair supporting the free edge of the 
prolapsing segment while the other supporting the segment 1cm laterally away from the 
free edge. Such a chordal distribution was chosen in this study so that the entire free edge 
is supported, and localized prolapse in the regions surrounding the neochordae can be 
eliminated. Though this arrangement resulted in excellent results in this study, it remains 
unclear if there is an “optimal” positioning of neochordae, other than to avoid crossing 
native chordae.  
7.2.4 CLINICAL IMPLICATIONS 
This study demonstrates the importance of tissue preservation over tissue 
resection to correct acute posterior leaflet prolapse with otherwise normal valve leaflets. 
The important message of this study is that etiologic classification of mitral valve 
prolapse is essential for appropriate surgical correction. Thus, the cardiologists when 
diagnosing mitral valve prolapse should quantify and appropriately describe the nature of 
prolapse (e.g. leaflet billowing or not, isolated prolapse or prolapse of entire leaflet etc) 







  Any clinical implications of this study must be stated circumspectly. Firstly, this 
study represents an acute case of leaflet prolapse due to isolated chordal rupture without 
any annular or leaflet pathologic change(s). Clearly, mitral valves with normal function 
and tissue properties were utilized which do not take into account any preexisting patient 
pathologies (e.g, bacterial endocarditis), which may impact the choice of mitral valve 
repair. In the chronic state, myxoid changes in the leaflet tissue and distension are 
observed and complex resection procedures are required in repairing such valves[9]. In 
this study, the neochordal length was determined with the valve closed, but such an exact 
measurement is impossible in the clinical setting due to the flaccid heart conditions under 
which the length is adjusted.  One other limitation is the use of the same valve 
preparation for all experimental groups, which dictated the order of the repair procedures.  
7.2.6 SUMMARY 
In summary, this study demonstrates that both resective and non-resective repair 
procedures are effective in eliminating mitral regurgitation due to acute posterior leaflet 
prolapse. However, conservatively resecting the leaflet without annular procedures or 
adopting procedures that completely avoid resection appear to improve post-repair valve 
function and geometry in this experimental model of acute chordal rupture. These 
findings corroborate recent clinical findings [10, 128, 129], emphasizing the importance 
of the leaflet preservation concept in mitral valve repair, and warrant caution in 





7.2.7 NEOCHORDOPLASTY VERSUS CHORDAL TRANSLOCATION FOR 
POSTERIOR LEAFLET PROLAPSE 
 In the previous study comparing resective and non-resective techniques for repair 
of posterior leaflet prolapse, focus was on comparing leaflet repair techniques to chordal 
replacement. The results clearly demonstrated that replacement of the ruptured chordae 
with artificial chordae improved hemodynamic and leaflet kinematic outcomes. 
Replacement of the chordae, however, is associated with two procedural challenges – [a] 
access to the papillary muscle tips to insert the neochordae; and [b] determining the 
length and orientation of the neochordae on a flaccid heart which is on cardiopulmonary 
bypass. Experienced surgeons have overcome these challenges, and few surgeons have 
also reported specialized calipers to pre-measure the loop length [130-132].  
 In this study, an easier method that can simulate the hemodynamic and kinematic 
outcomes of neochordoplasty was sought. Based on anatomical studies, translocation of 
the secondary chordae on the posterior leaflet to the prolapsing free edge was 
hypothesized to be a comparable technique and thus its efficacy was assessed. In the 
systolic closed position of a normal valve, the offset between the plane of secondary 
chordal insertion and marginal chordal insertion is small (~3mm). In this study it was 
hypothesized that translocation of the secondary posterior chordae to the marginal 

















 Results from this study demonstrate that hemodynamically, chordal translocation 
was comparable to neochordoplasty. Leaflet coaptation length was comparable to 
neochordoplasty and control conditions, thus confirming the hypothesis that secondary 
chordal translocation to the primary/marginal position is a good technique for acute 
posterior leaflet prolapse. Mobility of the posterior leaflet was preserved as well, but a 
slight basal motion of the coaptation was observed which is to be expected. The 
secondary chordae are longer but stiffer than the marginal chordae, which offsets a large 
basal offset of coaptation. The potential for clinical translation of this procedure is 
(C) (B) (A) 
Figure 7-15 (A) Schematic of a normal posterior leaflet with chordal insertions, and the
bottom image depicting the offset between the marginal and secondary insertions, (B)
Marginal chordal rupture, and (C) Translocated chordae after which a slight basal
movement of the coaptation is expected due to the longer length of the secondary
chordae than the marginal chordae 




significant; however variability in the chordal pattern and insertion points between 
patients should be carefully assessed.   
7.2.8 CLINICAL IMPLICATIONS 
Chordal translocation to a large extent eliminates the challenges associated with 
adjustment of neochordae length, or the mismatch in the mechanical properties between 
artificial ePTFE sutures and native chordae tendineae. Procedural ease of translocation 
may prove to be an attractive option for clinical use, especially at surgical centers without 
expertise in heart valve repair.  
7.2.9 LIMITATIONS OF THE IN VITRO PROLAPSE MODEL 
 The in vitro prolapse model mimics the acute setting of isolated posterior leaflet 
prolapse due to marginal chordal rupture. In human subjects that have fibroelastic 
deficiency, the prolapsing segment undergoes myxoid changes by the time of surgery 
resulting in significant thickening. Such thickening or distension of the prolapsing 
segment was not simulated in this in vitro model, which is a limitation of this study. 
7.2.10 SUMMARY 
In summary, chordal translocation and neochordoplasty have comparable acute 
hemodynamic and kinematic outcomes. With chronic clinical data already demonstrating 
the durability of neochordoplasty, similar results may be expected with chordal 
translocation as well. However, due attention must be paid to the type of chordal insertion 
and find appropriate methods to ensure physiological transfer of loads from the chordae 




7.2.11 MECHANICS OF THE CHORDAL INSERTION REGION 
 
Studies from the previous sections clearly demonstrate superior post operative 
valve hemodynamics with neochordoplasty and chordal translocation. However, an 
important aspect of these procedures that is often ignored is the method of insertion of the 
chordae into the leaflet. In current practice, the chordae insert into the leaflet at one focal 
point or using small loops (~3mm loops) to correct local prolapse, however whether such 
a design would mimic physiological transfer of loads from the sub-annular components to 
the leaflets is currently unknown.  
This study for the first time provides a detailed understanding of the mechanics of 
the region of insertion of the thick cylindrical strut chordae into the planar anterior 
leaflet. Data from this study shows a heterogeneous strain mapping over the insertion 
region with higher stretching of the tissue along the edges of the insertion zone than the 
center, as systole progressed. Temporally, as the cardiac cycle progressed from diastole 
to peak systole there was a gradual increase in stretch across the region, with highest 
stretch at the left and right edges of the insertion region and the lowest stretch at the basal 
end of the chordal insertion into the leaflet. The results show that the areal stretch rapidly 
increases at the apical segments (below horizontal line connecting marker # 15-19) and 
along the insertion zone edges, while minimal stretch was recorded at the central region 
around markers 4,10,11,12 during early systole. As systole proceeded, this pattern of 
stretch remained consistent but with increasingly higher stretch magnitudes at the edges 
of the insertion zone and a smaller region at the center that remains un-deformed. 
Examining the mesh deformation during systole it seems that the tissue along the axis of 




sides of this axis undergo significant out of plane deformation. In such a case, if the 
insertion zone had a uniformly distributed collagen matrix, one would expect that the 
maximum deformation would be at the central axis, as it acts like a fulcrum to the two 
bending edges. However, the experimental results show the contrary, with maximum 
stretch along the edges and very little stretching at the central axis. This not-so-obvious 
stretch pattern, we believe, is due to the micro structural arrangement of collagen fibers 
wherein the collagen core from the strut chord splits into two bundles that run along the 
leaflet boundaries, while the collagen in the interior/central part of the zone was more 
circumferentially aligned. The observed areal stretch pattern correlated very well with the 
facts known about the physiological function of the mitral valve, wherein the A2 and 
A1/A3 cusps move more basally to obtain good valve closure than the region of insertion 
of the strut chord. This basal cusp motion stretches the tissue increasingly at either edge 
of the chordal insertion zone than the central region, which is more or less a part of the 
leaflet already. 
The major and minor principal stretch maps also provide interesting insights into 
the transition of forces and resulting mechanics during valve closure. Initially at end 
diastole, the chordal insertion region seems to be in equilibrium between the tension from 
the leaflet and the chordae, evident from the radial orientation of the major principal 
vectors. At the beginning of valve closure, there were mainly radial stretches because the 
strut chordae pulled the leaflet relatively uniformly in radial direction as the anterior 
leaflet moved towards the annulus even if there is not much loading on the leaflet. As the 
anterior leaflet continued to move to coapt with the posterior leaflet, the ventricular 




tension by stretching itself in all directions against the transvalvular pressure. At the end 
of valve closure, chordae insertion reached the force equilibrium from tension of leaflet 
and chordae tension after leaflet coaptation. Though regionally these transitional stretch 
patterns are sensible, they are highly dependent on the leaflet coaptation as a boundary 
force condition. These results show a strong coupling between the major and minor 
principal directions, and the complex biomechanics of the chordal insertion zone.  
 The results from this study extend the mechanical measurements reported by 
Chen et al, performed under idealized equi-biaxial loading conditions on porcine anterior 
mitral leaflets [133]. The novelty of the current study the mechanical behavior of the 
chordal insertion region is quantified under physiological anatomical and loading 
conditions. Though the geometric and loading conditions are different in the two studies, 
the results can be compared to understand the overall trend in the mechanics. Along the 
radial direction, Chen et al. report a maximum stretch of 35% closer to the leaflet and  
20% closer to the strut chord and along the circumferential direction, a maximum stretch 
of 10% closer to the leaflet and ~17% closer to the strut chord. In this study, the marker 
array (except for marker # 31) represents the same region of interest as considered by 
Chen et al, and thus qualitative comparison between the results is justified. The results 
clearly shows that the average maximum stretch in the radial direction is ~40% near the 
leaflet and ~30% near the strut chord, thus agreeing with previous results. The average 
maximum stretch in the circumferential direction is ~45% near the leaflet and ~20% near 
the strut chord. The higher leaflet deformation in the circumferential direction in this 
study than the biaxial data could be attributed to the difference in the loading conditions 




heterogeneity in the stretch pattern nor the temporal changes in the stretch, thus limiting 
the extent to which a quantitative comparison can be performed.   
7.2.12 CLINICAL AND BASIC SCIENCE IMPLICATIONS 
This study provides detailed insights into the mechanics of the strut chordae 
insertion region, which are not only interesting from a scientific perspective, but also may 
have several clinical applications. To date several studies on the biomechanical of the 
mitral valve structure have been reported, but there is little understanding of the 
biomechanical events that develop the complex mitral valve structure from the 
endocardial cushions. It is speculated that the cushion tissue under increasing stretch 
from the papillary muscles separating from the myocardium clearly delineates the leaflet 
structure and the chordal structure. Though this hypothesis is yet to be verified, this study 
provides insights into the mechanics of the complex transition zone where the planar 
collagenous leaflet morphs into a cylindrical collagenous structure. In the future, this 
knowledge could help researchers investigate the logical sequence of events that govern 
the formation of different components of the mitral valve structure. From a clinical 
perspective, knowledge of the strut chordal insertion region may aid better surgical 
decision making in using techniques such as chordal cutting, where the strut chordae on 
the anterior leaflet are severed. Such procedures could potentially alter the local and 
global valve mechanics, and may have detrimental effects on the durability of the valve 
repairs. Even though diffusion of basic mechanics knowledge into clinical practice takes 
significant thrust and time, basic mechanics studies as this one may eventually aid 





Although this study elucidates the complex biomechanics of the chordal insertion 
region, it has some inherent limitations. In this study we used porcine mitral valves, 
which may to some extent differ in their structure, function and microstructure from those 
in humans. However in a previous study we have shown the structural similarity between 
porcine and human valves, and thus expect the differences to be within reasonable limits. 
In addition, the ventricular model used in this study does not represent the physiological 
contractile muscle model in humans and thus may have not completely simulated the 
loading conditions in the actual human heart. A static planar annulus was used in this 
study, which does not represent the physiologic saddle shaped, dynamic mitral annulus. 
The authors acknowledge this limitation and are developing a new annular model to 
mimic the sphincteric motion and 3-dimensionality of the annulus.  The complex 
collagen fiber distribution and orientation entails investigation of microstructure of the 
insertion region which is three dimensional. Finally, we assumed the reference image 
from which the anterior leaflet starts to move to annulus was a strain-free state during 
valve closure. It is possible that the chordae insertion region may bear some prestretch 
due to fluid drag forces on the chordae, even before systolic valve closure.  This may 
cause a small error in the stretch measurements.  However, given the high reproducibility 
of the measurements, we believe that this is a reasonable approach. 
7.2.14 SUMMARY 
In summary this study demonstrates the complex mechanics of the chordal 




between mitral valve components that was previously unknown. These findings may not 
only be relevant to the design of new repair techniques and percutaneous repair devices 
that seek to replace or relocate the ruptured chordae, but also have several implications 
towards understanding the embryonic development of the complex mitral valve structure.  
7.2.15 EDGE TO EDGE REPAIR FOR POSTERIOR LEAFLET PROLAPSE 
 Surgical repair of posterior leaflet prolapse is the current standard of care, but in 
octogenarians and high surgical risk patients mitral valve repair is still a challenge. 
Tolerance to cardiopulmonary bypass and immune response after cardiac surgery is poor 
in these patients. Thus such patients are managed using medical therapy and sometimes 
rejected surgery [129, 134-139]. To cater to these patients, small incision surgical 
techniques and endoscopic methods were developed that have been quite successful. 
Recently with the introduction of transcatheter aortic valves, significant focus is on 
percutaneous mitral valve repair and valve-in-valve replacement.  Established mitral 
valve surgical techniques, e.g. neochordoplasty, Alfieri stitch procedure etc, are now 
being adapted into transcatheter versions for use in these high risk patients. The Alfieri 
stitch or the edge-to-edge repair is one of the first mitral valve repair techniques to be 
adapted into a percutaneous delivery version, and is now commercially marketed (E-
valve, Abbott Laboratories, Boston, MA). Though appealing for its minimally invasive 
nature, these techniques have demonstrated sub-optimal results in clinical trials due to 
several reasons. The primary reason for failure is that all mitral valve lesions are multi-
dimensional problems, which require repair of the annulus, the leaflets, and sometimes 




repairs, and is expected to stabilize the repair and restrict any post-operative annular 
dilatation and recurrent regurgitation. However, a major drawback of percutaneous mitral 
valve techniques (leaflet or chordal repair technologies) is that concomitant mitral 
annuloplasty cannot be performed. Thus, several patients have mild to moderate 
regurgitation acutely after a percutaneous repair, which gets worse in the long term. 
Maisano et al. reported sub optimal results in their midterm follow up studies on surgical 
edge-to-edge repair without annuloplasty [98]. 23% of the patients who underwent edge-
to-edge repair for degenerative valve disease had moderate to severe regurgitation within 
3.7 years after surgery, and often the associated risk factor was annular calcification or 
other annular complications. These results clearly indicate that in the absence of an 
annular ring, mitral valve repair is inadequate and regurgitation recurs in most patients. 
However, the mechanism for failure of the edge-to-edge repair with annular 
complications is currently unknown, and is still speculative.  
 The objective of the current study was to understand the impact of mitral annular 
dilatation on the hemodynamic outcomes of edge-to-edge repair, and delineate the 
mechanisms for recurrent of regurgitation. Results from this study demonstrate that at 
normal annular size, edge-to-edge procedure effectively repairs isolated posterior leaflet 
prolapse and reduces regurgitation to trace levels. However, with minimal annular 
dilatation of 15% or 30%, significant regurgitation recurred even though no visible 
damage at the region of the edge-to-edge stitch was observed. These data confirm the 
clinical observations reported by Maisano et al, who demonstrated that annular lesions 




 To understand the mechanisms relevant to (repair) failure, in this study the leaflet 
coaptation lengths at the central A2-P2 cusps, and the commissural A1-P1 and A3-P3 
cusps were measured. With increasing annular dilatation, coaptation significantly 
decreased at the central and commissural cusps. At the A2-P2 cusps, leaflet coaptation of 
at least 5mm was always measured because the edge-to-edge stitch was placed at that 
distance above the leaflet free edge. During systole, the stitch ensured that the leaflet 
length below the stitch was coapting and thus a minimum coaptation was always 
measured. Most, clinical studies reported to date on this procedure measured this central 
coaptation length below the stitch and confirmed that good coaptation is preserved even 
with annular dilatation. These data are misleading for the aforementioned reasons, and do 
not explain the recurrence of mitral regurgitation with annular dilatation. Interestingly, in 
this study we found that commissural cusps typically have higher loss of coaptation due 
to annular dilatation after edge-to-edge repair. It can be speculated that with posterior 
displacement of the mitral annulus with annular dilatation, the edge-to-edge stitch tethers 
the commissural chordae, thus resulting in abnormal leaflet kinematics and regurgitant 
crevices in the coaptation line. The mechanisms described here are schematically 
depicted in Figure 7-16. 
7.2.16 CLINICAL IMPLICATIONS 
These data reveal that edge-to-edge repair though useful in few patient groups, 
may not be the most appropriate technique in patients with concomitant annular or sub 
annular lesions other than leaflet prolapse. Specifically, in valves without leaflet 




thus judicious patient selection is important. With advancements in percutaneous 
technologies, it may be useful to use concomitant annuloplasty techniques to perform 
annular stabilization while performing the edge-to-edge repair. 
7.2.17 LIMITATIONS 
The foremost limitation of this work is that the studies were conducted on normal 
mitral valves induced with leaflet prolapse due to chordal rupture. Leaflet billowing was 
not simulated in these studies, thus limiting the applicability of these results to non-
distended fibro elastic deficient valves. Secondly, only one central stitch was studied in 
this thesis, but clinical practice involves placing multiple stitches laterally along the 
coaptation zone until regurgitation is significantly reduced. But if multiple stitches 
created valve stenosis, and if it is clinically advisable to relieve regurgitation but create 
stenosis needs to be investigated.  
7.2.18 SUMMARY 
In summary, this study demonstrates that leaflet techniques such as edge-to-edge 
repair may be effective in eliminating regurgitation only in the absence of other annular, 
sub annular or chordal lesions. Often patients presenting with mitral valve prolapse have 
a variety of lesions, and just placing a clip across the two prolapsing leaflets may not be 

























Figure 7-16 (Top) Schematic depicting the stitch placement method, with the red arrows 
depicting the commissural force tethering on the stitch with annular dilatation; (Below) A
cross sectional view of the valve depicting the minimum coaptation length observed even
with annular dilatation. Since the edge-to-edge stitch is placed 5mm above the free edge, 





7.2.19 ANNULOPLASTY RING SELECTION – IMPLICATIONS OF FLAT VS. 
SADDLE SHAPED RINGS ON POSTERIOR LEAFLET MECHANICS 
Mitral annular motion and geometric changes have been of immense interest to 
cardiologists and cardiac surgeons, and repair strategies today are increasingly focusing 
on restoring the physiological shape of the mitral annulus. The seminal study by Levine 
et al. [140] has triggered great enthusiasm towards characterizing the mitral annular 
dynamics, which was subsequently accomplished in animal models and human subjects 
[17, 141]. However, clinical relevance of this knowledge has not been realized due to the 
lack of insights into the role of mitral annular saddle on valve function and mechanics. In 
the past 5 years, few studies have reported a potential impact of mitral annular saddle on 
leaflet curvature and mechanical strains on the anterior leaflet [50, 117, 142]. These 
studies laid the foundation on the importance of mitral annular saddle, and in this thesis 
these studies are extended to the posterior mitral leaflet, which is often the leaflet that is 
surgically repaired.  
Data from this study demonstrate an inverse correlation between the degree of 
non-planarity of the mitral annulus and the systolic mechanical strain on the P2 segment 
of the posterior mitral leaflet. As the mitral annular non-planarity increased from 0%  
10%  20% AHCWR, the peak areal strains reduced significantly. In comparison to the 
flat annulus (0% AHCWR), a 19.2% and 44.1% reduction in the peak areal strains were 
measured at 10% and 20% AHCWR, respectively. A similar trend was measured both in 
the circumferential and radial directions. In the radial direction (from annulus to free 
edge), the peak strains reduced from the flat annulus by 5.5% with a 10% AHCWR and 




parallel to the annulus) a reduction of 20.5% with 10% saddle and 34% with 20% saddle 
was measured.  
The results from this study demonstrate that the saddle shaped mitral annulus 
provides a mechanical benefit to the valve through a reduction in the leaflet strains. We 
speculate that the saddle shape of the annulus during systole optimizes force distribution 
among various mitral valve components, resulting in a minimal energy conformation of 
the valve. In a previous study from our group, Jimenez et.al, reported that mitral annular 
saddle optimizes chordal force balance by redistributing the forces between the anterior 
and posterior leaflets, compared to a flat annulus in which the forces are concentrated on 
the anterior leaflet [50]. The forces in the commissural chordae reduced by 35% from a 
flat to 20% saddle annulus, that may have imparted better leaflet motion and curvature 
during systole. Results from ongoing experiments in our laboratory demonstrate better 
systolic leaflet coaptation at the P1, P2 and P3 segments with improved leaflet curvature 
during peak systolic closure. This was also demonstrated in animal studies by Jensen et 
al. (Abstract # 14824 presented at AHA Scientific Sessions 2007: Jensen et al: ‘Saddle-
shaped Mitral Valve Annuloplasty Rings Improve Leaflet Coaptation Geometry). The 
temporal changes in the systolic strains on the P2 segment as recorded in this study, show 
a distinct difference in the total time of leaflet deformation (time taken by the leaflet to 
deform back to the reference state) between the three annular shapes. These results lead 
us to speculate that the increase in mitral leaflet curvature is a visible endpoint of the 






7.2.20 CLINICAL IMPLICATIONS 
While the complete story of the mitral annular saddle is yet to be explained, the 
results from this study have important implications towards current practices in mitral 
valve reparative therapies. Typically all degenerative mitral valve repairs involve 
resection of leaflet tissue, and use of sutures to reconstruct the diseased leaflet. The 
results from this study indicate that restoring the physiological saddle shape or restoring 
native mitral valve annular dynamics after the repair may reduce the forces on the suture 
lines and avoid suture dehiscence or tissue tearing in these regions. However, it should be 
noted that tissue tearing and suture dehiscence can also happen when excessive resection 
is utilized on fibroelastic deficient valves with only acute chordal rupture and no leaflet 
distension. Additionally, the spatial heterogeneity in the leaflet ultra-structure and the 
differences in the composition of the tissue may play an important role in suture 
dehiscence and thus the physiological and pathological characteristics of valve leaflets 
should be better understood.   
From a biological perspective, reducing the leaflet strains may also decelerate the 
biological progression of leaflet degeneration after mitral valve surgery. Pedersen et.al 
recently reported that in canine mitral valves, strain magnitude correlated with over 
expression of endothelin-1 receptors, which are the key drivers of valve degeneration 
[92]. Hence, if surgically restoring the saddle shape of the mitral annulus has the ability 
to reduce leaflet strains; it may potentially inhibit valve degeneration. However, at this 
time we are unable to comment more on this topic due to lack of human data that 





Although the in-vitro model adopted in this study simulates the physiological 
function, hemodynamics and mechanics of the normal mitral valve, it has some inherent 
limitations. Firstly, the mitral annulus has a dynamic sphincteric action that changes from 
a flat annulus during diastole to a saddle annulus during systole. In this study we adopt a 
static saddle annulus that simulates only the systolic position, which however does not 
impact the outcomes of this study as our focus is only on the systolic leaflet strains. 
Secondly, the mitral annulus also has an apical-basal motion, which was not simulated in 
this model. However, in a previous study from our group, we already demonstrated that 
such apical-basal motion does not impact the function and mechanics of the valve [48]. 
Finally, the rigid ventricular chamber used in this study does not mimic the ventricular 
motion, whose effects on mitral valve function are not studied.  
7.2.22 SUMMARY 
In conclusion, this study demonstrates that the non-planar saddle shape of the 
mitral annulus reduces mechanical strains on the clinically important P2 segment of the 
posterior mitral leaflet. Current strategies for mitral valve repair should acknowledge 
these native valve biomechanics, as it may have a potentially important role in increasing 





7.3 MITRAL VALVE REPAIR FOR FUNCTIONAL MITRAL 
REGURGITATION 
7.3.1 IMPACT OF 3D ANNULAR AND SUB-ANNULAR VALVE GEOMETRY 
ON THE HEMODYNAMIC EFFICACY OF MITRAL ANNULOPLASTY 
This study provides mechanistic insight into the failure of mitral annuloplasty in 
alleviating IMR based on the left ventricular and sub-annular mitral geometry. Three-
dimensional location of the papillary muscles is emphasized as an influential component 
of mitral valve repair efficacy. Specific 3-dimensional geometric alterations to the mitral 
valve due to the differences in the size and directionality of ventricular dilatation were 
modeled in the in-vitro flow simulator.  These data were examined to determine which 
specific distortions render the valve incompetent following annuloplasty, offering an 
assessment tool as to the benefit of mitral annuloplasty for an individual patient. 
Hemodynamic results from this study indicate that mitral annuloplasty reduces 
IMR effectively in the setting of apical papillary muscle displacement than apical-
posterior-lateral papillary muscle displacement. In patients with apical ventricular 
dilatation due to non-ischemic dilated cardiomyopathy, apically directed forces on the 
anterior leaflet tether primarily the A2 and P2 cusps of the mitral leaflets. Their tension 
restricts the degree of anterior and posterior leaflet mobility during systole, thus 
decreasing the mitral valve coaptation. As the annulus dilates in addition to papillary 
muscle displacement, the mitral leaflets move further away from each other and with 
restricted leaflet mobility are unable to coapt. Decrease in the leaflet coaptation length 




optimal valve closure. True sized annuloplasty reduced the septal-lateral dimension and 
increased the leaflet area available for coaptation, and as a result the coaptation length 
was higher and tenting area was reduced, but not comparable to the control groups. 
However, since no sub-valvular procedures were performed on the valve there was 
persistent leaflet tethering even after annuloplasty, which manifests as remnant 
regurgitation in these valves after annuloplasty.  
In the case of apical- posterior-lateral papillary muscle displacement due to 
ischemic dilated cardiomyopathy, MR was severe and annuloplasty left moderate to 
severe MR in these valves. While the influence of annular dilation is observed to remain 
comparably the same as that seen in the apically displaced PMs, the chordal tethering 
forces resulting from the combination of ventricular dilation directionality are distributed 
over a greater portion of the mitral leaflets. Unlike the apical displacement, significant 
tethering was measured at the central cusps (A2-P2) and the commissural cusps (A1-P1; 
A3-P3) as well. The commissural cusps are smaller in height and area compared to the 
central cusps, and have lesser leaflet area available for coaptation. Since annuloplasty 
restores physiological dimensions only along the septal-lateral dimension, MR still 
persists through the commissural cusps of the mitral valve.  
  In summary, this study demonstrates that sub-valvular geometry of the mitral 
valve has a significant impact on the outcomes of mitral annuloplasty in alleviating 
ischemic mitral regurgitation. This study emphasizes the need for a thorough clinical 
assessment of the patient’s valve geometry to define the underlying mechanisms of 




echocardiographic imaging techniques and a better understanding of valve anatomy and 
function should improve surgical decision making and the choice of appropriate repair 
strategies for a given patient, improving the overall outcomes.  
7.3.2 IMPACT OF 3D VALVE GEOMETRY ON SECONDARY CHORDAL 
CUTTING 
Secondary chordal cutting is a surgical procedure that is believed to have the 
potential to relieve sub-valvular tethering in patients with functional mitral regurgitation 
(FMR), when used concomitantly with mitral annuloplasty. Current literature on the 
efficacy of this technique report conflicting outcomes, with Levine et al, championing it, 
and Miller et al, challenging the procedure. Though data from both the groups provides 
interesting evidence the reasons for contradictory outcomes still remain elusive. In this 
study we hypothesize that the variability in the 3D geometry of the mitral valve between 
patients with FMR, could determine the potential success of secondary chordal cutting. 
Specifically, we sought to investigate if the differences in the systolic coaptation 
geometry of the mitral valve, due to variations in the direction of papillary muscle 
displacement within the ventricle, would impact the success of secondary chordal cutting 
in reducing FMR.  
This study was performed in an in-vitro left heart simulator, wherein the geometry 
of the mitral annulus and the spatial position of the papillary muscles can be precisely 
altered. Consequently, variations of cardiomyopathic etiologies can be simulated on the 
mitral valve, e.g. symmetric dilatation of LV in non-ischemic dilated cardiomyopathy or 




in-vitro model is unique in that it allows precise and reproducible papillary alterations 
which would be difficult to reliably simulate in a large animal model. Additionally 
control over the size of the mitral valves, hemodynamic conditions, heart rate and ability 
to reject valves with abnormal anatomies allows for a very well-designed and well-
controlled experiment, often difficult to achieve with animal or human studies. Finally, in 
the in-vitro system the regurgitation volume, 3D echocardiographs and videoscopic 
images of the valve can be simultaneously obtained and the results can be used to provide 
mechanistic insights.  
 Results from this study support two main findings: (a) undersizing the mitral 
annulus does not eliminate FMR in valves with significant sub-annular tethering; and (b) 
sub-annular geometry, i.e. extent of leaflet tethering and position of papillary muscles, 
impact the success of sub-valvular repair techniques. Clinical literature already shows 
that mitral annuloplasty has limited success in patients with dilated ventricles, whether 
the ring is rigid, semi-rigid or flexible. This study corroborates those clinical findings, 
and the results clearly show persistent MR even after true-undersizing of the mitral 
annulus. Though reduction in FMR was observed after annuloplasty, the remnant leakage 
volume was significant. Extensive leaflet tethering persisted after annuloplasty, and 
reduction along the septal-lateral length did not enhance leaflet mobility or enable better 
leaflet coaptation. Failure mechanisms of annuloplasty in this model of FMR can be 
explained in two ways – firstly, tethering of the anterior leaflet that is not relieved by 
annuloplasty and thus this procedure should not have any impact on the anterior leaflet 
mobility or curvature. Secondly, the posterior annulus is moved anteriorly to achieve 




the posterior leaflet moves anteriorly, the distance between the leaflet and the papillary 
muscle tip (on the outwardly dilating free wall) increases and restricts leaflet motion. 
Thus, annuloplasty could be morphing a bi-leaflet valve into a uni-leaflet valve and 
potentially causing mitral stenosis. By the same principles, correction of commissural jets 
(Carpentier Classification Type IIIB) due to asymmetric papillary muscle tethering may 
be even more complex. 
 Secondary chordal cutting is an appealing surgical procedure due to its procedural 
simplicity and its potential as a percutaneous approach. Theoretically, severing the two 
strut chordae on the anterior leaflet would significantly relieve anterior leaflet tethering 
and improve valve competence. However, the results from this study demonstrate that 
reduction in FMR and improved valve coaptation depend largely upon the 3-dimensional 
geometry of the valve, i.e. the spatial location of the papillary muscles in the ventricle. 
When the papillary muscles were displaced apically (only), chordal cutting with 
concomitant annuloplasty eliminated FMR by achieving a physiological coaptation 
length and tenting area. Whereas when the papillary muscles were displaced apically-
posteriorly-laterally, chordal cutting did not reduce the FMR volume or tenting area and 
the hemodynamic function of the valve did not improve compared to annuloplasty alone. 
This discrepancy in outcomes could be elucidated by focusing on the anatomy of the 
chordae tendineae in relationship to papillary muscle positions. Figure 7-17 demonstrates 
the chordal geometry of a porcine mitral valve, wherein the thick strut chordae inserts 
into the middle of the anterior leaflet and a web of marginal chordae branch out of the 
strut chord and insert at the rough free edge. When the papillary muscles are moved 




leaflet locally at the strut chordal insertion points without a large increase in force on the 
marginal chordae [49]. Thus the anterior leaflet though tethered locally, still allows the 
section of the leaflet between the two strut chordae to move during systole (Figure 
7-17D). Cutting the two strut chordae in this case can relieve the local tethering at their 
insertion points and thus restore physiological levels of leaflet coaptation. On the 
contrary when the papillary muscles were displaced apically-posteriorly-laterally, the 
entire section of the anterior leaflet between the two strut chordae is tethered and 
stiffened. The tethering is spread out over this entire region [143], with an equal increase 
in tethering forces among the strut and marginal chordae. Thus cutting the two strut 
chordae does relieve the tethering partially, but does not restore physiological mobility or 
coaptation, as seen in the in vitro study.  
7.3.3 CLINICAL IMPLICATIONS 
 The clinical implications of this study towards improving diagnosis of FMR and 
in appropriate patient selection for secondary chordal cutting are outlined below. Tenting 
area, leaflet mobility and leaflet coaptation length are three echocardiographic indices 
that can be used to predict the outcome of mitral annuloplasty and sub-valvular repair in 
cardiomyopathy patients. A recent paper on the initial clinical experience of secondary 
chordal cutting showed improved patient outcomes; however, the authors report that 6-8 
chordae were severed until complete valve competence was obtained [144]. Even though 
surgically this procedure may be appealing, it is worth taking pause considering the 
abnormal load distribution on the mitral valve that severing several chordae may impose. 




forces are evenly distributed among the chordae tendineae, and thus severing some 
chordae may impose non-physiological loads on the marginal chordae resulting in their 
subsequent rupture and potentially leading to leaflet prolapse. Thus, further studies are 
required to quantify the alterations in valve mechanics after chordal cutting before 
translation of this technique to clinical use. 
7.3.4 LIMITATIONS 
 The in-vitro nature of this work, poses inherent limitations in the direct 
application of these results to clinical practice. To achieve precise control over the mitral 
valve geometry and hemodynamic conditions, the atrium and ventricles were designed to 
be rigid and thus the physiological or pathological ventricular geometries were not 
simulated in this study. However, it is worth noting that the extent of papillary muscle 
displacement and the directions of displacement were based on animal and human 
literature, and thus represent the FMR lesion in humans. A custom annuloplasty ring 
made of titanium wire and silicone was used in this study which does not represent any 
specific commercially available annuloplasty ring, but at the same time allows unbiased 
understanding of the failure mechanisms of annuloplasty in FMR lesions. Finally, due to 
the unavailability of normal human mitral valves, porcine mitral valves were used in this 
study, which represent the human mitral valve anatomy very well[63].  
7.3.5 SUMMARY 
In summary this study demonstrates the need for careful assessment of the pre-
operative mitral valve geometry and relating the structure to the valve function. Such 




geometric perturbations of the mitral valve, and improve chronic outcomes of mitral 
















Figure 7-17 (A) Chordal distribution in a normal porcine mitral valve; (B)
Localized tethering at the strut chordal insertion region due to apical displacement
of the papillary muscles; (C) Increased tethering of both the base of the leaflet and
the free edge due to apical, posterior and lateral displacement of the papillary
muscles; (D) Short axis view of the anterior and posterior leaflet free edges after
apical papillary muscle displacement, depicting minimal tethering of the free
edge; (E) Significant tethering of the free edge with additional lateral and
posterior displacement of the papillary muscles that would restrict free edge






CHAPTER 8  
 
TRANSLATIONAL IMPACT OF CURRENT WORK 
 The clinical relevance of the work presented in this thesis is significant, for both 
the cardiac surgical community and medical device industry.  In relevance to congenital 
mitral valve repair, this study clearly demonstrates that the growth of cardiac structures 
with age renders the mitral valve repair insufficient in the long term. Thus, cardiac 
surgeons should emphasize on this aspect and seek to develop repair techniques that 
evolve with the changing cardiac size, or adopt biodegradable technologies that can 
control the relative rate of growth between the valve and the annulus. One such type of 
technology that is currently being considered for clinical trials in the United States of 
America is the Kalangos® biodegradable ring for pediatric valve repair. Adjustable 
annuloplasty ring systems such as the St Jude Medical Attune® annuloplasty ring, and 
the Mitral Solutions® adjustable ring system may be relevant in these patients. 
The data from this study also emphasizes the etiological classification of 
degenerative mitral valve lesions, and the importance of tailoring surgical techniques to 
the individual valve pathology. Focus should shift from using severity of regurgitation as 
the only diagnostic endpoint for referral to surgery, and move towards a thorough 




indices that isolate the regions of mitral valve prolapse, methods to correlate the regions 
of regurgitation with the leaflet kinematics, and planning the optimal surgical technique 
to correct the exact lesion are required. This thesis provides the hemodynamic and the 
biomechanics information for each surgical repair, which could be translated to clinical 
decision making. Additionally, the biomechanics information available from this study 
may be useful in optimizing annuloplasty ring shape or to develop medical device 
technologies that are more physiologically appropriate. 
Functional mitral regurgitation remains a clinical challenge with sub optimal 
results in the current era of “modern” cardiac surgery. The most important message of the 
last specific aim of this thesis is that the pre operative geometry of the mitral valve is the 
key determinant of acute and chronic surgical outcomes. A proper analysis of the mitral 
valve geometry, which includes: relative position of the papillary muscles from the mitral 
annular plane and the tips of the valve leaflets; leaflet kinematics including the motion of 
the leaflet tips throughout the cardiac cycle; and the overall shape of the leaflets with 
respect to papillary muscle tip position, is extremely important before attempting surgical 
correction. Though several annular and sub annular surgical techniques exist in the 
cardiac surgeons armamentarium, the focus needs to shift from a “one shoe fits all” mitral 














CHAPTER 9  
 
CONCLUSIONS 
• Morphological, hemodynamic and procedural factors contribute to poor durability 
of mitral repair, and a sequential investigation into the impact of each of these 
factors on the repair is important. This thesis for the first time provides insights 
into the mechanisms leading to failure of current mitral valve repair strategies, 
and clearly demonstrates the impact of clinical risk factors on the long term 
outcomes of repair. 
• Congenital mitral valve repair should consider the growth of cardiac structure in 
the post operative period, and thus strategies to either control the growth to 
desirable levels should be considered, or novel materials or repair techniques that 
can adapt and still maintain valve competence need to be developed. These 
concepts also pave the path for replaceable heart valve repair devices that can be 
adjusted or replaced percutaneously. 
• Degenerative mitral valve repair should primarily focus on etiologic classification 
of the valve lesions, calling for a larger role for the cardiologist to play from 
diagnosis till surgical decision making. Based on the data from this thesis, a 




identify the underlying causes of prolapse and choose the most appropriate 
surgical repair technique. 
• Functional mitral regurgitation manifests with a variety of pathologies and extent 
of severity in individual patients, and a careful assessment of the pre operative 
valve geometry may be crucial to develop a surgical strategy that is most optimal 
for complete elimination of regurgitation in that patient and ensure durable 
results. A paradigm shift from “one shoe fits all” approach towards an 

































CHAPTER 10  
 
FUTURE DIRECTIONS AND RECOMMENDATIONS 
10.1 DYNAMIC LEFT HEART SIMULATOR 
Future pulsatile models for the left heart simulator should shift from the current 
static mitral annulus and papillary muscle model towards mimicking the dynamic annular 
and sub annular components. Mitral valve geometry and function is largely governed by 
the transfer of forces between its different components. Thus, an in vitro model that 
allows for a physiological force balance between its various components under given 
hemodynamic boundary conditions is necessary.  
10.2 IN VITRO ACUTE STUDIES –TO- IN VIVO CHRONIC STUDIES 
To translate the knowledge from well controlled bench top experimental models 
to clinical use, there is a need to translate the acute findings from the in vitro model to 
chronic durability studies in in vivo chronic disease models. Ingenious methods to 
develop pathological animal models are necessary, with significant emphasis on 







10.3 SURGEON ON A CHIP APPROACH 
 
A paradigm shift from a generic mitral valve repair towards an individualized 
repair approach is becoming a reality with the advancements in biomedical imaging 
techniques. Utilizing latest technologies, a virtual geometric modeling approach to pre 
plan the valve surgery and tailor it to the individual patient is necessary. As depicted in 
Figure 10-1, the focus should shift from a cardiac surgeon driven operating room towards 
a multi disciplinary team of engineers and clinicians.  
 
 


































Table A1.1 – Hemodynamic data for  normal and pathological papillary muscle positions 
      NORMAL         PM 
DISP 
    
Expt Date 140 120 100 80 60 140 120 100 80 60 
2/1/07           
MR 36.5 32.9 28.3 24.4 19.6 36.5 35.4 29.9 25.6 19.6 
SV 20.8 20.9 21 21.1 20.7 20.5 20.2 21.6 19.8 20.5 
Absolute 8.2 4.6 0 0 0 8.2 7.1 1.6 0 0 
Fraction 28.3 18.0 0 0 0 28.6 26.0 6.9 0 0 
2/8/07           
MR 37.7 32.5 28.3 23.6 18.3 35.9 33 27.8 22.5 17.6 
SV 20.4 20.6 20.3 20.4 20.4 20.4 20.4 19.9 20.9 20.1 
Absolute 9.4 4.2 0 0 0 7.6 4.7 0 0 0 
Fraction 31.54 16.935 0 0 0 27.14 18.73 0 0 0 
2/13/07           
 MR 33.7 24.4 20.8 18.8 16.5 34.6 21.8 18.7 17 15.7 
SV 20.9 20.9 20.9 20.9 20.9 22.4 22.5 20.3 20.4 20.6 
Absolute 12.9 3.6 0 0 0 13.8 1 0 0 0 
Fraction 38.17 14.694 0 0 0 38.12 4.25 0 0 0 
2/26/2007           
MR 35.5 26.5 24.7 20.5 18.3 34.9 29.3 23.3 20.2 18.8 
SV 20.9 20.9 20.9 20.9 20.9 22.4 22.5 20.3 20.4 20.6 
Absolute 10.8 1.8 0 0 0 10.2 4.6 0 0 0 
Fraction 34.07 7.9295 0 0 0 31.29 16.97 0 0 0 
3/4/2007           
MR 25.5 20.3 18.1 15.2 14 31.7 24.3 19.6 17.9 15.9 
SV 20.6 20.3 21 21.2 20.9 20.1 21 20.9 21 19.9 
Absolute 7.4 2.2 0 0 0 13.6 6.2 1.5 0 0 
Fraction 26.43 9.7778 0 0 0 40.36 22.79 6.7 0 0 
3/26/2007           
MR 41.2 32.3 27.8 22.6 20.1 36.4 30 26.3 21.9 19.7 
SV 21.5 21.7 20.3 20.9 20.1 22.1 19.8 21.3 19.5 20.7 
Absolute 13.4 4.5 0 0 0 8.6 2.2 0 0 0 
Fraction 38.4 17.176 0 0 0 28.01 10 0 0 0 
3/28/2007           
MR 31.5 26.2 22.2 19.4 18.5 30.9 26.1 23.4 20.4 18.8 
SV 20.7 20.2 20.2 20 20.2 20.3 21.4 20.3 19.4 21 
Absolute 9.3 4 0 0 0 8.7 3.9 1.2 0 0 
Fraction 31 16.529 0 0 0 30 15.42 5.58 0 0 




      NORMAL         PM 
DISP 
    
Expt Date 140 120 100 80 60 140 120 100 80 60 
3/26/2007           
MR 36.5 33.2 29.8 23.7 20.8 36.3 33.3 31 28.9 27.3 
SV 20.3 21.9 21.1 19.6 20.3 19.9 20.1 21.4 21.1 20.5 
Absolute 6.7 3.4 0 0 0 6.5 3.5 1.2 0 0 
Fraction 24.81 13.439 0 0 0 24.62 14.83 5.31 0 0 
3/26/2007           
MR 22.6 18.5 15.1 13 12.6 22.4 20 16.5 16.2 15.4 
SV 20.3 20 20.4 21.2 20.7 20.9 20.1 21.1 21 20.5 
Absolute 7.5 3.4 0 0 0 7.3 4.9 1.4 1.1 0.3 
Fraction 26.98 14.53 0 0 0 25.89 19.6 6.22 4.98 1.44 
    
Mean 33.41 27.422 23.9 20.13 17.63 33.29 28.13 24.1 21.2 18.76
St Dev 5.97 5.64 5.14 3.98 2.771 4.569 5.398 5.1 4.12 3.61 
Absolute  9.51 3.52 0 0 0 9.39 4.23 0.77 0.12 0.03 
Std Dev 2.41 0.9718 0 0 0 2.652 1.875 0.74 0.37 0.1 
 
Table A1.2 – Hemodynamic data for a completely open cleft using the trifoliate concept 
     FULL 
CLEFT 
    
 140 120 100 80 60 
2/1/07      
MR 46.3 44.1 42.7 41.6 41 
SV 20 20.5 21.4 21.6 21 
Absolute 18 15.8 14.4 13.3 12 
Fraction 47.368 43.5 40.223 38.1089 37 
2/8/07      
MR 40.6 38.8 37.7 36.8 34 
SV 19.6 20 20 20.2 20 
Absolute 12.3 10.5 9.4 8.5 6 
Fraction 38.558 34.4 31.973 29.6167 23 
2/13/07      
 MR 47.4 44.6 42.4 41.8 40 
SV 26.7 18.7 20.1 19.9 20 
Absolute 26.6 23.8 21.6 21 19 
Fraction 49.906 56 51.799 51.3447 49 
2/26/2007      
MR 37 36.6 35.6 35.2 35 
SV 20.1 18.7 20.1 19.9 20 
Absolute 12.3 11.9 10.9 10.5 10 




     FULL 
CLEFT
    
 140 120 100 80 60 
3/4/2007      
MR 32.6 32.1 31.6 31 30 
SV 19.9 19.5 20.2 20.3 20 
Absolute 14.5 14 13.5 12.9 12 
Fraction 42.151 41.8 40.059 38.8554 38 
3/26/2007      
MR 38 39 37.4 37.3 37 
SV 22.5 20.3 20.5 20.6 20 
Absolute 10.2 11.2 9.6 9.5 8.7 
Fraction 31.193 35.6 31.894 31.5615 30 
3/28/2007      
MR 38.8 38.5 38.2 35.8 36 
SV 20.5 20.5 21.1 21.1 22 
Absolute 16.6 16.3 16 13.6 14 
Fraction 44.744 44.3 43.127 39.1931 39 
3/26/2007      
MR 37.2 36.3 33.4 32.7 33 
SV 21.7 21.1 21.4 21.9 21 
Absolute 7.4 6.5 3.6 2.9 3.2 
Fraction 25.43 23.6 14.4 11.6935 13 
3/26/2007      
MR 29.9 28.5 26.4 20.4 18 
SV 20.9 20.7 20.1 19.5 19 
Absolute 14.8 13.4 11.3 5.3 2.4 
Fraction 41.457 39.3 35.987 21.371 11 
      
Mean 38.644 37.6 36.156 34.7333 34 
St Dev 5.6714 5.14 5.1692 6.45 6.8 
Absolute  14.744 13.7 12.256 10.8333 9.8 
Std Dev 5.4909 4.81 5.0045 5.27091 5.4 




Table A1.3 Hemodynamic Data for Different Cleft Closure Lengths 
     1/3 
SUTURE
        2/3 
SUTURE
        3/3 
SUTURE
    
 140 120 100 80 60 140 120 100 80 60 140 120 100 80 60 
2/1/07                
MR 44.8 44.2 42.4 37.3 30.8 40.8 39.8 34.4 27.7 21.3 34.1 32.9 29.4 24.1 18.4
SV 20.4 19 20.9 21.9 20.6 19.6 21 21.5 20.2 19.8 21.1 21 21.1 20 20.5
Absolute 16.5 15.9 14.1 9 2.5 12.5 11.5 6.1 0 0 5.8 4.6 1.1 0 0 
Fraction 44.7 45.56 40.29 29.1 10.8 38.9 35.38 22.101 0 0 21.6 17.97 4.95 0 0 
2/8/07                
MR 38.5 37.4 35.2 34 26.8 38.1 35.7 29.8 24.7 19 37.2 34 28.8 23.2 17.9
SV 19.7 20.1 20.5 20.7 20.1 21.3 21 20.6 20.3 20.4 21.3 19.9 21.3 20.1 20.4
Absolute 10.2 9.1 6.9 5.7 0 9.8 7.4 1.5 0 0 8.9 5.7 0.5 0 0 
Fraction 34.1 31.16 25.18 21.6 0 31.5 26.06 6.7873 0 0 29.5 22.27 2.29 0 0 
2/13/07                
 MR 42.9 42.1 40.8 39.3 37.7 42.7 40.6 35.5 28.3 22.9 34.6 32.2 28.1 20.4 17.1
SV 21 20.4 19.4 20.9 21.4 21.1 21 21.4 20.2 19.6 21.2 20.3 20.9 20.4 20.5
Absolute 22.1 21.3 20 18.5 16.9 21.9 19.8 14.7 7.5 2.1 13.8 11.4 7.3 0 0 
Fraction 51.3 51.08 50.76 47 44.1 50.9 48.53 40.72 27.076 9.677 39.4 35.96 25.9 0 0 
2/26/2007                
MR 37.4 33.6 29.9 27.4 25.1 36.7 29.8 23.2 19.7 17.5 33 26.6 22.6 19.9 17.8
SV 20.2 19.4 21.8 20.5 20.5 21.1 20.7 21 20.9 22 23.8 21.7 20.6 20.7 20.6
Absolute 12.7 8.9 5.2 2.7 0.4 12 5.1 0 0 0 8.3 1.9 0 0 0 
Fraction 38.6 31.45 19.26 11.6 1.91 36.3 19.77 0 0 0 25.9 8.051 0 0 0 
3/4/2007                
MR 35 33.7 32.8 31.6 24.9 34 28.4 25.8 20.9 17.1 30.3 23.8 20 16.6 14.2
SV 19.5 20.7 21.2 21.3 20.1 20.8 19.2 20 19.4 22.2 21.8 19.8 19.7 20.5 19.7
Absolute 16.9 15.6 14.7 13.5 6.8 15.9 10.3 7.7 2.8 0 12.2 5.7 1.9 0 0 




     1/3 
SUTURE
        2/3 
SUTURE
        3/3 
SUTURE
    
 140 120 100 80 60 140 120 100 80 60 140 120 100 80 60 
3/26/2007                
MR 38.7 37.2 34.8 32.3 28.8 34.6 35.1 29 24.6 22.8 37.4 34.2 29.4 24.6 21.3 
SV 19.5 19.7 19.8 20.4 19.9 21.4 20.2 20.9 21.7 23 20.8 21.3 20.7 19.2 20 
Absolute 10.9 9.4 7 4.5 1 6.8 7.3 1.2 0 0 9.6 6.4 1.6 0 0 
Fraction 35.9 32.3 26.12 18.1 4.78 24.1 26.55 5.4299 0 0 31.6 23.1 7.17 0 0 
3/28/2007                
MR 38.8 36.2 34.3 33.1 32.5 35 32.4 32.1 29.8 26.5 32.6 24.8 21.5 19.6 18.5 
SV 21.6 20.4 20.7 21.4 21.1 19 20.3 20.8 21.6 21.5 20.9 20.8 22.1 22.5 23.1 
Absolute 16.6 14 12.1 10.9 10.3 12.8 10.2 9.9 7.6 4.3 10.4 2.6 0 0 0 
Fraction 43.5 40.7 36.89 33.7 32.8 40.3 33.44 32.248 26.027 16.67 33.2 11.11 0 0 0 
3/26/2007                
MR 36.2 33.6 31 30.7 29.8 32.2 31.2 30.5 30.4 29.7 32.4 30 30.2 28.3 26.9 
SV 20 21.3 20.4 20.7 21.1 21.3 21.1 20.9 21.2 19.7 20.7 21 20.8 21.3 20.2 
Absolute 6.4 3.8 1.2 0.9 0 2.4 1.4 0.7 0.6 0 2.6 0.2 0.4 0   
Fraction 24.2 15.14 5.556 4.17 0 10.1 6.222 3.2407 2.7523 0 11.2 0.943 1.89 0 0 
3/26/2007                
MR 29.5 26.2 23.5 19.5 17.2 23.8 18.6 15.9 13.9 12.9 22.6 17.7 15.1 13.7 12.6 
SV 19.4 19.7 20.7 21 20.3 20.3 20 21.2 21.2 21.3 21.4 21.5 20.1 20.2 19.5 
Absolute 14.4 11.1 8.4 4.4 2.1 8.7 3.5 0.8 0 0 7.5 2.6 0 0 0 
Fraction 42.6 36.04 28.87 17.3 9.38 30 14.89 3.6364 0 0 26 10.79 0 0 0 
                
Mean 38 36.02 33.86 31.7 28.2 35.3 32.4 28.467 24.444 21.08 32.7 28.47 25 21.2 18.3 
St Dev 4.42 5.253 5.66 5.76 5.72 5.47 6.66 6.0914 5.431 5.122 4.41 5.635 5.37 4.43 4.1 
Absolute  14.1 12.12 9.956 7.79 4.44 11.4 8.5 4.7333 2.0556 0.711 8.79 4.567 1.42 0 0 









































13-Feb 3.162 2.515 4.822 4.368 2.986 4.569 
26-Feb 2.282 2.148 2.406 3.606 3.967 2.025 
4-Mar 3.133 5.944 2.669 5.349 2.990 3.138 
26-Mar 3.074 3.451 1.533 1.532 2.980 3.638 
28-Mar 5.225 5.648 5.887 6.773 3.045 4.527 
Average 3.375 3.941 3.463 4.326 3.231 3.580 




Table A2.1 Hemodynamic and Echocardiographic Data for Posterior Leaflet Prolapse and Different Surgical Techniques to 
Repair Prolapse 





Regurgitation Volume 26.10 39.80 33.50 28.10 30.70 
Stroke Volume 70.50 71.90 71.00 71.10 71.40 
Regurgitation Fraction 37.02 55.35 47.18 39.52 43.00 
Absolute Fraction 0.00 18.33 10.16 2.50 5.98 
Leaflet Coaptation Length 13.00 0.00 13.00 10.10 8.00 
Tenting Height 9.00 0.00 10.00 12.00 7.00 
Coaptation from Anterior 
Annulus 19.00 0.00 22.00 21.00 25.50 
Coaptation from Posterior 
Annulus 18.00 0.00 16.00 15.00 11.00 
Anterior Angle 25.20 0.00 25.00 24.20 18.80 
Posterior Angle 24.80 0.00 34.60 35.80 37.30 





Regurgitation Volume 32.80 44.50 31.20 32.80 39.20 
Stroke Volume 81.40 81.90 80.20 72.80 77.40 
Regurgitation Fraction 40.29 54.33 38.90 45.05 50.65 
Absolute Fraction 0.00 14.04 0.00 4.76 10.35 
Leaflet Coaptation Length 13.00 0.00 14.00 9.00 8.00 
Tenting Height 12.00 0.00 13.00 12.00 14.00 
Coapt from Anterior Annulus 21.00 0.00 21.00 21.00 22.00 
Coapt from Posterior Annulus 14.00 0.00 16.00 14.00 12.00 
Anterior Angle 32.70 0.00 32.90 30.00 29.00 









Regurgitation Volume 25.90 58.40 29.00 25.70 30.10 
Stroke Volume 72.60 69.80 74.70 70.60 69.10 
Regurgitation Fraction 35.67 83.67 38.82 36.40 43.56 
Absolute Fraction 0.00 47.99 3.15 0.73 7.89 
Leaflet Coaptation Length 12.00 0.00 13.00 11.00 8.00 
Tenting Height 8.00 0.00 7.00 7.00 11.00 
Coaptation from Anterior 
Annulus 23.00 0.00 20.00 25.00 26.00 
Coaptation from Posterior 
Annulus 14.00 0.00 16.00 14.00 7.00 
Anterior Angle 25.70 0.00 22.30 18.30 20.00 
Posterior Angle 32.20 0.00 29.40 33.10 60.70 





Regurgitation Volume 31.50 36.60 24.60 24.10 28.90 
Stroke Volume 71.80 69.60 73.00 70.10 71.40 
Regurgitation Fraction 43.87 52.59 33.70 34.38 40.48 
Absolute Fraction 0.00 8.71 0.00 0.00 0.00 
Leaflet Coaptation Length 13.00 0.00 13.00 11.00 8.00 
Tenting Height 10.00 0.00 10.00 12.00 10.00 
Coaptation from Anterior 
Annulus 24.00 0.00 22.00 26.00 27.00 
Coaptation from Posterior 
Annulus 15.00 0.00 17.00 14.00 12.00 
Anterior Angle 32.80 0.00 29.80 24.90 25.30 









Regurgitation Volume 27.9 41.2 24.2 20.7 24.3 
Stroke Volume 71.4 72.2 72.1 73.2 74.4 
Regurgitation Fraction 39.07563025 57.06371191 33.56449376 28.27868852 32.66129032 
Absolute Fraction 0 17.98808166 0 0 0 
Leaflet Coaptation Length           
Tenting Height           
Coaptation from Anterior 
Annulus           
Coaptation from Posterior 
Annulus           
Anterior Angle           
Posterior Angle           





Regurgitation Volume 22.8 37.4 25 28.6 30.2 
Stroke Volume 72.9 73.6 71.6 72.1 74.2 
Regurgitation Fraction 31.27572016 50.81521739 34.91620112 39.66712899 40.70080863 
Absolute Fraction 0 19.53949723 3.640480953 8.391408823 9.425088461 
Leaflet Coaptation Length 10 0 11 9 6 
Tenting Height 9 0 9 10 14 
Coaptation from Anterior 
Annulus 20 0 17 20 21 
Coaptation from Posterior 
Annulus 12 0 15 11 10 
Anterior Angle 28.8 0 32.2 29 36.5 









Regurgitation Volume 28.9 37.4 34.3 32.7 28.3 
Stroke Volume 70.3 71.6 74.3 73.1 73.8 
Regurgitation Fraction 41.10953058 52.23463687 46.16419919 44.73324213 38.34688347 
Absolute Fraction 0 11.12510629 5.054668609 3.623711551 0 
Leaflet Coaptation Length 9 0 8 6 6 
Tenting Height 9 0 9 10 11 
Coaptation from Anterior 
Annulus 20 0 21 24 21 
Coaptation from Posterior 
Annulus 13 0 13 12 12 
Anterior Angle 27.6 0 26.3 32.5 36.1 
Posterior Angle 36.9 0 34.9 35.2 43.2 





Regurgitation Volume 23.9 35.6 25.2 24.5 25.3 
Stroke Volume 72.3 71.4 74.2 72.9 73.3 
Regurgitation Fraction 33.05670816 49.85994398 33.96226415 33.60768176 34.51568895 
Absolute Fraction 0 16.80323582 0.905555991 0.550973595 1.458980789 
Leaflet Coaptation Length 10 0 11 10 7 
Tenting Height 9 0 9 10 11 
Coaptation from Anterior 
Annulus 19 0 17 19 25 
Coaptation from Posterior 
Annulus 13 0 15 12 8 
Anterior Angle 34.3 0 30.8 33.9 26.7 












Regurgitation Volume 27.475 41.3625 28.375 27.15 29.625 
Stroke Volume 72.9 72.75 73.8875 71.9875 73.125 
Regurgitation Fraction 37.67256293 56.98956905 38.40169807 37.70565137 40.48801418 
Absolute Fraction 0 19.31700612 2.863693863 2.569257197 4.387034104 
St Error (Absolute Fraction) 0 4.306910005 1.247735448 1.03924914 1.592536404 
Leaflet Coaptation Length 11.43 0 11.85714286 9.442857143 7.285714286 
St Dev (Coaptation Length) 1.488047618 0 1.762708954 1.493198867 0.823754471 
Tenting Height 9.428571429 0 9.571428571 10.42857143 11.14285714 
St Dev (Tenting Height) 1.272418021 0 1.812653934 1.812653934 2.410295378 
Coaptation from Anterior 
Annulus 20.85714286 0 20 22.28571429 23.92857143 
St Dev (Coaptation from 
Anterior) 1.951800146 0 2.160246899 2.690370837 2.523697212 
Coaptation from Posterior 
Annulus 14.14285714 0 15.42857143 13.14285714 10.28571429 
St Dev (Coaptation from 
Posterior) 1.951800146 0 1.272418021 1.463850109 2.058663459 
Anterior Angle 29.58571429 0 28.47142857 27.54285714 27.48571429 
St Dev (Anterior Angle) 3.677602739 0 3.990703483 5.427355754 7.007478998 
Posterior Angle 33.57142857 0 34.25714286 37.41428571 51.15714286 




Table A2.2 Areal stretch at each marker on the chordal insertion region 
Time Marker 1 Marker 2 Marker 3 Marker 4 Marker 5 
0 1 1 1 1 1 
0.012 1.022690969 1.012026596 1.005461997 1.003604082 1.005541328 
0.024 1.048465522 1.026272234 1.012500427 1.007944172 1.011556006 
0.036 1.073835377 1.040351443 1.020377061 1.012972352 1.017826821 
0.048 1.094212767 1.050864064 1.027470936 1.018600908 1.024209621 
0.06 1.106593337 1.056087217 1.032494273 1.024549136 1.030479973 
0.072 1.110613121 1.057194056 1.035615422 1.030354444 1.03603727 
0.084 1.107909603 1.056700878 1.037997932 1.035914248 1.040422758 
0.096 1.102773599 1.056853608 1.040653868 1.041812287 1.044185863 
0.108 1.10220691 1.059266637 1.044010775 1.048770119 1.048707306 
0.12 1.112134865 1.06482843 1.048232953 1.057038308 1.055440486 
0.132 1.134948355 1.073951009 1.05358403 1.066469005 1.065650226 
0.144 1.170633454 1.086905862 1.0602132 1.076440052 1.079813882 
0.156 1.217224075 1.103387306 1.067567113 1.085569884 1.096679377 
0.168 1.269447705 1.121778619 1.074593889 1.092558893 1.113966658 
0.18 1.318395978 1.139543928 1.081069015 1.097519811 1.129814331 
0.192 1.3558006 1.154953873 1.088029376 1.101549688 1.142537905 
0.204 1.379741259 1.168270976 1.096245587 1.104800196 1.149784081 
0.216 1.394224406 1.180685682 1.104974707 1.105907709 1.149271327 
0.228 1.403865831 1.192449317 1.112627005 1.103623095 1.1407094 
0.24 1.413796743 1.20322926 1.118058488 1.097938829 1.126100407 
0.252 1.435251951 1.213836379 1.121003808 1.089605376 1.108054627 
0.264 1.478309816 1.225392334 1.121778098 1.080030015 1.089239574 
0.276 1.532719485 1.235902566 1.120497903 1.071430139 1.073207646 
0.288 1.576375332 1.239993977 1.116345709 1.06591233 1.064074099 
0.3 1.597824651 1.234067748 1.108154754 1.064190691 1.064599253 
0.312 1.599605503 1.220062603 1.096078012 1.065291503 1.074497913 
0.324 1.587759265 1.203809108 1.082482039 1.067488685 1.090793124 
0.336 1.566137777 1.191521892 1.071041458 1.069601101 1.109752903 
0.348 1.538295002 1.186847054 1.064547932 1.071504148 1.127954435 
0.36 1.507282746 1.188384812 1.063069956 1.073426413 1.141601523 
0.372 1.470404292 1.18915719 1.064114168 1.074744805 1.146099333 
0.384 1.417442711 1.179958684 1.064249367 1.073273981 1.137388015 
0.396 1.338853906 1.15489309 1.060338268 1.065858614 1.1141117 
0.408 1.2361894 1.115402048 1.050634791 1.050713008 1.079222714 
0.42 1.124748101 1.07105892 1.036682344 1.029935695 1.040061657 
0.432 1.027293722 1.035855196 1.023977097 1.009593383 1.006340469 




Time Marker 1 Marker 2 Marker 3 Marker 4 Marker 5 
0.456 0.926677429 1.013652074 1.018255187 0.993332311 0.980632624 
0.468 0.915399341 1.015119703 1.020952041 0.996967837 0.984844184 
0.48 0.919100769 1.019433611 1.02362939 1.003240402 0.99252183 
      
 
Time Marker 6 Marker 7 Marker 8 Marker 9 Marker 10 
0 1 1 1 1 1 
0.012 1.00591 1.01158 0.9991 1.00824 1.00643 
0.024 1.01227 1.0203 0.99719 1.01706 1.01314 
0.036 1.01889 1.02536 0.99487 1.02556 1.01953 
0.048 1.02552 1.027 0.99347 1.03267 1.02498 
0.06 1.03158 1.02635 0.99408 1.03778 1.02918 
0.072 1.03605 1.02552 0.99686 1.04103 1.03233 
0.084 1.03841 1.02777 1.00123 1.04329 1.03522 
0.096 1.03982 1.03613 1.00685 1.04613 1.03905 
0.108 1.04276 1.05099 1.01443 1.05139 1.04504 
0.12 1.04963 1.07039 1.02628 1.0605 1.05404 
0.132 1.06184 1.09203 1.04643 1.07436 1.06679 
0.144 1.07973 1.11459 1.07902 1.09342 1.08377 
0.156 1.10276 1.13846 1.12505 1.11709 1.10457 
0.168 1.13016 1.1658 1.18114 1.14368 1.12796 
0.18 1.16053 1.19826 1.24087 1.17075 1.1523 
0.192 1.19001 1.23522 1.29636 1.19556 1.17553 
0.204 1.21275 1.27518 1.34138 1.21602 1.19555 
0.216 1.22377 1.31541 1.37433 1.23107 1.21068 
0.228 1.22182 1.34959 1.39679 1.24018 1.21972 
0.24 1.20975 1.37227 1.4103 1.24393 1.2227 
0.252 1.19184 1.38278 1.41615 1.24482 1.22101 
0.264 1.17178 1.38139 1.41694 1.24561 1.21652 
0.276 1.15321 1.36815 1.41446 1.2462 1.21038 
0.288 1.14034 1.34719 1.40674 1.24462 1.20315 
0.3 1.13642 1.32683 1.39207 1.24052 1.19586 
0.312 1.14117 1.31307 1.37234 1.23526 1.18972 
0.324 1.15076 1.30483 1.35121 1.22989 1.18516 
0.336 1.16085 1.29572 1.33175 1.22455 1.18185 
0.348 1.1684 1.27812 1.31549 1.21889 1.17897 




Time Marker 6 Marker 7 Marker 8 Marker 9 Marker 10 
0.372 1.16773 1.196 1.28368 1.19899 1.16506 
0.384 1.1556 1.13757 1.2535 1.17737 1.14736 
0.396 1.13266 1.09601 1.2118 1.14682 1.12281 
0.408 1.10114 1.07959 1.1665 1.10992 1.09414 
0.42 1.06811 1.07183 1.12592 1.07104 1.06433 
0.432 1.04233 1.0693 1.09581 1.03881 1.04025 
0.444 1.02927 1.0688 1.08179 1.01993 1.02731 
0.456 1.02672 1.063 1.08739 1.01371 1.02459 
0.468 1.028 1.04713 1.10749 1.01449 1.02687 
0.48 1.02819 1.0216 1.13195 1.01746 1.02975 
 
Time Marker 11 Marker 12 Marker 13 Marker 14 Marker 15 
0 1 1 1 1 1 
0.012 1.00573 1.00577 1.00604 1.0061 1.00612 
0.024 1.01149 1.01137 1.0118 1.01183 1.01177 
0.036 1.01692 1.01649 1.01693 1.01682 1.01656 
0.048 1.02174 1.02102 1.02133 1.02097 1.0204 
0.06 1.02581 1.02498 1.02503 1.02435 1.02344 
0.072 1.02922 1.02842 1.02818 1.0272 1.0261 
0.084 1.03253 1.03185 1.03134 1.0302 1.02918 
0.096 1.03683 1.03635 1.03567 1.0346 1.03395 
0.108 1.04326 1.04317 1.04247 1.04169 1.04156 
0.12 1.0527 1.05325 1.05278 1.05245 1.0528 
0.132 1.06589 1.06743 1.06755 1.06779 1.06854 
0.144 1.08337 1.08627 1.0875 1.08846 1.08955 
0.156 1.10472 1.10936 1.11234 1.11429 1.11573 
0.168 1.12873 1.1355 1.14087 1.14423 1.14599 
0.18 1.15389 1.16299 1.17118 1.17635 1.17832 
0.192 1.1781 1.18936 1.20033 1.20756 1.20975 
0.204 1.19896 1.2118 1.22518 1.2346 1.23733 
0.216 1.21443 1.22811 1.24338 1.25515 1.25907 
0.228 1.22313 1.23695 1.25361 1.26772 1.27346 
0.24 1.22513 1.23851 1.25609 1.27233 1.28016 
0.252 1.22191 1.23452 1.25263 1.27071 1.28057 
0.264 1.21541 1.22711 1.2455 1.26503 1.27669 
0.276 1.20719 1.21803 1.23635 1.25675 1.26969 




Time Marker 11 Marker 12 Marker 13 Marker 14 Marker 15 
0.3 1.19108 1.20145 1.2186 1.23785 1.25053 
0.312 1.18593 1.19716 1.21364 1.23104 1.24227 
0.324 1.18283 1.19537 1.21135 1.22642 1.23588 
0.336 1.18064 1.19434 1.20993 1.22245 1.23015 
0.348 1.17799 1.19216 1.20725 1.21716 1.22325 
0.36 1.17284 1.18656 1.2007 1.20809 1.21269 
0.372 1.16205 1.1743 1.18674 1.19182 1.19483 
0.384 1.14329 1.15317 1.16316 1.16638 1.16773 
0.396 1.1188 1.12611 1.13364 1.13608 1.13651 
0.408 1.09148 1.09659 1.10232 1.10521 1.10572 
0.42 1.06349 1.06684 1.07145 1.07538 1.07629 
0.432 1.0408 1.0429 1.04707 1.05216 1.05339 
0.444 1.02845 1.02977 1.03392 1.0399 1.04123 
0.456 1.02595 1.02691 1.03111 1.03742 1.03876 
0.468 1.02834 1.02927 1.0333 1.03936 1.04078 
0.48 1.03104 1.03197 1.03556 1.04094 1.04254 
 
Time Marker 16 Marker 17 Marker 18 Marker 19 Marker 20 
0 1 1 1 1 1 
0.012 1.00544 1.00624 1.00598 1.00593 1.00595 
0.024 1.01071 1.0124 1.01181 1.01165 1.01167 
0.036 1.01546 1.01804 1.01709 1.01679 1.01677 
0.048 1.01957 1.02283 1.02161 1.02118 1.02111 
0.06 1.02308 1.02671 1.02532 1.02484 1.02472 
0.072 1.02617 1.02983 1.02843 1.02794 1.02778 
0.084 1.02936 1.03287 1.03157 1.03111 1.03093 
0.096 1.03368 1.03703 1.0359 1.0355 1.03533 
0.108 1.04038 1.04362 1.04265 1.04235 1.04224 
0.12 1.0506 1.05364 1.05278 1.05262 1.05262 
0.132 1.0656 1.068 1.0672 1.06725 1.06742 
0.144 1.08642 1.08734 1.08659 1.08694 1.08738 
0.156 1.11289 1.11137 1.11066 1.11142 1.11226 
0.168 1.14351 1.13881 1.1382 1.13948 1.14082 
0.18 1.17583 1.1677 1.16732 1.1692 1.17111 
0.192 1.20657 1.19535 1.19532 1.19779 1.20025 
0.204 1.2326 1.21901 1.21938 1.22236 1.22528 




Time Marker 16 Marker 17 Marker 18 Marker 19 Marker 20 
0.228 1.26395 1.24734 1.24824 1.2518 1.25538 
0.24 1.26864 1.25094 1.25181 1.25545 1.25924 
0.252 1.26779 1.24924 1.2498 1.2534 1.25733 
0.264 1.2636 1.24443 1.24429 1.24776 1.2518 
0.276 1.25738 1.23775 1.23669 1.23998 1.24408 
0.288 1.24949 1.22984 1.22799 1.23109 1.23516 
0.3 1.24099 1.22211 1.21981 1.2228 1.22677 
0.312 1.23342 1.21606 1.21365 1.21665 1.22049 
0.324 1.22727 1.21177 1.20951 1.21255 1.21627 
0.336 1.22196 1.20823 1.20619 1.20924 1.21281 
0.348 1.2164 1.20401 1.20215 1.20505 1.20843 
0.36 1.20858 1.19694 1.19512 1.19769 1.2008 
0.372 1.19468 1.18356 1.18163 1.1837 1.18641 
0.384 1.17149 1.16124 1.15923 1.16071 1.16289 
0.396 1.14157 1.13279 1.13104 1.13207 1.13373 
0.408 1.10899 1.1018 1.10078 1.10161 1.10288 
0.42 1.07684 1.07071 1.07067 1.07146 1.07245 
0.432 1.0514 1.04585 1.04673 1.04754 1.04838 
0.444 1.03779 1.03229 1.03383 1.03465 1.03542 
0.456 1.03573 1.02927 1.03122 1.03205 1.03281 
0.468 1.03999 1.03155 1.03368 1.03454 1.03531 
0.48 1.04515 1.0343 1.03641 1.03724 1.03801 
 
Time Marker 21 Marker 22 Marker 23 Marker 24 Marker 25 
0 1 1 1 1 1 
0.012 1.00598 1.00597 1.00595 1.00593 1.00599 
0.024 1.0117 1.01169 1.01167 1.01166 1.01178 
0.036 1.01681 1.01679 1.01679 1.01682 1.01699 
0.048 1.02113 1.0211 1.02112 1.02121 1.02141 
0.06 1.02469 1.02464 1.02468 1.02483 1.02505 
0.072 1.0277 1.02765 1.0277 1.0279 1.02812 
0.084 1.03082 1.03076 1.03082 1.03103 1.03124 
0.096 1.03521 1.03515 1.03522 1.03538 1.03559 
0.108 1.04212 1.04207 1.04212 1.04219 1.04242 
0.12 1.05254 1.05251 1.05251 1.05248 1.05271 
0.132 1.06742 1.0674 1.06735 1.0672 1.06741 




Time Marker 21 Marker 22 Marker 23 Marker 24 Marker 25 
0.156 1.11262 1.11266 1.11245 1.11204 1.11194 
0.168 1.14149 1.14157 1.14123 1.14064 1.14028 
0.18 1.17212 1.17224 1.17173 1.17091 1.17029 
0.192 1.20162 1.20178 1.20105 1.19997 1.19914 
0.204 1.22697 1.22719 1.22627 1.22488 1.22392 
0.216 1.24609 1.24642 1.24533 1.24362 1.24257 
0.228 1.25769 1.2582 1.25701 1.25495 1.25383 
0.24 1.26183 1.26255 1.26133 1.25898 1.25777 
0.252 1.26018 1.26113 1.25993 1.25735 1.25604 
0.264 1.25489 1.25606 1.25494 1.25222 1.2508 
0.276 1.24733 1.24871 1.2477 1.24495 1.2434 
0.288 1.23845 1.23992 1.23904 1.23637 1.23473 
0.3 1.22993 1.23135 1.23054 1.22804 1.22642 
0.312 1.2234 1.22462 1.22382 1.22151 1.22003 
0.324 1.21888 1.21982 1.21899 1.21688 1.21558 
0.336 1.21512 1.21577 1.21493 1.21303 1.21192 
0.348 1.21046 1.21086 1.21008 1.20843 1.20743 
0.36 1.20258 1.20281 1.20215 1.20083 1.19987 
0.372 1.18792 1.18807 1.1876 1.1867 1.1857 
0.384 1.1641 1.16422 1.16395 1.16348 1.16248 
0.396 1.13468 1.13481 1.13465 1.13442 1.13352 
0.408 1.10366 1.10383 1.10366 1.1034 1.1027 
0.42 1.07316 1.07337 1.07312 1.07272 1.07221 
0.432 1.04906 1.04931 1.04896 1.0484 1.04803 
0.444 1.03613 1.03641 1.03597 1.03531 1.035 
0.456 1.03355 1.03385 1.0334 1.03274 1.03236 
0.468 1.03607 1.03641 1.03604 1.03545 1.03488 




Marker 27 Marker 28 Marker 29 Marker 
30 
Marker 31 
0 1 1 1 1 1 1 
0.012 1.00596 1.00596 1.00596 1.00596 1.00596 1.00596 
0.024 1.0117 1.01169 1.0117 1.0117 1.0117 1.0117 
0.036 1.01686 1.01683 1.01683 1.01684 1.01684 1.01685 
0.048 1.02123 1.02119 1.02119 1.0212 1.0212 1.02122 






Marker 27 Marker 28 Marker 29 Marker 
30 
Marker 31 
0.072 1.0279 1.02784 1.02782 1.02783 1.02785 1.02787 
0.084 1.03104 1.03097 1.03095 1.03095 1.03097 1.031 
0.096 1.03541 1.03535 1.03533 1.03533 1.03534 1.03537 
0.108 1.04227 1.04222 1.04221 1.0422 1.04221 1.04223 
0.12 1.0526 1.05257 1.05257 1.05256 1.05256 1.05257 
0.132 1.06733 1.06735 1.06736 1.06735 1.06734 1.06734 
0.144 1.08722 1.0873 1.08734 1.08733 1.08731 1.08728 
0.156 1.11201 1.11217 1.11227 1.11227 1.11223 1.11217 
0.168 1.14046 1.14075 1.14091 1.14092 1.14084 1.14075 
0.18 1.17062 1.17103 1.17126 1.17127 1.17117 1.17103 
0.192 1.19961 1.20015 1.20045 1.20047 1.20033 1.20015 
0.204 1.22453 1.22518 1.22553 1.22556 1.22538 1.22516 
0.216 1.24329 1.24402 1.24443 1.24447 1.24427 1.244 
0.228 1.25464 1.25544 1.25589 1.25595 1.25574 1.25543 
0.24 1.25862 1.25947 1.25997 1.26007 1.25984 1.25951 
0.252 1.25689 1.25778 1.25833 1.25846 1.25824 1.25788 
0.264 1.25159 1.25251 1.2531 1.25326 1.25306 1.25269 
0.276 1.2441 1.24503 1.24566 1.24586 1.24568 1.2453 
0.288 1.23534 1.23626 1.23691 1.23713 1.23696 1.23659 
0.3 1.22696 1.22785 1.22848 1.2287 1.22854 1.22819 
0.312 1.22052 1.22138 1.22197 1.22216 1.222 1.22167 
0.324 1.21606 1.21688 1.21742 1.21756 1.2174 1.2171 
0.336 1.21238 1.21315 1.21364 1.21374 1.21357 1.2133 
0.348 1.20786 1.20857 1.20901 1.20909 1.20892 1.20867 
0.36 1.20023 1.20087 1.20127 1.20133 1.20117 1.20096 
0.372 1.18597 1.18651 1.18686 1.18691 1.18679 1.18663 
0.384 1.16263 1.16306 1.16335 1.16341 1.16332 1.16321 
0.396 1.13361 1.13394 1.13417 1.13423 1.13417 1.13409 
0.408 1.10282 1.10307 1.10325 1.1033 1.10325 1.10318 
0.42 1.07239 1.07261 1.07275 1.07279 1.07274 1.07267 
0.432 1.0483 1.0485 1.04862 1.04865 1.0486 1.04851 
0.444 1.03534 1.03553 1.03564 1.03567 1.03561 1.03551 
0.456 1.03275 1.03294 1.03305 1.03308 1.03302 1.03292 
0.468 1.0353 1.0355 1.03562 1.03566 1.03561 1.03551 






Table A2.3 Hemodynamic and Echocardiographic data for Edge-to Edge Repair 
Expt 1 Control Prolapse E2E-
Norm 
E2E-D1 E2E-D2 E2E-U1 E2E-U2 
        
MR 12.7 19.5 14.9 16.4 17 12.7 12.2 
SV 70.6 71.5 71.1 72.2 70.8 67.6 71.2 
MRF 17.98867 27.27273 20.9564 22.71468 24.0113 18.78698 17.13483
AMRF 0 9.284059 2.967731 4.726013 6.022631 0.798314 0 
LCL 11.3 0 13.5 10.5 10.7 14.3 14.1 
        
Expt 2 Control Prolapse E2E-
Norm 
E2E-D1 E2E-D2 E2E-U1 E2E-U2 
        
MR 16.7 24.8 16.8 18 20.3 16.6 14.7
SV 71.5 72.2 71.7 67.6 68.7 73.5 73.8
MRF 23.35664 34.34903 23.43096 26.62722 29.54876 22.58503 19.9187
AMRF 0 10.99239 0.074319 3.270576 6.192119 0 0 
LCL 13.1 0 13.4 10.3 10.3 12.6 12.5 
        
Expt 3 Control Prolapse E2E-
Norm 
E2E-D1 E2E-D2 E2E-U1 E2E-U2 
        
MR 14.8 25.4 16.7 20.4 21.9 15.1 13.1
SV 72.3 70.5 72.5 70.2 70.5 72.2 72.4
MRF 20.47026 36.02837 23.03448 29.05983 31.06383 20.91413 18.09392
AMRF 0 15.55811 2.56422 8.589566 10.59357 0.443865 0 
LCL 13.8 0 13.3 12.1 12 13.3 13.8 
        
Expt 4 Control Prolapse E2E-
Norm 
E2E-D1 E2E-D2 E2E-U1 E2E-U2 
        
MR 11.7 14.6 13.2 14.6 17.9 12.8 11.2
SV 72.5 68.8 71.6 72.2 68.5 73.1 72.1
MRF 16.13793 21.22093 18.43575 20.22161 26.13139 17.51026 15.53398
AMRF 0 5.082999 2.297823 4.083676 9.993456 1.372329 0 











E2E-D1 E2E-D2 E2E-U1 E2E-U2
        
MR 19.2 32.1 20.8 22.7 23 19.7 18.9
SV 67.8 72.5 71.6 70.7 69.9 71.8 71.6
MRF 28.3185 44.2758 29.0502 32.1075 32.9041 27.4373 26.3966
AMRF 0 15.9572 0.73169 3.78891 4.58556 0 0 
LCL 11.1 0 11 10.5 9.2 11.3 11.9 
        




E2E-D1 E2E-D2 E2E-U1 E2E-U2
        
MR 14.5 28.2 14.9 25.6 25.6 11.9 3.6
SV 68.9 67.9 71.7 71.3 68.2 70.2 68.6
MRF 21.0449 41.5316 20.7810 35.9046 37.5366 16.9515 5.24781
AMRF 0 20.4866 0 14.8596 16.4916 0 0 
LCL 9.6 0 8.3 7.5 6.4 9.1 9.9 
        




E2E-D1 E2E-D2 E2E-U1 E2E-U2
        
MR 21.8 27.9 23.4 25.3 25.4 23.3 22.3
SV 69.7 73.1 71.7 68.1 68 68.1 70.4
MRF 31.2769 38.1668 32.6359 37.1512 37.3529 34.2143 31.6761
AMRF 0 6.88999 1.35908 5.87434 6.07604 2.93749 0.39923 





E2E-D1 E2E-D2 E2E-U1 E2E-U2
MR 15.9142 24.6428 17.2428 20.4285 21.5857 16.0142 13.7142 
SV 70.4714 70.9285 71.7 70.3285 69.2285 70.9285 71.4428 
MRF 22.6562 34.6922 24.0464 29.1123 31.2212 22.6285 19.1431 
AMRF 0 12.0359 1.42783 6.45610 8.56500 0.79314 0.05703 
LCL 11.7857 0 11.4628 9.95428 9.47571 11.8142 12.4333 
        
STD MRF 0 5.51790 1.20965 4.11081 4.14553 1.07571 0.15089






















0.004 1.230099 1.035085 0.998796 1.005598 0.99787 1.000661 0.999373 1.052381
0.008 1.241411 1.063456 0.999731 1.012066 1.002636 1.000645 1.00583 1.078782
0.012 1.252885 1.106985 1.003853 1.019926 1.008469 1.000839 1.012883 1.116989
0.016 1.264509 1.165814 1.012536 1.02928 1.015364 1.001284 1.020478 1.166482
0.02 1.276268 1.237801 1.026717 1.040194 1.023198 1.002 1.028842 1.225736
0.024 1.288148 1.318824 1.046652 1.052609 1.031695 1.002972 1.038512 1.292467
0.028 1.300132 1.403547 1.071834 1.066255 1.040427 1.004143 1.050282 1.363966
0.032 1.312205 1.486336 1.101094 1.080601 1.048849 1.005426 1.065057 1.437435
0.036 1.32435 1.562091 1.132832 1.094892 1.056393 1.006714 1.083669 1.510243
0.04 1.336549 1.626856 1.165292 1.108248 1.062605 1.007911 1.106691 1.580024
0.044 1.348786 1.678188 1.196825 1.119821 1.067306 1.008966 1.134345 1.644674
0.048 1.36104 1.715302 1.226094 1.128993 1.070733 1.009899 1.166495 1.702355
0.052 1.373295 1.738995 1.252212 1.135561 1.073638 1.010806 1.202738 1.751612
0.056 1.38553 1.751356 1.27479 1.139876 1.077279 1.011859 1.242501 1.791578
0.06 1.397727 1.755274 1.293919 1.142897 1.083323 1.013271 1.285104 1.822127
0.064 1.409865 1.753866 1.310065 1.146117 1.093634 1.015271 1.329753 1.843797
0.068 1.421925 1.749953 1.323921 1.151382 1.109981 1.018084 1.37552 1.857482
0.072 1.433886 1.745729 1.336239 1.160619 1.133711 1.021927 1.421353 1.864042
0.076 1.445727 1.742636 1.34768 1.175537 1.165442 1.027032 1.46614 1.864071
0.08 1.45743 1.741438 1.35872 1.19735 1.204845 1.03368 1.508825 1.857953
0.084 1.468972 1.742401 1.369603 1.226564 1.250564 1.042228 1.548492 1.846129
0.088 1.480334 1.745512 1.380361 1.262884 1.300336 1.053114 1.584412 1.829365
0.092 1.491496 1.75065 1.390854 1.305227 1.3513 1.066818 1.616038 1.80886 
0.096 1.502437 1.757676 1.400836 1.351858 1.40047 1.083792 1.642997 1.786152
0.1 1.513137 1.766429 1.410004 1.400584 1.445243 1.104358 1.665116 1.762879
0.104 1.523576 1.776654 1.418046 1.448947 1.483831 1.128606 1.682478 1.740532
0.108 1.533735 1.787907 1.424671 1.494402 1.515471 1.156337 1.695464 1.720291
0.112 1.543596 1.799517 1.429622 1.53448 1.540387 1.187055 1.704741 1.702957
0.116 1.553139 1.810615 1.432701 1.566994 1.559548 1.220033 1.71116 1.688971
0.12 1.562346 1.820263 1.433777 1.590299 1.574333 1.254406 1.715618 1.678495
0.124 1.571201 1.827606 1.432807 1.603534 1.586223 1.289296 1.718912 1.671503
0.128 1.579685 1.832018 1.429853 1.606765 1.596576 1.323894 1.721659 1.667881
0.132 1.587782 1.833188 1.425085 1.600893 1.606491 1.35752 1.724274 1.667484
0.136 1.595477 1.831143 1.418776 1.587356 1.616724 1.389633 1.726997 1.670147
0.14 1.602756 1.826214 1.41128 1.567734 1.627645 1.419808 1.729934 1.675636
0.144 1.609603 1.818947 1.402992 1.54343 1.639247 1.447707 1.733071 1.683585




















0.156 1.627431 1.789618 1.377051 1.452883 1.674327 1.515156 1.741581 1.716224
0.16 1.63243 1.779138 1.368923 1.420117 1.684744 1.531586 1.742886 1.727765
0.164 1.636942 1.768803 1.361262 1.388089 1.694299 1.544848 1.742868 1.738817
0.168 1.640956 1.758636 1.354063 1.358213 1.70321 1.555012 1.741545 1.749324
0.172 1.644467 1.748501 1.347267 1.3318 1.711787 1.562282 1.73927 1.759535
0.176 1.647467 1.738151 1.340798 1.309857 1.720264 1.566987 1.736631 1.769893
0.18 1.649951 1.72726 1.334594 1.292943 1.728655 1.569566 1.734201 1.780837
0.184 1.651916 1.715443 1.328635 1.281128 1.736681 1.570526 1.732283 1.792604
0.188 1.653358 1.70227 1.322957 1.274032 1.743811 1.570396 1.730768 1.805101
0.192 1.654274 1.687287 1.317643 1.270936 1.749368 1.569677 1.729194 1.817907
0.196 1.654665 1.670037 1.3128 1.270917 1.75268 1.568795 1.726959 1.830396
0.2 1.654531 1.650123 1.308522 1.272984 1.753235 1.568075 1.723571 1.841957
0.204 1.653873 1.627265 1.304846 1.276199 1.750768 1.567729 1.71885 1.852226
0.208 1.652693 1.601377 1.301709 1.27976 1.74531 1.567853 1.712985 1.861225
0.212 1.650996 1.572593 1.298917 1.283056 1.737162 1.568447 1.706474 1.869339
0.216 1.648786 1.541258 1.296137 1.28568 1.726834 1.569424 1.699985 1.877096
0.22 1.64607 1.507862 1.2929 1.287425 1.714964 1.570628 1.694162 1.884795
0.224 1.642853 1.472944 1.288633 1.288273 1.702246 1.57185 1.689438 1.892049
0.228 1.639145 1.436994 1.282708 1.288378 1.689371 1.572838 1.685872 1.89741 
0.232 1.634954 1.400398 1.274503 1.288064 1.67698 1.57332 1.683057 1.89821 
0.236 1.63029 1.363428 1.263475 1.287791 1.665636 1.573029 1.680147 1.890743
0.24 1.625165 1.326276 1.249237 1.288123 1.655779 1.57173 1.676058 1.87082 
0.244 1.619589 1.289123 1.231627 1.289668 1.647704 1.569254 1.669834 1.83464 
0.248 1.613577 1.252189 1.21076 1.29301 1.641508 1.565501 1.661066 1.779747
0.252 1.60714 1.215753 1.187053 1.298646 1.637074 1.560467 1.650151 1.705821
0.256 1.600294 1.18013 1.161214 1.306927 1.634036 1.554215 1.638189 1.615061
0.26 1.593055 1.145608 1.134188 1.31801 1.631816 1.546867 1.626398 1.512005
0.264 1.585437 1.112377 1.107072 1.331833 1.629669 1.538579 1.615271 1.402831
0.268 1.577456 1.08047 1.081013 1.348126 1.626779 1.529517 1.603907 1.294327
0.272 1.569131 1.04975 1.0571 1.36647 1.622363 1.519836 1.589957 1.192809
0.276 1.560479 1.019951 1.036262 1.386388 1.615783 1.509661 1.570257 1.103271
0.28 1.551517 0.990763 1.019198 1.407443 1.606625 1.499064 1.541828 1.0289 
0.284 1.542264 0.961952 1.006333 1.429295 1.594719 1.48804 1.502778 0.970993
0.288 1.532739 0.961952 0.997799 1.451683 1.580109 1.476479 1.452774 0.970993
0.292 1.522961 0.961952 0.993452 1.474326 1.562965 1.464134 1.393166 0.970993
0.296 1.512949 0.961952 0.9929 1.496773 1.54346 1.450602 1.32697 0.970993
0.3 1.502723 0.961952 0.995551 1.518239 1.521658 1.435322 1.258777 0.970993





















0.308 1.481708 0.961952 1.007469 1.552803 1.470522 1.39669 1.139834 0.970993
0.312 1.470959 0.961952 1.015119 1.562117 1.440515 1.371903 1.099709 0.970993
0.316 1.460074 0.961952 1.022877 1.563247 1.407125 1.34279 1.075626 0.970993
0.32 1.449074 0.961952 1.030117 1.554282 1.370342 1.309316 1.065687 0.970993
0.324 1.437979 0.961952 1.036384 1.534003 1.330607 1.272042 1.065483 0.970993
0.328 1.426807 0.961952 1.036384 1.502253 1.288888 1.232203 1.065483 0.970993
0.332 1.415578 0.961952 1.036384 1.460132 1.246623 1.191661 1.065483 0.970993
0.336 1.404311 0.961952 1.036384 1.409956 1.205527 1.152682 1.065483 0.970993
0.34 1.393024 0.961952 1.036384 1.354939 1.167322 1.117547 1.065483 0.970993
0.344 1.381736 0.961952 1.036384 1.298682 1.133465 1.088107 1.065483 0.970993
0.348 1.370465 0.961952 1.036384 1.244596 1.104948 1.065403 1.065483 0.970993
0.352 1.359227 0.961952 1.036384 1.195416 1.082224 1.049516 1.065483 0.970993
0.356 1.34804 0.961952 1.036384 1.152929 1.065238 1.039684 1.065483 0.970993
0.36 1.336921 0.961952 1.036384 1.117957 1.05354 1.034628 1.065483 0.970993



































0.004 1.138874 1.044533 1.007327 0.999697 0.96301 1.0022 1.002202 1.014456
0.008 1.144466 1.080488 1.006365 0.99334 0.9655 1.003713 0.995288 1.027602
0.012 1.149979 1.132532 1.005669 0.986186 0.974371 1.005694 0.987954 1.047878
0.016 1.155405 1.200705 1.005736 0.979149 0.991811 1.008031 0.980508 1.076244
0.02 1.160739 1.282632 1.007113 0.973345 1.019466 1.010501 0.973263 1.112724
0.024 1.165973 1.373716 1.010297 0.969941 1.058074 1.012776 0.966582 1.156194
0.028 1.171101 1.468008 1.015625 0.969994 1.107255 1.014463 0.960929 1.204391
0.032 1.176116 1.559392 1.023217 0.974307 1.165485 1.015155 0.95692 1.254155
0.036 1.181012 1.642654 1.032968 0.983336 1.230239 1.01451 0.955309 1.30184 
0.04 1.185783 1.714125 1.044591 0.99716 1.298249 1.012318 0.95693 1.343816
0.044 1.190424 1.771874 1.057699 1.01552 1.365847 1.00856 0.962575 1.377008
0.048 1.194928 1.815559 1.071886 1.037908 1.42941 1.003435 0.972838 1.39939 
0.052 1.19929 1.846081 1.08679 1.06369 1.485857 0.997357 0.98797 1.410348
0.056 1.203506 1.865195 1.102127 1.092223 1.533134 0.990915 1.007774 1.410851
0.06 1.207569 1.875114 1.117698 1.122934 1.57052 0.984817 1.03158 1.403363
0.064 1.211477 1.878176 1.133364 1.15537 1.598626 0.979813 1.05831 1.391472
0.068 1.215223 1.876606 1.149013 1.189186 1.619084 0.97664 1.086643 1.37926 
0.072 1.218805 1.872375 1.164531 1.224113 1.634022 0.975969 1.115234 1.37049 
0.076 1.222218 1.867136 1.179787 1.25991 1.645531 0.978383 1.142943 1.367794
0.08 1.22546 1.862205 1.194633 1.296333 1.655286 0.984363 1.169014 1.372087
0.088 1.231415 1.85676 1.222559 1.370009 1.673289 1.008368 1.215512 1.396504
0.092 1.234123 1.857093 1.235478 1.406729 1.682113 1.026721 1.236578 1.411306
0.096 1.23665 1.859469 1.247705 1.443003 1.690625 1.049232 1.257008 1.42417 
0.1 1.238991 1.863556 1.259338 1.478486 1.69848 1.075581 1.277434 1.43339 
0.104 1.241148 1.868837 1.270539 1.512689 1.705333 1.105218 1.298288 1.438509
0.108 1.243117 1.874677 1.28151 1.544903 1.710909 1.137391 1.319655 1.440224
0.112 1.244899 1.880424 1.29247 1.574173 1.715053 1.171206 1.341234 1.440016
0.116 1.246493 1.885484 1.303614 1.599367 1.717713 1.205717 1.362388 1.439691
0.12 1.247899 1.889416 1.315091 1.619335 1.718917 1.240029 1.382312 1.440961
0.124 1.249117 1.891992 1.326973 1.633126 1.718732 1.273377 1.400266 1.44514 
0.128 1.250148 1.89322 1.339238 1.640165 1.717253 1.305185 1.415788 1.452959
0.132 1.250993 1.893311 1.351757 1.640363 1.714601 1.335082 1.428822 1.464514
0.136 1.251653 1.892616 1.364303 1.634082 1.710963 1.362876 1.43973 1.479309
0.14 1.25213 1.891552 1.376557 1.622003 1.706607 1.388507 1.44916 1.496393






















0.148 1.252542 1.889779 1.398649 1.583626 1.697271 1.433335 1.466416 1.53258 
0.152 1.252482 1.889549 1.407692 1.558652 1.693207 1.452556 1.475125 1.549351
0.156 1.252249 1.889861 1.414938 1.530379 1.690166 1.469601 1.483832 1.564035
0.16 1.251844 1.890653 1.420139 1.499023 1.688543 1.484394 1.492015 1.576068
0.164 1.251274 1.891793 1.423156 1.464771 1.688618 1.496849 1.498941 1.585137
0.168 1.250539 1.893101 1.423957 1.427922 1.690507 1.506921 1.503929 1.59112 
0.172 1.249646 1.894351 1.422604 1.38903 1.69413 1.514644 1.506579 1.59404 
0.176 1.248598 1.895255 1.419221 1.348997 1.699181 1.520166 1.506898 1.594029
0.18 1.247399 1.895431 1.413961 1.309093 1.70513 1.523745 1.505278 1.59129 
0.184 1.246055 1.894374 1.406969 1.270906 1.711252 1.525738 1.502349 1.586065
0.188 1.24457 1.891469 1.398361 1.236206 1.716689 1.526554 1.498803 1.578584
0.192 1.242949 1.886034 1.388222 1.206772 1.720524 1.526614 1.495222 1.56902 
0.196 1.241199 1.877389 1.376616 1.184193 1.721876 1.526305 1.492001 1.55746 
0.2 1.239324 1.864967 1.363623 1.169712 1.719984 1.525962 1.489352 1.543921
0.204 1.23733 1.848403 1.349382 1.164093 1.714265 1.525844 1.487352 1.528412
0.208 1.235224 1.827604 1.334118 1.167547 1.704354 1.526147 1.486014 1.511036
0.212 1.23301 1.802773 1.31817 1.179712 1.690089 1.526994 1.485329 1.492091
0.216 1.230696 1.774361 1.301966 1.199657 1.671482 1.528433 1.485285 1.472124
0.22 1.228288 1.742977 1.285996 1.225963 1.648643 1.530446 1.485856 1.451902
0.224 1.225792 1.709258 1.270737 1.256854 1.621706 1.532938 1.48697 1.432278
0.228 1.223214 1.67375 1.256595 1.290389 1.590762 1.535758 1.488487 1.413987
0.232 1.220561 1.636831 1.243847 1.324674 1.555827 1.538728 1.490167 1.397409
0.236 1.21784 1.598699 1.232622 1.358054 1.516854 1.541667 1.491676 1.382353
0.24 1.215058 1.559423 1.222905 1.389246 1.473795 1.544413 1.492615 1.367931
0.248 1.21222 1.477618 1.207424 1.442108 1.375835 1.548862 1.49116 1.334231
0.252 1.21222 1.435372 1.201222 1.4633 1.32174 1.550355 1.48813 1.310729
0.256 1.21222 1.392597 1.195688 1.481213 1.265313 1.551164 1.483316 1.280294
0.26 1.21222 1.349657 1.190498 1.496268 1.207787 1.551032 1.476638 1.242063
0.264 1.21222 1.306897 1.185263 1.508988 1.150678 1.549598 1.468015 1.19645 
0.268 1.21222 1.264581 1.179518 1.51991 1.09566 1.546397 1.457272 1.145257
0.272 1.21222 1.222855 1.172727 1.529522 1.044411 1.540923 1.44406 1.091439
0.276 1.21222 1.18176 1.164321 1.538197 0.998433 1.532708 1.42784 1.038593
0.28 1.21222 1.141276 1.153757 1.546151 0.958879 1.521408 1.407933 0.990301
0.284 1.21222 1.101412 1.140598 1.553415 0.926442 1.506876 1.383665 0.949501
0.288 1.21222 1.101412 1.124596 1.55981 0.926442 1.489188 1.354547 0.949501
0.292 1.21222 1.101412 1.105769 1.56493 0.926442 1.468613 1.32047 0.949501
0.296 1.21222 1.101412 1.08444 1.568133 0.926442 1.445548 1.281874 0.949501




















0.304 1.21222 1.101412 1.037017 1.565143 0.926442 1.393556 1.195957 0.949501
0.308 1.21222 1.101412 1.012826 1.556761 0.926442 1.365212 1.152343 0.949501
0.312 1.21222 1.101412 0.989717 1.542301 0.926442 1.335499 1.111158 0.949501
0.316 1.21222 1.101412 0.968654 1.520858 0.926442 1.304496 1.074352 0.949501
0.32 1.21222 1.101412 0.950395 1.491889 0.926442 1.272372 1.043344 0.949501
0.324 1.21222 1.101412 0.935423 1.455343 0.926442 1.239516 1.018853 0.949501
0.328 1.21222 1.101412 0.935423 1.411735 0.926442 1.206624 1.018853 0.949501
0.332 1.21222 1.101412 0.935423 1.362142 0.926442 1.17469 1.018853 0.949501
0.336 1.21222 1.101412 0.935423 1.308121 0.926442 1.144902 1.018853 0.949501
0.34 1.21222 1.101412 0.935423 1.25156 0.926442 1.118425 1.018853 0.949501
0.344 1.21222 1.101412 0.935423 1.194495 0.926442 1.096167 1.018853 0.949501
0.348 1.21222 1.101412 0.935423 1.138921 0.926442 1.078582 1.018853 0.949501
0.352 1.21222 1.101412 0.935423 1.086629 0.926442 1.065586 1.018853 0.949501
0.356 1.21222 1.101412 0.935423 1.039105 0.926442 1.056612 1.018853 0.949501
0.36 1.21222 1.101412 0.935423 0.997497 0.926442 1.050771 1.018853 0.949501



































0.004 1.003546 1.077382 1.002276 1.016216 0.943556 1.010628 0.999874 1.031322
0.008 1.002464 1.09759 1.016277 1.018945 0.959597 1.01219 0.992718 1.057284
0.012 1.001359 1.127222 1.033263 1.025438 0.989957 1.016387 0.985132 1.088234
0.016 1.00023 1.164207 1.052926 1.036245 1.036428 1.023412 0.977856 1.122309
0.02 0.999075 1.205912 1.074689 1.051653 1.098873 1.033233 0.971784 1.157125
0.024 0.997895 1.249548 1.097751 1.071642 1.175024 1.045555 0.96789 1.190155
0.028 0.996689 1.292549 1.121186 1.095858 1.260638 1.05984 0.967152 1.21915 
0.032 0.995456 1.332839 1.144071 1.123639 1.349995 1.075385 0.970484 1.242503
0.036 0.994195 1.368966 1.165614 1.154069 1.436659 1.091436 0.978675 1.259504
0.04 0.992906 1.400133 1.185256 1.186082 1.514447 1.107301 0.992355 1.270415
0.044 0.991587 1.42615 1.202703 1.218606 1.578405 1.122444 1.011951 1.276364
0.048 0.990239 1.447327 1.217915 1.250719 1.625589 1.136523 1.037637 1.279062
0.052 0.98886 1.46432 1.231031 1.281766 1.655446 1.149387 1.069251 1.28042 
0.056 0.987449 1.47797 1.242282 1.311386 1.669675 1.16104 1.106193 1.282145
0.06 0.986007 1.489143 1.251908 1.33942 1.671645 1.171587 1.147335 1.285419
0.064 0.984531 1.498615 1.260109 1.36575 1.665552 1.181189 1.190993 1.29072 
0.068 0.983022 1.506975 1.267022 1.390088 1.655574 1.190021 1.235011 1.297806
0.072 0.981478 1.514572 1.272733 1.41183 1.645212 1.198257 1.276965 1.305837
0.076 0.979898 1.521488 1.27731 1.430003 1.636939 1.206054 1.314463 1.313587
0.08 0.978282 1.527573 1.280827 1.44335 1.632131 1.213555 1.345494 1.319705
0.084 0.976628 1.532524 1.283387 1.45053 1.631231 1.220878 1.36873 1.322967
0.088 0.974936 1.536001 1.285124 1.450422 1.634009 1.228115 1.383746 1.322492
0.092 0.973204 1.537756 1.286187 1.442424 1.639853 1.23531 1.391091 1.31789 
0.096 0.971431 1.537713 1.286726 1.426704 1.647993 1.242448 1.392195 1.309322
0.1 0.969617 1.536 1.286862 1.404307 1.65765 1.249445 1.389113 1.297449
0.104 0.967759 1.53292 1.286683 1.377084 1.668078 1.25614 1.384142 1.283313
0.108 0.965858 1.52887 1.286235 1.347457 1.678562 1.262317 1.379405 1.268149
0.112 0.963911 1.524242 1.285546 1.318075 1.688383 1.267721 1.376496 1.253191
0.116 0.961918 1.519314 1.284639 1.291432 1.696812 1.272105 1.37631 1.239501
0.12 0.959878 1.514165 1.283554 1.269543 1.703154 1.275258 1.379074 1.227856
0.124 0.957789 1.508643 1.28236 1.253729 1.706821 1.277046 1.384545 1.218688
0.128 0.95565 1.502406 1.281152 1.244548 1.707434 1.277427 1.392256 1.212084
0.132 0.95346 1.495053 1.280041 1.241865 1.704901 1.276451 1.401714 1.207826
0.136 0.951219 1.486305 1.279129 1.245021 1.69946 1.274247 1.412489 1.20545 
0.14 0.948925 1.476187 1.278484 1.253065 1.691643 1.270998 1.424183 1.204329
0.144 0.946577 1.465132 1.27813 1.26498 1.682191 1.266911 1.436373 1.203765




















0.156 0.939205 1.435402 1.278345 1.316031 1.651724 1.251594 1.470278 1.199162
0.16 0.936636 1.429687 1.278545 1.336559 1.64271 1.246016 1.478503 1.1953 
0.164 0.934011 1.426714 1.278651 1.35836 1.634623 1.240424 1.484209 1.190083
0.168 0.931331 1.426024 1.278576 1.381088 1.627378 1.23494 1.487066 1.183694
0.172 0.928595 1.426665 1.278225 1.404207 1.620787 1.229683 1.487005 1.176464
0.176 0.925803 1.427448 1.277474 1.426942 1.614654 1.22477 1.484236 1.168822
0.18 0.922957 1.427272 1.276142 1.448279 1.608842 1.220304 1.479225 1.161225
0.184 0.920058 1.425409 1.273973 1.467025 1.603301 1.216361 1.472623 1.154099
0.188 0.917107 1.42165 1.27064 1.481907 1.598052 1.212976 1.465185 1.147786
0.192 0.914106 1.416225 1.265767 1.491687 1.593152 1.21014 1.457645 1.142512
0.196 0.911057 1.409526 1.258975 1.495278 1.588636 1.207808 1.450632 1.138372
0.2 0.907962 1.401721 1.249948 1.491843 1.58448 1.205903 1.444598 1.135327
0.204 0.904825 1.392412 1.238498 1.480873 1.580574 1.204338 1.439787 1.1332 
0.208 0.901649 1.380516 1.224624 1.462234 1.576712 1.203005 1.436246 1.131679
0.212 0.898439 1.364451 1.208547 1.436183 1.572576 1.20177 1.433844 1.130317
0.216 0.895199 1.342644 1.190709 1.403341 1.567712 1.200435 1.432309 1.128558
0.22 0.891933 1.314218 1.171744 1.36463 1.5615 1.198711 1.431273 1.125791
0.224 0.888648 1.279584 1.15241 1.321162 1.553117 1.196187 1.430314 1.121449
0.228 0.88535 1.240684 1.133516 1.274106 1.541538 1.192335 1.429021 1.115124
0.232 0.882046 1.200694 1.115844 1.22455 1.525577 1.18655 1.427068 1.10668 
0.236 0.878743 1.163222 1.100086 1.173398 1.503996 1.178232 1.424271 1.096319
0.24 0.87545 1.131213 1.086807 1.121352 1.475682 1.166886 1.420608 1.084573
0.244 0.872177 1.105838 1.076432 1.068977 1.439869 1.152228 1.416191 1.072231
0.248 0.872177 1.085591 1.069236 1.016829 1.396364 1.134256 1.411197 1.072231
0.252 0.872177 1.065799 1.065346 0.965596 1.34572 1.113258 1.405765 1.072231
0.256 0.872177 1.038798 1.064721 0.916159 1.289287 1.08976 1.399886 1.072231
0.26 0.872177 0.995112 1.067127 0.869551 1.229132 1.06441 1.393321 1.072231
0.264 0.872177 0.92584 1.072129 0.826806 1.167808 1.037841 1.385543 1.072231
0.268 0.872177 0.825896 1.0791 0.788756 1.108033 1.010539 1.375757 1.072231
0.272 0.872177 0.696974 1.08728 0.755873 1.052348 0.982759 1.362983 1.072231
0.276 0.872177 0.548701 1.095866 0.728221 1.00282 0.954512 1.346225 1.072231
0.28 0.872177 0.396872 1.104126 0.705514 0.960844 0.925607 1.324702 1.072231
0.284 0.872177 0.258994 1.111493 0.687245 0.927072 0.895754 1.29811 1.072231
0.288 0.872177 0.258994 1.111493 0.687245 0.927072 0.864695 1.26685 1.072231
0.292 0.872177 0.258994 1.111493 0.687245 0.927072 0.832322 1.232129 1.072231
0.296 0.872177 0.258994 1.111493 0.687245 0.927072 0.798773 1.195881 1.072231
0.3 0.872177 0.258994 1.111493 0.687245 0.927072 0.764476 1.16047 1.072231




















0.308 0.872177 0.258994 1.111493 0.687245 0.927072 0.696617 1.100953 1.072231
0.312 0.872177 0.258994 1.111493 0.687245 0.927072 0.664919 1.0796 1.072231
0.316 0.872177 0.258994 1.111493 0.687245 0.927072 0.635952 1.06417 1.072231
0.32 0.872177 0.258994 1.111493 0.687245 0.927072 0.610449 1.053931 1.072231
























Table A3.1 Hemodynamic Data under Different Pathological Conditions 
8-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 27.8 35.9 44.6
SV 72.3 72.6 73.2
MRF 38.450899 49.44903581 60.92896175
MRFA 0 10.99813678 22.47806272
    
    
9-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 24.8 35 41.9
SV 74 71.2 72.8
MRF 33.513514 49.15730337 57.55494505
MRFA 0 15.64378986 24.04143154
    
    
10-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 30.1 33.6 44.7
SV 70.7 73.1 71.7
MRF 42.574257 45.96443228 62.34309623
MRFA 0 3.390174859 19.76883881
    
    
11-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 22.7 26.9 32.7
SV 73 72.1 69.8
MRF 31.09589 37.30929265 46.84813754
MRFA 0 6.213402238 15.75224712
    
14-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 18.7 25.9 39.1
SV 72.9 73.4 70.1
MRF 25.651578 35.28610354 55.77746077
MRFA 0 9.634526039 30.12588327
    
16-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 20.5 35.5 44
SV 71.8 72.2 73
MRF 28.551532 49.16897507 60.2739726




17-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 24.6 28.7 37
SV 72.4 69.6 72.2
MRF 33.977901 41.23563218 51.2465374
MRFA 0 7.257731631 17.26863684
    
21-Jul Control Dilated + Apical Dilated + Apical + Lateral 
MR 25.4 31 41
SV 73.1 71.1 73
MRF 34.746922 43.60056259 56.16438356
MRFA 0 8.853640563 21.41746154
    
Average Control Disease Dilated + Apical + Lateral 
MR ` 31.64 40.57
SV 72.44 72.03 71.83
MRF 33.40 43.94 56.42
MRFA 0.00 10.54 23.02















Table A3.2 Hemodynamic Data under Annular and Sub-annular Repair 
8-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 30.9 41.4 28.9 43.2 
SV 71.2 70.6 71.3 72.4 
MRF 43.3988764 58.64022663 40.53295933 59.66850829 
MRFA 4.947977373 20.1893276 2.082060295 21.21760926 
     
9-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 29.8 36.9 27.7 40.6 
SV 72.1 72.8 71.5 71 
MRF 41.33148405 50.68681319 38.74125874 57.18309859 
MRFA 7.817970536 17.17329967 5.227745228 23.66958508 
     
10-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 27 35.9 27.2 39.3 
SV 73.4 73.4 72.3 71.4 
MRF 36.78474114 48.91008174 37.62102351 55.04201681 
MRFA 0 6.335824318 0 12.46775938 
     
     
11-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 25.8 30.8 25.9 32.6 
SV 69.9 73.1 74.9 74.5 
MRF 36.90987124 42.13406293 34.57943925 43.75838926 




14-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 23.7 33.6 23.3 34.6
SV 71 72.6 70.9 72.2
MRF 33.38028169 46.28099174 32.86318759 47.92243767
MRFA 7.728704187 20.62941423 7.211610085 22.27086017
16-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 28.2 40.5 25.4 30.3
SV 70 71 70.9 62.3
MRF 40.28571429 57.04225352 35.82510578 48.63563403
MRFA 11.73418225 28.49072149 7.273573749 20.084102
17-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 24.9 33.5 24.6 36.6
SV 70.8 71.2 73.5 71
MRF 35.16949153 47.0505618 33.46938776 51.54929577
MRFA 1.191590973 13.07266125 0 17.57139522
21-Jul Undersized+Apical Underized+Apical+Lateral Undersized+Apical+Ctcut Underized+Apical+Lateral+Ctcut
MR 30.1 30.1 27.9 36.2
SV 71.1 73.9 73.3 66.6
MRF 42.3347398 40.73071719 38.0627558 54.35435435
MRFA 7.587817778 5.983795161 3.315833773 19.60743233
Mean Annuloplasty Underized+Apical+Lateral Annuloplasty + CTcut Underized+Apical+Lateral+Ctcut
MR 27.19 36.09 26.14 36.74
SV 71.20 72.10 72.19 70.69
MRF 38.18 50.11 36.23 51.97
MRFA 5.60 16.70 3.61 18.56




Table A3.3 Averaged Data for marginal chordal forces measured under different experimental conditions 
 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
1 0 0 0 0 0 0 0
2 -9.5E-07 0.00049 -0.00011 2.67E-05 0.00015 0.000178 0.000168
3 -0.00031 -1.6E-05 -0.00021 -5.3E-05 -0.00073 0.000529 0.000238
4 6.48E-05 -0.00035 7.17E-05 0.000453 -0.00036 0.000599 0.00034
5 -0.00011 -0.00011 8.5E-05 0.000147 0.000139 0.00043 0.000283
6 -0.00027 8.38E-05 0.000124 0.000573 -0.00033 0.000985 0.000476
7 0.000186 8.29E-05 0.000117 0.00028 -0.00013 0.001101 0.001131
8 -9.7E-05 -0.00017 0.000122 0.000707 -6.1E-06 0.001162 0.001323
9 -8.3E-05 -0.00016 7.33E-05 0.000173 0.000155 0.001251 0.000736
10 0.000531 0.000118 0.000178 0.000453 4.44E-05 0.001089 0.00071
11 0.000426 0.000495 0.000311 0.00028 -0.00013 0.000812 0.001301
12 0.000141 0.000374 4.5E-05 0.00024 -0.00038 0.001575 0.001288
13 0.000257 0.000286 0.000218 0.000347 -7.4E-06 0.001131 0.001158
14 0.000473 0.000236 2.42E-05 0.00036 -0.00015 0.000907 0.00117
15 0.00063 0.000799 0.000178 0.00048 -0.00013 0.00117 0.001089
16 0.000603 0.000506 -1.7E-06 0.000587 0.000351 0.001407 0.001088
17 0.000646 0.000587 0.000447 0.000693 0.000206 0.001527 0.001434
18 0.00077 0.000461 0.000323 0.000667 9.83E-06 0.001766 0.001349
19 0.000781 0.000442 0.000614 0.000667 8.41E-05 0.001855 0.001141
20 0.000754 0.000661 0.000294 0.00064 1.74E-05 0.00159 0.001781
21 0.000518 0.000958 0.000377 0.001053 0.000166 0.001985 0.002021
22 0.000284 0.000616 0.000647 0.000947 0.000229 0.002078 0.001842
23 0.000579 0.000693 0.000801 0.00096 0.000251 0.002115 0.002133




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
25 0.000999 0.001023 0.000837 0.001067 0.000545 0.002044 0.001914
26 0.000375 0.000986 0.001041 0.001467 0.000141 0.002306 0.001845
27 0.000988 0.000938 0.000973 0.00124 0.000515 0.001996 0.002179
28 0.000741 0.000908 0.000871 0.001413 0.000537 0.00228 0.002056
29 0.00084 0.000939 0.000864 0.000973 0.000406 0.002203 0.001913
30 0.00033 0.001176 0.001203 0.00148 0.000411 0.00243 0.002275
31 0.000558 0.00113 0.001334 0.00156 0.000212 0.002564 0.002075
32 0.000978 0.000974 0.001551 0.00128 0.000451 0.002762 0.002261
33 0.001313 0.001221 0.001523 0.001733 0.000732 0.002585 0.002009
34 0.001073 0.00141 0.001713 0.0016 0.001011 0.00274 0.00285
35 0.000651 0.001023 0.001377 0.00184 0.000693 0.00249 0.002184
36 0.000764 0.001109 0.001845 0.001733 0.000904 0.002523 0.002066
37 0.000964 0.001695 0.001537 0.001907 0.001235 0.00266 0.001975
38 0.000953 0.001712 0.001687 0.001707 0.00116 0.002495 0.002172
39 0.000816 0.001448 0.001772 0.001947 0.001259 0.002716 0.002432
40 0.001 0.001477 0.001606 0.002067 0.001311 0.002703 0.002666
41 0.00117 0.001586 0.001861 0.002133 0.001132 0.003007 0.002103
42 0.001308 0.002072 0.001689 0.001627 0.001098 0.003108 0.002155
43 0.00124 0.001837 0.002086 0.001907 0.001074 0.00301 0.00276
44 0.001174 0.001811 0.001989 0.002533 0.001337 0.002931 0.002828
45 0.001387 0.001477 0.002083 0.00224 0.000892 0.003165 0.002703
46 0.00205 0.001786 0.002208 0.002053 0.001213 0.003521 0.002177
47 0.001716 0.001991 0.002394 0.00236 0.001494 0.003259 0.002784
48 0.001401 0.001642 0.002183 0.002053 0.001408 0.003457 0.002301




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
50 0.001991 0.002033 0.002756 0.00236 0.001989 0.003674 0.002756
51 0.001978 0.00257 0.002993 0.002307 0.001934 0.004075 0.003114
52 0.001895 0.002585 0.003243 0.002613 0.00202 0.003928 0.00322
53 0.00164 0.002353 0.003166 0.002933 0.002149 0.004435 0.003568
54 0.00197 0.002105 0.003278 0.003093 0.00241 0.004687 0.003442
55 0.002486 0.002312 0.003658 0.00308 0.002016 0.004447 0.002908
56 0.002042 0.00246 0.003592 0.003133 0.002259 0.00443 0.003311
57 0.002202 0.002615 0.003768 0.003227 0.002571 0.004653 0.003512
58 0.002114 0.00248 0.003768 0.003147 0.002286 0.004958 0.003683
59 0.002461 0.002804 0.004067 0.003027 0.002526 0.005033 0.003689
60 0.002693 0.002916 0.004042 0.00352 0.003016 0.005203 0.004084
61 0.002208 0.003241 0.004609 0.00352 0.002549 0.005408 0.003977
62 0.001784 0.003128 0.004663 0.0038 0.002361 0.005546 0.004213
63 0.002499 0.00331 0.005533 0.003987 0.003224 0.005727 0.004411
64 0.00253 0.003475 0.005598 0.00432 0.003646 0.00587 0.004143
65 0.002481 0.004115 0.006107 0.00436 0.003386 0.006331 0.004191
66 0.002356 0.004199 0.006401 0.004413 0.004194 0.006775 0.005006
67 0.002481 0.003849 0.006748 0.004853 0.004361 0.00728 0.005507
68 0.002831 0.004299 0.007144 0.004933 0.004051 0.007717 0.005464
69 0.003408 0.004949 0.007569 0.00508 0.004224 0.007958 0.00602
70 0.003283 0.005092 0.008135 0.006093 0.005051 0.007993 0.006616
71 0.002958 0.005125 0.008836 0.006547 0.004976 0.008601 0.006594
72 0.003288 0.005585 0.009714 0.00676 0.005109 0.009449 0.007205
73 0.00365 0.00588 0.010409 0.006933 0.005681 0.009834 0.007654




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
75 0.004004 0.006703 0.011943 0.007893 0.006137 0.010199 0.008383
76 0.004162 0.007588 0.013269 0.009027 0.006348 0.011324 0.009269
77 0.005291 0.00797 0.014464 0.009667 0.006792 0.011736 0.00929
78 0.005643 0.009164 0.015394 0.010827 0.007089 0.012362 0.009867
79 0.005906 0.009819 0.017506 0.011533 0.007667 0.013311 0.010869
80 0.006257 0.010736 0.019044 0.012547 0.008508 0.014075 0.011468
81 0.007455 0.011801 0.021456 0.01344 0.008633 0.015098 0.012586
82 0.00787 0.013203 0.024027 0.014947 0.009453 0.016536 0.01371
83 0.008468 0.014901 0.027022 0.015973 0.009718 0.017561 0.014926
84 0.009528 0.01676 0.030239 0.017147 0.01061 0.019127 0.016142
85 0.011047 0.018544 0.03357 0.018533 0.011685 0.020589 0.017682
86 0.01217 0.020722 0.037392 0.02036 0.013185 0.022317 0.019536
87 0.013245 0.02238 0.040665 0.022693 0.014354 0.023563 0.020973
88 0.014662 0.02429 0.044242 0.0256 0.015317 0.025268 0.022745
89 0.016673 0.0252 0.047952 0.02868 0.016265 0.027075 0.025632
90 0.018557 0.025969 0.051673 0.03212 0.017375 0.02948 0.028335
91 0.02015 0.027078 0.055083 0.036387 0.018717 0.031414 0.03142
92 0.02158 0.028536 0.057953 0.040373 0.019691 0.034102 0.034754
93 0.022728 0.029452 0.06051 0.044347 0.01996 0.038162 0.03917
94 0.023697 0.030123 0.062373 0.047627 0.020365 0.041951 0.043414
95 0.025245 0.031359 0.064388 0.05092 0.020904 0.045992 0.048398
96 0.026313 0.032627 0.066243 0.053667 0.021715 0.049557 0.052759
97 0.026679 0.03464 0.068243 0.055987 0.022172 0.053384 0.056618
98 0.027174 0.035603 0.070419 0.05824 0.02361 0.056804 0.060748




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
100 0.02831 0.038591 0.074466 0.064027 0.026465 0.063875 0.06904
101 0.028773 0.040187 0.07651 0.067413 0.027942 0.067237 0.073588
102 0.028626 0.041459 0.077769 0.070253 0.029327 0.070435 0.079213
103 0.028963 0.043162 0.079302 0.0734 0.031584 0.075222 0.084426
104 0.028541 0.04449 0.080104 0.0762 0.033152 0.080219 0.089482
105 0.02819 0.045379 0.080163 0.07884 0.034387 0.085935 0.093904
106 0.028057 0.04583 0.080254 0.08092 0.035615 0.092286 0.099219
107 0.028468 0.044415 0.0803 0.0824 0.037154 0.100263 0.103046
108 0.029108 0.042339 0.081042 0.084067 0.03883 0.107638 0.107458
109 0.03029 0.041011 0.081824 0.085827 0.039707 0.115095 0.112931
110 0.030116 0.040028 0.08279 0.088053 0.041205 0.120946 0.119172
111 0.029843 0.0386 0.083813 0.090773 0.043116 0.12644 0.127005
112 0.029101 0.037141 0.084538 0.094013 0.04509 0.13076 0.136339
113 0.028097 0.036317 0.084183 0.097307 0.046873 0.135277 0.144425
114 0.027099 0.036242 0.083109 0.100653 0.048738 0.13869 0.150718
115 0.026636 0.036278 0.081756 0.103373 0.050657 0.141337 0.157111
116 0.026288 0.03699 0.080589 0.105733 0.052784 0.144243 0.162577
117 0.026015 0.03706 0.079846 0.107333 0.054104 0.148071 0.168271
118 0.025938 0.037204 0.079142 0.108067 0.054999 0.152755 0.174458
119 0.0253 0.037353 0.078559 0.108907 0.055064 0.157193 0.18076
120 0.025532 0.037564 0.077705 0.10948 0.054611 0.16197 0.186621
121 0.026646 0.036971 0.077633 0.11052 0.054605 0.166341 0.192885
122 0.026532 0.03687 0.077328 0.11208 0.055497 0.169781 0.197572
123 0.026361 0.037415 0.077151 0.113813 0.055664 0.172635 0.201588




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
125 0.02594 0.036738 0.076713 0.11756 0.058086 0.175047 0.209446
126 0.025271 0.035884 0.076597 0.118787 0.058767 0.175796 0.212609
127 0.024474 0.035888 0.07636 0.119573 0.059424 0.176332 0.215301
128 0.02408 0.035726 0.076853 0.119853 0.059961 0.176689 0.217753
129 0.024364 0.035254 0.077043 0.120267 0.060356 0.17729 0.220298
130 0.02405 0.034623 0.076906 0.120027 0.060173 0.177975 0.222586
131 0.023832 0.03473 0.077497 0.120587 0.060402 0.178744 0.225083
132 0.023943 0.03463 0.077743 0.120787 0.060052 0.179406 0.226501
133 0.024107 0.035008 0.077771 0.121187 0.059312 0.180405 0.227861
134 0.024122 0.035157 0.078114 0.122053 0.058443 0.18018 0.229226
135 0.023985 0.034829 0.078108 0.122227 0.058191 0.179485 0.229788
136 0.023619 0.034728 0.078201 0.12192 0.057475 0.179133 0.230082
137 0.02302 0.034613 0.077888 0.121907 0.056277 0.178203 0.229733
138 0.023302 0.034353 0.077638 0.121813 0.05624 0.1764 0.229753
139 0.023144 0.034194 0.077703 0.121107 0.055319 0.174607 0.228589
140 0.022661 0.03403 0.077695 0.12064 0.053621 0.17373 0.227428
141 0.022116 0.033598 0.077301 0.1196 0.052858 0.172509 0.225554
142 0.021902 0.03346 0.077374 0.11812 0.051946 0.170674 0.223932
143 0.021844 0.03319 0.077298 0.116987 0.050928 0.169293 0.221198
144 0.02157 0.032945 0.077094 0.11604 0.049985 0.167915 0.218965
145 0.021362 0.0329 0.076964 0.115093 0.048839 0.166 0.216772
146 0.021049 0.032506 0.077081 0.11372 0.048105 0.164412 0.213596
147 0.021315 0.032553 0.076713 0.11268 0.046983 0.162385 0.21033
148 0.021314 0.031981 0.076528 0.11124 0.04578 0.160222 0.207712




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
150 0.020784 0.031311 0.076488 0.10908 0.04334 0.155736 0.200138
151 0.020856 0.031692 0.076841 0.107507 0.042167 0.153315 0.19654
152 0.020664 0.031647 0.076603 0.10644 0.040824 0.150923 0.192549
153 0.020225 0.03125 0.076736 0.1052 0.039354 0.148535 0.18865
154 0.020074 0.030787 0.076898 0.103853 0.038088 0.146416 0.18473
155 0.020017 0.030508 0.07703 0.102747 0.037519 0.14363 0.180396
156 0.020062 0.030785 0.07699 0.101467 0.035844 0.141008 0.175921
157 0.019775 0.030276 0.077316 0.100187 0.034995 0.138098 0.171931
158 0.01939 0.03003 0.077346 0.099413 0.034001 0.13507 0.167677
159 0.01923 0.029768 0.07738 0.09796 0.032394 0.132342 0.162898
160 0.019403 0.02959 0.07724 0.097027 0.031266 0.12881 0.157652
161 0.018883 0.029521 0.077334 0.095907 0.030121 0.125525 0.152894
162 0.018517 0.029106 0.076928 0.094827 0.028988 0.122828 0.14794
163 0.018494 0.028511 0.077179 0.09364 0.027948 0.119546 0.143293
164 0.018144 0.028592 0.076933 0.092707 0.027055 0.11666 0.138291
165 0.018286 0.028127 0.076916 0.090933 0.025884 0.113008 0.133598
166 0.017607 0.027466 0.076378 0.09 0.024947 0.109687 0.128805
167 0.017465 0.026905 0.075949 0.08908 0.023632 0.106153 0.124191
168 0.01735 0.026422 0.074938 0.087493 0.022898 0.103141 0.119238
169 0.017317 0.026131 0.074356 0.085507 0.02183 0.099852 0.114166
170 0.01686 0.025733 0.073066 0.08396 0.021073 0.096048 0.110119
171 0.016752 0.024628 0.071938 0.082213 0.020181 0.092168 0.106055
172 0.01622 0.023894 0.070772 0.08032 0.019128 0.088321 0.101569
173 0.016246 0.023383 0.0693 0.078867 0.018469 0.084668 0.097624




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
175 0.015511 0.022785 0.066423 0.075147 0.017482 0.076128 0.089815
176 0.015054 0.0221 0.064735 0.07312 0.01685 0.072244 0.086296
177 0.014983 0.02169 0.063208 0.070893 0.016333 0.068583 0.082711
178 0.014815 0.020892 0.061698 0.068933 0.016064 0.06502 0.079331
179 0.014709 0.019924 0.059514 0.06724 0.015405 0.061781 0.076028
180 0.013824 0.01944 0.058065 0.06532 0.014662 0.058675 0.073348
181 0.013397 0.01847 0.056155 0.062893 0.01433 0.055888 0.071021
182 0.01335 0.01775 0.054022 0.061307 0.014074 0.053391 0.068482
183 0.01328 0.017404 0.052228 0.059533 0.013484 0.050065 0.065498
184 0.012628 0.01688 0.050051 0.057253 0.012602 0.047504 0.063608
185 0.012013 0.015662 0.047392 0.05516 0.012092 0.044708 0.061355
186 0.011751 0.015294 0.045441 0.053333 0.011604 0.042698 0.059224
187 0.011375 0.014604 0.043548 0.050893 0.011541 0.040499 0.057565
188 0.010871 0.014029 0.041448 0.048667 0.011031 0.038012 0.055067
189 0.010255 0.013488 0.039349 0.045973 0.010581 0.03584 0.053263
190 0.009739 0.012618 0.036983 0.043733 0.009782 0.034255 0.051469
191 0.009808 0.012101 0.034935 0.04132 0.009319 0.032083 0.049376
192 0.008627 0.011773 0.032574 0.03932 0.00876 0.030507 0.046601
193 0.008524 0.01127 0.030663 0.03708 0.008653 0.028772 0.044687
194 0.007633 0.010329 0.028447 0.034747 0.008252 0.026757 0.042691
195 0.007519 0.009578 0.026281 0.032427 0.007793 0.024971 0.040378
196 0.007152 0.008981 0.024672 0.030067 0.006917 0.02363 0.03809
197 0.006557 0.008698 0.022272 0.02784 0.006491 0.021679 0.035918
198 0.006193 0.007928 0.020111 0.025453 0.006203 0.02029 0.033721




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
200 0.006005 0.007178 0.01691 0.021907 0.004871 0.017638 0.029708
201 0.005127 0.006569 0.015213 0.019627 0.004961 0.016176 0.027323
202 0.004688 0.00588 0.013812 0.018267 0.004241 0.01484 0.025362
203 0.004567 0.005282 0.011934 0.01644 0.003999 0.013501 0.023715
204 0.004308 0.004099 0.010398 0.015333 0.003461 0.012291 0.021969
205 0.004006 0.00395 0.009059 0.01344 0.003104 0.011864 0.019758
206 0.00369 0.003671 0.008145 0.012373 0.002598 0.010936 0.018268
207 0.003424 0.002517 0.007218 0.010973 0.00251 0.009557 0.016683
208 0.003232 0.001885 0.006319 0.00976 0.002345 0.00898 0.014962
209 0.003358 0.00171 0.005223 0.008333 0.002422 0.008171 0.013867
210 0.002873 0.001446 0.004763 0.007413 0.002273 0.007115 0.012702
211 0.00234 0.001252 0.003742 0.006333 0.001922 0.00615 0.01055
212 0.002259 0.00083 0.003293 0.005427 0.001853 0.00548 0.009607
213 0.002163 0.000549 0.002477 0.004693 0.00168 0.004819 0.008691
214 0.00242 0.000142 0.002238 0.004093 0.001769 0.004034 0.007468
215 0.001765 0.000193 0.001613 0.00348 0.001349 0.003267 0.006315
216 0.001478 2.57E-05 0.001463 0.002787 0.00124 0.002765 0.005324
217 0.001246 -0.0006 0.000428 0.001933 0.001268 0.002125 0.00452
218 0.001484 -0.00063 0.000593 0.001813 0.001353 0.00209 0.00369
219 0.000998 -0.00042 0.000628 0.00084 0.000861 0.001726 0.003033
220 0.000812 -0.00089 -0.00013 8E-05 0.000655 0.00184 0.002887
221 0.000808 -0.00109 1.58E-05 -0.00031 0.000762 0.001624 0.001677
222 0.00096 -0.00128 -0.00036 -0.00072 0.000917 0.001466 0.001584
223 0.000953 -0.00126 -0.0006 -0.00145 0.001015 0.001487 0.001248




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
225 0.000406 -0.00095 -0.00014 -0.0016 0.000384 0.001405 0.000251
226 0.000694 -0.00141 -0.00047 -0.00171 0.000563 0.00158 0.000358
227 0.000943 -0.00107 -0.00034 -0.00169 0.000677 0.001578 -1.3E-05
228 0.000438 -0.00088 -0.00041 -0.002 0.000391 0.00181 -0.00048
229 0.000385 -0.0005 -0.00042 -0.00203 0.000458 0.001976 -0.00055
230 0.000656 -0.00056 -0.00079 -0.00225 0.000645 0.001684 -0.00082
231 0.00088 -0.00072 -0.00044 -0.00239 0.000255 0.001729 -0.00067
232 0.001102 -0.00077 -0.00081 -0.00219 9.68E-05 0.001738 -0.00038
233 0.000655 -0.00032 -0.00084 -0.00223 -0.0002 0.00176 -0.00018
234 0.000399 -0.00072 -0.00076 -0.00235 -0.00065 0.002006 -0.00041
235 0.000536 -0.00066 -0.00112 -0.00211 -0.00052 0.001654 -0.00023
236 0.000763 -0.00095 -0.00143 -0.00184 -0.00081 0.001224 1.67E-06
237 0.000108 -0.00071 -0.00125 -0.00163 -0.00041 0.001344 4.33E-05
238 0.00065 -0.00072 -0.0014 -0.00173 -0.00095 0.001149 -0.00061
239 0.000466 -0.00082 -0.00135 -0.0018 -0.00122 0.000906 -0.00012
240 0.00064 -0.00074 -0.00185 -0.00132 -0.00112 0.000301 0.000173
241 0.000316 -0.00082 -0.00186 -0.00153 -0.00118 -1.9E-06 -3.9E-05
242 0.000475 -0.00061 -0.00146 -0.00159 -0.0015 -0.0003 4.67E-05
243 0.000652 -0.00081 -0.00184 -0.00191 -0.00189 -0.00042 0.000307
244 0.000439 -0.001 -0.0016 -0.00183 -0.00148 -0.00139 -5.1E-05
245 0.000447 -0.00122 -0.00209 -0.00227 -0.0016 -0.00173 0.000274
246 0.000635 -0.00077 -0.00218 -0.00231 -0.00137 -0.00144 0.000374
247 0.000485 -0.00097 -0.00246 -0.00207 -0.00146 -0.0018 -0.00028
248 0.000858 -0.00127 -0.00244 -0.00215 -0.00143 -0.00171 6.5E-05




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
250 0.000802 -0.00162 -0.00259 -0.00264 -0.00124 -0.00199 -0.00013
251 0.000763 -0.00091 -0.00235 -0.0026 -0.00127 -0.00167 -0.00028
252 0.000347 -0.00103 -0.00295 -0.00288 -0.00099 -0.00189 0.000238
253 0.000816 -0.00148 -0.00292 -0.00315 -0.00068 -0.00224 -1E-04
254 0.000374 -0.00152 -0.0031 -0.00301 -0.00077 -0.00194 0.000173
255 0.000276 -0.00108 -0.00378 -0.00303 -0.00109 -0.00183 -0.00044
256 0.000428 -0.00116 -0.00349 -0.00337 -0.00111 -0.00161 -0.00037
257 0.00029 -0.00151 -0.00343 -0.00323 -0.00075 -0.0017 -0.0008
258 0.000612 -0.00143 -0.00368 -0.00303 -0.00095 -0.00201 -0.00094
259 0.000379 -0.00128 -0.00381 -0.00307 -0.00124 -0.00218 -0.00041
260 0.000549 -0.0011 -0.00397 -0.0036 -0.00084 -0.0021 -0.00142
261 0.000697 -0.00112 -0.00408 -0.00339 -0.00073 -0.0023 -0.00189
262 0.000821 -0.00144 -0.00403 -0.0036 -0.00122 -0.00227 -0.00181
263 0.000553 -0.00175 -0.00451 -0.00324 -0.00134 -0.00244 -0.00169
264 0.00029 -0.00107 -0.00444 -0.00343 -0.00121 -0.00189 -0.00216
265 0.000205 -0.00128 -0.00436 -0.00352 -0.0013 -0.00203 -0.00223
266 0.00055 -0.00133 -0.00449 -0.00373 -0.00109 -0.00222 -0.00234
267 0.000616 -0.00147 -0.00457 -0.00333 -0.00123 -0.00239 -0.00273
268 0.000378 -0.00179 -0.00462 -0.00355 -0.00122 -0.00251 -0.00242
269 0.000216 -0.0018 -0.00469 -0.00333 -0.00113 -0.00219 -0.00265
270 0.000413 -0.00152 -0.00517 -0.00364 -0.00117 -0.00242 -0.00316
271 0.000399 -0.00183 -0.00508 -0.0034 -0.00129 -0.00258 -0.00346
272 1.43E-05 -0.00148 -0.00505 -0.00328 -0.00106 -0.00264 -0.00363
273 0.000391 -0.00167 -0.00534 -0.00355 -0.00087 -0.00273 -0.00365




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
275 0.00011 -0.00187 -0.0051 -0.00328 -0.00139 -0.00253 -0.00405
276 0.000193 -0.00248 -0.00515 -0.00317 -0.00131 -0.00287 -0.00392
277 0.000461 -0.00226 -0.00495 -0.00312 -0.00129 -0.0031 -0.00399
278 0.000212 -0.00176 -0.00525 -0.00333 -0.00128 -0.00361 -0.00365
279 5.71E-05 -0.00201 -0.00489 -0.00333 -0.00134 -0.00303 -0.00354
280 0.000249 -0.00201 -0.00533 -0.00315 -0.00099 -0.0032 -0.0041
281 -0.00011 -0.00216 -0.00516 -0.00297 -0.00112 -0.00316 -0.00376
282 5.24E-05 -0.00228 -0.00508 -0.0032 -0.00125 -0.00307 -0.00347
283 -8.1E-05 -0.00156 -0.00516 -0.00344 -0.00116 -0.00319 -0.00379
284 1.62E-05 -0.00204 -0.00514 -0.00311 -0.00098 -0.00302 -0.0038
285 -1.7E-05 -0.00174 -0.00529 -0.00287 -0.00152 -0.00323 -0.00344
286 -0.00025 -0.00173 -0.00517 -0.00335 -0.00136 -0.00351 -0.00349
287 -0.00027 -0.00233 -0.00533 -0.00291 -0.00159 -0.00288 -0.00368
288 -0.00047 -0.0023 -0.0055 -0.00284 -0.00144 -0.00317 -0.00367
289 -0.0001 -0.00187 -0.00516 -0.00307 -0.00165 -0.00341 -0.00368
290 0.000184 -0.002 -0.00559 -0.00283 -0.0017 -0.00322 -0.00353
291 7.05E-05 -0.00171 -0.00544 -0.00293 -0.00148 -0.00334 -0.00327
292 -8.7E-05 -0.0022 -0.00539 -0.00272 -0.00198 -0.00336 -0.00312
293 9.71E-05 -0.00222 -0.00511 -0.00253 -0.00188 -0.00302 -0.00357
294 -7.1E-05 -0.00223 -0.00514 -0.00276 -0.00225 -0.00309 -0.00333
295 -3.5E-05 -0.00198 -0.00511 -0.00251 -0.00169 -0.00317 -0.00283
296 -0.00013 -0.0018 -0.00542 -0.00241 -0.00155 -0.0031 -0.00313
297 -0.00031 -0.0019 -0.00533 -0.00225 -0.00172 -0.00244 -0.00333
298 3.81E-05 -0.00238 -0.00512 -0.00253 -0.00215 -0.00275 -0.00268




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
300 -0.00039 -0.0022 -0.00584 -0.00268 -0.00163 -0.00288 -0.00308
301 -5.5E-05 -0.00185 -0.00533 -0.00233 -0.00158 -0.00275 -0.00283
302 1.39E-18 -0.00194 -0.00531 -0.00217 -0.00157 -0.00237 -0.00302
303 -0.0003 -0.00201 -0.00524 -0.00201 -0.00173 -0.00221 -0.00295
304 -0.00026 -0.00212 -0.00495 -0.00257 -0.00183 -0.00229 -0.00242
305 -0.00013 -0.00163 -0.00488 -0.00205 -0.00167 -0.0024 -0.00216
306 6.48E-05 -0.0018 -0.00458 -0.00227 -0.00136 -0.00168 -0.00257
307 2.57E-05 -0.00196 -0.00486 -0.00212 -0.002 -0.00136 -0.00293
308 -0.00026 -0.00165 -0.00481 -0.00185 -0.002 -0.00162 -0.00271
309 2.19E-05 -0.0021 -0.00472 -0.00189 -0.00202 -0.00175 -0.00265
310 -7.3E-05 -0.00187 -0.00447 -0.0024 -0.00182 -0.0016 -0.00248
311 -8.9E-05 -0.00208 -0.00421 -0.00219 -0.00181 -0.0014 -0.00242
312 -1.6E-05 -0.00185 -0.00395 -0.00217 -0.00169 -0.00172 -0.00249
313 0.000132 -0.00182 -0.0041 -0.00232 -0.00165 -0.00161 -0.00293
314 -0.00018 -0.00184 -0.00411 -0.00239 -0.00169 -0.00141 -0.00267
315 -0.00032 -0.00167 -0.00406 -0.00213 -0.00162 -0.00171 -0.0026
316 -0.00039 -0.00201 -0.00387 -0.00227 -0.0015 -0.00156 -0.00282
317 -0.00051 -0.00182 -0.00397 -0.00203 -0.0016 -0.00168 -0.00291
318 -0.00067 -0.00178 -0.0039 -0.002 -0.00173 -0.00168 -0.00267
319 -0.00033 -0.00162 -0.004 -0.00216 -0.00121 -0.00189 -0.00323
320 -0.00057 -0.00191 -0.00361 -0.00227 -0.00147 -0.00162 -0.00315
321 -0.00062 -0.00175 -0.00379 -0.00237 -0.00142 -0.00167 -0.00301
322 -0.00069 -0.00178 -0.0039 -0.00228 -0.00121 -0.00175 -0.00296
323 -0.00079 -0.00185 -0.00357 -0.00219 -0.0015 -0.00166 -0.00305




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
325 -0.00018 -0.00203 -0.00373 -0.00216 -0.00147 -0.00215 -0.00291
326 -0.00067 -0.00216 -0.00376 -0.00244 -0.00139 -0.00196 -0.00294
327 -0.00087 -0.00213 -0.00403 -0.0026 -0.0014 -0.00219 -0.00312
328 -0.00064 -0.00212 -0.00393 -0.00265 -0.00128 -0.00266 -0.00293
329 -0.0003 -0.00236 -0.0039 -0.00228 -0.00116 -0.00235 -0.00328
330 -0.00073 -0.00227 -0.00382 -0.00265 -0.00125 -0.00251 -0.00295
331 -0.0006 -0.00201 -0.00411 -0.00265 -0.00131 -0.00263 -0.003
332 -0.00072 -0.00187 -0.00432 -0.0024 -0.00103 -0.00262 -0.00327
333 -0.00087 -0.00201 -0.00418 -0.00276 -0.00125 -0.00266 -0.00324
334 -0.00103 -0.00184 -0.00407 -0.00305 -0.0013 -0.00234 -0.00304
335 -0.00077 -0.00228 -0.00447 -0.00312 -0.00135 -0.0025 -0.00327
336 -0.00045 -0.00238 -0.00468 -0.00313 -0.00156 -0.00299 -0.00311
337 -0.00068 -0.00207 -0.00494 -0.00284 -0.00168 -0.00299 -0.00289
338 -0.00053 -0.00221 -0.0049 -0.00327 -0.00172 -0.00259 -0.00336
339 -0.00069 -0.00202 -0.00482 -0.00304 -0.00117 -0.0028 -0.00357
340 -0.00103 -0.0023 -0.00521 -0.00317 -0.00147 -0.00272 -0.00332
341 -0.00059 -0.00208 -0.0055 -0.00305 -0.00123 -0.00273 -0.00332
342 -0.00076 -0.00249 -0.00551 -0.00337 -0.00148 -0.00264 -0.00377
343 -0.00101 -0.00229 -0.00505 -0.00308 -0.00131 -0.00262 -0.00351
344 -0.00098 -0.00181 -0.00497 -0.00361 -0.00157 -0.00282 -0.00358
345 -0.00092 -0.00178 -0.00567 -0.00341 -0.00156 -0.00293 -0.00418
346 -0.00061 -0.00183 -0.00502 -0.00392 -0.0019 -0.00289 -0.00375
347 -0.00092 -0.00233 -0.00499 -0.00388 -0.00157 -0.00264 -0.00346
348 -0.0008 -0.00251 -0.00474 -0.00369 -0.0013 -0.00249 -0.00361




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
350 -0.00075 -0.00184 -0.00521 -0.00363 -0.00175 -0.00238 -0.00373
351 -0.0007 -0.00185 -0.00524 -0.00401 -0.00181 -0.00295 -0.00378
352 -0.00089 -0.00179 -0.00494 -0.00388 -0.00173 -0.00261 -0.0042
353 -0.00048 -0.0018 -0.00479 -0.00375 -0.00168 -0.00245 -0.00383
354 -0.00041 -0.0023 -0.00521 -0.00391 -0.00173 -0.00245 -0.00391
355 -0.00023 -0.00208 -0.0051 -0.00364 -0.00143 -0.00257 -0.00411
356 -0.00043 -0.00219 -0.00469 -0.00381 -0.00181 -0.00241 -0.00393
357 -0.0005 -0.00198 -0.0047 -0.0034 -0.00167 -0.00248 -0.00405
358 -0.00062 -0.0018 -0.00488 -0.00363 -0.00156 -0.00247 -0.00389
359 -7.7E-05 -0.00212 -0.0047 -0.00367 -0.00179 -0.00253 -0.00424
360 -0.00047 -0.00218 -0.0049 -0.00372 -0.00165 -0.00244 -0.00355
361 -0.00079 -0.00216 -0.00474 -0.00321 -0.00166 -0.0027 -0.00375
362 -0.00048 -0.00205 -0.00478 -0.00328 -0.00176 -0.00232 -0.00395
363 -0.00024 -0.00183 -0.00509 -0.00303 -0.0019 -0.00242 -0.00379
364 -1E-05 -0.0019 -0.00503 -0.00321 -0.00172 -0.00233 -0.00354
365 -0.00039 -0.00235 -0.00442 -0.00332 -0.00147 -0.00197 -0.00392
366 -0.0007 -0.00213 -0.0047 -0.00327 -0.00151 -0.00227 -0.00381
367 -0.00077 -0.0023 -0.00497 -0.00264 -0.00167 -0.00178 -0.00322
368 -0.00011 -0.0018 -0.00462 -0.00283 -0.00163 -0.00241 -0.00321
369 -0.00017 -0.00204 -0.00462 -0.00283 -0.00158 -0.00202 -0.00315
370 -0.00053 -0.00184 -0.0045 -0.00292 -0.00173 -0.00203 -0.00296
371 -0.0006 -0.00193 -0.00471 -0.00284 -0.00109 -0.00176 -0.00334
372 -0.00058 -0.0019 -0.00457 -0.00268 -0.00129 -0.00187 -0.00312
373 -0.00044 -0.0016 -0.00458 -0.00293 -0.00156 -0.00194 -0.00288




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
375 -0.00093 -0.00149 -0.00458 -0.00285 -0.00142 -0.00202 -0.00306
376 -0.00057 -0.00175 -0.00416 -0.00255 -0.00158 -0.00163 -0.00259
377 -0.00012 -0.00179 -0.0042 -0.00232 -0.00157 -0.00177 -0.00255
378 -0.00077 -0.00161 -0.00379 -0.00251 -0.00127 -0.00236 -0.00288
379 -0.00077 -0.00182 -0.00401 -0.00247 -0.00163 -0.00176 -0.00267
380 -0.0003 -0.00197 -0.00374 -0.00227 -0.00126 -0.00138 -0.00269
381 -0.00022 -0.00152 -0.00384 -0.00232 -0.00111 -0.00186 -0.00282
382 8.1E-05 -0.00178 -0.00398 -0.00243 -0.00133 -0.00168 -0.00299
383 -0.0005 -0.00198 -0.00336 -0.00221 -0.00105 -0.00193 -0.00228
384 -0.00047 -0.00195 -0.00351 -0.00219 -0.00126 -0.00192 -0.00278
385 -0.00026 -0.00183 -0.0034 -0.00227 -0.00123 -0.00183 -0.00309
386 -0.00035 -0.00198 -0.00348 -0.00243 -0.00138 -0.00178 -0.00301
387 -0.00076 -0.00156 -0.00365 -0.00183 -0.00103 -0.00186 -0.00281
388 -0.00055 -0.00184 -0.00326 -0.00212 -0.00069 -0.00182 -0.00298
389 -0.00059 -0.00217 -0.00294 -0.00247 -0.00104 -0.00162 -0.00266
390 -0.00013 -0.00231 -0.00315 -0.00213 -0.00109 -0.00144 -0.0026
391 -0.0001 -0.00159 -0.00298 -0.0022 -0.00073 -0.00162 -0.00265
392 -0.00065 -0.00186 -0.00246 -0.00245 -0.00105 -0.00165 -0.00244
393 -0.00065 -0.00194 -0.0029 -0.00191 -0.00103 -0.00124 -0.00266
394 -0.00045 -0.00156 -0.0024 -0.00191 -0.00081 -0.00132 -0.00297
395 -0.00029 -0.00101 -0.00251 -0.00192 -0.00137 -0.00113 -0.0028
396 -0.00029 -0.00112 -0.00221 -0.00207 -0.00123 -0.0012 -0.00225
397 -0.00075 -0.00145 -0.0023 -0.00211 -0.00113 -0.00106 -0.0027
398 -0.00072 -0.0013 -0.00205 -0.00221 -0.00075 -0.00087 -0.00253




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
400 -0.00026 -0.00115 -0.00201 -0.00152 -0.00076 -0.00097 -0.00193
401 -0.00035 -0.00113 -0.00175 -0.00187 -0.001 -0.0009 -0.00204
402 -0.00048 -0.00145 -0.00181 -0.00184 -0.00092 -0.00061 -0.00175
403 -0.00017 -0.00166 -0.00175 -0.00167 -0.00064 -0.00081 -0.00146
404 -0.00026 -0.00117 -0.00171 -0.00153 -0.00068 -0.00043 -0.00217
405 -0.00038 -0.00121 -0.00143 -0.00133 -0.0008 -0.00057 -0.00205
406 -0.00062 -0.00135 -0.00152 -0.00151 -0.00068 -0.00068 -0.00173
407 -0.00031 -0.00146 -0.0012 -0.00127 -0.00064 -0.00038 -0.00209
408 -3.7E-05 -0.00114 -0.00124 -0.00165 -0.00053 -0.00036 -0.00172
409 -0.00028 -0.0012 -0.00117 -0.00168 -0.00073 -0.0003 -0.0017
410 -0.00056 -0.0008 -0.00082 -0.00149 -0.00073 -0.00077 -0.00176
411 -6.6E-05 -0.00088 -0.00062 -0.00177 -0.00041 -0.00066 -0.0021
412 -2.3E-05 -0.00101 -0.00111 -0.00147 -0.00046 -0.0002 -0.00172
413 -0.00012 -0.00108 -0.00064 -0.00145 -0.00062 -0.00037 -0.00167
414 -0.00028 -0.00079 -0.00077 -0.00151 -0.00018 -0.00048 -0.00147
415 -0.00041 -0.00101 -0.00065 -0.00168 -0.00045 -7.3E-05 -0.00112
416 -0.00025 -0.00074 -0.00097 -0.00141 -0.00065 0.000278 -0.00105
417 -9.5E-06 -0.00052 -0.00087 -0.00117 -0.00056 0.000242 -0.00119
418 -0.00011 -0.00074 -0.00078 -0.00119 -0.00021 -7.5E-05 -0.00087
419 -8.5E-05 -0.00054 -0.00088 -0.00159 -0.00048 -0.00015 -0.00055
420 -0.0003 -0.00082 -0.00062 -0.00128 -0.0002 -0.00026 -0.00099
421 0.00015 -0.00057 -0.00044 -0.00101 -0.00028 0.000169 -0.0009
422 -0.00012 -0.0004 -0.0004 -0.00083 -0.00011 0.000131 -0.0006
423 -0.0004 -0.00024 -0.00051 -0.00107 -0.00031 8.19E-05 -0.00048




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
425 -0.00011 -0.00045 -0.00026 -0.00067 -0.00014 -4.6E-05 -0.00036
426 0.000337 -0.00062 -2.8E-05 -0.00055 0.000167 0.000208 -0.00055
427 2.76E-05 -0.0001 -0.00012 -0.00047 -6.1E-05 0.000287 -0.00067
428 0.00011 -0.00019 -0.0003 -0.00061 -0.00014 -8.7E-05 -0.00034
429 9.14E-05 -7E-05 -0.00026 -0.00037 0.000126 0.000192 -4.9E-05
430 0.000568 3.14E-05 -0.00028 -0.0002 0.000164 0.000261 -0.00055
431 0.000257 -3.5E-05 -0.00026 -0.00024 0.000273 0.000352 -0.00064
432 0.000186 5.24E-05 -6.8E-05 -0.00037 -5.7E-06 0.000469 1E-04
433 0.000555 8.38E-05 4E-05 -0.0002 0.000201 0.000412 -9.8E-05
434 0.000536 2.48E-05 0.000133 -0.00013 0.000194 0.000534 -2.3E-05
435 0.000524 7.62E-06 0.000267 1.33E-05 0.000219 0.000763 9.08E-05
436 0.000666 5.71E-05 1.58E-05 -0.00011 0.000279 0.000395 5E-05
437 0.000283 0.000261 2.17E-05 -4E-05 0.000231 0.000545 0.000162
438 0.000202 -0.00018 3.5E-05 -0.00029 0.000151 0.000858 0.000533
439 0.000538 7.71E-05 0.000624 0.00024 -0.00015 0.000814 0.000558
440 0.000639 0.000251 0.00045 0.00012 -7.2E-05 0.000694 0.000432
441 0.000615 0.000646 0.000645 0.00032 0.000143 0.001144 0.000481
442 0.001032 0.00046 0.000666 0.00032 -0.00021 0.001144 0.001192
443 0.000966 0.000213 0.000323 0.00016 -5.5E-05 0.001232 0.000929
444 0.000924 0.00051 0.000997 0.0004 0.000346 0.001492 0.000863
445 0.000644 0.00063 0.001228 0.00028 0.000176 0.001702 0.001235
446 0.000751 0.00084 0.000803 0.00024 0.000406 0.001551 0.001246
447 0.000652 0.001014 0.000757 0.000133 0.000547 0.001308 0.001023
448 0.000822 0.000622 0.000757 0.000653 0.000279 0.001845 0.001303




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
450 0.000746 0.000512 0.000888 0.000573 0.000301 0.001515 0.00114
451 0.000597 0.000799 0.001003 0.00092 3.11E-05 0.001812 0.001911
452 0.001272 0.00125 0.001089 0.0012 0.000173 0.001978 0.001569
453 0.000769 0.001295 0.001203 0.0012 0.000268 0.00181 0.001806
454 0.00101 0.001132 0.000872 0.000987 0.000376 0.002364 0.001721
455 0.000643 0.001165 0.001125 0.00108 0.000203 0.00223 0.002223
456 0.00139 0.000796 0.001017 0.000973 0.000519 0.001969 0.001962
457 0.001389 0.000348 0.001342 0.000987 0.000818 0.001996 0.001729
458 0.00137 0.000906 0.001428 0.001293 0.000732 0.002532 0.002177
459 0.001226 0.001123 0.001185 0.001373 0.000458 0.002039 0.002014
460 0.001856 0.000976 0.001139 0.00096 0.000586 0.002226 0.00157
461 0.001593 0.001141 0.001394 0.00144 0.001089 0.002547 0.002059
462 0.00138 0.000858 0.001312 0.001613 0.000547 0.002403 0.002137
463 0.001114 0.001187 0.001386 0.001693 0.000823 0.002205 0.001429
464 0.001517 0.001874 0.001433 0.002093 0.000469 0.002675 0.002133
465 0.001618 0.001539 0.001448 0.001987 0.000777 0.002764 0.002464
466 0.001394 0.001317 0.001369 0.00216 0.001204 0.002372 0.001598
467 0.000998 0.001111 0.001632 0.001907 0.000971 0.002466 0.001963
468 0.001428 0.001213 0.001446 0.00176 0.000637 0.00282 0.002435
469 0.001804 0.001471 0.001823 0.00188 0.000829 0.002488 0.001988
470 0.001201 0.001411 0.002054 0.001613 0.001091 0.002586 0.002651
471 0.001292 0.00147 0.001918 0.001933 0.000872 0.002594 0.002852
472 0.001257 0.00153 0.001853 0.00184 0.00111 0.002994 0.002686
473 0.001861 0.001753 0.002251 0.002133 0.001439 0.003268 0.00226




 Control Dil+A Dil+AP Dil+APL CT+Dil+A CT+Dil+AP CT+Dil+APL
475 0.001551 0.001811 0.002724 0.002333 0.001341 0.003243 0.002223
476 0.001419 0.001763 0.002562 0.00192 0.00172 0.003463 0.002614
477 0.001717 0.002175 0.00307 0.00208 0.002421 0.003454 0.002749
478 0.002145 0.001947 0.002448 0.00208 0.00201 0.003275 0.003048
479 0.002091 0.001968 0.002854 0.002013 0.002144 0.003179 0.003041
480 0.001735 0.001908 0.00316 0.002053 0.002386 0.003669 0.003051
481 0.001784 0.002643 0.003445 0.002267 0.002412 0.004245 0.003614
482 0.00145 0.00283 0.003442 0.0026 0.002459 0.004269 0.003241
483 0.001609 0.002568 0.00337 0.0028 0.002354 0.004224 0.003414
484 0.001286 0.002388 0.003842 0.00248 0.00208 0.00441 0.003852
485 0.001293 0.002546 0.003603 0.003027 0.002621 0.004748 0.003914
486 0.001812 0.002863 0.004629 0.00312 0.002512 0.004574 0.003474
487 0.00209 0.003456 0.004331 0.002893 0.002542 0.005132 0.003858
488 0.002003 0.00297 0.004527 0.003053 0.002799 0.005094 0.004217
489 0.001983 0.003423 0.004682 0.00316 0.003205 0.005348 0.004116
490 0.002207 0.003698 0.005376 0.003133 0.003232 0.005453 0.004443
491 0.00219 0.003563 0.005478 0.00348 0.003371 0.005929 0.005068
492 0.002209 0.00382 0.005595 0.00388 0.003491 0.005974 0.004989
493 0.002369 0.003942 0.006442 0.004093 0.003466 0.006368 0.005523
494 0.002468 0.003956 0.006668 0.004693 0.003981 0.006656 0.005742
495 0.002752 0.004308 0.006857 0.004893 0.003751 0.007084 0.005988
496 0.002685 0.004436 0.007223 0.004813 0.004603 0.007224 0.005931
497 0.002722 0.004267 0.007679 0.00528 0.00482 0.00765 0.006443
498 0.002918 0.00472 0.008278 0.00572 0.004499 0.008414 0.006998




APPENDIX # 2 


























%PROGRAM # 1 
2 %DATED - MARCH 29,2010 
3 %COMMENTED BY - MURALIDHAR PADALA 
4 %CODE TO CONVERT THE SELECTED SERIES OF TIFF IMAGES TO THE 
FORMAT SUITABLE 
5 %FOR FURTHER PROCESSING USING THE MARKER CODE 
6 %Eg. If an series of images for a valve in which marker analysis is desired 
7 %to be performed begins from 'a010.tif' and ends at 'a100.tif', this code 
8 %converts the series to start at 'new_000.tif' and end at 'new_090.tif' 
9 
10 % Input the string portion of the image sequence before conversion 
11 % Input the first file number and the total number of files in the sequence 
12 stringer=input('Please enter string portion of file name: ','s'); 
13 number=input('Please enter first file number: ','s'); 






20 % A loop to change the title of the files to the new format until the last 
21 % file number is reached. 
22 for ind=num:num+num2, 
23 newnum=int2str(ind); 
24 if ind < 10 
25 title1=strcat(stringer,'00',newnum,tiffer); 


















1 %PROGRAM # 2 
2 %DATED - MARCH 29,2010 
3 %COMMENTED BY - MURALIDHAR PADALA 
4 %Program to digitize the markers and obtain their [X,Y] coordinates from 
5 %a sequence of images. This program loads every 10th image in a sequence of 
6 %images, and the markers are manually digitized on these frames. A maximum 
7 %of 32 markers can be tracked at a time on each frame. 
8 
9 % Input Arguments 
10 fprintf(1,'Welcome to the heart valve marker tracking interface...\n'); 
11 fprintf(1,'\n'); 
12 % Enter the number of markers to be tracked on each frame 
13 points=input('Please enter the number of points to be tracked (1-32): '); 
14 fprintf(1,'\n'); 
15 % Enter the number of images on which the markers need to tracked. The 
16 % number of frames are always a multiple of 10 + 1 as the index on the 
17 % image sequence starts from 000. 
18 last=input('Please enter the number of the last image to be processed \n(remember the 
total number must be a multiple of 10 plus 1 like 51 or 131): '); 
19 fprintf(1,'\n'); 




24 save set/info total points first last offset; 
25 clear all; 
26 load set/info; 
27 %ray=zeros(16,2,2); 
28 
29 % Parameters that set the acceleration for the markers in the image 
30 % sequence. acc1 is the acceleration parameter for the first half of the 
31 % images and acc2 is the acceleration parameter for the second half of the 
32 % images. The values for acc1 and acc2 fall within [-2,2] with negative 




37 %Number of first file 
38 firstnum=1; 
39 %Number of last file 
40 secondnum=total; 
41 
42 % A continuous loop to select every 10th image from the total image 
43 % sequence, and to track individual markers on each of these images. 








49 %Initialize number of points to be tracked 
50 % set image titles 
51 title1=sprintf('set/new_%d.tif',n1); 
52 
53 %Read images 
54 image1=imread(title1,'tiff'); 
55 



















75 % Loop to write the marker coordinates to a file titled 'raynew'. 
76 for val1=1:2, 

















1 %PROGRAM # 3 
2 %DATED - MARCH 29,2010 
3 %COMMENTED BY - MURALIDHAR PADALA 
4 %Program to read the digitized 2D markers and review them to assess the 
5 %accurary of marker tracking 
6 
7 % Input the raynewer dataset to read in the marker coordinates 
8 load set/raynewer; 
9 load set/info; 
10 
11 % Use acc1 and acc2 to either decelerate or accelerate the marker 
12 % progression between images. acc1 is to be used for the first half of the 





18 %load set/raynew; 
19 %raynewer=raynew; 
20 
21 for val1=1:2, 
22 for val2=1:points, 







29 for val1=1:2, 
30 for val2=1:points, 





























56 hold on; 
57 
58 for np=1:points, 
59 
60 figure(6); 
61 hold on; 




64 hold off; 
65 
66 P1=0; 
67 [P1 P2]=ginput(1); 






















1 % PROGRAM # 4 
2 % DATED - MARCH 29,2010 
3 % COMMENTED BY - MURALIDHAR PADALA 
4 % Program to transform the marker coordinates from the image coordinates 
5 % into actual X-Y cartesian coordinates. 
6 
7 load set/info; 







15 load set/raynewest; 
16 raynewest=round(raynewest); 
17 for n1=1:total, 































%PROGRAM # 5 
2 %This program computes 3D coordinates (X,Y,Z) from 2D coordinates (U,V) by 
Direct 
3 %Linear Transform (DLT). The program utilizes the functions dltfu.m and reconfu.m 
4 %originally written by Christoph Reinschmidt from the University of Calgary (). 
5 % 
6 %There are 4 phases: Loading the 2D data sets, Calibrating camera coordinates, 
7 %Computing 3D coordinates, and Writing output file. 
8 % 
9 %(1)Loading 2D data sets- The program will ask for 2 filenames. These are where 
10 %the 2D coordinates are stored for each camera. Press ENTER for defaults (acoord 
11 %& bcoord). 
12 % 
13 %(2)Calibrating camera coordinates- The program will ask for 3 filenames. These 
14 %are where the 2D coordinates of cube corners (acal & bcal) and known 3D 
15 %coordinates of cube (reference) are stored. 
16 % 
17 %(3)Computing 3D coordinates- X,Y,Z coordinates will be calculated using the 
18 %least squares method. 
19 % 
20 %(4)Writing output file- The program will ask for a filename for the output 
21 %(markers3d). The program will also ask for 2 pressure files (ventricular and 
22 %transmitral). The output will be in the following format: 
23 % Row 1: #frames, #markers 
24 % Row n: frame#, time, LVpressure, TMpressure 
25 % Row n+1: X,Y,Z 
26 
27 %_________________________________END HELP 
TEXT___________________________________ 
28 % 3D location calc using part of KineMat demo 
29 % with addition of writing text file 
30 % May 27, 2001 
31 %This revision allows the operator to input filenames to be used. 
32 %This revision allows the 2D marker data to be read from separate files. 
33 %This revision adds frame number data to input and output marker files. 
34 %This revision sets default file names. 
35 %This revision reformats the output file. 7/5/01 
36 
37 clc 
38 disp(' ') 
39 disp('3D RECONSTRUCTION') 
40 disp('This program executes the 3d reconstruction routine.') 
41 disp('camera coefficients will be calculated and location of markers') 
42 disp('can be extracted.') 




44 disp('Press ENTER for filename defaults.') 
45 disp(' ') 
46 disp(' ') 
47 
48 disp('_____(1) LOADING 2D DATA SET _____') 
49 disp(' ') 
50 filename2dA=input('Enter the filename of the 2D marker coordinates for camera A 
(e.g. 
acoord.txt)> ', 's'); 
51 filename2dB=input('Enter the filename of the 2D marker coordinates for camera B 
(e.g. 
bcoord.txt)> ', 's'); 
52 if isempty(filename2dA) filename2dA='acoord.txt'; end %default file names 
53 if isempty(filename2dB) filename2dB='bcoord.txt'; end 
54 
55 disp(' ') 
56 disp('Loading marker data...') 
57 disp(' ') 
58 d1=load(filename2dA); d2=load(filename2dB); 
59 
60 %storing the frame numbers (entered in the first row of the data sets) 
61 %and removing the row from the matrix 
62 frmlim=[d1(1,:); d2(1,:)]; %row1 contains frame limits 
for camera1, row2 for camera2 
63 d1=d1(2:size(d1,1),:); d2=d2(2:size(d2,1),:); 
64 
65 mkrnum=size(d2,1)/(frmlim(2,2)-frmlim(2,1)+1); %mrknum is the number of markers 
per 
frame (i.e. 9, 16) 
66 
67 %cropping the larger matrix; matrices will not be the same size if a camera cannot see 
all markers 
68 delta=(frmlim(1,:)-frmlim(2,:))*mkrnum; %delta is the difference between 
rows 
69 
70 if delta(1) < 0 %the next 2 if statements 






76 if delta(2) > 0 %this probably won't ever be 









82 frmlim=[max(frmlim(:,1)) min(frmlim(:,2))]; %redefine new frame limits 
83 frmnum=frmlim(2)-frmlim(1)+1; %frmnum is the number of 
frames 
84 
85 D=[d1 d2]; 
86 disp('done') 
87 disp(' ') 
88 disp(' ') 
89 
90 disp('_____(2) NORMALIZING CAMERA COORDINATES _____') 
91 disp(' ') 
92 filenameAcube=input('Enter the filename of the first calibration set (e.g. acal.txt)> 
', 's'); 
93 filenameBcube=input('Enter the filename of the second calibration set (e.g. bcal.txt)> 
', 's'); 
94 filenameref=input('Enter the filename of the reference coordinates (e.g. reference. 
txt)> ', 's'); 
95 if isempty(filenameAcube) filenameAcube='acal.txt'; end 
96 if isempty(filenameBcube) filenameBcube='bcal.txt'; end 
97 if isempty(filenameref) filenameref='reference.txt'; end 
98 
99 disp(' ') 
100 disp('Loading calibration data and computing DLT coefficients...') 





105 disp(' ') 
106 disp('done') 
107 disp(' ') 
108 disp(' ') 
109 
110 disp('_____(3) 3D RECONSTRUCTION _____') 
111 disp(' ') 
112 disp('3D reconstruction of marker coordinates using DLT coefficients...') 









119 %disp(' ') 
120 disp('Press any key to continue.') 
121 pause 
122 disp(' ') 
123 disp(' ') 
124 
125 disp('_____(4) WRITING OUTPUT FILE _____'); 
126 disp(' ') 
127 %OUTPUT filename 
128 filename3d=input('Enter the filename for the OUTPUT (e.g. markers3D.txt)> ','s'); 
129 if isempty(filename3d) filename3d='markers3D.txt'; end 
130 
131 %Reading LV and TM pressure data 
132 filenamePV=input('Enter the filename of the ventricular pressure data (e.g. 
LVpq.txt)> 
','s'); 
133 if isempty(filenamePV) filenamePV='LVpq.txt'; end %default filename 
134 PV=load(filenamePV); 
135 
136 filenameTM=input('Enter the filename of the transmitral pressure data (e.g. 
TMpq.txt)> 
','s'); 
137 if isempty(filenameTM) filenameTM='TMpq.txt'; end %default filename 
138 TM=load(filenameTM); 
139 disp(' '); 
140 
141 %SYNCHRONIZE pressure 
142 for h=frmlim(1):frmlim(2) 
143 %P=[frame# time LVpressure TMpressure]; 
144 P(h-frmlim(1)+1,:)=[h PV(mod(h,250)*2+1,:) TM(mod(h,250)*2+1,2)]; 
145 end; 
146 
147 %WRITE the first row: [# of frames, # of markers]; 
148 [tempfile] = fopen(filename3d, 'wt'); 
149 count = fprintf(tempfile, '%d %d\n', frmnum, mkrnum); 
150 
151 %WRITE sets of data for each frame 
152 [tempfile] = fopen(filename3d, 'at'); 
153 for f=1:frmnum 
154 count = fprintf(tempfile, '\n%d %f %f %f\n', P(f,:)); 
155 Htemp=H((1+(f-1)*mkrnum):(f*mkrnum),1:3); 








161 disp(sprintf('Output is in %s.', filename3d)) 
162 disp('Please see help file for formatting.'); 
163 disp(' ') 
164 
165 disp('_____END OF PROGRAM _____') 
166 disp(' ') 
167 
1 function [H] = reconfu(A,L) 
2 %function [H] = reconfu(A,L) 
3 % Description: Reconstruction of 3D coordinates with the use local (camera 
4 % coordinates and the DLT coefficients for the n cameras). 
5 % Input: - A file containing DLT coefficients of the n cameras 
6 % [a1cam1,a1cam2...;a2cam1...] 
7 % - L camera coordinates of points 
8 % [xcam1,ycam1,xcam2,ycam2...;same at time 2] 
9 % Output: - H global coordinates, residuals, cameras used 
10 % [Xt1,Yt1,Zt1,residt1,cams_used@t1...; same for t2] 
11 % Author: Christoph Reinschmidt, HPL, The University of Calgary 
12 % Date: September, 1994 
13 % Last change: November 29, 1996 
14 % Version: 1.1 
15 
16 n=size(A,2); 
17 % check whether the numbers of cameras agree for A and L 
18 if 2*n~=size(L,2); disp('the # of cameras given in A and L do not agree') 




23 H(size(L,1),5)=[0]; % initialize H 
24 
25 % ________Building L1, L2: L1 * G (X,Y,Z) = L2________________________ 
26 
27 for k=1:size(L,1) %number of time points 
28 q=[0]; L1=[]; L2=[]; % initialize L1,L2, q(counter of 'valid' cameras) 
29 for i=1:n %number of cameras 
30 x=L(k,2*i-1); y=L(k,2*i); 
31 if ~(isnan(x) | isnan(y)) % do not construct l1,l2 if camx,y=NaN 
32 q=q+1; 
33 L1([q*2-1:q*2],:)=[A(1,i)-x*A(9,i), A(2,i)-x*A(10,i), A(3,i)-x*A(11,i);... 








39 if (size(L2,1)/2)>1 %check whether enough cameras available (at least 2) 
40 g=L1\L2; h=L1*g; DOF=(size(L2,1)-3); 
41 avgres=sqrt(sum([L2-h].^2)/DOF); 
42 else 
43 g=[NaN;NaN;NaN]; avgres=[NaN]; 
44 end 
45 
46 %find out which cameras were used for the 3d reconstruction 
47 b=fliplr(find(sum(reshape(isnan(L(k,:)),2,size(L(k,:),2)/2))==0)); 
48 if size(b,2)<2; camsused=[NaN]; 











3 function [A,avgres] = dltfu(F,L,Cut) 
4 % Description: Program to calculate DLT coefficient for one camera 
5 % Note that at least 6 (valid) calibration points are needed 
6 % function [A,avgres] = dltfu(F,L,Cut) 
7 % Input: - F matrix containing the global coordinates (X,Y,Z) 
8 % of the calibration frame 
9 % e.g.: [0 0 20;0 0 50;0 0 100;0 60 20 ...] 
10 % - L matrix containing 2d coordinates of calibration 
11 % points seen in camera (same sequence as in F) 
12 % e.g.: [1200 1040; 1200 1360; ...] 
13 % - Cut points that are not visible in camera; 
14 % not being used to calculate DLT coefficient 
15 % e.g.: [1 7] -> calibration point 1 and 7 
16 % will be discarded. 
17 % This input is optional (default Cut=[]) 
18 % Output: - A 11 DLT coefficients 
19 % - avgres average residuals (measure for fit of dlt) 
20 % given in units of camera coordinates 
21 % 
22 % Author: Christoph Reinschmidt, HPL, The University of Calgary 
23 % Date: January, 1994 




25 % Version: 1.0 
26 % References: Woltring and Huiskes (1990) Stereophotogrammetry. In 
27 % Biomechanics of Human Movement (Edited by Berme and 
28 % Cappozzo). pp. 108-127. 
29 
30 if nargin==2; Cut=[]; end; 
31 
32 
33 m=size(F,1); Lt=L'; C=Lt(:); 
34 
35 for i=1:m 
36 B(2*i-1,1) = F(i,1); 
37 B(2*i-1,2) = F(i,2); 
38 B(2*i-1,3) = F(i,3); 
39 B(2*i-1,4) = 1; 
40 B(2*i-1,9) =-F(i,1)*L(i,1); 
41 B(2*i-1,10) =-F(i,2)*L(i,1); 
42 B(2*i-1,11) =-F(i,3)*L(i,1); 
43 B(2*i,5) = F(i,1); 
44 B(2*i,6) = F(i,2); 
45 B(2*i,7) = F(i,3); 
46 B(2*i,8) = 1; 
47 B(2*i,9) =-F(i,1)*L(i,2); 
48 B(2*i,10) =-F(i,2)*L(i,2); 
49 B(2*i,11) =-F(i,3)*L(i,2); 
50 end 
51 
52 % Cut the lines out of B and C including the control points to be discarded 

















APPENDIX # 3 
 






































































































































1. Kanani, M., et al., Late incompetence of the left atrioventricular valve after repair 
of atrioventricular septal defects: the morphologic perspective. J Thorac 
Cardiovasc Surg, 2006. 132(3): p. 640-6, 646 e1-3. 
 
2. Treasure, T. and A. Hollman, The surgery of mitral stenosis 1898-1948: why did 
it take 50 years to establish mitral valvotomy? Ann R Coll Surg Engl, 1995. 
77(2): p. 145-51. 
 
3. Warden, H.E., et al., Controlled cross circulation for open intracardiac surgery: 
physiologic studies and results of creation and closure of ventricular septal 
defects. J Thorac Surg, 1954. 28(3): p. 331-41; discussion, 341-3. 
 
4. Rose, J.C., et al., The hemodynamic alterations produced by a plastic valvular 
prosthesis for severe aortic insufficiency in man. J Clin Invest, 1954. 33(6): p. 
891-900. 
 
5. Swanson, J.S. and A. Starr, The ball valve experience over three decades. Ann 
Thorac Surg, 1989. 48(3 Suppl): p. S51-2. 
 
6. Gao, G., et al., Forty-year survival with the Starr-Edwards heart valve prosthesis. 
J Heart Valve Dis, 2004. 13(1): p. 91-6; discussion 96. 
 
7. Carpentier, A., Cardiac valve surgery--the "French correction". J Thorac 
Cardiovasc Surg, 1983. 86(3): p. 323-37. 
 
8. Levowitz, B.S., et al., Thrombus formation at the mitral annulus caused by 
prosthetic rings. An experimental study. Am J Surg, 1962. 103: p. 481-6. 
 
9. Anyanwu, A.C. and D.H. Adams, Etiologic classification of degenerative mitral 
valve disease: Barlow's disease and fibroelastic deficiency. Semin Thorac 
Cardiovasc Surg, 2007. 19(2): p. 90-6. 
 
10. Flameng, W., et al., Durability of mitral valve repair in Barlow disease versus 
fibroelastic deficiency. J Thorac Cardiovasc Surg, 2008. 135(2): p. 274-82. 
11. Magne, J., et al., Ischemic mitral regurgitation: a complex multifaceted disease. 
Cardiology, 2009. 112(4): p. 244-59. 
 
12. Murashita, T., et al., Left atrioventricular valve regurgitation after repair of 





13. Gorman, J.H., 3rd, et al., Annuloplasty ring selection for chronic ischemic mitral 
regurgitation: lessons from the ovine model. Ann Thorac Surg, 2003. 76(5): p. 
1556-63. 
 
14. Gorman, J.H., 3rd, et al., Distortions of the mitral valve in acute ischemic mitral 
regurgitation. Ann Thorac Surg, 1997. 64(4): p. 1026-31. 
 
15. Gorman, J.H., 3rd, et al., Infarct size and location determine development of 
mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg, 1998. 115(3): 
p. 615-22. 
 
16. Gorman, R.C., et al., Pathogenesis of acute ischemic mitral regurgitation in three 
dimensions. J Thorac Cardiovasc Surg, 1995. 109(4): p. 684-93. 
 
17. Tibayan, F.A., et al., Geometric distortions of the mitral valvular-ventricular 
complex in chronic ischemic mitral regurgitation. Circulation, 2003. 108 Suppl 1: 
p. II116-21. 
 
18. Timek, T.A., et al., Ischemia in three left ventricular regions: Insights into the 
pathogenesis of acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg, 
2003. 125(3): p. 559-69. 
 
19. Timek, T.A., et al., Annular versus subvalvular approaches to acute ischemic 
mitral regurgitation. Circulation, 2002. 106(12 Suppl 1): p. I27-I32. 
 
20. Sharma, P., Sushruta Samhita - English Translation of Text and Dalhana's 
Commentary with Critical Notes. 1983. 
 
21. Dwivedi, G. and S. Dwivedi, Sushruta - the Clinician - Teacher Par Excellence. 
Indian Journal of Chest Diseases and Allied Science, 2007(49): p. 243-244. 
 
22. Harvey, W., Exercitatio Anatomica de Motu Cordis et Sanguinis in Animalibus. 
1628. 
 
23. The Circulatory System.   [cited; Available from: 
http://en.wikipedia.org/wiki/Circulatory_system. 
 
24. The Human Heart.   [cited; Available from: http://www.cts.usc.edu/. 
 
25. Trilayered Human Myocardial Structure.   [cited; Available from: 
http://www.jdaross.cwc.net. 
 





27. Silverthorn, D.U., Human Physiology: an Integrated Approach. III ed. 2003: 
Pearson. 
 
28. Adams, D. The Mitral Valve.   [cited; Available from: www.mitralvalverepair.org. 
 
29. Anderson, R. and A. Becker, Anatomy of the Heart. 1982. 
 
30. Tsakiris, A.G., et al., Size and motion of the mitral valve annulus in anesthetized 
intact dogs. J Appl Physiol, 1971. 30(5): p. 611-8. 
 
31. Levine, R.A., et al., Three-dimensional echocardiographic reconstruction of the 
mitral valve, with implications for the diagnosis of mitral valve prolapse. 
Circulation, 1989. 80(3): p. 589-98. 
 
32. Fenoglio, J.J., Jr., et al., Canine mitral complex. Ultrastructure and 
electromechanical properties. Circ Res, 1972. 31(3): p. 417-30. 
 
33. Lam, J.H., et al., Morphology of the human mitral valve. I. Chordae tendineae: a 
new classification. Circulation, 1970. 41(3): p. 449-58. 
 
34. Kalmanson, D., The Mitral Valve - A Pluridisciplinary Approach. 1976: 
Publishing Sciences Group. 
 
35. Liao, J., et al., Ultrastructure of porcine mitral valve chordae tendineae. J Heart 
Valve Dis, 2009. 18(3): p. 292-9. 
 
36. Liao, J. and I. Vesely, A structural basis for the size-related mechanical 
properties of mitral valve chordae tendineae. J Biomech, 2003. 36(8): p. 1125-33. 
 
37. Liao, J. and I. Vesely, Relationship between collagen fibrils, glycosaminoglycans, 
and stress relaxation in mitral valve chordae tendineae. Ann Biomed Eng, 2004. 
32(7): p. 977-83. 
 
38. Liao, J. and I. Vesely, Skewness angle of interfibrillar proteoglycans increases 
with applied load on mitral valve chordae tendineae. J Biomech, 2007. 40(2): p. 
390-8. 
 
39. Kunzelman, K.S. and R.P. Cochran, Mechanical properties of basal and marginal 
mitral valve chordae tendineae. ASAIO Trans, 1990. 36(3): p. M405-8. 
 
40. Lim, K.O., Mechanical properties and ultrastructure of normal human tricuspid 





41. Lim, K.O. and D.R. Boughner, Mechanical properties of human mitral valve 
chordae tendineae: variation with size and strain rate. Can J Physiol Pharmacol, 
1975. 53(3): p. 330-9. 
 
42. Lim, K.O. and D.R. Boughner, Morphology and relationship to extensibility 
curves of human mitral valve chordae tendineae. Circ Res, 1976. 39(4): p. 580-5. 
 
43. Lim, K.O. and D.R. Boughner, Scanning electron microscopical study of human 
mitral valve chordae tendineae. Arch Pathol Lab Med, 1977. 101(5): p. 236-8. 
 
44. Lim, K.O., D.R. Boughner, and D.G. Perkins, Ultrastructure and mechanical 
properties of chordae tendineae from a myxomatous tricuspid valve. Jpn Heart J, 
1983. 24(4): p. 539-48. 
 
45. Sedransk, K.L., K.J. Grande-Allen, and I. Vesely, Failure mechanics of mitral 
valve chordae tendineae. J Heart Valve Dis, 2002. 11(5): p. 644-50. 
 
46. Ritchie, J., et al., The material properties of the native porcine mitral valve 
chordae tendineae: an in vitro investigation. J Biomech, 2006. 39(6): p. 1129-35. 
 
47. Ritchie, J., J.N. Warnock, and A.P. Yoganathan, Structural characterization of 
the chordae tendineae in native porcine mitral valves. Ann Thorac Surg, 2005. 
80(1): p. 189-97. 
 
48. Jimenez, J.H., et al., Mitral valve function and chordal force distribution using a 
flexible annulus model: an in vitro study. Ann Biomed Eng, 2005. 33(5): p. 557-
66. 
 
49. Jimenez, J.H., et al., Effects of papillary muscle position on chordal force 
distribution: an in-vitro study. J Heart Valve Dis, 2005. 14(3): p. 295-302. 
 
50. Jimenez, J.H., et al., Effects of a saddle shaped annulus on mitral valve function 
and chordal force distribution: an in vitro study. Ann Biomed Eng, 2003. 31(10): 
p. 1171-81. 
 
51. Yamauchi, T., et al., Evaluation of the mitral valve leaflet morphology after 
mitral valve reconstruction with a concept "coaptation length index". J Card Surg, 
2005. 20(5): p. 432-5. 
 
52. Yamauchi, T., et al., Evaluation of the mitral valve leaflet morphology after 
mitral valve reconstruction with a concept "coaptation length index". J Card Surg, 





53. Nolan, S.P., et al., In vivo studies of instantaneous blood flow across mitral ball-
valve prostheses: effects of cardiac output and heart rate on transvalvular energy 
loss. Ann Surg, 1969. 169(4): p. 551-9. 
 
54. Nolan, S.P., et al., The influence of atrial contraction and mitral valve mechanics 
on ventricular filing. A study of instantaneous mitral valve flow in vivo. Am Heart 
J, 1969. 77(6): p. 784-91. 
 
55. Tsakiris, A.G., et al., Sudden interruption of leaflet opening by ventricular 
contractions: a mechanism of mitral regurgitation. J Appl Physiol, 1976. 40(2): p. 
132-7. 
 
56. Eckert, C.E., et al., In vivo dynamic deformation of the mitral valve annulus. Ann 
Biomed Eng, 2009. 37(9): p. 1757-71. 
 
57. Sacks, M.S., et al., In-vivo dynamic deformation of the mitral valve anterior 
leaflet. Ann Thorac Surg, 2006. 82(4): p. 1369-77. 
 
58. Sacks, M.S., et al., Surface strains in the anterior leaflet of the functioning mitral 
valve. Ann Biomed Eng, 2002. 30(10): p. 1281-90. 
 
59. He, Z., et al., In vitro dynamic strain behavior of the mitral valve posterior leaflet. 
J Biomech Eng, 2005. 127(3): p. 504-11. 
 
60. Salisbury, P.F., C.E. Cross, and P.A. Rieben, Chorda Tendinea Tension. Am J 
Physiol, 1963. 205: p. 385-92. 
 
61. Einstein, D.R., et al., Non-linear fluid-coupled computational model of the mitral 
valve. J Heart Valve Dis, 2005. 14(3): p. 376-85. 
 
62. Kunzelman, K.S., et al., Finite element analysis of the mitral valve. J Heart Valve 
Dis, 1993. 2(3): p. 326-40. 
 
63. Kunzelman, K.S., et al., Anatomic basis for mitral valve modelling. J Heart Valve 
Dis, 1994. 3(5): p. 491-6. 
 
64. Kunzelman, K.S., D.R. Einstein, and R.P. Cochran, Fluid-structure interaction 
models of the mitral valve: function in normal and pathological states. Philos 
Trans R Soc Lond B Biol Sci, 2007. 362(1484): p. 1393-406. 
 
65. Castaneda, A., et al., Cardiac Surgery for the Neonate and Infant. 1 ed. 1994: 
Saunders. 
 
66. Lev, M., The architecture of the conduction system in congenital heart disease. II. 




67. Bharati, S., et al., The surgical anatomy of common atrioventricular orifice 
associated with tetralogy of Fallot, double outlet right ventricle and complete 
regular transposition. Circulation, 1980. 61(6): p. 1142-9. 
 
68. Bharati, S. and M. Lev, The spectrum of common atrioventricular orifice (canal). 
Am Heart J, 1973. 86(4): p. 553-61. 
 
69. Bharati, S., et al., Surgical anatomy of the atrioventricular valve in the 
intermediate type of common atrioventricular orifice. J Thorac Cardiovasc Surg, 
1980. 79(6): p. 884-9. 
 
70. Backer, C.L., R.D. Stewart, and C. Mavroudis, Overview: history, anatomy, 
timing, and results of complete atrioventricular canal. Semin Thorac Cardiovasc 
Surg Pediatr Card Surg Annu, 2007: p. 3-10. 
 
71. Kahn, D.R., et al., Recent results after repair of atrioventricular canal. J Thorac 
Cardiovasc Surg, 1977. 73(3): p. 413-5. 
 
72. Midgley, F.M., et al., Experience with repair of complete atrioventricular canal. 
Ann Thorac Surg, 1980. 30(2): p. 151-9. 
 
73. Rastelli, G., J.W. Kirklin, and J.L. Titus, Anatomic observations on complete form 
of persistent common atrioventricular canal with special reference to 
atrioventricular valves. Mayo Clin Proc, 1966. 41(5): p. 296-308. 
 
74. Rastelli, G.C., et al., Surgical repair of the complete form of persistent common 
atrioventricular canal. J Thorac Cardiovasc Surg, 1968. 55(3): p. 299-308. 
 
75. Rastelli, G.C., P.A. Ongley, and D.C. McGoon, Surgical repair of complete 
atrioventricular canal with anterior common leaflet undivided and unattached to 
ventricular septum. Mayo Clin Proc, 1969. 44(5): p. 335-41. 
 
76. Rastelli, G.C., P.A. Ongley, and J.L. Titus, Ventricular septal defect of 
atrioventricular canal type with straddling right atrioventricular valve and mitral 
valve deformity. Circulation, 1968. 37(5): p. 816-25. 
 
77. Rastelli, G.C., W.H. Weidman, and J.W. Kirklin, Surgical Repair of the Partial 
Form of Persistent Common Atrioventricular Canal, with Special Reference to the 
Problem of Mitral Valve Incompetence. Circulation, 1965. 31: p. SUPPL 1:31-5. 
 
78. Barratt-Boyes, B.G. and J.M. Neutze, Primary repair of tetralogy of Fallot in 
infancy using profound hypothermia with circulatory arrest and limited 
cardiopulmonary bypass: a comparison with conventional two stage 




79. Carpentier, A., Surgical anatomy and management of the mitral components of 
atrioventricular canal defects., ed. R. Anderson and E. Shinebourne. 1978, 
Pediatric Cardiology: Churchill Livingstone. 
 
80. Kohl, T. and N.H. Silverman, Comparison of cleft and papillary muscle position 
in cleft mitral valve and atrioventricular septal defect. Am J Cardiol, 1996. 77(2): 
p. 164-9. 
 
81. Gillinov, A.M., et al., Durability of mitral valve repair for degenerative disease. J 
Thorac Cardiovasc Surg, 1998. 116(5): p. 734-43. 
 
82. Organization, W.H., Rheumatic Fever and Rheumatic Heart Disease - Report of a 
WHO Expert Cosultation. 2001, World Health Organization. 
 
83. Tyrrell, P.N., et al., Rheumatic Disease and Carotid Intima-Media Thickness. A 
Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol. 
 
84. Barlow, J.B. and W.A. Pocock, Mitral valve prolapse, the specific billowing 
mitral leaflet syndrome, or an insignificant non-ejection systolic click. Am Heart 
J, 1979. 97(3): p. 277-85. 
 
85. Barlow, J.B. and W.A. Pocock, The significance of aortic ejection systolic 
murmurs. Am Heart J, 1962. 64: p. 149-58. 
 
86. Barlow, J.B. and W.A. Pocock, The significance of late systolic murmurs and 
mid-late systolic clicks. Md State Med J, 1963. 12: p. 76-7. 
 
87. Barlow, J.B. and W.A. Pocock, The isolated systolic murmur. S Afr Med J, 1965. 
39(39): p. 909-18. 
 
88. Criley, J.M., et al., Prolapse of the mitral valve: clinical and cine-
angiocardiographic findings. Br Heart J, 1966. 28(4): p. 488-96. 
 
89. Carpentier, A., et al., Reconstructive surgery of mitral valve incompetence: ten-
year appraisal. J Thorac Cardiovasc Surg, 1980. 79(3): p. 338-48. 
 
90. Grau, J.B., et al., The genetics of mitral valve prolapse. Clin Genet, 2007. 72(4): 
p. 288-95. 
 
91. Pedersen, L.G., et al., Transcription levels of endothelin-1 and endothelin 
receptors are associated with age and leaflet location in porcine mitral valves. J 
Vet Med A Physiol Pathol Clin Med, 2007. 54(3): p. 113-8. 
 
92. Pedersen, L.G., et al., Increased expression of endothelin B receptor in static 




93. Gazoni, L.M., et al., A simplified approach to degenerative disease: triangular 
resections of the mitral valve. Ann Thorac Surg, 2007. 83(5): p. 1658-64; 
discussion 1664-5. 
 
94. Grossi, E.A., et al., Early results of posterior leaflet folding plasty for mitral valve 
reconstruction. Ann Thorac Surg, 1998. 65(4): p. 1057-9. 
 
95. Nakajima, M., et al., Leaflet folding plasty combined with annular plication for 
mitral valve repair. Ann Thorac Surg, 2004. 77(3): p. 1103-4. 
 
96. Falk, V., et al., How does the use of polytetrafluoroethylene neochordae for 
posterior mitral valve prolapse (loop technique) compare with leaflet resection? 
A prospective randomized trial. J Thorac Cardiovasc Surg, 2008. 136(5): p. 1205; 
discussion 1205-6. 
 
97. Zussa, C., et al., Surgical technique for artificial mitral chordae implantation. J 
Card Surg, 1991. 6(4): p. 432-8. 
 
98. Maisano, F., et al., The edge-to-edge technique: a simplified method to correct 
mitral insufficiency. Eur J Cardiothorac Surg, 1998. 13(3): p. 240-5; discussion 
245-6. 
 
99. Krause, A.H., et al., Early experience with mitral valve reconstruction for mitral 
insufficiency. Am J Surg, 1991. 161(5): p. 563-6. 
 
100. Salati, M., et al., Correction of anterior mitral prolapse. Results of chordal 
transposition. J Thorac Cardiovasc Surg, 1992. 104(5): p. 1268-73. 
 
101. Spencer, F.C., et al., Experiences with the Carpentier techniques of mitral valve 
reconstruction in 103 patients (1980-1985). J Thorac Cardiovasc Surg, 1985. 
90(3): p. 341-50. 
 
102. Fornes, P., et al., Correlation between clinical and histologic patterns of 
degenerative mitral valve insufficiency: a histomorphometric study of 130 excised 
segments. Cardiovasc Pathol, 1999. 8(2): p. 81-92. 
 
103. Filsoufi, F. and A. Carpentier, Principles of reconstructive surgery in 
degenerative mitral valve disease. Semin Thorac Cardiovasc Surg, 2007. 19(2): p. 
103-10. 
 
104. Braunberger, E., et al., Very long-term results (more than 20 years) of valve 
repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. 




105. Hueb, A.C., et al., Ventricular remodeling and mitral valve modifications in 
dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc 
Surg, 2002. 124(6): p. 1216-24. 
 
106. Kaji, S., et al., Annular geometry in patients with chronic ischemic mitral 
regurgitation: three-dimensional magnetic resonance imaging study. Circulation, 
2005. 112(9 Suppl): p. I409-14. 
 
107. Levine, R.A. and E. Schwammenthal, Ischemic mitral regurgitation on the 
threshold of a solution: from paradoxes to unifying concepts. Circulation, 2005. 
112(5): p. 745-58. 
 
108. Ahmad, R.M., et al., Annular geometry and motion in human ischemic mitral 
regurgitation: novel assessment with three-dimensional echocardiography and 
computer reconstruction. Ann Thorac Surg, 2004. 78(6): p. 2063-8; discussion 
2068. 
 
109. Watanabe, N., et al., Geometric deformity of the mitral annulus in patients with 
ischemic mitral regurgitation: a real-time three-dimensional echocardiographic 
study. J Heart Valve Dis, 2005. 14(4): p. 447-52. 
 
110. Watanabe, N., et al., Quantitation of mitral valve tenting in ischemic mitral 
regurgitation by transthoracic real-time three-dimensional echocardiography. J 
Am Coll Cardiol, 2005. 45(5): p. 763-9. 
 
111. Watanabe, N., et al., Mitral annulus flattens in ischemic mitral regurgitation: 
geometric differences between inferior and anterior myocardial infarction: a 
real-time 3-dimensional echocardiographic study. Circulation, 2005. 112(9 
Suppl): p. I458-62. 
 
112. He, S., et al., Integrated mechanism for functional mitral regurgitation: leaflet 
restriction versus coapting force: in vitro studies. Circulation, 1997. 96(6): p. 
1826-34. 
 
113. He, S., et al., Mitral valve compensation for annular dilatation: in vitro study into 
the mechanisms of functional mitral regurgitation with an adjustable annulus 
model. J Heart Valve Dis, 1999. 8(3): p. 294-302. 
 
114. Tahta, S.A., et al., Outcome after mitral valve repair for functional ischemic 
mitral regurgitation. J Heart Valve Dis, 2002. 11(1): p. 11-8; discussion 18-9. 
 
115. Agricola, E., et al., Echocardiographic classification of chronic ischemic mitral 
regurgitation caused by restricted motion according to tethering pattern. Eur J 




116. Srichai, M.B., et al., Ischemic mitral regurgitation: impact of the left ventricle and 
mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac 
Surg, 2005. 80(1): p. 170-8. 
 
117. Salgo, I.S., et al., Effect of annular shape on leaflet curvature in reducing mitral 
leaflet stress. Circulation, 2002. 106(6): p. 711-7. 
 
118. Votta, E., et al., The Geoform disease-specific annuloplasty system: a finite 
element study. Ann Thorac Surg, 2007. 84(1): p. 92-101. 
 
119. Bhattacharya, S. and Z. He, Role of annulus tension in annular dilatation. J Heart 
Valve Dis, 2009. 18(5): p. 481-7. 
 
120. Schievano, S., et al., Percutaneous mitral valve dilatation: single balloon versus 
double balloon. A finite element study. J Heart Valve Dis, 2009. 18(1): p. 28-34. 
 
121. Frakes, D.H., et al., Application of an adaptive control grid interpolation 
technique to morphological vascular reconstruction. IEEE Trans Biomed Eng, 
2003. 50(2): p. 197-206. 
 
122. Smith, D.B., et al., Surface geometric analysis of anatomic structures using 
biquintic finite element interpolation. Ann Biomed Eng, 2000. 28(6): p. 598-611. 
 
123. Takahashi, K., et al., Three-dimensional echocardiography improves the 
understanding of the mechanisms and site of left atrioventricular valve 
regurgitation in atrioventricular septal defect. J Am Soc Echocardiogr, 2006. 
19(12): p. 1502-10. 
 
124. Wetter, J., et al., Closure of the zone of apposition at correction of complete 
atrioventricular septal defect improves outcome. Eur J Cardiothorac Surg, 2000. 
17(2): p. 146-53. 
 
125. Acar, P., et al., Three-dimensional echocardiographic analysis of valve anatomy 
as a determinant of mitral regurgitation after surgery for atrioventricular septal 
defects. Am J Cardiol, 1999. 83(5): p. 745-9. 
 
126. Honjo, O., et al., Midterm outcome of mitral valve repair for congenital mitral 
regurgitation in infants and children. Interact Cardiovasc Thorac Surg, 2006. 
5(5): p. 589-93. 
 
127. Barlow, J.B. and C.K. Bosman, Aneurysmal protrusion of the posterior leaflet of 
the mitral valve. An auscultatory-electrocardiographic syndrome. Am Heart J, 





128. Dreyfus, G.D., et al., Posterior leaflet preservation in mitral valve prolapse: a 
new approach to mitral repair. J Heart Valve Dis, 2006. 15(4): p. 528-30. 
 
129. Perier, P., et al., Toward a new paradigm for the reconstruction of posterior 
leaflet prolapse: midterm results of the "respect rather than resect" approach. 
Ann Thorac Surg, 2008. 86(3): p. 718-25; discussion 718-25. 
 
130. Cagli, K., A simple method of making artificial chordal loops for mitral valve 
repair. Ann Thorac Surg. 89(2): p. e12-4. 
 
131. Smith, J.M. and H. Stein, Endoscopic placement of multiple artificial chordae 
with robotic assistance and nitinol clip fixation. J Thorac Cardiovasc Surg, 2008. 
135(3): p. 610-4. 
 
132. Seeburger, J., T. Kuntze, and F.W. Mohr, Gore-tex chordoplasty in degenerative 
mitral valve repair. Semin Thorac Cardiovasc Surg, 2007. 19(2): p. 111-5. 
 
133. Chen, L., F.C. Yin, and K. May-Newman, The structure and mechanical 
properties of the mitral valve leaflet-strut chordae transition zone. J Biomech 
Eng, 2004. 126(2): p. 244-51. 
 
134. Drury, N.E. and S.A. Nashef, Outcomes of cardiac surgery in the elderly. Expert 
Rev Cardiovasc Ther, 2006. 4(4): p. 535-42. 
 
135. Gammie, J.S., S.T. Bartlett, and B.P. Griffith, Small-incision mitral valve repair: 
safe, durable, and approaching perfection. Ann Surg, 2009. 250(3): p. 409-15. 
 
136. Gillinov, A.M., et al., Valve repair versus valve replacement for degenerative 
mitral valve disease. J Thorac Cardiovasc Surg, 2008. 135(4): p. 885-93, 893 e1-
2. 
 
137. Hanania, G. and J.P. Maroni, [Operative risk of heart valve surgery after 80 
years]. Ann Cardiol Angeiol (Paris), 2005. 54(6): p. 339-43. 
 
138. Lee, R., et al., Mitral valve repair in the elderly: operative risk for patients over 
70 years of age is acceptable. J Cardiovasc Surg (Torino), 2003. 44(2): p. 157-61. 
 
139. Maisano, F., et al., Quality of life of elderly patients following valve surgery for 
chronic organic mitral regurgitation. Eur J Cardiothorac Surg, 2009. 36(2): p. 
261-6; discussion 266. 
 
140. Levine, R.A., et al., The relationship of mitral annular shape to the diagnosis of 




141. Flachskampf, F.A., et al., Analysis of shape and motion of the mitral annulus in 
subjects with and without cardiomyopathy by echocardiographic 3-dimensional 
reconstruction. J Am Soc Echocardiogr, 2000. 13(4): p. 277-87. 
 
142. Jimenez, J.H., et al., A saddle-shaped annulus reduces systolic strain on the 
central region of the mitral valve anterior leaflet. J Thorac Cardiovasc Surg, 
2007. 134(6): p. 1562-8. 
 
143. Watanabe, N., et al., Geometric differences of the mitral valve tenting between 
anterior and inferior myocardial infarction with significant ischemic mitral 
regurgitation: quantitation by novel software system with transthoracic real-time 
three-dimensional echocardiography. J Am Soc Echocardiogr, 2006. 19(1): p. 71-
5. 
 
144. Borger, M.A., et al., Initial results of the chordal-cutting operation for ischemic 
























 Sai Muralidhar Padala, was born on December 23, 1982 in Hyderabad, Andhra 
Pradesh, INDIA. He obtained his Secondary School Certificate from Sri Satya Sai Vidya 
Vihar in 1998, completed Intermediate from Little Flower Junior College in 2000, a 
Bachelor of Engineering (B.E) degree in Mechanical Engineering from Osmania 
University, India in 2004 and a Master of Science (M.S) degree in Mechanical 
Engineering from Georgia Institute of Technology in 2008. Prior to joining Georgia 
Institute of Technology, Murali worked as a research intern in 2002 in the Integrated 
Combined Cycle Power Plant (IGCCPP) division of Bharat Heavy Electricals Limited 
and completed a one-year competitive internship in 2004 in the Hypersonic Propulsion 
Division of the Indian Defense Research and Development Organization. At Georgia 
Institute of Technology, he received the American Heart Association Pre-doctoral 
Fellowship in Cardiovascular Disease in 2008 and the Biomedical Engineering Gandy 
Diaz Teaching Fellowship in 2009. His hobbies include watercolor painting, 
photography, creative writing, travelling and outdoor activities.  
 
 
 
